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Abstract
MicroRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression
through RNA interference (RNAi). Human miRNAs are generated via a series of enzymatic
processing steps. In particular, in the cytoplasm, the precursor miRNA (pre-miRNA) is recog-
nized and cleaved by a complex containing the RNase III enzyme Dicer and several non-catalytic
accessory proteins. HIV TAR element-binding protein (TRBP) is a constituent of the Dicer com-
plex, which augments complex stability, has effects on the cleavage kinetics and on the cleavage
site and potentially functions in substrate recognition and product transfer to the RNA-induced
silencing complex (RISC). TRBP is composed of three double stranded RNA binding domains
(dsRBDs). The RNA binding region of TRBP is composed of the first two dsRBDs and an unchar-
acterized interdomain region. The present study reports the in vitro biophysical characterization
of the RNA binding region of TRBP in the apo state and in the RNA bound state with the two
successive cytoplasmic precursors of the oncogenic human microRNA miR-155, the hairpin pre-
miR-155 and the related Dicer product miR-155/miR-155* duplex. The study shows that the
RNA binding region of TRBP is monomeric and comprises two independent double-stranded
RNA-binding domains connected by a 60 residues flexible linker. The first dsRBD, uncharacter-
ized previously in solution, undergoes a full folding/unfolding equilibrium in a wide range of
physico-chemical conditions. The two first dsRBDs of TRBP can interact with one microRNA
precursor and two RNA binding regions can interact with one precursor molecule. The RNA-
binding region of TRBP interacts with both pre-miR-155 and miR-155/miR-155* duplex with
similar affinities. In the complex with one RNA binding region of TRBP bound to either pre-
miR-155 or miR-155/miR-155* duplex, no evidence of contact between the two dsRBDs were
observed and the protein interacts with both precursors via the same protein binding surface.
The data presented here suggest that the RNA binding region of TRBP can play a role before and
after processing of pre-miRNAs by Dicer, including in the RISC loading complex.
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Motivations
General motivations Various aspects have guided the choice of the system studied in the
present work. First, at the time of the subject definition, microRNAs (miRNAs) represented a
recent field discovered a decade ago that revolutionized the conception of gene regulation and
the design of in vitro gene expression experiments. MiRNAs are small RNAs that regulate post
transciptionaly gene expression of most cell mechanisms in a wide variety of multicellular eu-
karyotes. The clear involvement of miRNAs in cancers has been proved for a wide variety of
neoplasias and as a result miRNAs have started to gain interest for potential applications in
oncology. As a consequence of these interests over the past decade, there has been a drive to
understand the biology of the regulation by miRNAs and the structural biology of miRNA bio-
genesis. For the latter goal, X-ray crystallography, electron microscopy and NMR spectroscopy
have been used to get insight into some complexes involved in the biogenesis. However most of
the structural data have been obtained on unbound parts of the proteins. There was a general
lack of structure and dynamics studies of complexes allowing to describe the location of the com-
ponents, to determine how one component interacts with others and to understand how these
complexes work in miRNA biogenesis.
In particular, one key protein called TRBP is part of all the cytoplasmic complexes involved in
miRNA biogenesis and this has attracted our attention. It is thought to be involved in the recog-
nition of miRNA precursors, which seems a challenge since there are more than 1000 different
precursors in humans. Many biochemical studies have sought to explore the mechanism for RNA
recognition by TRBP or examine how TRBP associates with other proteins, in particular with the
enzyme Dicer. Structural studies of TRBP have elucidated the isolated 3D structures of the first
two double stranded RNA binding domains (dsRBDs) as well as the second dsRBD in complex
with a short siRNA duplex. Negative stain electron microscopy studies of miRNA biosynthesis
complexes containing TRBP have also been reported, however the level of resolution was not yet
sufficient to accurately describe the localization of TRBP in these complexes or to determine how
it interacts with other components. Thus despite these efforts, the exact role and mechanism of
TRBP in human miRNA precursor recognition and processing remained unclear. In particular
the way the multiple RNA binding domains could interact with the miRNA precursors was not
known, neither the stoichiometry of these complexes. Some of the main questions were: Are all
the domains involved? Is there one precursor binding each domain? Where do the domains bind
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on the miRNA precursors? etc. Moreover, some properties of the protein within the biogenesis
pathway could not be explained with the limited structural data available.
Additional properties of TRBP made it an interesting protein to study. It contains double
stranded RNA binding domains, a fold which is widely present in the proteins involved in
miRNA biogenesis in all the organisms possessing this biological pathway. Various studies have
demonstrated an important variability of the behavior and roles of these domains. Despite it
was first supposed that these domains were all equivalent, it is now clear that each one has a
special set of properties. As more and more dsRBDs are studied, a pleiotropic character of the
behavior and dynamics of these domains is emerging. Thus, working on TRBP was also attrac-
tive because of the possibility to discover new behaviors and to expand the knowledge on these
variable domains.
Personal motivations In addition to the general motivations that led me to choice this thesis
theme, I had a strong methodological interest. I had previous experience in proteomics, an active
field that can provide a wide, multidimensional view of the states of cells. Despite lots of infor-
mation and discoveries can result from this field, I’ve been frustrated that it was often impossible
to explain mechanistically what was going on without high resolution, site-specific information
on the macromolecules. This is the main goal of structural biology. One of the most used tech-
nique able to provide high resolution structure of macromolecules - the study of x-ray diffraction
by molecules crystals - is sometime inducing states in the crystal that are irrelevant in solution.
Taking into account in particular that many proteins involved in miRNA biogenesis, and in par-
ticular TRBP, were predicted from their sequence to be highly flexible, it was necessary to perform
the studies in solution. Liquid state NMR spectroscopy appeared as a method of choice for tack-
ling human miRNA biogenesis complexes in solution with high precision information. However,
this technique couldn’t easily answer all the questions on this complex. In order to get relevant in
depth information on the system, it was required to use multiple complementary and compatible
in solution biophysical techniques.
Thesis contents The present manuscript classically starts (part I) by a review of the available
data of the biological system studied and analogous systems in the small silencing RNA context
in multicellular organisms. The second part is devoted to an introduction of the biophysical tech-
niques used with the aim to explicit the information required for an appropriate understanding
of the experimental work performed. The practical implementation of these techniques adopted
in this work in also included in this part. The next part (part III) presents the production strategy
of the miRNA binding region of TRBP and of the cytoplasmic precursors of the oncogenic hu-
man miRNA miR-155. The biophysical characterization of the isolated protein and RNA macro-
molecules are then presented (part IV), before the macroscopic and site specific studies of the
RNA binding region of TRBP with miR-155 precursors.
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Part I
Polymorphism and pleiotropy of dsRBDs in mi/siRNA biogenesis
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This part aims to present the context of the work performed in this thesis by critically reviewing
the literature and analyzing some structural data related to the role of double stranded RNA
Binding Domains (dsRBD) in the biogenesis of two classes of small silencing RNAs, microRNAs
(miRNAs) and short interfering RNAs (siRNAs) in multicellulars. The presentation is split in
four chapters, which will go from the most general considerations to the more detailed ones on
dsRBDs :
- Chapter 1: General presentation of miRNAs and small silencing RNAs. The chapter sets
the rich biological context by focusing on the microRNAs and siRNAs as post-transcriptional
regulators in multicellulars.
- Chapter 2: Roles of dsRBD containing proteins (dsRBP) in miRNA and siRNA biogenesis.
This is the biological functional context of the work performed in this thesis. The requirement
of multiple proteins containing dsRBDs in mi/siRNA biogenesis is underlined. The chapter
presents the very diverse roles of each dsRBP protein along the mi/siRNA pathways, includ-
ing the network of interactions, but without mechanistic details. This chapter will underline the
abundance of dsRBDs at the different stage in the biogenesis of miRNAs and also the variety of
miRNA pathways (i.e. diverse substrates to be recognized) in different model organisms. This
chapter is required for an appropriate biological understanding of chapters 3 and especially 4.
- Chapter 3: Sequence and fold comparison of the dsRBDs involved in miRNA and siRNA
biogenesis. The second chapter is devoted to a comparison of the chemical and structural features
of dsRBDs involved in microRNA biogenesis, including original statistical analyzes on dsRBDs
structures underlying the polymorphism of dsRBDs in mi/siRNA biogenesis. A partition of
dsRBDs fold in their apo state into 4 classes in proposed and discussed.
- Chapter 4: Comparison of specific roles of dsRBDs in dsRBP mi/siRNA biogenesis proteins.
The comparison is made transversally for different organisms and pathways to emphasize the
pleiotropy of dsRBDs in mi/siRNA biogenesis. Such a review on the role of dsRBDs in mul-
ticellular miRNA and siRNA biogenesis is original and was not performed before. It suggests
multiple research directions.
To avoid repetition and to better understand the biological context of this thesis, the data
specific to the protein TRBP studied in this thesis is spread along chapters 2, 3 and 4.
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Chapter 1
MicroRNAs and short interfering RNA silencing in multicellulars
This chapter focuses on the main types of microRNA and siRNA biogenesis pathways in mul-
ticellulars, underlying the similarities of the different pathways and in particular the abundance
of dsRBDs related to these pathways. Prokaryotes also have an RNAi based mechanism but it
is only analogous (not homologous) to the one of eukaryotes (245). The present bibliographical
review only focuses on the RNAi mechanisms in eukaryotes.
1.1 History and definitions in the small regulatory RNAs world
Discovery of a gene regulation mechanism based of RNA interference in multicellulars. Be-
fore the start of the 1990s, the known mechanisms of gene regulation could be partitioned into
three subsets: pretranscription regulation of the chromatin state, transcription regulation and
translation regulation. After various experiments in the 1990s, when some groups managed to
inhibit genes by dsRNAs, in 1993 a group found in Caenorhabditis elegans (C. elegans) that the gene
lin-4 codes for a small RNA that inhibit the expression of the product of the gene lin-14 via an
antisense RNA/RNA interaction (164). From 2000, progressive identification of small regulatory
RNAs present in different plant and animal species proved the existence of a relevant general
phenomenon. These small RNAs of about 20 to 30 nucleotides mediate what is called RNA
interference or RNA silencing. This phenomenon is the inhibition of the expression of a specific
messenger RNA, either by degradation of the RNA or by the inhibition of its translation, in which
a small-RNA/mRNA base pairing is involved. The two terms silencing and interference coexists
because an historical distinction that appeared to be irrelevant. The small regulatory RNA will
be generically called small silencing RNA from now, an explicit expression already employed in
the literature and with the advantage that it does not match with the ones devoted to previously
recognized subgroups
Building a partition of the plethora of small silencing RNAs Deep sequencing studies in
many eukaryotes have led to the discovery of a plethora of small silencing RNA. A tendency to
name apparently original ones have led to a profusion of names for subgroups of small silencing
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RNAs. The main groups are called microRNA (miRNAs), small interfering RNA (siRNA) and
piwiRNAs (piRNAs). However, even with this simple classification, the definition of the first two
classes are not consistent between different works and appear to strongly depends on particular-
ities of the model organisms that is the subject of the article giving the definition. For instance
the partial base pairing complementarity of mammalian microRNAs with their messenger RNA
(mRNA) target is often used as a definition in mammals to distinguish them from siRNA with
a perfect base pairing complementarity. However in mammals a few so called miRNAs are rec-
ognized to fully base pair with their target and in plants, miRNA base paring is almost always
perfect (59). As a result, it seems important to assess at one stage whether the useful definition
from the past or only valid in one species have still a value in light of the whole set of discover-
ies. Many variables are inconsistently used to define the different types of small silencing RNAs
in the literature: their global origin (endogenous or exogenous), the structure of the precursor
(duplex, hairpin...), the subset of protein required for their biogenesis, the length of the small
silencing RNA and the extension of base pairing. The three main recognized classes of small
silencing RNAs have similar length between 19 and 25 for miRNAs, 20 to 25 for siRNAs, and 26
to 31 for piRNAs and all trigger an mRNA silencing (degradation or translation inhibition) me-
diated by a complex containing a protein of the Ago type. It could appear tempting to unify all
these small regulatory RNA in a larger group. However, these differences in biogenesis seem to
have functional meaning. In mammals, miRNAs are known to be post transcriptional regulators
of gene expression. Endo-siRNA pathway in mammals seems required for oocyte maturation
and preimplantation and meanwhile miRNA function is repressed during these embryonic de-
velopment steps (253). Another example, in plants the siRNA pathway is an antiviral mechanism
for viruses with a dsRNA produced during the viral reproduction cycle. However, the biological
function of miRNAs and siRNAs are sufficiently different to distinguish them on this basis (6). A
classification using the proteins involved in the biogenesis has already been recognized as a good
way to define classes of small silencing RNAs (99). Importantly it enables to define homogeneous
groups of small RNA valid whatever the species among the ones under study.
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Figure 1.1: Simplified pathway illustrating the biogenesis of miRNAs and siRNAs in multicellular
organisms in three main steps.
Definition of the main classes of small silencing RNAs Taking into account the previous
paragraph, I propose the following definitions for 6 recognized classes of small silencing RNAs.
A general simplified pathway of the biogenesis of siRNAs and miRNAs is presented in fig. 1.1.
The following definition are not definitive and these groups are a way to discriminate the rather
blur ensembles of small silencing RNAs.
- canonical microRNAs: genome encoded single-stranded RNA molecules, produced in eukary-
otic cells from hairpin precursors generated from a primary RNA transcript containing at least
one local hairpin structure, by two cleavages catalyzed by endoribonuclease III enzymes (6; 297).
Note The cleavage are catalyzed by Drosha and/or Dicers and exceptionally without Dicer re-
placed by the Ago protein (e.g. hsa-miR-451: Drosha and Ago2 dependent for its biogenesis
(38; 291; 293)).
- mirtron microRNAs: endogenous single-stranded RNA molecules, produced in eukaryotic
cells from spliced-out of introns with a hairpin potential and a debranching enzyme, and then
cleaved by a Dicer enzyme (279).
- miRNA derived from functional RNA requiring Dicers for their processing: small nucleolar
RNA (snoRNA) and tranfer RNA (tRNA)) Note Small nucleolar are RNAs of 70-200 nucleotides
in length that participates in nuclear ribonucleoprotein complexes where they serve as antisense
guide, like miRNAs. SnoRNAs are abundant, well conserved and participate in nucleotide modi-
fication on some ribosomal RNA (189). The dicer requirement for miRNA derived from snoRNA
in humans has been shown (71) and in mice (9). These miRNAs (198) are mentioned here for the
sake of exhaustivity ; the extensions of these classes of miRNAs are unclear. The regular discov-
ery of original cases of small silencing RNAs suggests that it is likely that other classes of small
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silencing RNA exists.
- endo-siRNA: endogenous short/small interfering RNA (siRNA) originating from long en-
dogenous duplexes and that require endoribonucleases III for their processing and require Dicer
enzymes.
- exo-siRNA: exogenous version of siRNA. SiRNAs originally referred to exogenous RNA,
widely used to silence genes experimentally in vivo and in vitro. Note: The sources can be either
viral or biotechnological for research or medical goals and can correspond to short hairpin RNAs.
- piwiRNA: small RNA generated by a Dicer and Drosha independent pathway and associ-
ated to piwi class of Argonautes proteins (143). Note They are mainly derived from transposons
and repeated elements. In Drosophila melanogaster, Zebrafish and mouse, they are involved in
the germline development, germline DNA intergrity and silencing of selfish DNA elements, re-
viewed in (143)
Focus of miRNAs and siRNAs Among the 6 previously defined classes of small silencing
RNAs, piRNA represents the most distinct (and abundant) class, with very different proteins
involved in the biogenesis, a lack of piRNA sequence conservation in contrary to miRNA and
siRNA and distinct biological effects. The experimental work in this thesis has been performed
with human TRBP and miRNA precursors, so present development will not include piRNA but
will focuses on both miRNA and siRNAs. Both miRNA and siRNA pathways appear to be in-
terconnected. The idea is that it is only by taking into account the large diversity (families and
members of these families) of small silencing RNA undergoing biogenesis with shared complexes
that the role of the member of these complexes (including the dsRBDs) will be adequately under-
stood. Indeed TRBP protein is involved in both miRNA and siRNA biogenesis. Another interest
of reviewing the literature on siRNAs is that many experimental biophysical data, especially in
mammals were performed with siRNAs or siRNA like molecules rather than miRNA. This is
because of the high interest in exogenous siRNA as a research and medical tool. Additionally, a
review not centered on TRBP but covering the role of the dsRBD containing protein in multicel-
lular miRNA and siRNA biogenesis enables to put the known properties of TRBP in a broader
evolutionary context.
Nomenclature of miRNA and siRNA MicroRNA names (6) are formed by the concatenation
of :
- a species prefix that identify the organism (e.g. "hsa-" for human)
- the word "mir-" for miRNA genes, "miR-" for mature miRNA in mammals and "MIR-" in
plants
- a number assigned to a miRNA sequence whatever the organism. The same number can
also be assigned to very similar miRNAs.
- a possible letter to distinguish very similar miRNAs
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- sometimes the words "-5p" or "-3p" to precise which strands (5’ or 3’) of the precursor stem
that contains the miRNA. Recent data indicate that for many cases both strands of the miRNA
duplex can be loaded, but usually with a clear strand bias, one strand being more loaded on a
messenger RNA than the other one. The notation using a star (*) after the name of the miRNA
indicate a strand much less loaded or not loaded on a messenger RNA. Example: hsa-miR-155-
5p, the duplex hsa-miR-155/hsa-miR-155*
SiRNAs are commonly named using their target gene name, the word "-siRNA-" and a num-
ber to distinguish them. For instance : p53-siRNA-2.
1.2 Properties and biological functions of miRNAs and siRNAs
The definitions of the previous classes of small silencing RNAs are used here to present the
main properties of miRNAs and siRNAs although many do not strictly differs between the
classes. They are presented in parallel on common themes to facilitate the comparison. The
biogenesis of the different types of miRNA and siRNA are presented in the next part.
1.2.1 Phylogenetic repartition of miRNAs and siRNAs
miRNA An RNAi machinery seems to have appeared before the emergence of eukaryotes,
from archeal, bacterial and phage proteins implicated in DNA repair and RNA processing (245).
The key proteins involved in miRNA biogenesis are conserved in plants and metazoans. On the
contrary, the homology between miRNA exists in both plant and metazoans but is not shared
between these two clades, indicating a separate evolution of miRNA in these two groups from
a common ancestor (245). RNAi may have been originally selected as an antiviral mechanism
against viruses with a double stranded RNA formed during their replication cycle. miRNAs are
present in plants including some unicellulars (e.g. unicellular green alga, Chlamydomonas rein-
hardtii), in metazoans and in the virions that can infect them. Existence of the mirtron microRNA
pathway has been shown in Drosophila melanogaster, in C. elegans (37), mouse and humans (152).
The fungi possess proteins of the RNAi machinery but have not functional miRNAs.
endo-siRNA This recently found class of small RNA seems ubiquitous in eukaryotes, has been
found in plants, C. elegans, Drosophila melanogaster (somatic and germ cells) and in mammals (99)
including mouse oocyte, male germ cells (253) and mammalian brain (251) where is seems to
have a role in neuronal gene expression.
1.2.2 Number of known miRNAs and siRNAs in humans
A general database exists for non coding RNAs (http://biobases.ibch.poznan.pl/ncRNA).
Identified microRNAs are stored and annotated in the miRBase (http://microrna.sanger.ac.uk/).
The number of entries in the database at the time of writing is about 22000, some of them being
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conserved in all the organisms. About 1000 miRNAs are known in human and many of them
have variants. About 240 mirtrons miRNAs are predicted in mouse and humans (152). The
number of the recently discovered endo-siRNAs in humans is still nuclear
1.2.3 Chemical structure of precursors and mature miRNAs and siRNAs
miRNAs and siRNAs are polymers of Uridine, Guanosine, Adenosine, Cytosine and Inosine.
The ends are 5’-phosphorylated and 2’-3’-hydroxylated apart in plants and some metazoans
where miRNAs are 2’OH methylated. A common property of these RNAs is their size, about 22
nucleotides (nt) +/- 3 nt. microRNAs in mammals have usually bulges and mismatches in their
structure. From here, most microRNA illustrations will be given with hsa-miR-155-5p which will
be written miR-155 and its complementary strand, miR-155*. MiR-155 is one of the best known
miRNA, recently reviewed in (70). It is produced from the gene MIR155HG (entrez gene id:
114614). Both the 5p and 3p(*) strands of the microRNA 155 can be loaded on a messenger RNA
and lead to mRNA inhibition, but the 5p version, oncogenic, is the most known. The example of
hsa-miR-155-5p is given in fig. 1.2 at different steps of the miRNA pathway and with one of its
target, the messenger RNA of the tumor protein 53-induced nuclear protein 1 (TP53INP1).
1.2.4 Targets and effects of miRNAs and siRNAs
MiRNAs and siRNAs silence genes by mRNA degradation or inhibition of translation (253),
the exact mechanism depends on the organism as well as the extent of base pairing with
the mRNA. MiRNAs mainly target the 3’ untranslated region of mRNAs. They act as post-
transcriptional regulators of gene expression. All known plant microRNAs have a perfect base
pairing with their target, leading to the cleavage of the mRNA. On the contrary, most animal miR-
NAs have an imperfect base pairing with their target mRNAs like miR-155. The miRNA/mRNA
interaction triggers mRNA silencing with association with protein factors of the RISC complex
that promote an increase of mRNA decay or repress the translation of the mRNA (81). The non
perfect base paring can be restricted to only 7 base pairs (21). The miRNA targets appear de-
termined by the so-called seed region which is located between nucleotides 2 and 8 the mature
miRNA. MicroRNAs can target very different processes in the cells ranging from development,
cell differentiation, cell division and apoptosis (27). However, it is still unclear what is the amount
of genes regulated by miRNAs. Bioinformatics studies predict that about 60% of eukaryotic genes
could at least partially match in humans (88) but this does not ensure that the gene is significantly
regulated by the miRNA, the ratio between miRNA and mRNA being an important factor to take
into account.
SiRNAs target viruses, mobile elements and can regulate chromatin assembly in some organ-
isms. The silencing mechanism is very similar than the miRNA one. Their artificial exogenous
counterparts are artificially designed to knock down gene function in vivo and in vivo.
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Figure 1.2: Predicted secondary structure of the human oncogenic miRNA hsa-miR-155-5p precursors
at different steps of the biogenesis using information from miRbase. A. Secondary structure of the pri-
mary miRNA 155. Because of the long length of the miRNA primary transcript and TP53INP1 mRNA,
most of their sequence is represented by a series of starts (***) of arbitrary length. B. Secondary structure
of the pre-miRNA 155 after cleavage by Drosha/DGCR8 (microprocessor) complex. C. Secondary struc-
ture of the miRNA/miRNA* duplex of miRNA 155. D. Secondary structure of the predicted interaction
sites between hsa-miR-155-5p and one of its target messenger RNA TP53INP1 in the 3’ untranslated re-
gion (100) at the RISC level in the miRNA pathway. The interaction shows the so called seed sequence
at nucleotides 2 to 8, which is the main base pairing region, as well as additional interactions. The base
pairing is imperfect as usual in mammalian miRNAs.
1.2.5 Involvement of miRNAs and siRNAs in diseases
Because of the wide range of processes regulated by miRNAs, some are involved in human
diseases (262) and especially in cancers, reviewed in (94; 205; 165). Some miRNAs have onco-
gene or tumor suppressor. Hundreds of miRNAs are dis-regulated in cancers cells. MiRNAs
have been found to be involved in all the steps of tumorigenesis. Interestingly, tumor progno-
sis using miRNAs expression profile is more reliable than prognosis based on messenger RNAs.
Involvement of non canonical miRNAs and endogenous siRNAs in diseases is yet unclear but
expected according to (287). The canonical human microRNA miR-155 (5p) has causal effects in
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various cancers and diseases (70) including acute lymphoblastic leukemia, diffuse large B-cell
lymphoma, breast cancer, pancreatic cancer, hepatocellular carcinoma and hypertension. For in-
stance, hsa-miRNA-155-5p silences the pro-apoptotic Tumor Protein 53 Induced Nuclear Protein
1 (TP53INP1) fig. 1.2. Where hsa-miR-155-5p is overexpressed, this microRNA contributes to
the lack of apoptosis in cells, one of the phenotype contributing to cell malignancy. Mutations
in the machinery responsible of mi/siRNA biogenesis have also been reported to be linked with
cancers. For instance in human Dicer, there have been more than forty human heterozygous
germline mutations reported worldwide (85), most of them related with cancers. A mutant of
the protein TRBP lacking its last domain has also been reported in cancers (193). In addition,
the antibiotic enoxacin has been shown to be a cancer specific growth inhibitor, an effect that
was proposed to be related with the interaction of this drug with TRBP (192). The truncated
oncogenic mutant of TRBP does not interacts with this drug (192).
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Chapter 2
Diversity of the functions of dsRBPs in mi/siRNA biogenesis
From the discovery of microRNA, biogenesis pathways were studied in different model organ-
isms. The key protein members and the order of their contributions are rather well understood.
Some proteins involved in miRNA biogenesis like the human TRBP were actually discovered
before the microRNAs (97). A large diversity of miRNA and siRNA pathways exists in different
organisms. For the purpose of this review, a selection of organisms had to be made. Model or-
ganism belonging to different multicellular clades with abundant data available on dsRBD con-
taining Proteins (dsRBPs) including functional roles, interactions and structures were selected:
the vertebrate Homo sapiens, the worm Caenorhabditis elegans, the insect Drosophila melanogaster
and the plant Arabidopsis thaliana. A few relevant data are also included from various rodents
and the Frog Xenopus Leavis when useful.
2.1 dsRBDs are a common feature in proteins involved in small RNA bio-
genesis
There is always at least one RNaseIII enzyme involved in mi/siRNA biogenesis, an RNA in-
terference silencing complex with an Ago protein, and some dsRBD containing proteins (dsRBP)
involved along the biogenesis. When multiple organisms and small silencing RNAs are com-
pared, the most common RNase III enzyme in miRNA and siRNA biogenesis appears to be Dicer.
Taking into account the recently discovered non canonical miRNA pathways, I propose here a
split of miRNA and miRNA biogenesis pathways in multicellular into three main phases, devel-
oped in the next paragraphs: primary precursor production, generation of a short dsRNA from
the precursor, and small RNA loading on a/some messenger RNA(s). These steps are the ones
introduced in fig. 1.1.
Representative examples of dsRBD containing proteins involved in miRNA and siRNA bio-
genesis are presented for the model organism species covered here in fig. 2.1. It shows the
primary domain organization of dsRBP proteins, underlying the abundance of the dsRBDs.
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Figure 2.1: Cartoon view of members of the main classes of dsRBD containing proteins involved in
mi/siRNA biogenesis in Homo sapiens and Arabidopsis thaliana. The relative lengths of the domains are
proportional to their actual sequence length, obtained from the Uniprot database. The domain organiza-
tion of Arabidopsis thaliana HEN1 was obtained from the available 3D structure of the protein (256). The
axis below the figure represents the length in residues units.
The next section develops the main features in common in the miRNA and siRNA pathways
of the selected organisms along the three main phases of the biogenesis. It might not be general
rules as huge diversity exists in multicellulars ; the words metazoans and plants are used for
convenience with this in mind. Then the specificities of the pathways of the selected model
organisms are presented successively. This aim at introducing the multiple dsRBD containing
proteins in their biological context, before a focus in the next chapter of their detailed roles in the
biogenesis of small silencing RNAs where the presentation will no longer follows phylogenetic
partitions.
2.1.1 Generation of mi/siRNA primary precursors and ADAR dsRBDs
Primary precursor synthesis The primary RNA (pri-miRNA or pri-siRNA) can be considered
the first RNA structure that contains the dsRNA region containing the small silencing RNA that
will be loaded by the RISC complex. Its nature is small RNA dependent :
- Canonical pri-miRNAs are generated from a defined locus by the RNA polymerase II (or
sometimes III). The primary transcript of miRNAs can contain multiple hairpins and each of
them can give rise to a different microRNA.
- the primary transcript of mirtrons miRNA corresponds to some gene introns in mRNA gen-
erated by a RNA polymerase and a debranching enzyme.
- for miRNA derived from other cellular RNAs (snoRNA and tRNA), the latter RNA are the
primary transcripts.
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- primary transcripts of endo-siRNAs are still poorly known.
- dsRNA part of viral replication cycle is often a primary transcript of siRNA in plants.
Metazoan pri-miRNA edition by the dsRBD containing ADAR enzymes In metazoans, the
primary transcript generation phase can also include an RNA edition step (base editing, methy-
lation), reviewed in (209). Metazoans double stranded RNA specific adenosine desaminases
(ADAR) catalyze the conversion of adenosine (A) to inosine (I) by a deamination of double
stranded RNAs. ADAR proteins have been studied in various metazoans (human, Rats, Frogs,
etc). In human, about 16% of primary microRNAs are edited in the brain (136). Adenosine to
inosine editing consequences are diverse: they can range from an inhibition of the processing
of some pri-miRNA by Drosha (208), a diminution of RNAi to a change of the seed sequence of
some miRNA as inosine preferentially interacts with cystidine that can be sufficient to change
the miRNA target without interfering with the maturation process. The edition can be tissue
dependent. In mouse, miR-376-5p edition changes its target from threonine and tyrosine kinase
to different target including phosphoribosyl pyrophosphate synthetase 1, a change confirmed in
vivo (138).
ADAR protein weight is about 120 to 150 kDa. The topology from the N-terminus to the C-
terminus comprise typically two DRADA repeats, three double stranded RNA binding domains
and an adenosine to inosine editase domain. As an example, the domain organization of ADAR1
of human is given in fig. 2.1 .
2.1.2 pri-mi/siRNA cleavage to small dsRNA duplex involves many dsRBDs
The primary RNA precursor is cleaved by RNase III enzymes, often multiple times. These
enzymes belong to the family Drosha (i.e. RNase III enzymes of class 2) and Dicers (i.e. RNase III
enzymes of class 3), possessing at least one dsRBD, usually more. The cleavages can be spatially
separated, like miRNA in metazoans where one cleavage occurs in the nucleus and the second
in the cytoplasm after a nuclear export of the RNA. In such case, the intermediate RNA between
the two cleavage reactions is called a "precursor" miRNA (pre-miRNA). The result of this phase
is a double stranded RNA (dsRNA) of about 20 (+/- 3) nucleotides in length. Drosha and Dicers
have systematically a set of dsRBD containing cofactors, often dispensable, that have multiple
dsRBDs (2 to 3). Very few miRNAs have been reported to escape part of this phase, like hsa-miR-
451 (38; 291; 293) integrated in the next phase as a hairpin and not as a dsRNA duplex.
Drosha In metazoans, the production of canonical pri-miRNAs and their processing to a pre-
cursor miRNA (pre-miRNA) occur in the nucleus and is catalyzed by Drosha enzyme with its
indispensable cofactor called DGCR8 in vertebrate and Pasha in invertebrates. Drosha enzymes
contain usually two RNase III domains and a C-terminal dsRBD. The cleavage product has a
5’-phosphate and a 3’-hydroxyl with a characteristic 2-nt 3’-overhang. The 2 nt 3’ overhangs of
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pre-miRNA hairpins are recognized by Exportin-5/Ran-GTP complex and then exported to the
cytoplasm (210). Subsequent step of metazoan miRNA biogenesis occur in the cytoplasm with
Dicer enzymes. pre-miR-155 is one example a product of Drocha cleavage fig. 1.2.
Dicers In plants miRNA biogenesis fully occur in the nucleus and is catalyzed by Dicer en-
zymes (like the second cytoplasmic step in metazoans). Dicer enzymes weight about 220 kDa and
contain from N-terminus to the C-terminus, at least a PAZ domain and two RNase III domains.
In mammals and plants Dicer(s) are more complex than in other multicellulars and contain an
helicase domain, a PAZ domain, a domain of unknown function called DUF283 that is very likely
to be a non canonical dsRBD, two RNase III domains, and one or two C-terminal dsRBDs. There
is only one C-terminal dsRBD in mammals and usually 2 in plants fig. 2.1 . Apart from mam-
mals, Dicer is often present in multiple variant and in that case usually each one is predominantly
devoted to a pathway (e.g. siRNA vs. miRNA). Dicer PAZ domain region has a pocket that rec-
ognize the heterogeneous 3’overhang (183; 180) and the 5’ phosphorylated end interacts with a
conserved pocket around the PAZ domain (213), which seems to be the most important recog-
nition pocket. The three dimensional distance from the 5’ phosphorylated end to the RNaseIII
domains determine the length of the Dicer product. The 5’ pocket is conserved in Dicers with
a pre-miRNA cleavage activity like in human and Drosophila Dicers and likely in other higher
eukaryotes; it is not conserved in Giardia and fungi, unknown in plants (40; 213). There are usu-
ally multiple double stranded RNA binding partners (dsRBD) for each Dicer, containing two to
three dsRBD. SiRNA processing from long dsRNA precursors usually require more than 2 Dicer
cleavages, versus one for canonical microRNAs in metazoans and two in plants. Thus, contrary
to microRNA, high number of siRNA can be generated from a siRNA precursor
2.1.3 Loading of the small RNA on the messenger RNA(s) and dsRBDs
RISC and RLC Eventually one or both strand of the dsRNA, called the miRNA or siRNA tar-
gets a messenger RNA (297; 141) with an interaction mediated by the complex responsible for
small RNA-directed RNA interference, called the RNA-Induced Silencing Complex (RISC). The
RISC complex is the effector complex of RNAi. The core of RISC is composed of a dsRBD free
Ago protein and a small silencing RNA. In the case of miRNA, the word "miRISC", miRNA in-
duced silencing complex is used and "siRISC" with siRNAs. The RISC becomes functional after
the release of one of the strand of the miRNA/miRNA* duplex, usually miRNA*. Loading the
mi/siRNA on the mRNA require an unwinding of the duplex and is performed by the RISC
loading complex (RLC), which is usually a subset of the RISC and contain the Ago protein. The
RLC apparently contains the Dicer/cofactor/dsRNA complex thus contains the same dsRBD as
the ones in the Dicer complex, although their effects might be different. In addition to the pro-
tein involved in miRNA biogenesis, the RISC complexes contain additional proteins that won’t
be described here. Similarly, there are various additional dsRBD free proteins that regulate the
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miRNA biogenesis pathways. They include P53 in human, hnRNPA1 in C. elegans for instance.
The known ones don’t have dsRBD and thus are not included in this review.
MiRNA and siRNA extracellular signaling: systemic and more Once the mi/siRNA is iso-
lated, RNAi can occur in the cell or elsewhere since it is systemic i.e. mi/siRNA can propagate
from cell to cell. Thus mi/siRNA effects are not limited to the cell that produces it. The nature
of the potential proteins members involved in this process is still unclear. RNAi in plants and
nematodes can be involved in extracellular signaling pathways (274). It appears to be an efficient
mechanism for these organisms that use RNA interference as an antiviral mechanism since from
a localized contact with the virus, the defense is spread to other parts of the organism. Studies
in mammals, using others antiviral mechanisms, are actively performed to investigate whether
a similar mechanism could exist and their potential effects (development, antiviral...). By now,
it has been found that in mammals, miRNA can be actively secreted from tissues and present
in stable entities in the serum, reviewed shortly in (300). A siRNA transporter called SID-1, ho-
mologous to the C. elegans SID-1 protein involved in siRNA transport has been discovered in
humans (61). The transport is bidirectional and has been shown in the case of microRNA-21 to
be an important factor for the resistance to gemcitabine in human adenocarcinoma cell (68). Po-
tential roles of dsRBDs in these process in not known. Surprisingly, miRNA regulation can occur
between very distinct clades as a recent study found that food intake (300) can regulate mRNA
expression of the "predator": rice, containing MIR168a can inhibit LDL receptor aptamer protein
1 expression in human liver.
2.1.4 Variety of dsRBD containing proteins involved in mi/siRNA biogenesis
Thus, RNA interference appears as the last step of a progressive biogenesis pathway always
orchestrated by dsRBD containing proteins and by Ago proteins. Four types of proteins contain
dsRBDs in miRNAs and siRNAs pathways fig. 2.1 :
- in ADAR enzymes containing multiple dsRBDs (3 in each human ADAR1 and ADAR2)
- in RNaseIII enzymes (Drosha and Dicers) at their C-termini in one or two copies, and possi-
bly one in the DUF283 region.
- in the cofactor of RNaseIII enzymes, with a common topology of two to three repeated
dsRBDs. DsRBD containing cofactors (TRBP, PACT, HYL1, etc) are involved in multiple steps of
the small silencing RNA biogenesis and their role is potentially not the same along the pathway.
In the light of the diverse data on dsRBD containing cofactor, it can’t be excluded at the time of
writing that these proteins might be linked to an unknown/unrealized phenomenon.
- to this list can be added proteins that interact with the cofactors and also possess dsRBDs and
mediate an important interplay with other pathways, which is the case of the interferon-induced
double-stranded RNA-activated Protein Kinase R (PKR) in mammals.
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2.2 Roles of dsRBPs in mi/siRNA biogenesis in some well characterized
multicellulars organisms
This is the biological functional context of the work performed in this thesis. A simplified
overview of the mi/siRNA pathways is given in fig. 2.2.
Figure 2.2: Simplified overview of the siRNA and siRNA biogenesis pathways in Arabidopsis thaliana,
C. elegans, Drosophila melanogaster and Homo sapiens. There are many subtle features and uncertainties in
these pathways and the reader is referred to the main text for more details about the protein names and
functions.
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2.2.1 dsRBPs in Arabidopsis thaliana mi/siRNA biogenesis
Types of small silencing RNA pathways in Arabidopsis thaliana MiRNAs, exo- and endo-
siRNAs pathways exists in Arabidopsis thaliana. RNAi is used for development and regulation
(miRNA), chromatin structure (endo-siRNA) and anti viral defense (exo-siRNA).
In plants, contrary to metazoans, small silencing RNA biogenesis occurs in the nucleus. The
model system Arabidopsis thaliana possesses multiple Dicer-like enzymes and each small silencing
RNA precursors is differentially targeted by a subset of DCL proteins, a feature that seems to
have been evolutionary selected to face the multiplicity of plant viruses (19). MiRNA primary
precursors are produced by the RNA polymerase II. The generated transcripts have a stem-loop
structure usually longer than the one in mammals. Primary endo-siRNA depends on the RNA
polymerase IV and V (289), associated with DRB2 and DRB4, two dsRBD containing cofactors
with antagonistic effects (62). A dsRBD free RNA dependent polymerase is associated to siRNA
production
Dicers-like in mi/siRNA biogenesis: two to three dsRBDs Arabidopsis thaliana has four Dicer
Like (DL) ribonucleases, DCL1, DCL2, DCL3 and DCL4. Each of them has major roles but de-
spite these trends, the DCL proteins are partially complementary. DCL1 participate in microRNA
biogenesis (150). DCL2 produces virus-derived siRNAs as an antiviral mechanism and endo-
siRNAs (95), and DCL3 produces endogenous siRNAs (289). DCL4 is the main processor of
endogenous RDR6-dependent trans-acting siRNAs, a subgroup of piRNAs (95) and of virus de-
rived siRNAs (52). Additionally a dsRBD in the former DUF283 region, Arabidopsis thaliana Dicer
like ribonucleases have 2 dsRBDs at their C-termini called DCLn-A and DCLn-B respectively
with n in {1,3,4 } , apart from DCL2 with only one dsRBD.
DRB cofactors in miRNA biogenesis: pairs of dsRBD Four dsRBD containing double
stranded RNA binding Proteins (DRBs) cofactor assist miRNA biogenesis in Arabidopsis thaliana:
DRB1 (also called HYL1), DRB2, DRB3, DRB4 and DRB5. A pull down assays (and far-western
assay using denaturing gels) study has proposed that each member of the DRB family interacts
directly and specifically with one partner of the DCL family (e.g. HYL1/DCL-1 ; DRB-4/DCL-4)
(122), a property that would suggest a specific modulation of the DCL family by their respective
cofactors. As with Drosha in mammals, hairpin contained in the pri-miRNAs are processed by
a complex composed of DCL1 (two C-ter dsRBD) and its cofactor HYL1 (two dsRBD) as well as
the zinc finger protein Serrate (SE) (176; 181). Both HYL1 and SE are required for an accurate
processing of DCL1 and they accelerate the cleavage rate of some pri- and pre- miRNAs (57).
DRB2, DRB3 and DRB5 have their expression restricted in the shoot apical meristem region (62)
and function in non canonical microRNAs pathways in Arabidopsis thaliana. DRB2 is important
for miRNA biogenesis in the shoot apical meristem region (62) where the two cofactors HYL1
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and DRB-2 are involved in a complex regulation of the biogenesis. DRB2 is either antagonist or
synergetic to HYL1 (DRB1) depending on the microRNA (62). HYL1 is localized mainly in the
nucleus and has a putative nuclear signalization at its N-terminus. DRB2 is localized in the cyto-
plasm (122). DRB3 and DRB5 are not involved in the miRNAs processing steps but are required
to mediate RNAi of non canonical miRNAs associated with DRB2 (64).
DRBs have a pair of dsRBD at their N-terminal side fig. 2.1. Plant cofactors do not have a C-
terminal dsRBD but a sequence without homology to other known proteins to date, with repeats
of residues (28 res repeats for HYL1)
HEN-1 in mi/siRNA biogenesis: 2 dsRBDs in a methyltranferase In Arabidopsis thaliana, the
methyltransferase Hua Enhancer 1 (HEN1), with 2 dsRBDs catalyze the methylation of the 2’-
hydroxyl group at the 3’ end of the miRNAs and siRNAs before the RISC step.
Thus about 8 dsRBDs are involved in plant miRNA biogenesis and 4 in siRNA biogenesis. The
involvement of HYL1 or a similar dsRBD containing protein in Arabidopsis thaliana siRNA biogen-
esis is unclear. Enlightening this ambiguity would be interesting to understand the specificities
of miRNAs vs siRNA biogenesis in Arabidopsis thaliana and the role of HYL1 dsRBDs.
2.2.2 dsRBPs in Caenorhabditis elegans mi/siRNA biogenesis
Types of small silencing RNA pathways in C. elegans The C. elegans genome encode at least
112 microRNAs with no obvious phenotype in deletion mutants, thousands of endo-siRNAs that
act on mRNA transcripts related to spermatogenesis and transposons, exo-siRNAs and a specific
class of 21U RNA (235). The last class is characterized by a 21 nucleotide long RNA with a 5’
uridine-monophosphate and conserved in other nematodes (235). The deletion mutations in 83%
of C. elegans miRNAs genes shows that the related miRNAs are not essential for its development
and viability without major abnormal phenotypes (196). This has been interpreted as significant
redundancy in miRNAs or the pathways they regulate.
Particularities of the miRNAs and siRNAs pathways in C. elegans miRNA. Canonical
miRNA biogenesis in C. elegans is performed from RNA polymerase II primary transcripts 5’
capped and polyadenylated with a stem loop structure. The Microprocessor complex is com-
posed of Drosha-1 and Pasha-1 (DRSH-1 ad PASH-1) (82). The stem loop pre-miRNAs of about
70 nt has bulges in its stem. After export to the cytoplasm, it is cleaved by a Dicer protein, DCR-1,
also involved in siRNA pathway. Four mirtron miRNAs are also directly processed by DCR-1 in
the cytoplasm (82). siRNA. DCR-1 has one dsRBD containing cofactor called RDE-4 (260; 214)
and the biogenesis of exo-siRNAs require another protein, RDE-1 (82). C. elegans DCR-1 forms
a complex with RDE-4 during the first steps of RNAi, from long dsRNA to short siRNA duplex
precursors. RDE-4 is however not required for the development of C. elegans (260). DCR-1 part-
ner RDE-4 means RNAi defective-4, a property that from which derives its name; it is required
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for the production of siRNAs (260). The processing of endo and exo siRNAs is rather complicated
is still unclear (82). There are multiple types of Argonaute proteins in C. elegans, not reviewed
here (82).
Topology of the dsRBD containing protein involved in miRNAs and siRNA biogenesis in C.
elegans. C. elegans DCR-1 (1910 residues) has a predicted typical metazoan domain organiza-
tion, with a predicted dsRBD fold between the helicase domain and the PAZ domain. The siRNA
related DCR-1 cofactor RDE-4 (385 residues) is a protein of about 44 kDa and is predicted to have
a tandem of dsRBDs in the N-terminal part and a long C-terminal region (260).
2.2.3 dsRBPs in Drosophila melanogaster mi/siRNA biogenesis
Types of small silencing RNA pathways in Drosophila melanogaster RNAi in Drosophila
melanogaster is mainly devoted to viral defence, reduction of the spread of transposons, struc-
tured loci and overlapping transcripts. RNA Polymerase II synthesise the primary transcript
of canonical microRNAs. It contains a hairpin with imperfect base pairing, contrary to plants.
Additionally, some miRNA precursors in Drosophila melanogaster are produced from mirtrons
(211; 236). MiRNA precursors are exported in the cytoplasm by exportin 5. An endo-siRNAs
pathway exist in Drosophila (43). Endogenous siRNAs are produced from hairpin transcripts
or dsRNAs from mobile elements (92). RNAi is an efficient anti-viral mechanism in Drosophila
(114). The precursors of exo-siRNAs derive from dsRNAs appearing during viral replication
or by biotechnologically introduced long dsRNAs or hairpins. siRNA biogenesis generates siR-
NAs of about 21 nucleotides whereas miRNAs are comprised between 21 and 24 nucleotides
(92). The topology of the dsRBD containing proteins involved in miRNAs and siRNA biogenesis
in Drosophila melanogaster is given in fig. 2.1 and the main biological roles of these proteins are
given in the next paragraphs.
Drosha/Pasha Canonical miRNAs are cleaved in the nucleus by Drosha with its indispensable
cofactor Pasha (54) producing a 60-70 nt stem-loop product with 2 nt-3’ overhang extremities.
The canonical pri-miRNA has a 7-methyl guanosine cap and poly(A). siRNA precursors are not
dependent of Drosha/Pasha.
Dcrs Two Dicer-like proteins, Dicer-1 (Dcr-1) and Dicer-2 (Dcr-2), are involved in miRNAs and
(endo, exo)-siRNA biogenesis respectively (268; 168). Dcr-1 does not have a functional DExD/H
domain so miRNA biogenesis is not ATP dependent. Contrary to Dcr-1, Dcr-2 has a functional
DExD/H domain, and ATP hydrolysis is required for the processing of long siRNAs, and seems
to have the ability to use its helicase domain to cleave internal regions of long siRNAs (277). So
both Dcr-1 and Dcr-2 alone have the ability to process pre-miRNAs, the absence of the DExD/H
domain in Dcr-1 restricts it to the processing of pre-miRNA. The Dcr-1 and Dcr-2 cleavage prod-
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uct of pre-miRNAs and pre-siRNAs respectively are sorted into two distinct Ago enzymes, Ago-1
and Ago-2 respectively.
dsRBD containing cofactors: R2D2 and Loqs There are four dsRBD containing cofactor in
Drosophila melanogaster: R2D2 (172), and three Loquacious (Loqs) isoforms: Loqs-PA, Loqs-PB,
Loqs-PD. R2D2 and Loquacious isoforms are paralogs (37% similarity and 25% identicity in the
dsRBD regions (92). R2D2 and Loqs act at the same level than human TRBP and PACT. The
different roles of these dsRBD containing cofactor are particularly complicated and not yet fully
clear. The dsRBD cofactor R2D2 is required in both Dcr-1 and Dcr-2 pathways (212). Loquacious
proteins are generated from a primary transcript by alternative splicing: Loqs-PA (3dsRBDs),
Loqs-PB (3dsRBDs) and Loqs-PD (2 dsRBDs). The third dsRBD of Loqs present in Loqs-PA and
Loqs-PB is a non canonical dsRBD and is required for the interaction with Dcr-1 (296; 84). Loqs-
PD is the isoform specialized in the endo-siRNA pathway (306; 119). Loqs-PD has a special 22
residues carboxy-terminal sequence that is required for the interaction with Dcr-2 (120; 197) and
not Dcr-1 (306); maybe the site, a part of it, allows the rest of the protein to fold as proposed in
(197).
MiRNAs production is associated to Dcr-1. Although Dcr-2 alone has the ability to cleave both
pre-miRNAs and pre-siRNAs as previously mentioned, inorganic phosphate and R2D2 inhibit
pre-miRNAs cleavage (30). Loqs-PA and PB are associated to Dcr-1 for pre-miRNAs processing.
They both contain three dsRBDs as their homologue TRBP and PACT. Loqs-PD is dispensable
for miRNA biogenesis. Loqs-PB increase miRNA biogenesis, by an unknown mechanism (better
affinity, enzyme turnover, conformational change, etc). The presence of Loqs-PB alters the size of
miRNAs, generating miRNA isoforms sufficiently different to have distinct targets that the ones
generated without Loqs-PB or generated with Loqs-PA.
SiRNAs production is associated to Dcr-2 and the cofactors R2D2 and Loqs-PD. R2D2 and
Loqs-PD act sequentially in the siRNA pathway. First, Loqs-PD is involved in the processing
of the double stranded RNA with Dcr-2 (increase affinity, although Dcr-2 might work without
it) (187). Dcr-2 interacts with R2D2 and Loqs-PD, forming the RISC-loading complex (RCL).
R2D2 prevents Dcr-2 from processing pre-miRNAs (30). Then R2D2 is required for Dcr-2 to
load endo-siRNAs or exo-siRNAs into Ago2-RISC (83; 266). Loqs appear dispensable for the
miRISC assembly (174). R2D2 prevent the loading of siRNA precursors on Ago-1 (83). However
other studies have concluded that R2D2 is dispensable for siRNA production (173), including
endo-siRNAs so these molecules appear as potentially non dispensable guides of the small RNA
biogenesis.
RISC Mismatches in the central region of miRNA/miRNA* duplex with an initial uridine nu-
cleotide in the miRNA favor the integration on Ago-1 whereas good base pairing in the central
region of the siRNA duplex with an initial cystidine favor the integration in Ago-2 (92). Ago-2
RISC silence mRNA with high complementarity. The loading of miRNAs and siRNAs on RISC is
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helped by Hsp90 and Hsc70. For siRNA, after degradation of the passenger strand, the methyl-
transferase Hen-1 adds a 2’-O-methyl group to the 3’ end of the guide strand (125).
2.2.4 dsRBPs in Homo sapiens mi/siRNA biogenesis
Types of small silencing RNA pathways in Drosophila melanogaster As in other mammals,
in Homo sapiens both miRNAs and endo-siRNAs pathways exist and contrary to many multicel-
lulars, the RNAi is not directly used as an antiviral response. The antiviral response for dsRNAs
longer than 30 nucleotides is mediated by the interferon pathway in which the dsRNA binding
protein PKR is involved, which is however linked to the mi/siRNA pathway. Shorter dsRNAs
(21 to 25 nt) induce the RNAi mechanism, a property that is used by some viruses encoding miR-
NAs. Other pathways include the mirtrons (279) and snoRNA derived miRNA (292; 198). The
diversity of key proteins involved in mi/siRNA is much smaller than that of other metazoans
like Drosophila melanogaster or plants ones.
Figure 2.3: Illustration of the canonical miRNA biogenesis pathway in humans.
Microprocessor complex and canonical miRNAs From non coding RNA or mRNAs introns
(142), polymerase II or sometimes III synthesise long 1-2 kbp primary transcripts (pri-miRNAs)
that contain one or more 60-70 base pair (bp) stem-loop structure which includes the 20-25 nu-
cleotides (nt) miRNA. Multiple hairpins can lead to distinct microRNAs. Intronic miRNAs could
be generated before the splicing of introns (142). In the nucleus, most canonical pre-miRNAs
are produced by the microprocessor complex. The enzymatic component of the microprocessor
is the type 2 RNase III endoribonuclease Drosha (166) that interacts with a dsRBD-containing
protein, DGCR8 (DiGeorge syndrome critical region gene 8) (111). DGCR8 binds to 10 bp of
stem of the hairpin and is necessary for Drosha catalysis (111). Drosha enzymes may dimer-
ize to form a heterotetrameric complex with DGCR8 (112). Similarly multiple copies of DGCR8
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seem to be involved in the interaction with primary miRNA precursors (72). The product of
the microprocessor is an imperfect hairpin of about 55 to 70 nucleotides (nt) in length contain-
ing/characterized by a 3’ two nucleotide overhang fig. 1.2. The 2 nt 3’ overhangs of pre-miRNAs
hairpins are recognized by Exportin-5/Ran-GTP complex and then exported to the cytoplasm
(210). A representation of the biogenesis of canonical miRNAs in humans is given in fig. 2.3.
Mirtrons and other non canonical miRNAs Recently high-throughtput sequencing in mam-
mals has demonstrated the existence of microprocessor independent processes that can generate
canonical miRNAs like precursors (9): mirtrons and functional RNA derived miRNAs. Mirtrons
are non canonical pre-miRNAs generated by splicing of short introns with a hairpin potential
(279). The splicing product is a lariat which has the 30 branch-point is ligated to the 50 end (279).
After cleavage of this product by a lariat debranching enzyme, the mirtron can fold as a hairpin.
This product have in majority 1:1 overhangs (17) can then be exported to the cytoplasm by ex-
portin 5, as canonical pre-microRNA (211). Recently, a subclass of mirtron that does not require
splicing by Drosha has been discovered (121).
Human Dicer has at least 3 know cofactors: manganese ions are required for the catalysis and
two proteins TRBP and PACT have been shown to be members of the Dicer complex (presented
in the next paragraph). The subcellular localization of the Dicer complex is mainly the cytoplasm
but there are recent evidences of presence of Dicer and TRBP in the nucleus, whose function
is unknown (7). Interestingly, Dicer is found in association with ribosomal DNA chromatin in
mammalian cells (249). Electron microscopy analysis has revealed a characteristic L-shape (155).
Dicer has a helicase/ATPase region but it is ATP independent (226; 298). The efficiency of Dicer
processing seems to depend strongly on the structure of the substrate RNA. Human Dicer cleaves
faster pre-miRNAs that dsRNAs in vitro, suggesting that the recognition and/or the processing
of these substrates might be different. It has been shown that maximal cleavage rates with a
Michaelis Menten model differed by more than 100 fold (178).
Eight domains have been identified on human Dicer, which are from N- to C-terminal: a
region called DExD/H helicase comprising an helicase ATP binding domain with a DECH box
and a Helicase C-terminal region, a central dsRBD (55) (formerly called DUF283 region as in other
Dicer enzymes), a PAZ domain, two RNaseIII domains and a C-terminal dsRBD. Mutations that
prevent cleavage of one of the RNase III domains have no effect on the cleavage capability of the
other (299) showing that the two catalytic sites in the RIIIa/RIIIb function independently of each
other. The Helicase region of Dicer is dispensable for RNA processing.
Dicer cofactors: TRBP and PACT Dicer is believed to interact with two homologous proteins,
HIV-1 transactivation response (TAR) element binding protein TRBP (35; 109; 148) and simul-
taneously or alternatively with PACT (167; 148). Both TRBP and PACT are reliably predicted
from sequence homology to be composed of 3 dsRBDs, which has been proved for the first two
dsRBDs of TRBP (290) and the first dsRBD of PACT (RIKEN, PDBid 1dix).
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TRBP. TRBP is homologous to PACT (42% identity) and to Drosophila melanogaster Loqs1 (233).
There are two isoforms of TRBP resulting of splice variants, called TRBP1, TRBP2 (109). TRBP1
and TRBP2 differ at their N-terminus by 22 more residues in TRBP1. The functional difference
between these two isoforms has not been reported. High sequence conservation exists between
the C-terminal dsRBD of TRBP, PACT and loqs (109). TRBP/Dicer interacts independently of the
presence of dsRNAs (109). The exact roles of TRBP and PACT still remain not perfectly clear.
They are both dispensable for the activity of Dicer in vitro. TRBP is important for both miRNAs
and siRNA biogenesis, originally demonstrated in (35; 109) and reviewed in (233) which underlie
some inconsistencies in both studies regarding the effect of TRBP depletion and its Dicer stabi-
lization activity. Multiple studies performed from these original articles show clearly multiple
effects of TRBP that will be detailed through this review. An electron microscopy surface of the
human-Dicer bound to TRBP has been solved a 20 Åresolution by negative staining (156), show-
ing the expected L shape of the enzyme but not allowing to assess the position of TRBP in the
density. The Dicer-TRBP complex can be sensitive to Adenosine to Inosine editions. For pri-miR-
155, such edition at two defined positions in the stem part close to the cleavage site replace an
A:U by an wobble pair U.I which block its cleavage by Dicer so the precursor accumulates (137).
A study performed on the protein TRBP in HeLa cells (and insect cells) has shown that TRBP
exists as a mixture of multiple phospho-isoforms, the most abundant form being however the
non-phosphorylated protein (215). Four serine phosphorylation sites exist in TRBP all of which
are located in the inter-domain regions (215). Phosphorylation of TRBP by the mitogen-activated
protein kinase (MAPK) Erk has been shown to stabilize the interaction between TRBP and Dicer
but not significantly affect the dicing activity of the complex (31).
PACT. PACT shares 42% identity with TRBP. TRBP and PACT can interact independently of
Dicer and dsRNA (148; 44). PACT is able to bind TRBP and Dicer, without requiring an interme-
diate RNA. Like TRBP, PACT is dispensable for Dicer cleavage of miRNA precursors (167). How-
ever, contrary to TRBP, PACT does not facilitate Dicer cleavage (167). Actually, PACT presence in
the Dicing step of Dicer is unclear since a study (7) failed to detect PACT in immunoprecipitation
of Dicer but found TRBP and Ago2. However, PACT is positively involved in RNAi mediated by
siRNA (167). PACT associates to the RISC complex with Dicer, TRBP and Ago2 (167). Depletion
of PACT reduces the efficiency of RNAi and affects accumulation of mature miRNAs (167). It
not yet a clear whether there is a differentiated role between TRBP and PACT for the processing
of the different classes of small silencing RNAs. Neither is clear whether TRBP and PACT are
partially redundant in mi/siRNA biogenesis.
PKR and its relations with TRBP and PACT. The interferon-induced double-stranded RNA-
activated Protein Kinase R (PKR) is a dsRNA dependent serine/threonine protein kinase. It tar-
gets multiple proteins including eIF2α which causes a reduction of protein synthesis, reviewed
in (263). TRBP and PACT have opposite effects on PKR: TRBP inhibits PKR (45; 108) whereas
PACT activates PKR (108; 220; 217; 216). PKR is a key protein in the initiation of the inter-
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feron network suggesting links between miRNAs maturation and antiviral response via TRBP
and PACT. Induced interferons are pro-apoptotic. PKR is composed of two dsRBDs in tandem
and a C-terminal kinase domain. Additionally, since TRBP can be phosphorylated on serines, a
phosphorylation of TRBP by PKR is a possible additional regulational link between small RNA
biogenesis and PKR. A stress-induced phosphorylation at serine 287 of PACT weakens its inter-
action with TRBP and this increase PACT activation of PKR (248). Thus PACT and PKR together
with their relationship with TRBP blur the separation between mi/siRNAs and the interferon
pathway. This link is interesting in the light of the frequent (and potentially ancestral) use of
RNAi against viruses.
miRNAs editing by ADAR1 and ADAR2 In human two ADAR enzymes, ADAR1 and
ADAR2, are involved in mi/siRNA biogenesis (295). ADAR2 possess multiple isoforms and
locates in the nucleus, whereas ADAR1 shuttles between the nucleus and the cytoplasm. The edi-
tion of miRNAs has been shown to occur from the primary precursor. Since ADARs are present
in both the nucleus and the cytoplasm, miRNA precursors are potentially edited at multiple steps
during their biogenesis.
RLC and RISC: multiple dsRBDs The RISC loading complex is composed of Ago2, Dicer and
TRBP (106). Dicer is a key enzyme in RLC (238) and RISC complex for miRNAs (106) and siRNAs
(238). Depletion of Dicer impedes RNAi with siRNA duplexes (56). The miRNAs loading com-
plex (miRLC) composed of Ago2 and Dicer is formed prior to their binding with a pre-miRNA
(186). Importantly, it is not clear whether the Dicer/TRBP complex that processes pre-miRNAs
exists independently to the RLC complex, despite the fact that Ago2 is not required for this pro-
cessing. Multiple experimental data suggest it is likely that the complex responsible for pre-
miRNAs processing and miRNAs loading on Ago2 (RLC) are the same (106; 186; 167) with a cou-
pled processing of miRNAs precursor and loading on Ago2. These studies report pre-miRNAs
processed by RCL complexes containing Ago2 proteins. Once the small RNA is loaded on Ago2,
the components of the RCL disassemble. Both TRBP and PACT are members of RISC (167). RISC
has about 10 fold greater activity with the pre-miRNA Dicer substrate compared to siRNA du-
plexes (106). Recently, RNA helicase A (RHA) has been identified as human RISC-associated
factor (232). Depletion of RHA reduces the concentration of active RISC and as a consequence di-
minishes RNAi, which underlines the importance of this enzyme as a RISC loading factor (232).
RHA unwinds double-stranded RNA (and DNA) from 3’ to 5’. Human RNA helicase A has two
dsRBDs in tandem on its N-terminal side (fig. 2.1 which lead to potentially 8 dsRBDs involved in
human RLC/RISC. There are four Ago proteins in human (239) and they seem to be involved in
miRNA biogenesis. Among them only Ago2 has an endonuclease activity for mRNA strands that
display complementarity to the bound miRNA (called slicer activity). The association between
some Ago proteins and a class of small RNA or a special silencing effect is unclear. Ago proteins
do not have dsRBDs.
30
Chapter 3
Sequence and fold comparison of dsRBDs related to mi/siRNAs
This chapter focuses on the sequence and fold specificities of the dsRBDs in miRNA biogen-
esis. The general properties and variability of well characterized dsRBDs related to mi/siRNA
biogenesis in multicellular organisms will be presented. As each new study of a dsRBD often
shows new features as well as standard ones, the knowledge of the dsRBD group in multicellular
is evolving quickly and various reviews have regularly aimed at underlying the common fea-
tures and particularities of these domains (240; 188; 80; 264; 34; 58). The main general results will
be synthesized in a first part. An original structural comparison analysis will then be performed
on the dsRBD related to mi/siRNA biogenesis to systematically compare their dsRBD fold and
to relate them to their function.
3.1 General features of double stranded RNA binding domains
3.1.1 Definition of double stranded RNA binding domains
The family of protein domains able to bind to double stranded RNA, now known as double
stranded RNA Binding Domains (dsRBD), has been discovered in 1992 (254). The affinity of
these domains to dsRNAs is actually not a sufficient or necessary property to define them. Other
domains can bind dsRNAs like zinc finger domains or RNA recognition motifs for instance and
some dsRBDs do not bind dsRNAs. Double stranded RNA binding domain are also called double
stranded RNA binding motif (dsRBM). A few authors consider (mainly in PKR papers) that a
dsRBD is the repetition of two dsRBM (305), but this is a minority in the literature since one
dsRBM is enough to bind dsRNAs, since dsRBMs are not always in tandems and since they
can often behave as independent folded structures. In 1995, the first structure of a dsRBD was
reported (237): the second dsRBD from Xenopus Leavis Xlrbpa (a homologue of PACT) interacting
with dsRNA. Xlrbpa is a 33 kDa protein similar to human PACT and TRBP that contains three
dsRBDs. It is considered the reference dsRBD. Multiple NMR spectroscopy and x-ray studies
from then have investigated the structures and properties of a multitude of similar domains.
These data enable to defined canonical dsRBDs as domains "with an α1 − β1 − β2 − β3 − α2
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topology with α-helices formed on the same face of an antiparallel three strand β-sheet and able
to bind double stranded RNA. Because of the variability of dsRBD, the dsRBD class borders is
rather fuzzy and non canonical dsRBD terminology (sometime called dsRBD type B) is used for
domains with the same fold and no dsRNA binding affinity or a moderate difference in the fold
compared to common dsRBDs, like additional helices at the extremities or extended secondary
structures.
3.1.2 Common features of canonical dsRBDs
Figure 3.1: Example of the fold of a typical dsRBD, TRBP-dsRBD2 interacting with stacked 10 bp
dsRNA (PDBid 3adl). The dsRBD is represented in green and the main residues involved in the in-
teraction with dsRNA are represented as tubes colored according to their atomic composition (carbon:
light green, oxygen: red, nitrogen: blue, phosphor: ochre). The dsRNA covalent bounds and atoms
are represented as gray tubes apart from the regions interacting with the protein, colored: the phos-
phate backbone and a guanine, represented like the protein interacting residues. A. Side view of the
dsRBD/protein complex. Hydrogen bounds between the dsRBD and the dsRNA are represented with
gray dashed lines. The name of the main interacting residues, the names of the secondary structure ele-
ments and the position of the three dsRBD RNA interacting regions are given. B. 35° inclination of the A
view from the top towards the reader. C. 90° inclination of the A view from the top towards the reader.
Structural data on canonical dsRBDs interacting with dsRNAs have invariably reported com-
mon features of the interaction that were reviewed in multiple articles (80; 264; 34; 58; 240): The
crystal structure of the interaction between TRBP-dsRBD2 and two short 10 bp dsRNAs stacked
collinearly is given as illustration in fig. 3.1.
- an elongated fold that binds dsRNAs so that the main axis of elongation of the two molecule
are almost parallel. The domain do not wrap around the dsRNA helix. Only a small part of the
dsRNA is involved in the interaction, potentially enabling multiple dsRBDs to bind close to each
other.
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- the preferred nucleic acid binding partner of canonical dsRBDs is dsRNA but some dsRBDs
have lower affinities for ssRNA, dsRNA and RNA/DNA hybrids.
- both the dsRBD and perfect A-helix dsRNA usually undergo very limited structural changes
upon binding.
- the typical dsRBD interaction surface on dsRNA corresponds to about 16 base pair i.e. 1.5
turn of RNA helix. However, dsRBDs seem to be able to accommodate smaller interaction sites.
Outside of the small silencing RNA proteins, it has been shown that apical loops of hairpins can
interacts with some dsRBDs (285; 275). A group solved by NMR spectroscopy a structure of
Saccharomyces cerevisiae Rntp1 with a snoRNAR47 stem-tetraloop of 14 base pair (285), which is
slightly shorter than the canonical dsRNA recognition site by dsRBD. They concluded that the
tetraloop is recognized and the importance of this interaction has been demonstrated with in
vivo experiments. However the moderate size of the physiological RNA does not prove that the
loop site is preferred compared to an RNA with long dsRNA regions. The structure shows that
the first helix has an orientation very favorable for the interaction with the minor groove of the
loop of its target RNA. Absence of interaction with an apical loop has also been observed in the
structure of ADAR2-dsRBD2 where the α1 helix is not favorably oriented for an interaction with
the minor groove of the loop, but present with ADAR2-dsRBD1. There is a lack of information
on the behavior of most dsRBDs involved in mi/siRNA biogenesis regarding potentials hairpin
apical loop interactions.
- the loop lengths are variable, which makes the dsRBD chain length variable, between 65 to
90 residues. Some dsRBDs have an additional helix in C-terminal but so far such dsRBDs were
not reported in proteins related to mi/siRNA biogenesis.
- dsRBDs interact mainly with non sequence dependent parts, with the phosphate backbone
and 2’OH groups of the ribose mediated by hydrogen bounds or by water. Interactions with
base rings have been detected in some structures (188), which will be presented in section 4.2.2.
Three binding regions have commonly been reported on dsRBDs interacting with dsRNA, called
region 1, 2 and 3 following the N-terminal to C-terminal sequence. Region 1 corresponds to a
side of the first short helix α-1. It is neutral or slightly negatively charged, usually with a con-
served glutamate. It interacts with the minor groove of the dsRNA helix via the 2’OH of the
ribose sugars. Region 2 comprise the loop between stand β-1 and β-2, is neutral or slightly nega-
tively charged with a small positively charged part, commonly a GPxH motif with an important
histidine residue. This region binds to dsRNA minor grove, especially with the 2’OH groups
of the ribose sugars. Region 3 is the N terminus extremity of helix 2, positively charged with a
conserved KKxAK motif (x: any residue), and binds to major grove RNA via direct or water me-
diated contact with the phosphodiester backbone. Along the dsRNA helix, the region appears in
the order (1,3,2) or (2,3,1). Despite many dsRBD/dsRNA structures were solved with stacked 10
bp dsRNAs, which could introduce some biases, structure with longer dsRNAs show the same
interaction interface. A detailed review of the many residues involved in the dsRBD/dsRNA
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interaction is presented in (188).
- Flexible loops. The flexibility of loop 2 has been detected for each dsRBD on which relaxation
NMR studies have been performed (204; 229). This was also detected in the bound state for the
third dsRBD of Drosophila staufen and a hairpin RNA (229). Additionally, in the crystal state, the
flexibility of the second loop of Xrlbpa dsRBD2 has been detected. The loop 2 is very flexible for
DGCR8-dsRBD1 and the dsRBD of Drosha (284). Loop 1 is often flexible but the flexibility seems
not required for dsRNA binding: it is not found flexible in the 10−8- 10−12 s−1 time scale by NMR
spectroscopy relaxation in DGCR8-dsRBD1 whereas it is flexible in the unique dsRBD of Drosha
that does not bind in vitro with a primary construct of miRNA 16-1 (284).
- the sequence is mainly conserved in the last third of the dsRBDs chain (i.e. C-terminal side).
This corresponds to the largest α helix which interacts via hydrophobic residues with one side of
the β-sheet and with the helix α1. These interactions form the hydrophobic core of the dsRBDs
and appear fundamental to maintain the dsRBD fold. For dsRBDs that binds dsRNA, residues
in the RNA binding region 1, 2 and 3 are also conserved. So called non canonical dsRBDs have
usually good sequence conservation in the helix α2 and diverge more elsewhere.
- environment of the dsRBD. dsRBDs are always associated with other domains which often
include other dsRBDs. In the data available up to now, the dsRBDs form mainly an independent
fold in proteins and have usually a flexible linker of variable length that attach them to other
domains.
3.2 Fold comparison of dsRBDs involved in mi/siRNA biogenesis
3.2.1 Selection of a set of well characterized dsRBDs involved in mi/siRNA biogenesis
Only the dsRBDs for which structural information is available will be given consideration here.
Previous reviews on dsRBDs have already underlined the sequences specificities with multiple
alignments as well as the regions important for interaction with dsRNAs. However no studies
have concentrated on a systematic structural dsRBDs fold comparison. In the past 10 years, the
number of dsRBDs structures solved in miRNAs and siRNA biogenesis pathways has highly
increased, enabling to propose an original comparison of their fold. Because of the definition of
dsRBDs using a fold rather than a well defined sequence motif, the search of the set of known
dsRBD structures in miRNAs and siRNA biogenesis was performed with a three dimensional
topology search. For the purpose of this study, the second dsRBD of TRBP with advantageous
canonical structures solved in the apo and RNA holo form will be taken as reference. The solution
structure of the second dsRBD of TRBP in the apo form (PDBid: 2CPN, (290)) was used as a
template and the dsRBDs structures were obtained using the DALI server (124). Then dsRBDs of
proteins involved in miRNAs or siRNA biogenesis pathways, with Z-score over 2 were selected
and sorted whether the dsRBD is in the apo or holo form regarding its interaction with dsRNAs.
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As already mentioned, despite not directly involved in the small silencing RNAs processing,
the protein PKR that can interacts with TRBP and PACT and with 4 solved dsRBDs structures
was included in the set. 20 PDB structures corresponds to dsRBDs in the apo form, 2 of which
are almost identical and 2 contain 2 dsRBDs so 21 dsRBDs structures are available in relation to
the miRNAs/siRNAs pathway. Among these 21 dsRBDs structures, 3 corresponds to the same
dsRBD and were obtained with different methods or within a different protein construct. 8 PDB
files correspond to holo forms of dsRBDs mainly with short dsRNAs stacked collinearly. More
dsRBDs folds were studied by in solution by NMR spectroscopy (19 dsRBDs) than by crystal by
x-ray diffraction (11 dsRBDs). Despite that for some dsRBD like TRBP-dsRBD2, the structures of
both apo and holo forms are very similar, this might not be a general rule. Thus, since more data
are available for dsRBDs in apo form, the comparison was performed with this set of data. To
facilitate the comparison, the parts of the structures not included in the pure dsRBD region were
removed from the PDB file. Using the Stride program to define the secondary structure (89),
the criterion used was to select the subset of the PDB file between one residue before the start
of the first helix of the dsRBD and one residue after the end on the second helix of the dsRBD.
A summary of the different dsRBDs related to miRNAs and siRNA biogenesis available in the
PDB to date is given in tab. 3.1. Solution structures of the first two dsRBD of RDE-4 have been
solved but not yet added to the PDB (36). The sequence and fold features of this set of dsRBD is
presented in the next two paragraphs.
3.2.2 Global sequence comparison of dsRBDs involved in miRNAs and siRNA biogenesis
Multiple alignments of the dsRBDs in relation to miRNAs and siRNA biogenesis in multi-
cellulars that adopt an α − β − β − β − α fold determined experimentally in the RNA apo was
performed as detailed in the figure legend of fig. 3.2. The columns of aligned residue with a
normalized entropy over 0.35 are colored according to the code defined in the figure legend. The
result is given in fig. 3.2 and shows some typical sequence feature of dsRBDs mentioned previ-
ously. In particular, the important sequence conservation in the long α2 helix is remarkable. This
alignment is the basis of the following structural comparison.
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Table 3.1: PDB structures selected for a fold comparison of dsRBDs involved in miRNA and siRNA biogenesis. The information id slitted for all dsRBDs
contained in the structures. (*: the sequence of Mus musculus C-terminal dsRBD of Dicer is the same in Homo sapiens ; Xenopus leavis RBPA is also called PRKRA-b,
like human PACT (PKRA). Holo annotations: (1): 10 bp dsRNA stacked collinearly ; (2): 22 nt, anologue of miR173/miR173* ; 3: GluR-2 RNA stem-loop.)
Organism Protein -dsRBD PDBid Apo vs holo Context Method Reference
Homo sapiens TRBP-dsRBD1 3llh apo isolated x-ray (290)
Homo sapiens TRBP-dsRBD2 2cpn apo isolated NMR (290)
Homo sapiens PACT-dsRBD1 2dix apo isolated NMR RIKEN
Arabidopsis thaliana HYL1-dsRBD1 2l2n apo isolated NMR (231)
Arabidopsis thaliana HYL1-dsRBD1 3adg apo isolated x-ray (294)
Arabidopsis thaliana HYL1-dsRBD2 2l2m apo isolated NMR (231)
Arabidopsis thaliana HYL1-dsRBD2 3adj apo isolated x-ray (294)
Mus musculus* Dicer-dsRBD 3c4b 3c4t apo RNaseIIIb x-ray (60)
Homo sapiens DGCR8-dsRBD1 1x47 apo isolated NMR (201)
Homo sapiens DGCR8-dsRBD1 2yt4 apo DGCR8 core x-ray (252)
Homo sapiens DGCR8-dsRBD2 2yt4 apo DGCR8 core x-ray (252)
Homo sapiens Drosha-dsRBD 2khx apo isolated NMR (201)
Drosophila melanogaster ADAR-dsRBD1 2ljh apo isolated NMR (14)
Rattus norvegicus ADAR2-dsRBD1 2b7t apo isolated NMR (257)
Rattus norvegicus ADAR2-dsRBD2 2b7v apo isolated NMR (257)
Homo sapiens PKR-dsRBD1 1qu6 apo dsRBD pair NMR (203)
Homo sapiens PKR-dsRBD2 1qu6 apo dsRBD pair NMR (203)
Mus musculus PKR-dsRBD1 1x49 apo isolated NMR RIKEN
Mus musculus PKR-dsRBD2 1x48 apo isolated NMR RIKEN
Arabidopsis thaliana DCL1-dsRBD1 2lrs apo isolated NMR (23)
Arabidopsis thaliana DCL4-DUF283 2kou apo isolated NMR (227)
Homo sapiens TRBP-dsRBD2 3adl holo(1) isolated x-ray (294)
Xenopus leavis RBPA-dsRBD2 1di2 holo(1) isolated x-ray (237)
Arabidopsis thaliana HYL1-dsRBD1 3adi holo(1) isolated x-ray (294)
Arabidopsis thaliana HEN1-dsRBD1 3htx holo(2) full protein x-ray (127)
Arabidopsis thaliana HEN1-dsRBD2 3htx holo(2) full protein x-ray (127)
Rattus norvegicus ADAR2-dsRBD1 2l3j holo(3) dsRBD pair NMR (256)
Rattus norvegicus ADAR2-dsRBD2 2l3j holo(3) dsRBD pair NMR (256)
Rattus norvegicus ADAR2-dsRBD1 2l3c holo(3) isolated NMR (256)
Rattus norvegicus ADAR2-dsRBD2 2l3k holo(3) isolated NMR (256)
36
Figure 3.2: Multiple alignment of the dsRBDs in relation to miRNA and siRNA biogenesis in multicel-
lulars that adopt an α − β − β − β − α fold determined experimentally in the RNA apo form up to 31
march 2013. The sequence alignment was performed with the MUSCLE program (65) which uses only
sequence and not structural information. The Shannon’s information theoretic entropy (246) was used
with a 10 letter alphabet to measure the residue diversity with a classification close to the convention
of Mirny and Shakhnovich (195) (Hydrophobic and Aliphatic [V,I,L,M], Aromatic [F,W,Y], Polar [N,Q],
Positive [H,K,R], Negative [D,E], Tiny [A,G], Serine and Threonine [S,T], Proline [P], Cysteine [C] and
Gaps [-]) and normalized using an implementation in the GNU R bio3D package (103). The color scheme
is the following one: (A, V, M, I, L, F, C and W) are colored in light blue, (S, T, N and Q) are colored in
green, D,E and R,K are colored in purple and red respectively, H and Y in blue-green and G are colored
in orange. Aligned residues with a normalized entropy of conservation value below 0.35 are not colored.
The type of secondary motif per residue follows the sequence alignment and was determined from the
available structures using the Stride algorithm (89). Alpha helices are represented in blue and sheets
in orange. Species legend: hsa: homo sapiens, ath: Arabodopsis thaliana, dme: Drosophila melanogaster, rno:
Rattus norvegicus. As two structures are available for the first two dsRBDs of Arabodopsis thaliana HYL1,
both are mentioned but only one per dsRBD was used (solution structures 2l2m and 2l2n). The bottom
of the figure represents the secondary structure determined from the PDB files by the Stride algorithm
(89).
3.2.3 Global fold comparison of dsRBDs involved in miRNAs and siRNA biogenesis
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The comparison of the sequence of dsRBDs gives limited information on their diversity. The
goal of this part is to compare their N-ter-α-β1-β2-β3 α-Cter fold. This is often performed using
an all atom superposition of the structures with a minimization of the root mean square deviation
(RMSD) between the structures. However since the RMSD weight each atom equally, deviation
in any directions are considered the same so it is often hard to analyze accurately such superpo-
sitions when multiple substructures are variably positioned. Another possibility to compare the
structures is to identify the most invariant region of the protein ("rigid core") which can be used
to fit all the structures on it. This approach proved to be useful to identify some flexible regions
that are likely to be related to the regions that are variable between different related proteins of
distinct organisms. The superposition on a core approach was used here using the R package
bio3D (103) implementing a previously described algorithm (98). The principle is to start form
a sequence alignment of the dsRBDs and then align the structures using the sequence aligned
residues as guides fig. 3.2 . The ensemble of all residues fully aligned in the sequence alignment
is considered as the core. The 3D structure ensemble is then averaged and the deviation of each
atom to the average structure is estimated (98). The alignment position with the highest deviation
is removed from the calculation and the structural averaging - deviation estimation - deletion is
repeated until no residues remains. And eventually the part the proteins with deviation under a
given volume are selected to define a core. A 2A2 limit was used here. The superimposed struc-
tures are represented using VMD (128). The corresponding superposition on all the apo dsRBDs
of tab. 3.1 is given in fig. 3.3.
Figure 3.3: Result of the three dimensional alignment of the apo dsRBDs available structures from
proteins related to mi/siRNA biogenesis in multicellulars listed in tab. 3.1 The alignment strategy is
explained in the text ; the structures are aligned on the long helix α2. Only the backbone of the dsRBDs
are represented using tubes colored in blue for α helical secondary structure, in yellow for β sheets and
in gray for loops. A, B and C represent different views of the alignment rotated around the dimension
of higher dispersion of the dsRBDs atoms
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Because of the variability of the dsRBDs structures, the structural part most common ("core")
is reduced to 15 residues of the long helix 2 from positions 64 to 78 in the alignment and close
to the small β3-α2 loop. The comparison of the dsRBDs using this helix as a reference could
appear artificial for such small protein domains but the analysis shows that this long helix is a
key common structural feature among the dsRBDs and inspection of the structures show that the
dsRBD fold is organized around this helix fig. 3.3. Both the β-sheet and the shorter N-terminal
helix interact with the central C-terminal helix. The choice of this helix is also consistent with the
high sequence conservation in this part of the protein.
The superposition shows a very high variability in the β1-β2 loop region and secondarily in
the relative orientation of the N terminal helix compared to the C-terminal one. As many struc-
tures were solved by NMR, the diversity of the loop positions might just reflects lack of constrains
in this region or irrelevant position constrained by the crystalization in the X-ray studies but it
worth to note that the atomic position in these loops were not use in the classification process.
The length of the N-terminal helix also appears to be variable (fig. 3.2 & fig. 3.3). The α1-β1
loop is also variable with 2 dsRBDs being extreme regarding this feature having unusual long
loops (dsRBD of human Drosha and DUF283 domain of Arabidopsis thaliana DCL4). A simplified
synthetic view of the variability of dsRBDs fold can be obtained by the realization of a partition
of the structures based on the superposition. To distinguish as much as possible the folds, an ex-
ploratory statistic approach was used, with the workflow Principal Component Analysis (PCA)
- Hierarchical clustering. The PCA is performed on a matrix which lines correspond to each
dsRBD structure and which the columns corresponds to the repeated association of the x, y and z
coordinates of the alpha carbon of residues fully aligned in the sequence alignment (i.e. no gaps
in the sequence alignment, cf fig. 3.2). Importantly this removes the artifacts of the potentially
unconstrained (possible in NMR) or overconstrained (possible in crystal) flexible loops as their
sequence are very variable and correspond to regions not used in the alignment. The 37 fully
aligned residues in fig. 3.2 were used. Then using the PCA basis as a new set of discriminat-
ing variables, a hierarchical clustering can be efficiently performed. The results of this strategy
are given in fig. 3.4. This approach should enable to identify the main structural features on
which the structures differ in the context of the superposition performed. The higher the num-
ber of structure and their diversity, the more relevant are the results of this approach. We can
notice that there is a lack of dsRBDs from RNaseIII enzymes involved in small RNA biogenesis
which could lead to a change of the classes size and number. The 3 repeated dsRBD structure
determined in different context enable to perform an internal validation of the method.
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Figure 3.4: A. Hierarchical classification of the dsRBDs folds on the PCA basis. B., C., D.: Coloration
of each dsRBD according to the group it belongs to, defined from the succession of: sequence alignment
- structural alignment - PCA of residues fully aligned in the sequence alignment - hierarchical classi-
fication. (B.) The tree is thus colored to highlight the four groups. B., C. and D. represent different
orientation of the alignment along the axis of main dispersion of dsRBDs atoms using the same color
scheme than A.
The hierarchical classification is well structured and suggested a relevant partition of the se-
lected dsRBDs into 4 classes. The dsRBDs in the global superposition are colored according to
their belonging to each class in fig. 3.4 to underline the differences.
Description of Group 1: human Drosha C-terminal dsRBD The C-terminal dsRBD of human
Drosha (PDBid: 2khxD, (201)) is the first to be isolated with this analysis in a group because of its
multiple unusual features. The structure of this dsRBD has been solved by NMR spectroscopy.
As remarked by the authors of the structural analysis, this dsRBD has an unusual extended α1-
β1 loop negatively charged (see alignment), a unique dsRBD feature at the time of writing. This
extension does not correspond to one the typical RNA binding region of dsRBDs interacting
with dsRNA. The structural alignment shows also differences in the position of the β1 strand.
This dsRBD has the common sequence feature of dsRBDs and global charge distribution in the
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binding regions 1 and 2 but lack the common abundance of basic residues in region 3 (201).
The functional effects of these features are not yet known. Human Drosha C-terminal dsRBD is
required for pri-miRNAs processing by Drosha (111), however a study on the isolated dsRBD did
not detected RNA binding properties (284). Interestingly, various studies have reported the lack
of affinity for Drosha to its pri-miRNA substrate, which is linked to the requirement of its cofactor
DGCR8 for canonical pri-miRNAs processing. This complex seems to possess unusual dsRBDs
which could be linked to an unusual dsRNAs recognition, potentially linked to the abundance of
bulges and mismatches in the canonical primary RNA. Further studies of the full complex would
be required.
Description of Group 2 and 3: dsRBDs belonging to tandems dsRBDs of group 2 and 3 ap-
pear very similar and do not differ by large insertions in the loops. Some of the main differences
are position and orientation of helix α1, which appears variable. Additionally, the length of the
β2-β3 are similar in this two groups but their position are different on average. The method-
ological influence of the position on these loops has been mentioned in the description of the
classification method. It is however important to remark that these loops were not involved in
the classification process. The two main differences identified between group 2 and 3 localize
in two of the three RNA binding region of the dsRBD. And since the reference helix α2 is taken
as a reference for the comparison, this implies a difference of relative position of the 3 dsRNA
binding regions. Most dsRBDs of available structures belong to these two groups. Importantly,
the two structures of the first dsRBD of DGCR8 are found to be the closest and belong to the
same group 3. Three of the four structures of the two dsRBDs of HYL1 solved by NMR spec-
troscopy and x-ray diffraction by two different groups localize in the second group. The second
dsRBD of HYL1 by NMR spectroscopy and x-ray diffraction are found to be the most similar in
this analysis. However the first dsRBD of HYL1 solved by x-ray is classified in the third group
which indicates an effect related to the methodology so the belonging of this dsRBD to a group
is not clear. Interestingly, apart for the mentioned case of HYL1 dsRBD1 and for DGCR8, all the
dsRBDs belonging to a tandem have their partner that belongs to the same group. This is unex-
pected and could suggests the two main class of dsRBDs solved could correspond to two main
classes of dsRBDs. It is however not straightforward to find obvious functional relations between
the proteins belonging to a same group and as previously mentioned the structural differences
are subtle. In particular, it is surprising to see that human and murine PKR dsRBDs belong to
groups 2 and 3 respectively. On the contrary DGCR8 has its two dsRBDs in two different groups.
This is interesting as the dsRBD pair of this protein is the most unusual among the ones reported.
It is described in the part devoted to dsRBDs tandems (section 4.3.1). Group 3 possess a Dicer
dsRBD fold that is sufficiently scarcely reported to be worth a comment. In Arabodopsis thaliana,
DCL-1 can bind dsRNAs, like DCL-3 (122). In DCL1, the two dsRBDs were found to be essen-
tial for the microRNA processing. In the article reporting the solution structure of DCL1-B by
NMR spectroscopy (23) the authors underlined the canonical dsRBD fold of this dsRBD with its
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particularities and interestingly, they found that DCL1-B is not specific to dsRNAs as it is able to
bind dsDNAs. This is an uncommon property in the dsRBs group (23). It would be interesting
to know what is the molecular basis for this property (fold/chemical features) and to analyze if
these Dicer dsRBD could be involved in the growing reported association of Dicers with chro-
matin.
Description of group 4: two isolated Dicer dsRBDs Group 4 is very small and composed of
two Dicer dsRBDs, Arabidopsis thaliana DCL1-DUF dsRBD and the C-terminal dsRBD of human
Dicer. Another DCL-1 dsRBD, part of the C-terminal tandem is found in the group 3. The fold
of these two dsRBDs is very unusual and characterized by a helix α1 orientated between 45° and
90° to its position in other dsRBDs. A special orientation of this helix belonging to the dsRNA
binding region 1 has already been mentioned outside of the small silencing RNA field in Saccha-
romyces cerevisiae Rntp1 as a way to facilitate interaction with loops (285). Interestingly, the role
of the central DUF283 of Dicers, suspected to be a dsRBD is still elusive. The solution structure
Arabidopsis thaliana DCL4 DUF has been solved by NMR spectroscopy (227) and indeed shows a
dsRBD fold. In addition to obvious special orientation of the first helix, the authors also report a
flexible 18 residue C-terminus, maybe a part of a linker with other DCL-4 domains and a lack of
the conserved histidine in region 2. Interestingly, we can also note here that the two structure of
this group have a reduced β2-β3 loop, corresponding to the dsRNA binding region 2. If the struc-
tures of these two isolated Dicer dsRBDs reflect the ones in the RNA holo form, it would strongly
suggest a different way of interacting with the dsRNA substrate. DCL-4 DUF dsRBD has been
reported to interact only very weakly with a perfect duplex dsRNA, the interaction being only
detected by slight perturbation monitored by two dimensional NMR spectroscopy experiments
(N-HSQC) with a 13 fold dsRNA excess and not by EMSA or by ITC (227). Interestingly, the
deletion of the central dsRBD of human Dicer has only a limited impact of the pre-siRNA and
pre-miRNA cleavage activity (178) which suggests it is not a key domain required for a global
dsRNA affinity. Thus, the existence of this small group raises interesting question on the role of
isolated Dicer dsRBDs.
The goal of this classification was mainly to present the different structures of apo dsRBDs and
to find potential trends. Importantly, there is a lack of Dicer dsRBD in this classification. More
structures would be necessary in the apo and holo form to see how stable the groups 2 and 3 are
and to find a potential biological meaning or an origin of the fold differences. The fact the three
dsRBDs in this comparison that does not belong to tandems have original folds (groups 1 and 4)
might be coincidence but it appears attractive to investigate whether the "groups" 1 and 4 reflect
undersampled classes of dsRBDs fold with specialized roles.
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Chapter 4
Functionalities enabled by the dsRBDs in mi/siRNA biogenesis
Using the information presented in the three previous chapters, this chapter aims to compare
the distinct roles of dsRBDs involved in mi/siRNA biogenesis with a strong link to the function
of the protein that contains them and to the potential structural data available. dsRBDs related
to mi/siRNA biogenesis are always associated with catalytic domains, either directly within the
same polypeptidide chain (Dicer, Drosha, ADAR, RHA and PKR) or indirectly in cofactors inter-
acting with these enzymes (TRBP, PACT, Loqs, DRBs etc). These dsRBDs add various function-
alities to these enzymes (specificity, accuracy, localization etc). Despite many of these effects are
likely to be interdependent, the present chapter tries to sort, potentially artificially, different roles
of the dsRBDs in the mi/siRNA biogenesis pathways :
- dsRBDs in RNaseIII cofactors modulate enzyme activity
- mi/siRNAs precursor recognition properties added by dsRBDs and funneling roles
- effects of the arrangement of dsRBDs in tandems
- dsRBDs and protein/protein interactions
4.1 dsRBDs in RNaseIII cofactors modulate enzyme activity
Apart from a few cases like the requirement of DGCR8 for human Drosha, dsRBD containing
cofactors are usually dispensable for the activity of their enzymes. Multiple experiments have
shown however that these cofactors modulate the activity of the Dicer enzymes in different ways,
including changes in the specificity and efficiency.
4.1.1 RNA dependent effects of dsRBD containing cofactors in Dicing efficiency in multi-
cellulars
In various multicellulars, the dsRBD containing cofactors have a variable effect on the RNa-
seIII enzyme they are associated to. In Arabidopsis thaliana, HYL1 and Serrate (SE) stimulates of
the amount of cleavage product for miR-167b with an enhancement between 2 and 20 fold (57).
In Drosophila melanogaster, Loqs is not required for Dcr-1 to bind to miRNA/miRNA* duplexes
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(174). As with other organisms, the effects on the detection of the cofactor Loqs is miRNAs de-
pendent, either null or corresponding to a decrease of miRNAs production (174). In humans,
the effect of TRBP on pre-miRNAs cleavage by Dicer is RNA dependent (31; 162). TRBP usually
enhances Dicer activity of a few folds (2-10) but some negative effects on Dicer efficiency have
also been reported for some precursors. The pre-miRNA dependent effects could be linked to a
differential binding of TRBP, influencing the interactions of the TRBP/pre-miRNA complex with
Dicer and/or a conformal change of Dicer (which is suggested to be autoinhibited by the heli-
case domain to which TRBP binds (178)). The structural basis of these differences remains elusive
but is likely to be related to be special RNA recognition properties of dsRBDs, developed in this
chapter.
4.1.2 dsRBP containing cofactor have an effect on the accuracy of Dicer enzymes in plants
In Arabidopsis thaliana where DCL1 products are highly heterogeneous regarding their length
and sequence for a given precursors (which are long in plants), the addition of HYL1 and Serrate
enable to have a well defined product corresponding to the physiological miRNA (57). DCL1
associates with HYL1 (113) for an accurate pre-miRNA processing (149; 57). HYL1 increased the
accuracy defined with the expected product for miR-176b from 11% to 22%, and this reach 68%
with serrate. These effects have been reported as a requirement for DCL-1 of these cofactors for
an accurate processing. The related processes may be similar to the isomiRs ones, developed in
section 4.1.3 .
4.1.3 dsRBDs influence the isomiR production by Dicers in metazoans
The seed sequence of miRNAs determine the mRNA target. The seed region is located be-
tween nucleotides 2 and 8 in the mature miRNA fig. 1.2. For canonical miRNAs in metazoans,
the role of Drosha and Dicer cleavage on the length of miRNAs depends first on which strand
is the small silencing RNA that is to be loaded. If the miRNA is in the 5’-3’ strand, Drosha de-
termines the 5’ end and Dicer determines the 3’ end, the opposite being true. Recently, various
studies in different organisms have found that the presence of the dispensable dsRBD contain-
ing cofactors of RNaseIII enzymes could influence the length of the cleavage product, leading to
different miRNA isoforms. These different miRNAs, differing by their 5’ or 3’ by one to two nu-
cleotides in length, are called isomiRs. IsomiRs are differentially expressed in tissues and during
development in Drosophila melanogaster (79) and in human (163), underlying that this process is
very likely to be regulated. Importantly, the 1 to 2 nucleotide can be sufficient to change the seed
sequence and/or the extremity of the small RNA duplex having the most stable base paring.
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4.1.3.1 Loqs-PB and TRBP have an effect the isomiRs distribution
In Drosophila melanogaster, the dicing product of pre-miRNAs by Dicer-1 is affected by Loqs-PB.
It is not the case for Loqs-PA, generating product of length identical to the Dicer-1 alone (91). The
length of the miRNA with either Dicer-1 alone or Dicer-1 with Loqs-PA is mainly a 21 nt RNA.
In the presence of Loqs-PB, Dicer-1 cleaves mainly a region two more nucleotide longer than
without Loqs-PB. Since the miRNA-307a is in the 3’-5’ arm of the pre-miRNA precursor, Dicer-
1/Loqs-PB processing leads to two more nucleotide at the 5’ end of the miRNA-307, leading to
a change of the seed sequence. In the study, target genes have only been identified for the long
isomiR form. Only the resulting iso-miRNA produced with Loqs-PB can target the predicted
target mRNAs of glycerol kinase and taranis, a property verified in vitro for these two genes. As
a result, Loqs-PB appears to be necessary for the production of the functional isomiR. A similar
phenomenon has been found with miRNA-87, with the generation of a miRNA one nucleotide
longer (91) and with miR-316, with one nucleotide shorter miRNA product. In the latter case, the
miRNA corresponds to the 3’-5’ arm and the one nucleotide change does not result in a different
seed sequence. This phenomenon is not systematic as the processing of pre-miR-let-7 in vitro
leads to the same product independently of the presence of Loqs-PA or Loqs-PB.
In homo sapiens, this effect has been detected with the TRBP cofactor of Dicer but not with
PACT (91; 162). The effect of TRBP is the generation of isomiRs with one nucleotide more than
the canonical sequence. It has been reported for pre-miR-29, pre-miR-200a and pre-miR-34c and
pre-miR-132-3p (162). For instance with pre-miR-132, both strands pre-miR-132-5p and pre-miR-
132-3p can be produced in vivo and lead to distinct silencing. With Dicer alone there is a strong
excess of pre-miR-132-3p, a 21 nt RNA whereas with TRBP, there is also a significant amount of
22 nt RNA product. In the latter case, both RNA have a distinct seed sequence. Interestingly,
the change in sequence, changes the strand loaded on RISC, a phenomenon that is compatible
in this example with a change of the extremity of the duplex with the most stable base pairing
(162) (a phenomenon presented later in section 4.2.1.2). This example shows that even if the seed
sequence is not modified, the change of 1 or 2 nucleotides at the extremities of the miRNA duplex
can change the proportion of strand loaded on the RISC complex.
4.1.3.2 Towards a mechanistical understanding of Dicer cofactor effects on the isomiRs dis-
tribution
The first article reporting the cofactor effects on isomiRs production in Drosophila melanogaster,
aimed at approaching the underlying mechanism. In the study, it was found using chimeras of
pre-miR-let-7 and pre-miR-307a that the stem of the pre-miR-307a stem loop determines the pos-
sibility for Loqs-PB to affect the dicing position (91). As the Dicer product length is determined
by the distance between the PAZ domains and the RNaseIII domains and since no real dsRBD
sequence specificity have been found yet in this pathway, a model based on structural features
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on the precursor has been proposed in which Loqs-PB could either extend the pre-miRNA stem,
leading to an elongated precursor stem and a shorter product (like pre-miR-316) either shrinking
the stem, leading to a longer product (like pre-miR-307a and pre-miR-87) either with no changes
in the stem length (like pre-miR-let-7) (91; 92). A key role of the internal loop is expected in this
model; the loop could be either stabilized by the shrinking of the stem, or destabilized by the
stem elongation. There is a need of high resolution structure of Dicer/partners/pre-miRNAs to
clarify this.
The similarity between Drosophila Dicer-1 and human Dicer with one cofactor, Loqs-PA and
PACT respectively, having no effect on the length of the product whereas the other one, Loqs-PB
and TRBP respectively, has one seems interesting. Difference between these two pairs of cofac-
tors could help to understand some requirements for the mechanisms. With two instances, one
can only speculate on the reasons that underpin these properties. The main known common dif-
ference between [Loqs-PA, PACT] and [Loqs-PB, TRBP] is the length of the region between the
two first dsRBDs and the last non canonical dsRBD. This region is longer in [Loqs-PB, TRBP] than
in [Loqs-PA, PACT]. Additionally, TRBP has a longer interdomain region between the first two
dsRBD. Assuming the prediction of the interdomain region as linker holds true, the longer linker
of Loqs-PB could allow the dsRBDs to cover the surface of the precursor with fewer constraints
than in [Loqs-PA, PACT]. It would be interesting also to know if there is a stoichiometry dif-
ference between [Loqs-PA,PACT] and [Loqs-PB,TRBP] interaction with some pre-miRNAs and
affinity differences between the domains, and especially what is the extent of binding of the two
first dsRBDs on the same precursor molecule: one dsRBD only binds, the first two binds, or even
more if the stoichiometry is higher than 1. Certain dsRBD containing cofactor might be more
efficient in stabilizing certain precursor structure than other cofactors.
These effects raise many questions: Is the ratio between Loqs-PA and Loqs-PB in Drosophila
and PACT/TRBP in human a way to regulate in miRNA biogenesis? And more generally, what
is the exact biological significance of these pairs of cofactors with distinct properties? In humans,
TRBP and PACT are linked to other pathways, in particular the Interferon pathway where TRBP
inhibits PKR whereas PACT activates it.
4.2 mi/siRNA precursor recognition properties added by dsRBDs and fun-
neling roles
Apart from the canonical recognition of dsRNAs by dsRBDs presented in the Chapter 2, one
can distinguish three additional feature of the RNA that can be recognized by some dsRBDs:
the structure of different classes of small silencing RNA precursor, enabling to funnel some pre-
cursors in dedicated pathways, the hybridization stability in RNA duplexes and the ability to
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interact with specific bases in RNA duplexes.
4.2.1 dsRBDs and potential funneling roles of miRNAs and siRNAs classes
4.2.1.1 Various dsRDP cofactors contribute to miRNA vs. siRNA funneling
Some organisms have distinct sets of Dicer/cofactors, with clear trends in their substrate tar-
gets. dsRBP cofactors seem to have a key role in this sort of "funneling". In Arabidopsis thaliana
DCL1 and HYL1 (i.e. DRB1) participates in the biogenesis of miRNAs and endo-siRNAs but
among the multiple DCL/DRB complexes, it is the only complex reported to participate in
miRNA biogenesis, suggesting that the complex has a special properties enabling the recognition
of miRNA precursors. MiRNA biogenesis is partially impaired without HYL1, with a decreased
formation of the pre-miRNAs (and misplaced cleavages) (149). This suggests that dsRBDs of
HYL1 are a key factor in the recognition of miRNA precursors. Similarly, in C. elegans, RDE-4 is
involved in the initiation of the RNAi pathway which may occur within a single complex, as sug-
gested by the initial requirement of RDE-1 an Ago like protein for the association of Dicer-1 with
dsRNAs (260). In the first biochemical study of RDE-4, no interactions have been found between
RDE-4 and miRNA precursors (260). However RDE-4 binds dsRNA (260) in an apparently non
sequence specific manner (214). This suggests that RDE-4 participate in the separation between
the siRNAs pathway in C. elegans and the apparently less important miRNAs pathway. The un-
derlying mechanism is not known but as suggested by a similar funneling process in Drosophila
melanogaster, it may be related to a subtle interaction between the cofactor and its enzyme rather
than a pure discrimination by the cofactor. Indeed R2D2 is essential to load endo-siRNA duplexes
to Ago-2 and also to prevent their binding to Ago-1 (212). SiRNAs in Drosophila melanogaster are
directed to Ago-1 in the absence of R2D2.
4.2.1.2 Human dicer C-terminal dsRBD as a potential contributor of miRNAs preference
The main difference between most pre-siRNAs and pre-miRNAs is the presence of a loop on
pre-miRNA. Additionally in metazoans some mismatches and bulges in the stem of pre-miRNAs
are not present in pre-siRNAs. Human Dicer can cleave both miRNAs and siRNA precursors. Ki-
netic studies have shown that human Dicer alone was able to process much faster pre-miRNAs
than pre-siRNAs. In multiple turnover conditions, maximal cleavage rates of the Michael and
Menten models of these two classes of precursors differs by more than 100 fold using classical
double stranded siRNA precursors(31). Thus Dicer alone can discriminate between these two
substrates. Human dicer C-terminal dsRBD is close the RNase III active sites suggesting a role
in dsRNA binding (73). The deletion of this domain in full length human Dicer lead to a strong
reduction of pre-miRNAs processing by human dicer (178; 299) and its deletion in a Dicer with-
out the region including the helicase to the end of the PAZ domains also require the dsRBD for
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substrate binding (179). A study focused on the C-terminal dsRBD of human Dicer has shown
that both long double stranded siRNA precursors and miRNAs hairpin precursors can interact
with it with an affinity of the same magnitude (283). With perfect duplex resembling siRNA
precursors substrate (33 bp) and product (22 bp), human dicer C-terminal dsRBD has a similar
affinity which suggest that this dsRBD cannot distinguish between the substrate and product of
Dicer and thus is not involved in the release of the product based on the length of the dsRNA
(283). To mimic miRNAs, adding an octa-U loop to a duplex increased the affinity by a factor of
almost 2 compared to the RNA duplex (283). It would be interesting to perform this comparison
for more dsRNAs and miRNAs molecules. From these studies, the C-terminal dsRBD contribute
to Dicer substrate binding and potentially slightly to a distinction between siRNAs and miRNA
precursors. Potential mechanistic explanation of the difference observed awaits detailed struc-
tural data. The stoichiometry of the isolated C-terminal dsRBD of human Dicer with a dsRNA
was estimated to be 1:1 with sedimentation velocity AUC (283). A crystal structure of a part of
mouse Dicer containing the C-terminal dsRBD with 100% sequence identify with the equivalent
domain in human showed a characteristic αβββα fold (60) with a few particularities. NMR relax-
ation studies have shown that the β1-β2 loop was not really flexible, which did not impaired high
affinity dsRNA binding (with micro-molar affinity in the study conditions). Significant flexibility
compared to the rest of the dsRBD was detected in β2-β3 loop and β3-α2 loop (283). β2-β3 loop
is on the opposite side on the canonical dsRNA binding interface of dsRBD. The high flexibility
in β3-α2 loop has also been detected in Drosophila staufen-dsRBD3 in the apo and holo state. Di-
rect relationship between the loop dynamic and binding properties of the dsRBD remains to be
determined. The miRNAs/siRNAs differential binding might occur in the context of the whole
Dicer/cofactors/dsRNAs complex where cooperativity mechanisms with the different domains
able to binds dsRNAs could exists. A similar comparison would be interesting with the cofactors
of Dicer (TRBP and PACT). A study has already shown that TRBP could increase similarly the
dicing rate of both pre-miRNAs and pre-siRNAs (31).
As mi/siRNA precursors are asymmetric molecules, many works have investigated the poten-
tial orienting effect of the dsRBD containing cofactor of RNaseIII enzymes. Indeed, the presence
of a stem-loop structure and the apparent asymmetry in the base pairing stability of the two
extremities of siRNA appeared as attractive orientation factors for the proteins.
In Drosophila melanogaster, R2D2 also binds to the more stable extremity of the siRNA duplex
whereas Dcr-2 binds to the less stable extremity, allowing the RCL to asymmetrically load siRNA
duplexes on Ago2 (267). Ago2 catalyses the degradation of the passenger strand and then cleaves
the mRNA targeted thanks to its slicer activity (230). The two dsRBD tandems of R2D2 are
both required for siRNA binding and for the asymmetrical loading of siRNA on RISC (173).
The detection of an effect of the base paring stability difference on the strand loaded and in
relation to a dsRBD containing cofactor has motivated the search of a similar phenomenon in
other organisms.
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HYL1 in Nicotiana benthamiana is involved with AGO1 for miRNA strand selection and directs
guide strand selection based on the base paring stability asymmetry of the miRNA duplexes (63).
It was observed that the strand with a 5’ lower thermostability was preferentially loaded. The
mechanism is probably based on a preferential orientation of the miRNA duplex in the RISC
complex triggering the miRNA* degradation (63). DCL4/DRB4 miRNAs and siRNA biogene-
sis seems to have a different mechanism (63), especially since the thermostability rules of the
extremities does not seem to explain the strand loaded.
It has been suggested that TRBP can sense the asymmetry of siRNA in vitro (28). TRBP pref-
erentially crosslinks to the 3’ends of the guide strands of siRNAs (105). However, Dicer and Ago
alone seems have been reported to be able do this themselves. Human Dicer is able to sense
the asymmetry and even to cycle if the orientation of the substrate is not ideal (207). The effect
of TRBP which remains to be demonstrated for microRNA precursors could contribute the Dicer
and Ago effects. Apart from the fact the more stable base paired extremity of small silencing RNA
duplexes is expected to have a structure closer to a stable RNA A helix, structural determinants
that underpin the preferential binding of some dsRBPs to these sites are not clear.
4.2.2 Some dsRBDs are dsRNAs sequence sensitive interactants
Among the dsRBDs involved in mi/siRNA biogenesis, various ones were reported to have
base specific interactions. Commonly reduced to one for most dsRBDs, this feature appear very
important in ADAR (ADAR2) dsRBD1 and dsRBD 2 according to an in solution structure of
human ADAR2 with its natural substrate, complemented by mutational experiments (188). The
sequence specific interactions in dsRBDs were reviewed recently in (188) and in (12) for ADARs.
The case of the solution structure of the first dsRBD of human ADAR2 interacting with GluR-2
RNA stem-loop (256) is given as example in fig. 4.1.
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Figure 4.1: Sequence specific interaction in the complex between the first dsRBD of human ADAR2
and the GluR-2 RNA stem-loop (PDBid: 2l3c ; (256)). The dsRBD is represented in purple and the main
residues involved in the interaction with dsRNAs are represented as tubes colored according to their
atomic composition (carbon: light green, oxygen: red, nitrogen: blue, phosphorus: ocre). The RNA is
represented as a gray tube apart from the phosphate backbone. A hydrogen bounds between the dsRBD
in the phosphate backbone is represented in gray (K128). Residues involved in specific interactions with
the bases and their interactions are represented in green (Met84 and Val104: hydrophobic interactions;
Glu 88 : hydrogen bound).
Sequence specific interaction with dsRBDs: only ADARs? Two regions of the dsRBD are
involved in sequence specific interactions (188; 12) :
- helix α1. A methionine interacts with an adenine and a glutamine interacts with a guanine.
These interactions that could not occur with different bases are thus sequence specific. This
feature has been reported in the two dsRBDs of human ADAR2 (188).
- β1-β2 loop that interacts with the minor groove. This interaction is a hydrogen bound be-
tween the backbone carboxy group of a residue in the loop and the amino group of a guanine.
This amino group is a specificity of guanine in the minor grove so the sequence specificity of this
interaction. This interaction has been more frequently found than the one with helix α1 with dif-
ferent base pairs involving guanines (GC in two orientations compared to the axis of the dsRBD
and GG): Xenopus laevis Xlrbpa, Arabidopsis thaliana HYL1-dsRBD1, human TRBP-dsRBD2, hu-
man ADAR2-dsRBD2 and human ADAR2-dsRBD2 with a GG pair (188). The importance of this
interaction for the function of ADAR2 has been demonstrated by in vitro experiments by replac-
ing the G-C base involved with A-U base pairs (256). These experiments showed a decrease of the
affinity of the dsRBD for their RNA substrate by a factor of 1.5 and 6.5 fold for dsRBDs 1 and 2. in
vivo experiments with double mutations in loop 2 residues involved in the interaction to change
loop backbone structure in both dsRBDs decreased by about 80% ADAR2 editing (256). Another
sequence specific interaction in the β1-β2 has been reported in Arabidopsis thaliana HYL1-dsRBD1
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between the N3 atom of a guanine and a serine hydroxyl group (294; 256).
Multiple dsRBDs with sequence specific interaction capabilities like the two dsRBDs of hu-
man ADAR2 could increase the sequence specificity of the dsRBD containing protein.
Global sequence influence on dsRBDs binding: example of TRBP Taking into account the
available data, important sequence specificity in all the proteins involved in the recognition and
successive cleavage of miRNAs and siRNA precursors would be highly surprising. Indeed, there
is a very large diversity of sequence of small silencing RNA precursors to be recognized and pro-
cessed. However, a slight sequence effect could have been evolutionary selected to trigger some
processing variation and on the other hand, some dispensable cofactor at one stage (TRBP, PACT)
could also have a slight specificity not incompatible with the variable processing properties ob-
served with them.
Interestingly, a moderate influence on the dsRNA sequence has been observed for TRBP. In
the second published paper on TRBP (96), before any structural data, experiments performed on
the peptide composed of residues 208 to 228 (position updated compared to the paper to take into
account a plasmid LacZ fusion adding 39 additional residues) reported a much higher affinity
for purely a G-C hairpin compared to its A-U counterpart. This region corresponds to the long α
helix at the end of the second dsRBD (region 3), which is not involved in specific base interaction
in the available structure of the full dsRBD. Whatever the actual interaction surface with this
peptide which is the core of the second dsRBD, it is expected that the important KKxxK motif
(x: any residue) has a strong contribution to the interaction and suggest a sequence influence
of the sequence on its binding capacities. This could just correspond to a base pairing stability
difference between the two hairpins and would require deeper investigations but is worth noting.
A large scale experimental study on 701 siRNAs has investigated the role of dsRNA sequence
on TRBP binding by comparison of the binding affinities of multiple dsRNAs (135). They found
that the nature of the residue at every 3nn∈N+1 position in siRNAs correlate with TRBP affinity
(and with RNAi activity in vivo). Adenines at positions 3n and 3n1+1 and uridine at position
3n+1 have a positive effect on RNAi. Guanine and cytosine bases at these positions led to a
negative effect on RNAi. Analysis of the binding of 29 siRNA strongly suggested that TRBP has
a key role in this property. It will be also interesting to know the potential role in this context of
the sequence specific interaction between TRBP-dsRBD2 β1-β2 loop that interacts with a guanine
in the minor groove. Precise positions of A and U might retrain the number of configurations of
TRBP/siRNA complexes and lead to an increase of the affinity.
4.3 Effects of the arrangement of dsRBDs in tandems
When a succession of multiple dsRBD copies is present in a dsRBP protein, there is a systematic
affinity difference for dsRNAs between the dsRBDs which usually corresponds to an association
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of a canonical dsRBD with a slightly less canonical dsRBD regarding the sequence. Importantly,
the affinity relationship appears to be always the same for the different RNA analyzed in dif-
ferent works. The presence of multiple dsRBDs has been suggested to increase the affinity for
RNA, the RNA specificity or to help the protein to bind simultaneously multiple dsRNAs. The
latter possibility has however not been demonstrated so far. This part intend to present the most
relevant data and to underline that the effects of this a priori simple organization are likely to be
multiple and far from being clear.
4.3.1 dsRBDs in tandems are frequently independently folded units
All solution studies in dsRBD tandems, using liquid state NMR spectroscopy, have shown
that the dsRBDs were independently folded, with no intramolecular interaction between these
domains in the apo form. This has been shown for the first two dsRBDs of HYL1 (231), for
human PKR (203) and human ADAR2 (256). There are thus no evidences for an obvious coher-
ent increase of RNA binding surface. This flexibility could enable the dsRBD to bind multiple
molecules or to bind with multiple dsRBDs on one dsRNA, which is the case for human PKR.
The structure of DGCR8 core in a crystal has been reported (252) and constitutes an excep-
tion among the literature on the fold of dsRBD in tandems. The structure includes the tandem
of dsRBD with an arrangement resembling a two fold symmetry. The dsRBDs are compactly
folded, interacts with each other and are linked by a small alpha helix with their putative RNA
interacting surfaces oriented on opposite sides of the complex. If these properties also exist in
solution, the two dsRBDs do not seem to be able to bind the same pri-miRNA or a simultane-
ous binding would require a bending of a pri-miRNA. Solution state experiments have aimed
to explore this possibility, including a backbone assignment by NMR spectroscopy (234). The
exact roles of DGCR8 dsRBDs which are fundamental for Drosha activity remains elusive but
the structural difference between the two dsRBDs remarked in the fold classification suggests a
different behavior than most of the dsRBD tandems.
4.3.2 Affinity differences between dsRBDs in tandems
dsRBDs in tandem with high affinity for dsRNA: mainly dsRNA affinty contributors? The
dsRBDs with high dsRNAs affinity have systematically a canonical dsRBD fold and they are
usually not reported to be involved in protein/protein interactions. The first dsRBD of HYL1 and
the second dsRBD of TRBP are both dsRBDs with the highest RNA affinity in the tandem they
belong to and have been extensively studied in solution and behave as monomers. Interestingly,
domain swapping of the first dsRBD of HYL1 with the second dsRBD of TRBP has shown that
the latter domain can supplant the one of HYL1 in vivo and in vitro (294). This suggests the main
role of some high affinity dsRBDs in RNaseIII cofactor might be restricted to RNA binding.
In enzymes containing dsRBDs, the dsRBD with the weakest affinity for dsRNAs can even
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appear dispensable for the known function of the enzyme. The RNA editing enzyme ADAR1 of
human and Xenopus laevis, has three dsRBD. In human, the third dsRBD is the most important in
human for dsRNA binding in solution (175). It is also the case in Xenopus (22). The first dsRBD
contribute to RNA binding, while the second dsRBD appear dispensable for ADAR function
(175).
Structural investigation on the dsRNAs affinity differences between dsRBDs in tandems:
example of HYL1 and TRBP Various structural and dynamical arguments have been proposed
to explain the affinity differences between dsRBD in tandems. The case of Arabidopsis thaliana
is interesting as extensive data from different groups are available. Two independent groups
have investigated the structure of the two dsRBD of HYL1, at its N-terminus in crystal by X-
ray diffraction (294) and in solution by NMR (231). The first dsRBD of HYL1 in a crystal has a
canonical dsRBD fold (294) and in solution by NMR (231). A crystal structure of this domain
with a 10 bp dsRNA has been solved (294). This domain has a fold very similar to the ones of
the second dsRBD of TRBP and of Xenopus leavis dsRBD-2. Both HYL1 dsRBDs can interact with
RNA but the affinity of the second dsRBD is much lower than the one of the first (122; 294; 231).
Difference in affinity between the two dsRBDs of HYL1 are about a factor of 10 (1: 740 nM ; 2: 10
µM in (231)). HYL1 second dsRBD has a non canonical fold (294). In the crystal of apo dsRBD2,
this dsRBD has significant changes in the regions 1 and 2 of the canonical dsRBD, compared
to the second dsRBD of TRBP and of the first dsRBD of HYL1 crystallized with the same 10
bp dsRNA (294). The β1-β2 loop is conserved in the first dsRBD of the different dsRBPs in
Arabidopsis thaliana (DRB1-DRB5) but not in the second one (231). This difference appears as a
key factor in the RNA affinity difference between these two domains. The changes correspond to
a different helix orientation in region 1 and a different loop configuration in region 2 (294). These
remarks perfectly match with the global differences observed in the classification of the dsRBDs
folds performed in fig. 3.4 .
The structures of the first and second dsRBDs of TRBP solved by x-ray diffraction and NMR
spectroscopy respectively have a very similar fold (group 3 of the fold classification). The second
domain of TRBP has a cation-π stabilizing interaction which has been proposed to contribute to
its higher stability and affinity compared to the first dsRBD, despite a sequence contribution is
likely (290).
4.3.3 Tandems of dsRBDs as a way to cooperatively increase dsRBPs affinity for dsRNAs?
The dsRBDs in tandem with a weaker affinity for dsRNAs have been proposed in the dis-
cussion of many articles to be sensitive to structural feature of the RNA but this has not been
demonstrated yet. In this case, some positive cooperativity would be expected for the binding
of appropriate RNAs. More generally, various studies have aimed to characterize the coopera-
tivity between multiple dsRBDs in tandem but the evidences reported are often insufficient to
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conclude clearly. One study report that Arabidopsis thaliana HYL1 dsRBD-1 has an affinity for
dsRNAs about 40 fold weaker than the full HYL1 (294) whereas another one find that the affinity
of a tandem construct with both dsRBDs is similar to the one of the first dsRBD (about 0.7 µM
in this study) with a miRNA/miRNA* duplex (231). The difference between these two studies
might reflect different behavior of the dsRBD on different RNA or reflect foreseen biases related
to the different techniques used (ITC vs. EMSA respectively). A key difficulty in these analyzes
is to adequately take into account the differences of stoichiometry between the experiments with
dsRBDs in tandem and isolated dsRBD. In PKR the tandem of dsRBDs in PKR, the first dsRBD
has the highest affinity for dsRNAs (265). The tandem dsRBD construct of PKR has an affinity 10
times higher than the affinity of the first dsRBD, which is also 10 times higher than the affinity of
the second dsRBD (265). This relation suggests a positive cooperativity in the binding of PKR to
the dsRNA analyzed. In TRBP, the two first dsRBDs bind to the same siRNA precursor molecule
and seems to increase the global affinity for it, compared the single domains (290). This property
could also have a role in the miRNA duplex length.
4.3.4 Tandems of dsRBDs as discriminators between mi/siRNA precursors and dsRNAs
products?
A role of dsRBDs tandems in the discrimination between dsRNAs occurring along the pathway
is conceivable. However, apart from the aforementioned possible case of the C-terminal dsRBD of
human Dicer, no significant binding differences have been clearly reported along a small silenc-
ing RNA pathway. Arabidopsis thaliana HYL1 can bind pri- pre- and miRNA/miRNA* duplexes
with similar affinities (294). In C. elegans, a study has proposed to compare the affinity of RDE-4
with long and small dsRNAs. In this study, RDE-4 has been reported to binds with more affinity
to long dsRNAs, a decrease over than a thousand times in the (single) dissociation constant is
reported in (214) comparing a 650 bp dsRNA with a 40 bp dsRNA, the latter being in the mi-
cromolar range. This has been interpreted as the ability of RDE-4 to distinguish between long
and short siRNAs. Although mentioned by the authors themselves, the obvious difference of
stoichiometry between the two RNA constructs (visible in the gel mobility shift analyzes) and its
effect on the estimation dissociation constant have not been taken into account so the difference
of affinity cannot yet be considered relevant.
4.3.5 dsRBD tandems as slicers on dsRNAs
The propagation of some dsRBDs on dsRNAs was reported recently, at the end of 2012, and at
the time of writing, only one publication reports it using single molecule fluorescence analyzes
(147). The studies were performed on three examples of dsRBD containing protein cofactors
with dsRBDs organized in tandems: human TRBP and PACT and Drosophila melanogaster R3D1-
L. These various examples enable to take this study into consideration here. Since the process
is ATP independent, they called the propagation on dsRNAs a one dimensional "diffusion" pro-
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cess (147). Using single molecule fluorescence resonance energy transfer and one-color protein-
induced fluorescence enhancement, the study reports that TRBP has a continuous and periodic
movement from one end to the other end of Watson-Crick base paired dsRNA of length over 15
base pairs, moving along larger distances on longer RNA and probably moving along the entire
length of the RNA. No diffusion was detected on DNA/RNA hybrid, DNA/DNA duplexes or
on single stranded RNA. Interestingly, only the tandem of dsRBDs belonging to the N-terminal
part of TRBP, known as the dsRNA binding region was found to be required for the diffusion
process and each isolated dsRBD was not sufficient for the diffusion process to happen. The one
dimensional "diffusion" process has also been detected for the Dicer/TRBP complex, the diffus-
ing complexes having the ability to cleave the dsRNA (147) whereas human Dicer alone did not
have the ability to diffuse on the dsRNA. The diffusion behavior was also observed with PACT
and R3D1. Thus some dsRBD tandems can be grouped under a larger set of proteins that have the
ability to diffuse on double stranded nucleic acids; the three examples reported in (147) are the
first examples of diffusion on dsRNA. This one dimensional diffusion process could enhance the
affinity of dsRBD for dsRNAs. It may also be one of the key roles of dsRBD containing proteins
that are cofactor of RNaseIII enzymes in small silencing RNA biogenesis.
Despite the authors did not emphasize on differences between miRNA precursors and siRNA
precursors, it is noteworthy that the average length of pre-miRNA precursor stem is 15-18 nt
which is very close the minimal length for diffusion that they reported for dsRNAs. Additionally,
the systematic motifs in miRNA precursors, bulges and loops, appear to impede the diffusion
of TRBP. Thus the diffusion mechanism might be even more important for the processing of
siRNAs related long dsRNAs or be a phenomenon avoided by the special propertied of miRNA
precursors. The phenomenon could explain the increased or decreased efficiency of human Dicer
associated with TRBP for some small RNA precursors. It will be very interesting to know why
two dsRBDs are required and especially if the very common differences of affinity and dynamics
observed in tandem dsRBDs is involved, as well as the potential role of the interdomain region.
The relation between this diffusion property and other properties of TRBP remains to be elucided.
4.4 dsRBDs and protein/protein interactions
A common feature reported or strongly suggested in many dsRBD containing cofactors is the
ability of the dsRBD possessing a non canonical dsRBD fold to interacts with other proteins, that
belong to the small silencing RNA biogenesis pathway or not. In the miRNA biogenesis path-
ways, these interactions are mainly homodimerization, intramolecular interactions, interaction
with other dsRBD containing cofactors and importantly with RNaseIII enzymes responsible for
the small RNA precursor cleavage. Interactions with proteins not required for the biogenesis of
small silencing RNA, are less characterized but appear as an important link between small RNA
biogenesis pathways and other cells pathways (e.g. interferon pathway via PKR). At the time
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of writing no structure showing the interaction between two dsRBDs has been reported, even
outside of the miRNAs field. The discussion is centered on the biochemical properties of these
interactionsin the model organisms considered here.
4.4.1 Both dsRNA and dsRBD/dsRBD interaction capabilities within a dsRBD?
One of the most common protein/protein interaction mediated by dsRBDs in mi/siRNA bio-
genesis is the interaction mediated by the C-terminal dsRBD of RNaseIII cofactors. In a few
case this region might not be a dsRBD. Homo and hetero dimerization have been reported for
TRBP and PACT, using yeast two hybrids (42), between PACT and PKR in an RNA independent
fashion (217), and with PACT itself in vivo and in vitro (218). For PACT (218) reports the region
containing the first two dsRBD as involved in a homodimerization process, whereas authors of a
review mention they couldn’t demonstrate dimerization with the first two dsRBDs of PACT (58).
Interactions between the first two dsRBDs of PACT have been suggested (220) but the authors
did not rule out the possibility of an interaction mediated by an RNA. Similarly for TRBP, the role
of the dsRBDs with a dsRNA binding affinity in these protein/protein interactions is not clear in
these studies using mainly pull down assays (dsRBD 1 and 2). In PKR, the abilities of the first
dsRBD to dimerize and of the second to oligomerize have been reported (265). The dsRBD-2 of
HYL1 has less affinity than the first one for dsRNA. According to the study reporting a crystal
structure of the dsRBD2 of HYL1 (294), the second dsRBD of HYL1 has a putative dimerization
interface but the data provided do not enable to conclude definitively of the relevance of the
potential protein/protein interaction interface in which this domain is involved. Additionally,
the affinity of the proposed interaction is not known (294). Deeper biophysical studies will be
required to assess the relevance of the interaction in solution and to check the binding interface
suggested by the crystal structure. Additionally an independent study found that the second
dsRBD of HYL1 behaves as a monomer in solution (231). However the second dsRBD of HYL1
can interacts with the central non canonical dsRBD of DCL-1 (227) with weak dsRNAs affinity.
Pull down assay have reported that the second dsRBD of HYL1 is essential for HYL1 interaction
with DCL-1 (122).
All these data are rather unclear and not consistent between the studies. Surprisingly, in an ar-
ticle using NMR spectroscopy, ITC and EMSA to underline a weak interaction between a dsRBD
and a dsRNA (227), only pull down assays are used to show the existence of a dsRBD/protein in-
teraction, a property presented a central in the article. It seems strange that these dsRBD/dsRBD
interaction are almost only studied by pull down assays, a useful technique that has however
many limitations in particular its inability to prove direct interactions. No results have been re-
ported so far using techniques different from the pull down experiments, apart a complement by
Far western assay with denaturing gel in one study centered on the interaction between HYL1
and DCL-1 by pull downs (122). This might reflect difficulties in handling these interacting do-
mains or indicate very low binding affinities that can be hard to detect with other methods. How-
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ever, some the structure of some of these domains (PACT-dsRBD1) have been used for structural
studies that require high concentration. Thus, because of the systematic report of dsRBD/dsRBD
protein interaction reported with pull down assays during the last 18 years, the relevance of
the results could also be questioned. In (261) the authors mentioned that "Freshly purified full-
length HYL1 is monomeric but multimerization occurred after prolonged incubation of the pro-
tein" so additional biophysical data are required to prove the relevance of the pull down assays,
with emphasis on the relevance of the incubation times. The safe conclusion at this stage for
dsRBD/dsRBD interaction of dsRBD with dsRNAs affinity seems to be that in pull down as-
says, some dsRBDs give the same result that the one expected for a protein with self associating
capabilities and that such interaction have not be published with any biophysical method.
4.4.2 The C-terminal domain of dsRBP cofactors as a mediator of multiple protein/protein
interactions
Despite the unclear results for the aforementioned dsRBD/dsRBD interactions, the third
dsRBD of both PACT and TRBP that apparently do not bind dsRNA are consistently reported
to be involved in protein/protein interactions (154). They mediate both their homodimerization
and interaction with other proteins including PKR and Dicer. The third domain of PACT with
only weak binding affinity for PKR is involved in the activation of PKR (220). The C-terminal
region of TRBP interacts with a 165 residue region of Dicer located between the ATPase and
the helicase domain of Dicer (48). Interestingly, an autoinhibition process of human dicer by
its N-terminal domain including the helicase domain has been shown (178) for a perfect duplex
dsRNA subtract of 35 base pair RNA with perfect base pairing. With this RNA, the full length
Dicer is 65-fold less effective to process the RNA duplex than its catalytic core. The autoinhibi-
tion effects is very small with pre-miRNA tested (pre-miR-hlet-7) in (178) and pre-miR-30a (167).
This differential inhibition suggests that the helicase could contribute to distinguish the hairpin
substrate with the shorter duplex product. A potential role of TRBP in relation with a regulation
of this inhibition related to the binding of its third dsRBD is possible. In Arabidopsis thaliana HYL1
can be immunoprecipitated with DCL1 via DCL1-B in the presence of RNase A (149) ; the direct
interaction between these proteins has been proposed with pull down assays. A HYL1 mutant
disturbs miRNAs expression whereas a mutation in the ATPase/DExH-box RNA helicase do-
main of DCL-1 has been reported to restore miRNAs expression (261). The results suggest a
relation between the helicase domain of DCL-1 and HYL1.
Interestingly in C. elegans, RDE-4 can form a homodimer in solution mediated by the C-
terminal domain (214) which may not be a dsRBD. This interaction increases the affinity of RDE-4
for long dsRNAs (214). The C-terminal domain is required for siRNA biogenesis (214). RDE-4 can
also interact with Dicer-1, RDE-1 and DRH-1, a conserved DExH-box helicase required for RNAi
in C. elegans (260). Interestingly, this helicase protein is the most similar protein in C. elegans to
the helicase of Dicer-1 (260). In Drosophila melanogaster, the C-ter of R2D2 is required for binding
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to Dicer-2 (170) and R2D2 binds to the helicase domain of Dicer-2 during endo-siRNA biogenesis
(212). Dicer-2 and R2D2 mutually stabilize in vivo (173). Similarly, the C-terminus specific part
of the PD isoform of Loqs-PD can interact with the DExD/D-helicase domain of Dicer-2 (120).
As with R2D2, Loqs-PD binds to the helicase domain of Dicer-2 during endo-siRNA biogenesis
(212). Again, in fly, the C-terminus of these proteins might not be a dsRBD but the effects and
partners of the interactions strongly resemble, suggesting an analogy within these C-terminal
regions.
Structural characterization of the helicase interaction with non canonical dsRBDs and of its
direct effects on Dicer awaits further characterization.
4.4.3 Simultaneous dsRNA and protein interaction in the dsRBDs of HEN-1 enzyme
A structure of Arabidopsis thaliana S-adenosyl-l-methionine-dependent methyltransferase Hua
Enhancer 1 (HEN1), presented in the part on mi/siRNA in plants was solved by x-ray diffraction
(127). The structure shows the two isolated dsRBDs interacting with a 22 nt a miRNA duplex sim-
ilar to miR173/miR173*. One of the dsRBDs has a resolved unusually long β1-β2 loop involved
in a protein interaction with the methyltransferase domain. This structure is particularly interest-
ing as it is the only structure of a full dsRBD containing protein with its substrate in si/miRNA
biogenesis and of a dsRBD with both dsRNAs affinity and protein/protein interaction proper-
ties. It strongly suggests that dsRBDs can help to orient other domains via both dsRNA and
protein/protein interactions, including the catalytic domains around the RNA substrate.
Figure 4.2: Structure of Arabidopsis thaliana HEN-1 in complex with a 22 nt duplex similar to
miR173/miR173*. The dsRBDs are represented in yellow, the LCD domains in pink, the PLD domain
in purple and the methyltransferase domain in red. The structure shows a dsRBD (on top) involved in
both dsRNA and protein/protein interaction with the methyltransferase domain via its long β1-β2 loop.
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4.4.4 Protein/protein interactions with dsRBD and subcellular localization in mi/siRNA
biogenesis
Schizosaccharomyces pombe Dicer enzyme Dcr1 is not involved in small silencing RNA biogen-
esis but in heterochromatin assembly. Its C-terminal dsRBD has the ability to bind nucleic acid
but this binding property is dispensable for the function of Dcr1 (13). This domain has however
a zinc coordination site that is essential for the nuclear localization of Dcr1 and its function in
heterochromatin assembly, suggesting that the main function of Dcr1 C-terminal dsRBD is nucle-
ocytoplasmic trafficking. Interestingly, the second dsRBD of Arabidopsis thaliana DCL1, DCL1-B
is essential for the localization of DCL-1 in the so-called dicing bodies in the nucleus (73). This
is might be mediated by a protein/protein interaction in which DCL1-B is involved (149). This
suggested a potential broad importance of C-terminal dsRBD of Dicer in their localization.
In human, pri-miRNAs can be edited by ADAR1 or ADAR2 (295). ADAR1 shuttles between
the cytoplasm and the nucleus. The nuclear localization of ADAR1 depends on the interaction
between its third dsRBD and transportin-1 (TRN1) (90). The third dsRBD of ADAR1 appear
highly homologous to other dsRBD. DsRNA binding by ADAR1, involving the third dsRBD
abolish nuclear import via TRN1 binding and its export via exportin-5 binding (90). Thus ADAR
dsRBDs appear involved in the signalization of a dsRNA sensitive nucleocytoplasmic transport.
Despite human Dicer and TRBP do not have known nuclear localization signals and are
mainly present in the cytoplasm, some studies have found that a fraction of these proteins local-
ize in the nucleoplasm (7). Human Dicer localization in the nucleoplasm seems to be mediated
via interaction with nucleoporins, co-immunoprecipitated with Dicer (7).
Conclusion Thus, dsRBDs are a particularly interesting pleiotropic small protein domain in
mi/siRNA biogenesis despite globally similar folds. Many roles and original phenomenon are
frequently discovered like the recent diffusion property on dsRNAs and on the contrary some are
getting less reported like the annealing activity of dsRBD. It was demonstrated that the dsRBD
of Xlrbpa promotes RNA strand annealing i.e. RNA chaperone activity (123), not correlated
with their affinity for dsRNAs. This activity is found in the full length protein and also with its
isolated dsRBDs. A similar annealing activity has been found in PKR (265), which seems to be
related to a straightening effect of PKR dsRBDs on a RNA/DNA hybrid with a bulge (305). This
could be linked to a cooperativity between the dsRBD, the binding of one could help the other
dsRBD of a tandem or from different proteins. However there is lack of structural information
of dsRBD with imperfect A helix dsRNA so the significance and extension of this process with
different dsRBDs and dsRNAs remains to be determined. This is in fact a general comment of
the data available on dsRBDs in metazoan miRNA biogenesis. Despite almost all metazoan pre-
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miRNAs are imperfect dsRNA structures, the relation of these irregular features with the binding
of dsRBDs remains very elusive. In the same spirit, the mutual effects of the dsRBDs interactions
with miRNA precursors are still very unclear.
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Part II
General strategy and biophysical techniques
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This part starts by a chapter that explicit the scientific strategy that frames all the work I report
here. This strategy has been applied through the usage of biophysical techniques that are the
object of the following chapters.
This part contains the following chapters :
- Chapter 5: Strategy: system, workflow and biophysical techniques
- Chapter 6: Characterization of chemical equilibriums in solution
- Chapter 7: Principles, implementation and interpretation of Size Exclusion Chromatography
(SEC)
- Chapter 8: Principles, implementation and interpretation of Size Exclusion Chromatography
coupled to Multiple Angle Laser Light Scattering (SEC-MALLS)
- Chapter 9: Principles, implementation and interpretation of Sodium Dodecyl Sulfate Poly-
acrylamide gel electrophoresis (SDS-PAGE)
- Chapter 10: Principles, implementation and interpretation of isothermal titration calorime-
try for the study of chemical equilibrium
- Chapter 11: Principles, implementation and interpretation of sedimentation velocity Ana-
lytical Ultra-Centrifugation for the study of reversible interactions.
- Chapter 12: Introduction to NMR spectroscopy to study secondary structures and some
exchange processes
It is not the goal of this part to develop all the theoretical and practical aspects of the biophys-
ical methods used. This practice would have contaminated and diluted the thesis work reported
here. Excellent books and articles already exist for most of the biophysical methods used and
are given as references. However, together with the description of the technique implementation
used in this work, it was necessary for each technique to present the key properties required to
understand the origin of the signal, the assumptions used to derive the theoretical framework of
the technique, the biases and the non trivial processes leading to indistinguishable results. This
is necessary to understand the data analysis and the exact contribution of the experiments to the
knowledge of the system. The next parts of this thesis will strongly be based on this part. The
motivations that led progressively to the choice of specific techniques are developed in Chapter
5.
The Nuclear Magnetic Resonance (NMR) spectroscopy chapter is not as developed as the other
methods taking into account the large theory and diversity of the NMR experiments. A lot as
many excellent books are devoted to this and many theses written in the host laboratory have
already detailed the NMR methods developed here and used. The main NMR theoretical and
practical aspects as well as the complementarity with the other methods are presented.
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Chapter 5
Strategy: system, workflow and biophysical techniques
5.1 Definition of the biological systems to be studied
5.1.1 RNA binding region of TRBP
The ScanProsite server (50) was used on the sequence of the long isoform of TRBP (TRBP1) to
get a preliminary prediction of the boundaries of the dsRBDs of TRBP. The program predicted 3
dsRBDs in positions 30-97, 159-227 and 298-361. The available structures of TRBP dsRBD1 and
dsRBD2 solved before the start of the thesis were perfectly compatible with this prediction using
the residues 22-105 and 150-225 respectively. To complement this domain prediction, a secondary
structure prediction and a prediction of disordered segments was performed by the two open
source programs Psipred (133; 191) and Disopred2 (276) respectively. Psipred predicts 3 states for
each residue (helical, sheet, coil), the percentage of the ones being correct (Q3 score) is estimated
to be 77 %. Disopred2 is based on a database of missing fragments in solved crystal structure,
a simple approach recognized as biased by the authors of the algorithm because of the multiple
sources of missing fragments. This was used to define potential addition of a few residues at
the boundaries of the predicted domains to avoid cutting potentially longer secondary structural
motifs. The last dsRBD of TRBP does not interacts with dsRNAs (147) and since this dsRBD and
potentially the interdomain region between dsRBD2 and dsRBD3 are predicted to be involved
in protein/protein interactions and not in the interactions with RNA, this work has focused on
the RNA binding region of TRBP comprising the first two dsRBDs. Attempts in this thesis to
work at high concentration with full length TRBP confirmed, as explicited in some articles, the
difficulty to work with this protein when isolated. Protein constructs have been designed before
the start of the thesis in order to analyze the RNA binding region of TRBP. The idea was to study
the full RNA binding region as well as isolated domains to compare their behavior in isolated
form with their behavior in the RNA binding region. This led to the following constructs with
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TRBP meaning the TRBP2 isoform and TRBP1 the elongated isoform that has a 21 more residues
at its N-terminus: TRBP-dsRBD1 (19-99), TRBP1-dsRBD1 (1-99) TRBP-dsRBD2 (156-228), RNA
binding region of TRBP, TRBP-dsRBD1&2 (19-228, including the two first dsRBDs). The name
of the TRBP isoform will be only used for the construct TRBP1-dsRBD1 (1-99) including the N-
terminal extension corresponding to the isoform TRBP1. Inclusion of 3 residues from TRBP1
in the TRBP1-dsRBD1 (1-99) construct enable an easier NMR assignment of the first residues of
TRBP2, starting at position 22. The sequences and boundaries of the constructs TRBP1-dsRBD1
(1-99) and TRBP-dsRBD2 (156-228) are given in fig. 5.1 .
Figure 5.1: Sequence of TRBP1 (uniprot Q15633) and coloration of residues of TRBP-dsRBD1 (red)
and TRBP-dsRBD2 (green) constructs. 1: proline 144 reported as an alanine in the original sequence of
TRBP ((97), GeneBank: M60801). TRBP2 isoform starts at residue 22. The PSIPRED secondary structure
prediction are indicated above the sequence using orange for sheets, blue for helices and yellow for coils.
Disopred2 prediction of disordered regions is indicated by red stars "*".
The TRBP sequence used for the designed work was performed with the original reported
TRBP sequence by A. Gatignol (97) in 1991. The constructs were designed in December 2007. In
October 2008, a sequence conflict was reported at position 144 in the interdomain region between
the first two dsRBDs because of a mis-identified C nucleotide replaced by a G in the original se-
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quence. As a result in the protein sequence at position 144, the reported alanine is actually a
proline (139-TRSPA-144 protein motif instead of 139-TRSPP-144). This is indeed an error since
a tblastn (5) performed with TRBP1 residues 18 to 228 against the NCBI human Expressed Se-
quence Tags (EST) database and the NCBI human nucleotide sequences database on April 2013
did not revealed the protein motif "TRSPA" but only "TRSPP" apart from the first reported TRBP
sequence. The proline to alanine mutation has not been reported to date in any article devoted
to TRBP even in the successive articles of Gatignol on TRBP including a TRBP review in 2013
(47) and is still not mentioned in the original GeneBank entry (M60801, with its only version
M60801.1). The actual TRBP sequence used in most articles is not clear. The original sequence
with the alanine 144 has been used in this project. The finding in this thesis of the very high flex-
ibility of the interdomain region of TRBP make that no changes are expected in relation to this
mutation for the global properties studied here regarding the free protein and its interaction with
miR-155 precursors. A slight rigidification localized to the residues 143 and 144 in the sequence,
forming a proline-proline motif is possible, similar to the one seen in the other proline-proline
motif of the linker. A natural serine/phenylalanine variant of TRBP at position 251 correspond-
ing to the interdomain region of TRBP has also been reported. This variant belongs to a TRBP
region which is not part of the RNA binding region construct used in this thesis.
5.1.2 Precursors of hsa-miR-155
The two precursors of hsa-miR-155, corresponding to the steps before and after Dicer cleavage
and expected to interact with TRBP were selected in this study fig. 5.2 .
Figure 5.2: Predicted secondary structure of two selected successive precursors of the human onco-
genic microRNA hsa-miR-155-5p, before and after Dicer cleavage. A. Secondary structure of the pre-
miRNA 155 after cleavage by Drosha/DGCR8 (microprocessor) complex. B. Secondary structure of the
miRNA/miRNA* duplex of microRNA 155 after Dicer cleavage.
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5.2 Multiple working hypotheses and associated technique presentation
Multiple working hypotheses Experimental methods that give results that can unambigu-
ously be linked to a single phenomenon are very rare, if they exist. This motivates the multiple
working hypotheses work flow firstly clearly reported by the geologist Chamberlin in 1890 in the
old series of Science (32), reprinted in (33). The approach used throughout this work is consis-
tent with this work flow. Instead of focusing on a leading (exiting) hypothesis and checking its
consistency with the results, the multiple working hypotheses consists of the definition of all the
processes parallel or successive, compatible or exclusive, that could lead to the result observed
given the current knowledge of the experimental system. Additional experiments or informa-
tion can then restrain the number of these working hypotheses. Chamberlin article has lately
been followed by various articles on "strong inference" a concept named by Pratt (222). Although
interesting and being the source of a flow of informative scientific and philosophical papers,
strong inference is only a subset of the Chamberlin strategy in which multiples hypotheses are
not obviously exclusive. A recent article has aimed to underline these differences (69). Multiple
working hypotheses strategy has found recent quantitative analogy with the development of in-
formation theoretic approaches including the Akaike Information Criterion and Akaike weights
for model selection. This quantitative approach will also be used in this work. Distinct mecha-
nisms that can lead to the same apparent result are very scarcely reported in the texts devoted to
the teaching of biophysical techniques. They will be particularly underlined in the second part
of this thesis since they are essential for an appropriate scientific reasoning with the available re-
sults. These principles motivated the way the experimental methods are presented, as developed
in the next paragraph.
Structure of the biophysical techniques presentation nl
- Principles and implementation, explains the origin of the signal observed and its relations with
some properties of the system under study. The exact implementation of the technique in this
work is given here including the material and devices used. The juxtaposition between the prin-
ciples and the implementation in two successive paragraphs rather than in different chapters
aims to have a compact document and so that the protocols steps justification are easily under-
standable for a wide range of readers with different backgrounds.
- Data analysis and related approximations and biases, gives the theory used for the data analysis
used in this work and insists on known systematic biases and on the multiple approximations
that defines condition to be checked during a data analysis.
- Non-trivial indiscernible processes. Among all the processes that can contribute to the signal
observed, whose description is the goal of the "Principles and implementation" parts, some com-
bination will lead to the same signal. This can correspond either to two similar processes in the
system with only one being detected, either to two processes that generate indistinguishable sig-
nals. These combinations of processes are then indistinguishable without additional dedicated
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experiments. I define here what I called "non-trivial indiscernible processes", as indistinguish-
able process that can lead to the same result for a given experimental technique. Trivial sources
of confusion will not be developed in this part, like the fact that the set of possible results is usu-
ally constrained by the experimental device. The "non-trivial indiscernible processes" could also
have been called sources of confusions, sources of indistinguishability, sources of ambiguities,
sources of multiple interpretations. It is my point of view that the presentation of experimental
data analysis and associated conclusions cannot be presented safely without the addition in the
conclusion of the list of the main processes that can lead to similar experimental results. For a
clear identification, the non trivial indiscernible processes defined in this step of the presentation
will be marked with brackets ({ }).
5.3 Selection of biophysical methods
5.3.1 Multiple compatible biophysical methods
A particular effort has been used in this thesis to use, when possible and reasonable, various
experimental in solution biophysical methods to study the system. Each biophysical technique
is sensitive to a subset of properties of the system under study and has a set of biases. As a
consequence - already underlined - almost systematically, multiple hypotheses on the system can
explain a given result obtained with one method. However, the set of sensitive properties and
biases of one method is usually not fully shared by another one. The combination of techniques
sensitive to different properties can restrain the number of theories that could explain the set of
available results. This enables to get more reliable conclusion than a single method study. The
selected methods were chosen to be compatible: all had to be applicable on the same system
in solution with the same physico-chemical environment (buffer, temperature, pH,etc). There is
limited interest to choose different methods to build a model if we know at the beginning that
the conditions are so different that highly different behavior is expected in each method.
The main in solution biophysical method used in this work, which is one of the most informa-
tive and the specialty of the lab where this work was performed, is liquid state Nuclear Magnetic
Resonance (NMR) spectroscopy. It was used for the characterization of free TRBP proteins con-
structs, miR-155 precursors and their interaction surfaces.
5.3.2 Comparison of common methods to characterize macromolecular interactions
Selection criteria for a technique to study TRBP/miR-155 macroscopic equilibrium In order
to define the macroscopic equilibrium (stoichiometries and binding constants) between TRBP
proteins constructs and miR-155 precursors, a selection of additional methods has been per-
formed among the ones enabling to do this.
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Table 5.1: Comparison of methods to characterize macroscopic equilibriums in vitro. In the columns "dissociation constant estimation"
and "stoichiometry estimation", "yes" means that is expected to be determinable in most cases but not guarantied and 1:1 means
restricted to 1:1 interactions ; "possible" means that it is only reasonably determinable in a small range of situations not detailed here.
method abbreviation molecular label-
ing free
immobilization
free
porous matrix
free
dissociation con-
stant estimation
stoichiometry
estimation
theoretical foun-
dation
Nuclear mag-
netic resonance
NMR yes yes yes possible possible quantum me-
chanics
Isothermal titra-
tion calorimetry
ITC yes yes yes yes molar ratio thermodynamics
Analytical ultra
centrifugation
svAUC yes yes yes yes yes thermo/ hydro-
dynamics
Surface plas-
mon reso-
nance
SPR yes no yes yes, 1:1 no quantum me-
chanics
Gel shift assay GSA yes yes no yes yes empirical
Cg multi-angle
laser light scat-
tering
cg-MALLS yes yes yes possible possible quantum me-
chanics
Filter binding as-
say
FBA yes no no yes, 1:1 no empirical
Micro ther-
mophoresis
MTA no yes yes yes no under debate
Fluorescence po-
larization
FP no yes yes yes possible empirical
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The methods that were preferred for this study were selected, to reduce biases, regarding the
following criteria :
- No molecular labeling requirement for the macromolecules. In this case the experiment reports
the binding properties of a chimera, and the best way to show that the chimera has no effect is
to do the study without the molecular label. This appeared particularly unsuitable for the rather
small macromolecules used in this study.
- No binding requirement for the protein or RNA on a surface or interaction in a solid (e.g.
filter binding assay, surface plasmon resonance). Since the system under study is supposed to be
soluble, this binding can alter the availability of the binding sites. The dynamics of the system
can also be affected and the dynamics is well known to be have links with binding properties.
- Homogeneous technique i.e. that does not require separation of bound and free forms that
could alter the equilibrium or the stoichiometry, like a porous matrix or a crystal.
5.3.3 Selection of methods for binding constant estimation and stoichiometry determina-
tion
The goal here is not to review the following methods but to present the mains strengths and
weaknesses of the methods regarding the previously criteria adapted for the of this thesis tab.
5.1. Additionally to the labeling requirement, the size of TRBP[19-228] (22 kDa) and of miR-155
precursors (> 15 kDa) made not fluorescence polarization a good choice since it is suitable for
ligands of molecular weight under 10 kDa (2). Thus, among the methods compared and with
the selected criteria, NMR, ITC and AUC appear to be good candidates for the characterization
of the macroscopic equilibrium of TRBP and microRNA precursors. In well behaved systems for
NMR, this method can be used to estimate the dissociation constants for all detected resolved
sites. However, in many cases where intermediate exchange happen, some observed nucleus
have severe line broadening that strongly complicate this analysis and it can be hard to get the
stoechiometry, which is a key parameter. Additionally with the standard labeling techniques
some large complexes can be missed in the analysis. For reactions with non zero reaction en-
thalpies, ITC can often give fast determinations of dissociation constants and molar ratios in a
more direct way than NMR and AUC. It can also provide estimation of binding enthalpies. Thus
ITC has been selected for the macroscopic equilibrium characterization. However, as underlined
in chapter 10, ITC does not give the exact stoichiometries but molar ratios, so the validity of the
binding constants requires a check of the actual stoichiometry. Additionally some reactions with
almost zero enthalpy of reaction do not give ITC signal and can be missed by ITC. It was thus
required to complement ITC with another method to study the stoichiometry. Ideally the method
used to confirm the molar ratio and to determine the stoichiometry should not be based on the
fitting of a one dimensional curve by increasingly complicated models, like what was done in
ITC. A more direct evidence for the stoichiometry was preferred.
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Motivations for the choice of ultracentrifugation methods for stoichiometry determination
of the interaction Although an apparently simple parameter, potential stoichiometry values
of a system are usually difficult to constrain experimentally. Few methods can do this rather
directly at the time of writing. The main ones are given in the following list with their respective
main advantages and limitation :
- Native mass spectrometry is sensitive to the mass of the complex in a gas phase. It has not
constraints on the molecular weight and can enable to propose combination of the masses of
the individual partners that match the mass of the complex. This can lead to constrained and
often unique possibilities of stoichiometries. However this method does not work in liquid state,
is restricted by now to stable protein complexes and not yet mature for transient protein/RNA
interactions.
- Cross linking strategies have been proposed for protein/RNA complexes (116). The method
is based on an irradiation with ultraviolet light (254 nm) that triggers the cross linking between
nucleotides and residues. It does not require chemical modification of either the proteins or
the RNA. Then a "native" mass spectrometry analysis can be used to get information about the
stoichiometry. Although elegant, there are no guaranties that the cross linkers will only cross
linked relevant interactions or inducing structural changes that might impact the network of
interactions.
- Size exclusion chromatography and MALLS. SEC is not perfectly in solution, involve sepa-
ration of free and bound species that can affect the equilibrium and as already mentioned, has
no rigorous theoretical foundation to analyze the data when an interaction happen. It could be
coupled to MALLS but it seems very hard to satisfy the classical MALLS assumption (see chapter
8) with a transient complex. Additionally if a complex elute in one peak in SEC, MALLS data
analysis will give a weight average of its components that will be difficult to interpret.
- Composition-Gradient Multi-Angle static Light Scattering (CG-MALS) is based on the mea-
surement of the light scattering signal from a series of solutions of different macromolecular
composition. This method is truly in solution, has foundation in thermodynamics and enables
to record data in a few minutes. However, it does not allow to get directly a distribution of the
species in solution. Data analysis requires the additional methods like SEC-MALLS which can be
ambiguous with transient complexes. Finally, this powerful method did not appear to be the best
choice after the ITC analysis since it also requires fitting a one dimensional curve with models of
varying stoichiometry.
- Sedimentation study by ultracentrifugation works in solution for any type of macromolecule
and for a wide range of size up to 100 kDa. The method has foundations in thermodynamics
and hydrodynamics ; all the parameters of the equations that describe sedimentation behavior
are experimentally determinable. It however requires long experiments of at least 5 to 6 hours. It
enables to get many curves that can be processed to get information on the size/sedimentation
coefficient distribution of species in solution. Rather direct information of the stoichiometry can
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then be extracted from these distributions. Because of the large differences in its theoretical foun-
dations compared to ITC and because of the possibility of getting information on the distribution
of species in solution, this method has been selected to complement the ITC data. Moreover,
a wide range of dissociation constants can be studied in AUC (dissociation constants between
10−9 and 10−4). The two dimensional HN NMR experiments and one dimensional proton exper-
iments have shown that the protein and RNA samples used in this work were stable for longer
period than the one required for svAUC.
Comparison of AUC experimental methods and motivations for the use of sedimentation
velocity experiments The idea of the ultracentrifugation techniques is to get hydrodynamic
parameters from the study of the sedimentation of macromolecules in a strong gravitational field
of over 10000 g. There are two complementary methods to study biological macromolecules
with an ultracentrifuge: sedimentation velocity (svAUC) and sedimentation equilibrium exper-
iments. Sedimentation velocity uses a strong gravitational field and long cells to maximize the
resolution. It can give information about size, shape, masses and molecular interactions. Sed-
imentation equilibrium uses a lower gravitational field and short cells in order to reach faster
the equilibrium. It can provide information about molecular mass, association constants and
stoichiometry. Both methods can be used to study interactions. However, the resolution of sedi-
mentation equilibrium is lower and the required long experimental time, a few days, is a major
constraint for many samples compared to the shorter one for sedimentation velocity (4-6 hours).
The former method also requires very high quality data that are not guaranteed a priori. Since
the AUC method was mainly used to confirm the molar ratio proposed in the ITC analysis and
to determine the stoichiometry, to avoid the potential apparition of irrelevant species due to the
long storage of the particle, sedimentation velocity experiments were used here.
5.3.4 Main biophysical methods used
Thus NMR studies were associated with other in solution methods: Isothermal Titration
Calorimetry (ITC), Sedimentation Velocity Analytical Ultra Centrifugation (svAUC) and Mul-
tiple Angle Laser Light Scattering (MALLS). These methods were complemented by size Exclu-
sion Chromatography (SEC) and SDS-Polyacrylamide gel electrophoresis. Although not purely
in solution techniques, the last two methods were useful for their contribution to the purifica-
tion process and to the purity analysis. Each method gave some information on the system that
couldn’t be safely extracted from the other methods used. They also gave information that can be
used to check that there is some common behavior between the techniques. All this information
has then been assembled to build a model of the interaction between the RNA binding region of
TRBP and the stem-loop and duplex precursors of the human microRNA 155.
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Chapter 6
Characterization of chemical equilibriums in solution
6.1 Macroscopic and microscopic chemical equilibriums
Non covalent interactions between molecules involve weak forces including electrostatic and
hydrogen bounding forces. Also called transient interactions, they are involved in most life pro-
cesses. Their characterization is one of the key to understand biological processes and they are
also of great interest for drug design. An atomic resolution knowledge of inter macromolecular
interactions would require to know the magnitudes of these forces or potentials for the set of
dynamically interacting atoms. Another simpler and useful way to characterize the interaction
is to consider sets of interacting atoms. Two description of these set are usually reported: we can
either differentiate each sets of sites that interacts ("microscopic" description of the equilibrium)
either only differentiate the different sets of species that can associate ("macroscopic" description
of an equilibrium). Each equilibrium can be defined by a chemical equation, representing mass
and charge conservation as illustrated in fig. 6.1.
Figure 6.1: Illustration of the microscopic description (A.) and the microscopic description (B.) of a
chemical equilibrium involving two species M and L. M has two interaction sites (s1 and s2) for L and L
has one interacting site for M. The sites are represented with vertical bars (|). Microscopic and macro-
scopic association constants names are given for each sub equilibrium and defined later in the main
text.
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Both microscopic and macroscopic equations of the equilibriums can be quantitatively com-
plemented with thermodynamic and kinetic parameters. In particular the study of the system at
equilibrium enabless to get estimates of the concentrations of the species at equilibrium and so
quantify how displaced is the equilibrium and so the strength of the interaction. The full micro-
scopic description is richer in information than the macroscopic one since the exchange between
each assembly state can involve multiple paths according to the sites involved fig. 6.1. An interest
of the macroscopic interaction is that it is sufficient to globally compare the behavior of various
molecules and give very useful information to design a study at a higher precision. The goal of
this part is to present the main classical thermodynamic theory for the study of the macroscopic
equilibrium from titration experiments. The development will focus of the necessary approxima-
tions and the relation between the quantity actually measured and the quantities of real interest.
6.2 Thermodynamical quantification of equilibrium displacement
6.2.1 System, environment and strategy to study macromolecular interactions
Interacting molecules The system in this study contains the protein TRBP and microRNA pre-
cursors, often mixed together to study their potential interaction. If an interaction happens, the
interacting system might not be reduced to different associations of these macromolecules but
additional species from the surrounding media can participate in the reaction. These additional
species can be protons, metal ions that neutralize the charged residues, etc.
Overall strategy The common general strategy to study equilibrium is to monitor during a
titration some physico-chemical probes perturbed upon the interactions as a function of variables
representing the amount of species introduced progressively in the system. This is what have
been done is this work with different methods. The deconvolution of the sources of perturbation,
not only reduced to the interaction process, is the key to the quantification of the interaction.
Specific development will be devoted to this analysis in the chapters devoted to the biophysical
techniques used for this study. Two phenomena common to each technique are worth to define
here and consist the first two approximations in the following development :
- ApproximationAInter0: biologically reasonable interaction conditions. In the interaction char-
acterization of macromolecules, some interactions contribution are qualified specific while others
are said to be nonspecific. The original idea behind this distinction seemed to separate the rel-
evant versus irrelevant interactions. Although commonly used, these terms are hard to define
since the two situations are described by the same physical forces. An extreme case to illustrate
the idea of irrelevant interactions is the aggregation of some monomeric proteins in vitro envi-
ronment with very low salts concentration, whereas no such protein/protein interactions exists
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in vivo. Interesting discussion on the meaning of "specific" vs. "nonspecific" interactions have
already been published in many places but without improvements of the concepts, for instance
in (11). The point of view adopted in this work was to choose chemical environment conditions
for the in vitro studies not too far from the in vivo ones in temperature, pressure, ionic strength
and pH. These simplified conditions aim to be able to underline the relevant fundamental prop-
erties of the isolated molecules, despite the intracellular effects (crowding, etc) are not taken into
account. This is one of the key assumptions for in vitro studies, enabling to discuss the results in
the lights of the in vivo data available. If the assumption is not fulfilled, the study is reduced to
the biophysical study of the interaction of two biological polymers.
- Approximation AInter1: negligible macromolecular alteration. The first approximation in the
interaction studies is that potential temporal physico-chemical variation of the macromolecules
between the initial and the final state have to be negligible compared to the changes linked to the
interactions. These undesirable physico-chemical changes can be caused by oxidation reactions
(so the importance of a reducing agent for non disulfite bound containing proteins), enzymati-
cally catalyzed reactions like peptide bound cleavage that can be caused for instance by a bacte-
rial contamination. The latter phenomenon should be negligible for highly pure macromolecules
and will be checked for the different methods. This assumption is referred as AInter1.
6.2.2 Macroscopic equilibrium constant vs measured concentration constant
The following development contains important assumptions that are required to derive the
standard relations used in the data analysis for the thermodynamical characterization of the equi-
librium. These assumptions are commonly not reported in the biochemical studies and while
their explicitation is important to modulate the conclusions obtained with methods used to char-
acterize equilibrium constants.
Macroscopic equilibrium constant Let’s consider a closed system in which happen the follow-
ing reversible reaction, with n species (n ∈ N∗) Aj,j∈{1,n} of stoichoimetric coefficients νj,j∈{1,n}
:
n
∑
j=1
νj Aj = 0 (6.1)
The equilibrium will be studied at constant exterior pressure P and temperature T in this
work with variable molar quantities of the species involved nj,j∈J1,nK. In these conditions, the
appropriate energy potential is the Gibbs energy G(T, P, nj,j∈J1,nK). Using the fact Gibbs energy
is a state function of the variables pressure P, temperature T and of the molar quantities of the n
species j, Nj and using the second principle of thermodynamics, the equilibrium condition is :
n
∑
j=1
νj
(
∂G
∂nj
)
︸ ︷︷ ︸
µj
= 0 (6.2)
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with the µj,j∈J1,nK term called the chemical potential of the species j. By similarity to the ex-
pression of the chemical potential of an ideal gas, the composition dependency (xj,j∈{1,n}) of the
thermodynamic potential of a type of solutions with N components is expressed with a reference
chemical potential µre fj (T, P) as :
∀ j ∈ J1, nK, µj = µ
re f
j (T, P) + RT ln(xj) (6.3)
This relation defines what is called an ideal solution (53). Some consequences of this definition
is that for any pair of molecule in the solution, the mean strength of the interactions are the same,
the enthalpy of mixing of the reactants and products mixed in their equilibrium proportions is
zero and the volumes are additive. However and importantly, this equation does not describe
real solutions for which the two previous implications are usually not verified experimentally.
An additional term in the logarithm has thus been added (53) to account for this behavior and
misleadingly called activity "coefficient". This coefficient, noted γj is actually a function of T, P
and the molar fraction of all the species in solution. Thus the general expression of the variation
of chemical potential of the species j at constant P and T in a real solution can be expressed as :
∀ j ∈ J1, nK, µj = µ
re f
j (T, P) + RT ln(γj(T, P, x1:N)xj︸ ︷︷ ︸
aj
) (6.4)
The activity of a component in solution aj,j∈{1,n} is defined as the function in the previous log-
arithm. The arbitrary reference standard states pressure has been chosen following UIPAC rec-
ommendation: p◦ = 105Pa, which is also the ambient temperature used in this study. The refer-
ence temperature is added to define this state and set to be 298.15 K. It is the temperature used in
this study as recommended (8) partly because this common temperature facilitates comparisons
between different studies but more biochemical details on the choice of the physico-chemical
conditions of the system are developed in the part devoted to the set up of macromolecules pro-
duction protocol. Since the solutes in this study are irrelevant ionic solids in their pure form in
the defined standard state, following UIPAC recommendations the asymmetric solvent/solute
convention is used to define the reference states of the chemical species (53), using an infinite
dilution state for the reference chemical potential.
Approximation AInter2: if the solutes participating in the reaction are very dilute, it is possible
to neglect the moles of these solutes compared to the moles of the solvent. This approximation
will lead a negligible bias in this study since the concentration of pure water is 55.56 M, much
higher than the concentration of the solutes with a total concentration less than 200 mM. Thus,
the reference chemical potential for a solute Aj∈{1,n} is defined from a hypothetical state at an
infinite dilution at the same pressure and temperature as the one in the study. The chemical
potential expressed in concentrations using a reference concentration (C◦) of 1 mol/L can be
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expressed as :
∀j ∈ J1, nK, µj(T, P) ≈
AInter2
µ
in f
j (T, P) + RT ln
(
γj(T, P, [A1:N ])
[Aj]
C◦
)
(6.5)
The expression of the activity coefficient is obviously the main difficulty in the use of this
relation. Because of the definition of an ideal solution, the activity coefficient will approach unity
as the concentration become infinitely low. Many works have aimed to give explicit expression of
the activity coefficients. The related expressions are however hard to include in the modeling of
the processes that can be monitored with current biophysical methods. The activity coefficient is
particularly important in electrolyte solutions like in the system under study since for two ions of
opposed charge z+ and z−, the attractive electrostatic force is inversely proportional to (only) the
square distance r between these two ions: z+z−
r2
. For example, even H2SO4 a component with few
charges has an activity coefficient significantly different from 1 at 500 µM in water at 25°C: 0.885
(53). Introduction of the last expression of the chemical potential into the equilibrium equation
leads to :
n
∏
j=1
(
[j]
C◦
)νj
︸ ︷︷ ︸
Kc
≈
AInter2
n
∏
j=1
[
γj(T, P, [A1:N ])
]−νj exp

−
n
∑
j=1
νjµ
inf
j (T, P)
RT


︸ ︷︷ ︸
K(P,T)
(6.6)
with the K(T, P) term called the reaction constant. Practically, without any knowledge on
the activity coefficient, only the concentration fraction of the equilibrium constant can be stud-
ied from titration experiments, which is called concentration "equilibrium constant" (Kc). The
concentration "equilibrium constant", Kc is rigorously not a constant at fixed pressure and tem-
perature since the activity coefficients depends on the composition of the system. The previous
formula relate this concentration "constant" to the actual equilibrium constant. The closer to ide-
ality the solution is the closer the two constant.
Another complication comes from the fact only a subset of the n reacting species might be
known. For intance some species different to the biological polymers can be involved in the
reaction: protons, mineral ions etc (8). These potential p species not taken into account imply to
rewrite the measured concentration constant Kcm as :
Kcm =
def
p
∏
j=1
(
[j]
C◦
)νj
≈
AInter2
n
∏
j=p+1
(
γj(T, P, x1:N)
)−νj p∏
j=1
[j]−νj K(T, P) (6.7)
Relevance and goals of the macroscopic equilibrium characterization in this study As a
result of the previous considerations, the measured Kcm "concentration binding constant" is ac-
tually not exactly the binding constant K because of the approximation AInter2 (of negligible
effects), of the non ideality of the solution (i.e. activity coefficient different from 1) and of the
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species involved in the equilibrium and not considered in the expression of K. The last two as-
pects might not be negligible at all; they are not required approximations and will be mentioned
in the data analysis. Furthermore, the measured concentration constant Kcm,measured is not the ex-
act Kcm for three additional reasons depending on the experimental method: potential unknown
co-reactions happening in parallel to the reaction under study and contributing to changes of the
concentrations of the species involved in the equilibriums, systematic biases and random errors
in the estimation of Kcm coming from the measurement process. The relevancy of an approach
neglecting the activity coefficient difference to unity or the contribution of co-reactions can be
questioned without a specific studies or strong theoretical arguments. For instance, despite the
macromolecules used in this study for interaction characterization are all used at low concen-
tration (20 µM to 800 µM), they are highly charged so it does not seems reasonable to assume
that the activity coefficients are equal to one. Instead of making many unrealistic assumptions,
the point of view adopted in this work was to fully explicit the quantities actually measured
and then discuss the meaning of the measured value in the light of the available information
on the system. This enables to clearly separate the rigorous theoretical expression of the mea-
sured quantity from its interpretation and to avoid silent error propagation. Moreover, the fact
the concentration constant is not the actual equilibrium constant is not a limit to achieve some
characterization goals of the system. If the goal of the experiment is the estimation of the reaction
Gibbs energy variation, an accurate binding constant estimation is required but it may not be the
case for some applications like finding minimal conditions to shift the equilibrium towards one
complex. The goal of the macroscopic equilibrium study of this work is not to have absolutes
parameter estimation or to infer what happen into the cell conditions. It is mainly done, with the
previous limitations in mind, to :
- define the nature of the equilibriums involved in the system
- compare with the same framework the behavior of macromolecules with different partners
- define estimates of the equilibrium constants that enable to find the conditions under which
the system is saturated or under saturated, in order to design deeper biophysical investigations,
including the definition of the interaction surfaces.
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Chapter 7
Principles, implementation and interpretation of SEC
Definition and main biophysical applications of SEC Size exclusion chromatography (SEC)
is a chromatography technique whose separation principle is based on the size of the molecules.
It is also called gel permeation or gel filtration chromatography but the UIPAC recommended
name is SEC. SEC is commonly used as a purification step and associated with Multiple Angle
Light Scattering (MALLS), to estimate polymer molecular weight (see next chapter).
7.1 Principles and implementation of SEC
1. SEC column - RNase free equilibration The column for size exclusion chromatography is
composed of a rather inert matrix of polymer particles that contain many pores of controlled size.
Implementation SEC was performed with an analytical Superdex S75 10/300 GL column (GE
Healthcare). This column is composed of a spherical composite of cross-linked agarose and
dextran with an average particle size of 13 µm. The column was pre-equilibrated with a phos-
phate buffer (23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10 mM MgCl2 and 5 mM β-
mercaptoethanol) prepared in RNase free conditions with RNase free components. These RNase
free conditions enable to purify protein for RNA interaction studies. The volume of this col-
umn (CV) was 24 ml. SEC column was previously washed sequentially with 1.6 column volume
of RNase free water, 0.5 M NaOH, 2 M NaCl and RNase free water. Between sets of sequential
experiments, the column was stored in an aqueous solution with 20% ethanol. Before each exper-
iment, the ethanol was removed with 1.6 CV RNase free water and the column was equilibrated
with 1.6 CV gel filtration buffer described previously. A constant 0.5 ml/min buffer flow rate
during the equilibration was controlled using the "BioLogic" system (Bio-Rad)
2. Injection of the sample on the column A small volume (<1/40 CV) of the mobile phase
containing the macromolecule under study is loaded on the top of the column.
Implementation A 50 µl (< 0.084/40 CV) and 500 µl (< 0.84/40 CV) injection loops were used
to inject the sample for SEC coupled to MALLS or for SEC only respectively. Before the start of
an experiment, the injection loop used was systematically washed sequentially with RNaseZAP
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(Sigma-Aldrich), RNase free water (>40 ml) and RNase free SEC buffer.
3. Elution The pumping rate is set to be constant and assumed to be so, which is controlled
with the pressure monitoring at the column output. That’s why the time variable to describe
the evolution of the chromatography is usually converted as a volume variable to describe the
peaks characteristics. During the elution of the mobile phase, the average residence time of the
molecules and complexes within the pores will depends on their average shape and size. Small
molecules will tend to be more effectively trapped by the pores than large molecules that will
more likely migrate between them. Molecules larger than the pore size will be excluded from
the pores and will elute first at an unresolved volume called the dead volume of the column or
exclusion limit. At the other extreme, molecules smaller than the smaller pores will all elute the
latest, at the same time. This is called the permeation limit. For molecules that elute between the
two limits with different hydrodynamic properties, the SEC column implies a difference of the
length of the average path followed by the molecules and so different elution volumes. Since the
molecules were injected almost at the same time, species with similar hydrodynamic properties
will elute almost at the same time. SEC does not concentrate the molecules during the elution.
Implementation The elution was performed at a constant 1 ml.min−1 flow rate. The value of
the dead volume of the column was estimated using a solution of Blue Dextran (≈ 8ml) of molar
weight of about 2M Da.
4. Signal recording: UV, refractometry and MALLS During the elution of the mobile phase
the liquid going out of the column can be analyzed using various type of detectors including UV,
Multi-Angle Laser Light Scattering (MALLS), Viscometer, Refractometers and Mass Spectrome-
try.
Implementation For SEC only experiments, the chromatography was monitored with an UV
detector working at 280 nm and 260 nm. Other detectors were used for the SEC-MALLS config-
uration (see next chapter).
7.2 SEC data analysis
Contributions to the elution volume of a species in SEC : The main variable of SEC-UV chro-
matography is the time dependent UV signal of the mobile phase. The peaks correspond to the
elution volume of the UV absorbing species. Elution volumes at the exclusion or permeation
limit indicate that the chromatographic column used is inappropriate to resolve the correspond-
ing species. The SEC method is empirical with no well defined theoretical foundation that can
quantitatively explain the elution volume in the fractionation range of a given species from a set
of its properties. Two kinds of phenomena are known to contribute to the elution volume in the
fractionation range of a given column :
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- Exclusion mechanisms. This is the process already mentioned, the key process of SEC. It is dif-
ficult to link quantitatively the exclusion behavior of the molecules to a well defined biophysical
parameter despite many articles have been published on this topic. The viscosity radius ap-
peared as a good candidate compared to many others including mass, second virial coefficient,
diffusion coefficient, etc (225). It is sometimes used in the so called universal calibration (159)
and modified universal calibrations but further studies have found exceptions to them.
- Potential adsorption There are undesirable potential non size exclusion mechanism corre-
sponding to the adsorption between of the molecule on the stationary phase. The stationary
phase of the SEC used is made of cross-linked agarose and dextran. Some proteins are able to
interact with the glucose residues.
Applications of SEC in this thesis As a result of the lack of clear theoretical foundations
of SEC, a rigorous quantitative experimental analysis of the elution volume could not be per-
formed. An experimental quantitative analysis would require using a calibration with other
macromolecules. However such a calibration is of limited information since the choice of an
appropriate set of proteins would require prior knowledge of the related properties for the pro-
tein under study. These calibrations have not been used in this work. However, SEC can be used
quantitatively to estimate the protein purity. It can also be used qualitatively using a series of SEC
profiles performed at different concentrations to assess whether a resolved species self-associate
in the concentration range used. Indeed, if the populations of free and bound macromolecules
are significantly different in the concentration range used, there will be a shift of the peak or
multiple peaks with varying intensities. SEC was used in this work for these two qualitative and
quantitative applications.
7.3 Non-trivial indiscernible processes in SEC
Five important and compatible non-trivial indiscernible processes in SEC are listed here :
- Both a single monomeric macromolecule, a highly stable complex or macromolecules in-
volved in a fast association equilibrium compared to the duration of the SEC experiment can
lead to a single peak in the chromatogram. Working at multiple concentrations can help to dis-
criminate these situations
- Differences or similarities of elution might not be only related to exclusion processes (cf
adsorption process above).
- Multiple conformers of a species with different exclusion properties in fast exchange com-
pared to the duration of the SEC experiment won’t be detected. The elution volume will depend
on the hyrodynamic properties of the conformers and on their populations.
- Very large fibrillar aggregates may not be able to enter the column and thus may not be
detected.
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- If an equilibrium is going on in SEC, a quantitative study of resolved populations at equilib-
rium might not reflect the real thermodynamic behavior in solution because of the influence of
the column matrix that segregate components during the elution.
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Chapter 8
Principles, implementation and interpretation of SEC-MALLS
Definition and main biophysical applications of SEC-MALLS In static Multiangle Laser
Light Scattering (MALLS) experiments, a monochromatic light scattered from a system is mea-
sured as a function of the angle between the incident beam by a set of detectors. This technique
is also called classical scattering or total intensity scattering. MALLS measurements can give es-
timations of molar mass, molecular root mean square radius and information on intermolecular
interactions
8.1 Principles and implementation of SEC-MALLS
1. Multi-angle light scattering detector - implementation Because of the variability of
MALLS detectors design, I directly describe briefly here the system used, a DAWN EOS (Wy-
att Instruments) with a laser with a vacuum wavelength of 690 nm and 18 detector positioned at
different angles, measured from the oriented axis of the laser beam (fig. 8.1).
Figure 8.1: Photodetectors setup for the MALLS DAWN®. EOSTM respecting real angles and with the
notations of tab. 8.1(1).
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This MALLS detector was used in line after a SEC chromatography step with the same pa-
rameters than the one described in the previous chapter. An in-line Differential Refractive index
Detector (DRI) (RI 2000, Spares) was also used after the MALLS detector to follow the differential
refractive index of the SEC eluate relative to the solvent (1.34), with the following set-up: [SEC at
≈ 25°C] −→ [UV detector at ≈ 25°C] −→ [MALLS at 25°C] −→ [DRI]. The basic notations used
in the MALLS part are given in tab. 8.1
Table 8.1: Notations used in the following MALLS equations
Notation Definition
V volume of the solution that scatter
N number of particles in the volume V
Na Avogadro constant
c mass concentration (kg/l) of the molecule in V
η number of segments in the volume V (see section 8.2)
nmol refractive index of the solvated molecule
nsol refractive index of the solvant
λ0 vacuum wavelenght of the incident wave
I0 intensity of the laser beam
θ angle between the incident beam and the detectors
dθ distance between the volume and the detectors
Iθ scattered intensity at the angle θ
dΩθ solid angle of the collected scattered light of the detector at angle θ
ng refractive index of the glass of the measurement cell
ns refractive index of the solvent used in the study
nre f refractive index of the reference compound used for the MALLS calibration
Rθ excess Rayleigh ratio of the solute under study
a characteristic radius of the molecule
2. Laser lamp and detector equilibration - implementation This step needs one hour for the
DAWN system used (1).
3. Calibration and normalization of the MALLS detector The signal measured in a static
light scattering experiment is mainly the angular dependency of the scattering intensity Iθ. For
a solute, the signal can be quantified as the excess Rayleigh ratio of the solute under study. This
ratio is defined here as the excess of scattering of the molecules under study over the scattering
of the solvent. For a vertically polarized light it is defined with scattering intensities coming from
a volume V into a detector with :
∀ θ ∈ [1, 2π], Rθ =
(Iθ − Iθ solvent) d
2
θ
I0 V
(8.1)
As the measured volume depends on each detector in a way difficult to precisely quantify,
related to the geometry of the cells, the estimation of Rθ is done using an empirical relation
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between Rθ and Iθ :
∀ θ ∈ [1, 2π], Rθ = fcal,θ(nre f , ns, ng)
(Iθ − Iθ solvent)
I0
(8.2)
This relation requires the use of the calibration of one detector at 90° with a chemical of known
Rayleigh ratio and refractive index nre f . It is followed by a normalization of all the detectors with
an isotropic scatter in the solvent used for the study at the same pressure and flow rate (1). This
procedure enables to estimate the calibration function fcal,θ(nref, ns, ng). The exact procedure
is device dependent. Since fcal,θ(nref, ns, ng) does not depends of the scattering molecule, the
calibration can be applied to any other system.
Implementation The calibration was done with HPLC grade toluene (filtered), a solvent with a
high Rayleigh ratio. The calibration was checked with bovine serum albumin, a well character-
ized protein.
8.2 Data analysis of MALLS signal and related biases
Laser diffraction for MALLS can be conveniently studied non quantum mechanically using
the Maxwell equations. An approximate analytical solution of these equations for MALLS has
been developed and is widely applied to biological macromolecules. It is not the goal here to
derive the MALLS equation from the Maxwell equations. However, I list in the following part
the approximations that are used to derive the main equations used to fit SEC-MALLS data.
These approximations mainly come from the seminal works of Zimm and Wyatt (307; 286) and
are still widely used. However many approximations were criticized by their authors themselves
and require discussion for a proper analysis of MALLS datasets.
System Let’s consider within the measured volume slice a monomeric macromolecule or a sta-
ble oligomer characterized by a molar mass M. The following development holds true under
this assumption of monodispersity. A simple adaptation of the results to the case of a mixture
of multiple species of distinct molar masses is given afterwards. The incident light is polarized
vertically. The N molecules are considered to be composed of a set of η scattering dipoles scatters
called segments (286).
Hypothesis 1 The first condition required for the following development is that the size of the
macromolecules studied is below λ0 i.e. 690 nm. This limit corresponds to very large macro-
molecules and is easily checkable from the experiment results. This condition of validity is noted
AMALLS1
Hypothesis 2 and consequences: Rayleigh-Gans-Debye approximation This approximation
is: the incident wave is unaffected by the scattering molecules (286). With the notations of tab.
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8.1, the Rayleigh-Gans-Debye approximation (AMALLS2) can be defined quantitatively :
 |
nre f
ns
− 1| ≪ 1 molecular and solvent refractive indexes differences are negligible
2a 2πnsλ0 |
nre f
ns
− 1| ≪ 1 total phase shift of the incident wave through the sample is negligible
(8.3)
Under the Rayleigh-Gans-Debye approximation, the excess Rayleigh ratio at an angle θ in a
volume dτ with −→sθ being the difference between the unit vectors of incident and scattered rays,
and~r the vector between successive scattering segments in the volume dτ can be expressed as
(286) :
Rθ =

4π2n20
(
dn
dc
)2
NA(
λ0
n0
)4c

(η2N2
V2
) ∫
ρ(r) exp(2πi−→s
−→r
λ0
n0
)dτ (8.4)
The integration is over all orientations and magnitude of r at constant s.
To my knowledge, the application of the RGD approximation to biomolecules has not been
studied generally. Although obviously useful, it seems that it introduce errors. A.R. Jones (132)
mention three studies on spheres showing that if a signal error under 10% is expected with the
RGD approximation, the following conditions are required :


nmol
nsol
6 1.25
2a 2πn0λ0 → 0
(8.5)
Here the refractive index of the solvent is 1.34. The refractive index of the protein is unknown
but is usually between 1.5 and 1.65 (115) for proteins. Assuming the highest value of 1.65, we
have nmolnsol = 1.23. This suggests that the accuracy may not be higher than 10% for some spherical
proteins.
The second condition of the Rayleigh-Gans-Debye approximation means that polarization ef-
fects due to the anisotropy of molecules should not occur. This seems a more limiting assumption
than the previous one, especially for the highly asymmetric RNA molecules. Anyhow it seems
more relevant for small macromolecules, like the ones used in this work, than for very large ones
(223).
Hypothesis 3 : molecules composed of independent scattering segments (AMALLS3). The rel-
ative position of two segments is characterized by the vector~r. The radial distribution function
of the segments in a molecule corresponds to the probability of finding a segment at a distance
r from another one in a volume dτ. It is the sum of two disjoint contributions: two segments
belong to the same molecule or they belong to distinct molecules. The probability P of finding
one segment at a distance r from another one in a volume dτ is easily expressed as the sum of the
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probabilities of the two scenarios :
P = (ηρinter(r)dτ) + (ηρintradτ) (8.6)
The internal density can be expressed using the normalized intensity distribution function
(307) :
P(θ) =
∫
ρ(r)exp(2πi ~s
~r
λ
)dτ (8.7)
Hypothesis 4 and consequences: Single point intermolecular contact restriction and concen-
trations infinitely small (AMALLS4). In the previous equations, the expression of the external
density terms is harder. Under the hypothesis that two molecules can interact only at one single
contact and with infinitely small concentrations, we have, with X a unexplicited term :
∫
lim
c→0
[ρinter(r)]exp
(
2πi~s~r
λ
)
= η2XP2(θ) (8.8)
This hypothesis is due to Zimm that recognized that this was the approximation most likely
not valid in the MALLS equation derivation (307). As a consequence of this approximation, the
SEC-MALLS cannot be used rigorously for the study of a mixture of particles with transient in-
termolecular large site interactions in the time scale of the experiment (1 data/seconds recorded).
The potentially complexes and biased species separation from the SEC add also a complication.
This is why the SEC-MALLS method was not applied in this work to study the protein/RNA
stoichiometry and affinity. If the concentration is high, other terms should be added in this ex-
pression but there are difficult to describe quantitatively (286). In the eluate of SEC, the concen-
tration of each slice is different from the others and is not "infinitely small". It is however widely
assumed that these concentrations are sufficiently small for this approximation to be useful.
Summary: Debye-Zimm equation Under the hypotheses {AMALLS i, i ∈ {1, 2, 3, 4}}, the
equations previously given can be combined in the so called Debye-Zimm equation. The excess
of scattering of the molecules under study over the scattering of the solvent at an angle θ in a
volume dτ can be expressed like this (286) :


Rθ =

4π2n20
(
dn
dc
)2
NA(
λ0
n0
)

McP(θ) [1− 2 (−−Naη2X2M2 )MP(θ)c]
P(θ) =
∫
ρ(r)exp(2πi~s ~rλ0
n0
)dτ
(8.9)
where X is a term not explicited here representing short range interactions. Importantly,
this result has been derived with no assumption on the molecular shape/conformation of the
molecule under study. The use of this equation requires to explicit the normalized intensity
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distribution function P(θ) also called the form factor (3). It can be expressed generally as a poly-
nomial development :
P(θ) =
+∞
∑
j=0
(−1)j αj
[
2k sin
(
θ
2
)2j]
(8.10)
with the αj being proportional to
∫
r2j dM. Interestingly, the second coefficient α1 has an easy
interpretable value :
α1 =
1
3
r2g with : r
2
g =
1
M
∫
r2 dM (8.11)
where r is the distance from the center of gravity g of the molecule. rg is called the mean
square radius of the particle.
Practical use of the Debye-Zimm equation in this work The Debye-Zimm equation has two
unknown parameters, the calibration constant already discussed and the increment of refractive
index. The MALLS signal Rθ depends on the square of the differential refractive increment
(
dn
dc
)2
.
However, with the concentration of polymer measured with the Differential Refractive Index
(DRI) detector, the concentration term c in the Debye-Zimm equation is replaced by c =
RIsignal
dn
dc KRI
which lead to a linear dependence of the MALLS signal on dndc (272). The error on
dn
dc has thus
much less effects with the use of a DRI detector. The estimation of dndc , required to analyze the
MALLS data, can be performed by multiple ways :
- Direct experimental determination of dndc usually require large quantities (a few mg) of macro-
molecules and dry weight measurements to be able to accurately determine the relation between
the refractive index measured with a DRI and the macromolecular concentration. This direct
method is thus often impractical for biological macromolecules for which such quantities are
very difficult or costly to obtain.
- It could also possible to estimate dndc using the knowledge of the concentration of the sample
before the SEC-MALLS experiment and assuming a total recovery of the material going out the
column but this is a strong assumption (possible adsorption in the column, imperfect injection,
...) so it can lead to errors that reach 20% (288).
- Consensus values. Many measurement in the literature have suggested that the distribution
of dndc was very narrow. An extensive theoretical study on human proteins has shown that the
dn
dc at 589 nm has an almost Gaussian distribution with a mean of 0.190 ml.g
−1 and a standard
deviation of 0.003 ml.g−1 (304). Thus a common approach is to use "consensus" values of about
0.185 in phosphate buffer saline at 25°C (278). According to a theoretical study on the dndc values
for human proteins (304), using the consensus value can lead to a maximum error of 10% for
unmodified proteins.
- A study proposes a theoretical calculation of dndc from the protein sequence (304). The predic-
tion uses however strong assumptions in its derivation using in particular the Lorentz-Lorenz
equations, valid for a few crystal structures, a point not discussed in the article. The proposed
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approach applied to the MALLS conditions (25°C, laser wavelength of 690 nm and solvent refrac-
tive index of 1.34) lead to 0.1777 ml.g−1 for both TRBP-D1D2 and TRBP-D2 and 0.1776 ml.g−1 for
TRBP-D1.
Thus using the calculated value will lead to a molecular weight estimations 4% lower than
with the one estimated with the consensus value in phosphate buffer at 25°C. Since this error is
moderate, the choice of one of the two approaches for TRBP constructs will not introduce major
differences in the molecular weight estimation for monomeric macromolecules. To avoid the use
of the strong assumptions of unknown effects in the theoretical calculation of dndc , the experimen-
tally supported consensus values of 0.185 at 690 nm and 25°C for the protein constructs, leading
to a potential molecular weight estimation error of 10 %, was preferred in this study.
A lack of information on dndc for RNA does not enable to use very appropriate values. The
same value than the one of the protein has been used in this study.
Adaptation for multiple masses Since the elution from a SEC peak can be composed of dif-
ferent species of distinct masses, the precedent equations can be expressed in this more general
case by replacing the mass M by the a mass average M using data from each fraction i, here the
"weight"-average (286) :
Mw = ∑
i
ci Mi/ ∑
i
ci (8.12)
Fitting of the Debye-Zimm equation - implementation The data are then globally fitted for
each SEC peak with the Debye-Zimm equation using the previous expression of P(θ).Different
arrangement of the Zimm equation can be used to perform the fit of the data (Debye, Zimm and
Berry models). Molecular masses were estimated here with the Debye model using ASTRA soft-
ware version 5.3.4.20 (Wyatt Instruments). As P(θ) is an infinite series, the fitting is done with
the first terms (j ∈ {1, 2, 3}) and the different models can be compared with model comparison
techniques. The first two terms are usually sufficient for fitting molecules with rg < 30 nm (it was
the case in this study) but for rod-like molecules inclusion of the second order term in sin(θ/2)
can be required for the characterization of data collected at high angle even for much smaller
molecules (286). The variables to be fitted are thus these αi,i∈{1,2,3...}, the weight average molecu-
lar mass Mw and if included, the second virial coefficient A2. This coefficient was set to 0 in this
study.
Thus one checkable hypothesis (AMALLS1) and 3 approximations (AMALLS i, i ∈ {2, 3, 4})
are required for the use of the MALLS equations to be fitted for the estimation of molar masses.
These last three approximations are obvious sources of bias in MALLS. According to the previous
discussion, it seems reasonable to estimate the maximum error on the estimated mass to range
between 10 % (because of the assumptions in the Debye-Zimm equation derivation) and up to
20% because of the potential errors on the increment of refractive index, although the estimation
might be more accurate for some systems. The imprecision on dndc , if it is not accurately measured
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experimentally, can be critical to discriminate between large multimeric species whose mass dif-
ference can be small. Independently to the previous potential biases, some errors can come from
the noise of the data and the fitting process. They are reported here from the ASTRA software
version 5.3.4.20 fits, taking into account the noise in each detector and the fitting procedure (3).
Other parameters like the root mean square radius is poorly determined form small macro-
molecules below 10 nm / 50 kDa. Their accurate measurement would require to have more signal
so higher concentration or slower elution rates.
8.3 Non-trivial indiscernible processes in SEC-MALLS
Some important MALLS only non-trivial indiscernible processes are listed here :
• {A monomeric species} and {a mixture of species of different molar weight eluting at the
same time} from SEC can lead to the same estimated average molar mass. Despite the
SEC separation before MALLS is a key step to diminish the polydispersity of the samples
measured, there is still a risk to have multiple species analyzed at the same time and thus a
bias on the estimated mass.
• An imprecision on the increment of refractive index or a significant biais linked to the
approximations 1,2 and 3 can impede the discrimination between various possibilities of
larges complexes with similar molar masses.
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Chapter 9
Principles, implementation and interpretation of SDS-PAGE
Definition and main biophysical applications of SDS-PAGE SDS-PAGE stands for Sodium
Dodecyl Sulfate (SDS) PolyAcrylamide Gel Electrophoresis (PAGE). Gel electrophoresis enables
in parallel high resolution separation of many macromolecules in a mixture. SDS-PAGE method
is highly used for characterizing macromolecular sample homogeneity. The method used here
correspond to a slightly modified version of the one described by Laemmli (153).
9.1 Principles and implementation of SDS-PAGE
1. Sample preparation for SDS-PAGE. We consider in this paragraph either proteins or nu-
cleic acid that will be called generically macromolecules. The samples SDS-PAGE are prepared
by heating macromolecules in a Sodium Dodecyl-Sulfate (SDS) solution with a high concentra-
tion of reducing agent. SDS (CH3-(CH2)10-CH2OSO3-Na+) is an anionic detergent that triggers
a temperature catalyzed denaturation of the macromolecules. The reducing agent reduces the
disulfite bounds.
Implementation A 4× solution for the sample preparation contained 128 mM Tris at pH 6.8,
10% glycerol, 2% SDS, 730 mM β-mercaptothanol and a small amount of bromophenol blue and
was used at a 1× final concentration. The samples were heated at 95°C during 5 minutes. To
remove potential aggregates, heated sample were then centrifuged during 10 minutes at 25°C
and 18000 g just before loading them on the gel.
2. Gel preparation for SDS-PAGE Polyacrylamide gels are formed by polarization of cross
linked acrylamide and bisacrylamide. The gel has globally uniform pores, whose size is depen-
dent on the percentage of acrylamide. Polymerization with a comb enables to make wells in the
stacking gel.
Implementation Gels were prepared in this work using two 1 mm staked gels 8× 7 cm gels with
15 wells, a staking gel with 7.5% of 291 acrylamide/bisacrylamide for sample loading and concen-
tration, and a running gel with 15% of 291 acrylamide/bisacrylamide for the macromolecules sep-
aration. The composition of the staking and running gel solutions for two gels are given in tab.
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9.1 for a two gel preparation. The TEMED (Tetramethylethylenediamine) and APS (Ammonium
persulfate) are added and mixed extemporaneously just before the gel casting in a Mighty small
dual gel caster device. The staking and running were poured successively in the caster device
with an time interval long enough for the running gel to polymerise. A solution of isopropanol
was added during this interval at the top of the running gel to avoid surface irregularities. The
alcohol was then removed with an abundant water wash. The electrophoresis was performed at
180 V using a SE 250 Mighty Small II system.
Table 9.1: Composition of the running and staking gel solution to prepare 2 80 × 70 × 1 mm
gels.
Solution Vol. running gel (ml) Vol. staking gel (ml)
water 4.125 4.4
Tris 2M pH 8.8 2.05 0
Tris 1M pH 6.8 0 0.73
SDS 10% (w/v) 110.10−3 55.10−3
Glycerol 50% (v/v) 143.10−3 0
Acrylamide/bisacrylamide 291 40% 4.125 826.10
−3
TEMED 11.10−3 10.3.10−3
APS 10% (w/v) 80.10−3 30.10−3
3. Electrophoresis Samples are loaded in the stacking gel wells. An electric field is then ap-
plied to the gel with the positive charge being at the opposite position of the samples to trigger
their migration. The protein-SDS complex depends mainly of the length of the peptidic chain
(about 1.4 g SDS/g protein i.e. about 1 SDS molecule per 2 residue (221)). The macromolecules-
SDS complexes being highly negatively charged, it is considered that the main factor that con-
trol the migration is the length of the polymer, which is the property of interest when per-
forming SDS-PAGE. The chemical composition has also an incidence. It has been shown that
acidic and basic proteins migrate not as expected taking only into account their chain length.
Acidic proteins (negatively charged) tend to bind less SDS (negatively charged) than the aver-
age, which results in a higher mobility. It is the contrary for basic proteins (e.g. Histone H1,
troponin 1) (110). Additionally, proteins with high proline content have a decreased mobil-
ity probably as a result of increased rigidity and kinks (110). As a result of these phenomena,
an interpretation of the value of the SDS-PAGE protein mobility by its molar mass in order to
estimate it gives errors of a least 10 % but they can reach 30 % (110). Moreover, non full denat-
uration state of the macromolecule during the migration is also expected. It has been shown
by NMR that polypeptidic chains, even in the presence of strong denaturants like 8 M urea,
guanidine hydrochloride or SDS are not completely random coils. So the chemical composition
is also likely to impact these conformation and the mobility.
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Implementation The electrophoresis was performed at a constant voltage of 180 to 220 V in a
migration buffer (25 mM Tris, pH 8.3, SDS 2 g/l and glycine 14.4 g/l).
4. Macromolecule detection - electrophoretic mobilities After the end of the migration, the
macromolecules are commonly detected by staining. A solution of Coomassie blue is often
used for its convenience. The stainability of a protein with Coomassie blue band depends on its
chemical composition (110), on the density of macromolecules in the band (206) and the staining
increases with time. As a result of the time dependence property, for quantification purpose it
is required that the set of macromolecules used for calibration are stained simultaneously as the
other lanes to be studied.
Implementation The gels were incubated with a fixing solution (10% (v/v) acetic acid, 45%
ethanol and 45% water) during 10 minutes, stained (10% (v/v) acetic acid, 45% ethanol, 45%
water, 600 mg/l Coomassie Blue R250) and destained with a solution of 10% acetic acid and
then stored in distilled water. The different species detected by the staining solution can be
seen as bands that can be characterized by their electrophoretic mobility µ. With E the electric
field (V.cm−1) and v the migration rate (cm.s−1), it is defined as: µ = vE . The mobility of a
sample of interest is often compared to the ones of known macromolecules mixtures called
standards.
9.2 Non-trivial indiscernible processes in SDS-PAGE
Some of the main non-trivial indiscernible processes in SDS-PAGE are listed here :
- {A pure protein sample} and {the same sample with additional very large aggregates} that
can’t enter the gels will lead to the same apparent result. The systematic addition of the col-
oration of the stacking gel can help to detect such aggregates. Lack of detection can also happen
with small contaminants like small peptides that can be eluted from the migration or lost during
the fixing/staining step. Thus, the lanes might not reflect the full macromolecular composition
of the sample.
- {A basic protein} and {a smaller neutral protein} can lead to two bands with the same
electrophoretic mobility. Many similar scenarios based on the multi-factorial determinants of
the electrophoretic mobility can be imagined.
- {A pure sample with two different migrating species in the gel linked to imperfect denatu-
ration} and {a sample with two distinct species in solution} can lead to the same indistinguish-
able two band result.
- {A monomeric protein}, {a homo-oligomeric protein} or {a protein covalently linked to
other undetected macromolecules} can all elute with one band. A one band signal does not
give information on the covalent or non covalent macromolecular assembly state in solution.
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Chapter 10
Full cell ITC for the study of chemical equilibrium
Definition and main biophysical applications of ITC UIPAC proposes the following defini-
tion of Isothermal Titration Calorimetry (ITC) (244): "an ITC measurement consists of monitor-
ing the transfer of heat between an analyte solution in a sample vessel and a reference solution
in a reference vessel upon injection of a small aliquot of titrant solution into the sample vessel
at a fixed ITC operating temperature". Compared to many biophysical methods, calorime-
try is an old field that started with biological studies performed by Lavoisier and Laplace in
the 1780s on guinea pigs (158). Calorimetry has received in increasing interest in molecular
biophysics linked to the development of increasingly sensitive calorimeter with small sample
requirements. ITC is widely used to determine thermodynamics parameters of biological inter-
actions between combinations of proteins, nucleic acids and small molecules.
10.1 Principles and implementation of full cell ITC
I describe here a typical full cell calorimeter and how is generated the signal from a mixture of
two solutions. The full cell titration starts from a cell filled at the beginning of the experiment.
The injection of liquid in the cell during the titration leads to the ejection of a similar liquid
volume out of the cell.
1. Calorimeter Let’s consider the monitoring of the mixing of two solutions using a full cell
ITC. I describe here the main parts fig. 10.1. The calorimeter contains two lollipop shaped cells,
a sample cell and a reference cell. Cells are made with an inert material and have heaters on
their flat part. Their inner volume range between 2 ml and 200 µl depending on the calorime-
ters; the inner volume of the syringe is much smaller. The two cells are placed in an adiabatic
shield regulated at the desired temperature Texp. Both cells are connected to the outside of the
adiabatic shield by long and thin access tubes. The mains steps in the ITC set-up to the signal
recording are described in the following part.
Implementation The full cell ITC system used in this thesis is an ITC-200 from MicroCal fig.
10.1. The inner cell volume is 201.4 µl while the syringe volume is 35 µl. Cells are in Hastelloy-
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C. It is at the time of writing the most sensitive ITC apparatus available and the one using the
smallest amount of liquid.
Figure 10.1: Simplified scheme of a full cell calorimeter realized from the original description of Wise-
man et al. (280). This scheme corresponds to the calorimeter used in this study. The heaters (htr) are
colored in red. Thermopiles that measure temperature difference are represented in blue circle with the
name of the parameter measured in the circle and arrows pointing to the calorimeter elements com-
pared. The injection and homogenizing syringe in the sample cell is not represented. Cal.: calibration.
F.B.: Feed-Back
2. Wash The sample cell and the injection syringe are part of the calorimeter so in order to
avoid adding reactions to the potential ones that are the goal of the study, these elements require
to be extensively cleaned before the start of the experiment. This is particularly important for
work with RNA since RNases are commonly used to calibrate the calorimeter (78).
Implementation In the present study, before a series of experiment, the sample cell and the
injection syringe were washed using an incubation during 5 minutes in RNase ZAP (Sigma-
Aldrich) diluted in RNase free water. An extensive wash was done using a long needled RNase
free syringe with RNase free water, stopping a few washes after no longer moss due to the
RNase ZAP (Sigma-Aldrich) was detected visually. This corresponds to 15 to 20 washes. Ad-
ditional 5 washes were done with the RNase free buffer used to solubilize the macromolecules.
The cell was stored filled by the buffer until the loading of the sample and the syringe was
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dried. To avoid inter-experiment contamination, at least 6 wash steps with both water and
buffer were performed between each experiment.
3. Filling - implementation A long RNase free needled syringe is used to fill the cell and the
access tube with the analyze solution. The reference cell is usually already filled indifferently
with water or a buffer. The hypothesis that both cells are filled is required for the analysis so it is
very important that there are no bubbles in the cell. That’s why it is first necessary to degas the
sample solution or to centrifuge it to remove bubbles in the solution. Moreover, it is required
to add slightly more volume than the sum of the cell volume and the access tube volume to
be sure that the system has been completely filled. The access tubes enable potential bubbles
located at the top of the cell to go up. The syringe is filled as any syringe. The samples were
only centrifuged here (18 000 g during 10 min at 25°C) since this avoids the risk to increase the
concentration of the macromolecules by evaporating some solvent components.
4. Potential small non collected injection Before the insertion of the syringe into the cell, it
might be useful to do a small injection to have a homogeneous movement of the syringe piston
(199) to avoid special behavior of the first recorded point. This step was not performed here.
5. Insertion of the syringe into the cell and stirring After the filling, the syringe is placed
into the cell. This action cause part of the solution in the cell to go out of the access tube so the
volume of solution in the cell is now Vcell −Vsyringe in cell. The syringe has a small paddle at his
tip fig. 10.1 that is used to homogenize the cell solution using a circular motor that rotate the
whole syringe from this step to the end of the experiment. Stirring has to be sufficient for a fast
mixing.
Implementation A 800 rpm stirring was chosen in this study.
6. Thermal equilibration of the cell The thermal regulation circuit works permanently but it
will have a key role from this step till the end of the experiment.
- Temperature control mechanism. The temperature is controlled in the range [2-80°C] via a
feedback mechanism. The adiabatic shield is regulated to the temperature Texp. A thermopile
connects the adiabatic shield with the reference cell and produces a signal proportional to their
temperature difference ∆T2. This signal is amplified and fed to the feedback heater on the jacket
to maintain its temperature very close to Texp. In parallel, to prevent heat leaks from the sample
cell to the surrounding, a thermopile measure the temperature difference ∆T1 between the sam-
ple cell and the reference cell, which is compensated by the sample cell feed back heater. This
is the important signal monitored over time. Because the temperature regulation is performed
by heaters, this regulation will work better when Texp is higher than the room temperature; for
lower temperature, a coolant circuit is used in the system (water or dry air).
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- Signal recorded. To avoid recording noise, a constant power below one milliwatt is dissipated
in the heater of the reference cell. This will trigger the cell feedback circuit described previously
that will drive ∆T1, back to 0 K. The signal of the "injected power" is recorded over time via a
computer. In the absence of a temperature change in the cell, the recorded feedback power will
be constant.
- Calibration. Accurate measurement of the power related to the solution mixing require a
calibration correction by measuring the heats of standard chemical reaction and performing
internal electrical pulses heating checks. The electrical correction is implemented via a constant
power applied to the cell heaters. The correction is performed by a devoted heater on the
sample cell. Ideally a standard reaction is used to check that the calorimeter is well calibrated.
It has to be underlined that contrary to the adiabatic shield, the temperature of the syringe
is not controlled in the ITC-200 calorimeter and is at room temperature. So despite the titrant in
the syringe arrow tip will have time to equilibrate at the cell temperature, there will be a ther-
mal transfer between the room and the cell. This effect can be significant when the temperature
of the room is highly different from the one of the cells (e.g. 61°C in (308)). So it is important to
maintain the temperature of the room constant. Ideally about 30 minutes are required for the
equilibration. This is assessed by waiting to the time required to have an almost constant base-
line before the beginning of the experiment. For this purpose, before the start of the injections,
the temperature difference between the cell and the jacket is monitored in live.
Implementation. The room temperature between 22°C and 23°C and at least 20 minutes equi-
libration were used to reach an almost flat baseline.
6. Isothermal titration and signal recording A motor drives the plunger to inject a controlled
small volume amount from the syringe to the cell. The mixing is finished within a "few seconds"
after injection, according to MicroCal "visual inspection" at 400 rpm (280). The observable in
ITC is the input of power over time delivered to the sample cell feed back heater required to
maintain its temperature equal to the one of the reference cell. If the mixing cause a change of
the temperatures between the two cells, there will be a change of the feedback power followed
by a progressive return back to the baseline. If the solution mixing is exothermic, it will create
a negative contribution to the power signal measured; if the solution mixing is endothermic,
it will create a positive contribution to the signal. If an exothermic or endothermic chemical
reaction is happening, the shape of the peaks will have a fast almost linear part and a slower
decreasing part. The delay between injections should be long enough for the baseline to go back
to a constant value. Otherwise, the signal is not interpretable quantitatively. In ITC datasets of
solution mixing associated with one or more reactions, the first injections will give large heats
because the majority of the injected titrant, in small proportion, will bind to the analyte in excess
in the cell. During the titration, binding sites of the ligand or the analyte will get saturated in the
cell and the peaks area will decrease, not obviously to zero. At one point there will no longer be
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changes in the signal, indicating a saturation in the titration. The experiments have to reach this
point in order to exploitable. A classical example of recorded signal, for an exothermic reaction,
is given in the result part in fig. 17.1.
10.2 ITC data analysis for thermodynamic reaction characterization, related
biases and proposition of a new systematic strategy
Two main motivations have led to the redaction of an "experiment design and data analysis"
part for ITC, in a more comprehensive way than what has been done for the other techniques :
- Lack of published demonstration of ITC fitting equations. Despite ITC is widely used and that
the principles rely on simple thermodynamics, to my knowledge, there is no published full
demonstration of the widely reported ITC equations used to fit the experimental data. This
might not appears as a big deal since they are not long to demonstrate but it appears that
when reported into the articles, the ITC equations are stated without the explicitation of the
hypothesis, approximations and boundaries that are necessary to derive these equations from
basic thermodynamics. This is particularly striking for the widespread "single sites models", a
special microscopic model that is often erroneously considered as a generally applicable model
(actually restricted to one set of independent sites). Thus there is a risk to over/mis-interpret
some ITC datasets. The full equations and their validity conditions are summarized in this
chapter.
- Explicitation of a reliable strategy to fit ITC data. The most used ITC equation to fit the data is
based on the one set of independent sites microscopic models. It provides affinity constants, re-
action enthalpies and molar ratios. Additionally to the point raised in the previous paragraph,
it is well known that the floating molar ratio parameters can be biased with error on the active
concentration of the molecules under study. I emphasize here the approach used in the thesis
using global fitting of the ITC data by successive series of multiple models compared with an
information theoretic approach. This aims at determining the relevant information content of
the ITC data and is implemented in the GNU R language (228).
10.2.1 Baseline correction of ITC datasets
Slight differences of temperature of the room during the experiment or underfilled cell, might
cause continuous drift of the ITC signal baseline. So the first step in ITC data analysis is a base-
line correction. Some manufacturer software encourages to manually adjust the baseline. How-
ever this practice can introduce a non reproducible user dependent bias. It can also encourage
bad practice consisting in back-adjusting the baseline to improve the fitting for the selected
model. Moreover manual baseline correction is not compatible with the high throughput pro-
cessing of multiple datasets. Before 2012 no automated ITC baseline correction algorithms have
98
been proposed in the literature. In mid-2012, a good baseline correction has been proposed,
base on singular value decomposition (140).
Implementation. In the work presented here, the moderate baseline correction required to
adjust the datasets were performed using a combination of two general baseline correction
algorithms working well for the structure of the available datasets. R baseline package was used
to implement these corrections (169). The first one is Asymmetric Least Squares Smoothing
(ALS) (66). Using the terminology used in the latter article, this algorithm was used with λ = 0
and p = 0.01. This first correction worked well but was imperfect for the smallest injection
at the end of the titration. A second correction was used to improve the first one, based on
Iterative Restricted Least Squares (IRLS), an algorithm implemented in the R baseline package
(169). Using the terminology used in the latter reference, this algorithm was used with λ1 = 0,
λ2 = 5 and wi = −0.2. It has to be underlined here that the choice of the parameters is not
appropriate for any datasets, and has to be adjusted for different datasets. Thus, the proposed
approach can be qualified as semi-automated baseline correction.
10.2.2 Secondary measurable from baseline corrected ITC data
After baseline correction, there are two types of data that can be extracted from ITC curves :
- peaks integrals. The integration of the power over time for each peak gives a vector of heat
transfers with one component for each injection.
- peaks shapes. Kinetic studies of enzymatic reaction by ITC were pioneered by Julian Sturtevant
(reviewed in (18)). Recently a group (25) has proposed to extract kinetics information from the
peaks shapes in more general cases but the method is still at a development stage.
This part is devoted to the extraction of thermodynamic parameters from the vector of heat
transfers. Let I be the number of injections and ti the time at which the injection i end, t0
is defined as the beginning of the titration. Let Q be the vector of heat transfers during the
titration. For a given reaction involving the titrant, the magnitude of the heat transfers at each
titration step will depend on the amount of titrant injected into the cell. The standardized vector
of heat transfers q is obtained by dividing each component of Q by the corresponding number
of moles injectant :
{
q ∈ RI/∀ i ∈ J1, IK, qi =
Qi
ninjectant(i)
, Qi =
∫ ti
ti−1
P(t)
}
(10.1)
This standardization enables to compare easily the integrated data of two different experi-
ments using different concentration of titrant. Modelization of the continuous ITC power sig-
nal (dq/dt) with ordinary differential equation can give interesting insight into the properties
of binding models (280; 224). This approach is not used here where the more common mod-
elization of the vector of heat transfer is used. The next part presents the thermodynamical
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modeling of the vector q.
10.2.3 Total concentration estimation at each titration step
Before starting the thermodynamic modelization of the system, it is necessary to calculate the
total concentration of each titrant and analyte solution at each step of the titration. There is a
least 3 different formulas found in the literature with no justification for most of them. They
derivation depends whether it is considered that the expelled volume after each titration has a
composition similar to the one present in the cell before the injection or whether the mixing is
fast enough so that the expelled volume will progressively be charged by the injected material.
A demonstration of the different formulas under their different hypothesis of validity is given
in annex section 20.4
Implementation. In the experiments performed here, the injection last about 0.5 - 1 seconds
and the spinning is performed at 800 rpm so about 13 rotations by second occur. It seems likely
that in these conditions there will be a continuous mixing during the injection. The dilution will
depend on the usually poorly known viscosity of the solutions and the geometry of the cell and
stirrer. However, a full hydrodynamic study of the mixing is not required to solve this since in
the range of injected volumes used, the two extreme case, "no mixing" and "mixing" will lead to
very similar total concentration estimation in the common ITC conditions. Since the continuous
mixing approach seemed more appropriate this is the one I choose to use in this thesis (AITC1).
The total concentration expressions are given in section 20.4 and in section 10.2.5.1.
10.2.4 Energetic modelization of ITC heats transfers
Application of the first principle of thermodynamics Only the beginning of the demonstra-
tion is given here to underline some key approximations/hypothesis. The remaining part is
available in the annex section 20.4 We consider a reaction happening without gas production
(AITC2). At each injection of a volume v in the sample cell, a similar volume will be expelled in
the collect bath. The resulting elevation of liquid in the collect bath is very moderate because
its diameter is much larger than the diameter of the narrow access tubes fig. 10.1. The resulting
increase of pressure in the calorimeter cell can thus be neglected. The pressure P is assumed to
be constant from now (AITC3).
According to the first principle of thermodynamic applied the volume corresponding to the
inner part of the calorimeter cell, the variation of internal energy U, of kinetic energy Ek and the
potential energy Ep are linked to the work W and to the thermal transfers Q exchanged with
the outside with :
∆U + ∆Ec + ∆Ep = W + Q (10.2)
The content of the cell does not undergo variations in kinetic or potential energies so: ∆U =
W + Q. Assuming no gas is released during the titration (AITC4), V, P and T are constant. Since
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H = U + PV we have for the system: ∆H = ∆U (107). So the measured thermal transfer is :
Q = ∆Hmixing −Wmixing (10.3)
The goal is then to express Q as a function of the thermodynamic parameters of the reaction,
which require explicitation of the enthalpy and work terms :
Work contributions on Q The work of mixing corresponds to the work required to perform
the titration. It has been shown (107) that the injection work was detected by ITC, leading to
small positive contributions to the signal. This work can be interpreted as the energy required
to compensate the energy dissipated by the friction of the fluids during the injection (107). But
a contribution to the friction forces linked to the movement of the liquid in the long narrow
access tube can also be conceived.
Enthalpy contributions on Q They can be classified into two groups :
- Enthalpies linked to the potential reactions under study. This is the enthalpy we usually want
to measure. This enthalpy depends on the sum of surface weak forces, solvation changes and
conformational changes involved in the reactions.
- Enthalpies not directly linked to the reaction under study: enthalpies associated to the dilution
of the titrant and/or analyte if they are involved in an equilibrium with themselves, enthalpies
due to the imperfect mismatch of the syringe and cell buffer and reaction with a buffer compo-
nent (acido-basic reactions). In the latter case, the potential reaction under study occurs with
the release or undertake of protons that will lead to parallel acido/basic reactions with the
buffer system. The magnitude of these enthalpy variation contributions depends on the ion-
ization enthalpy ∆Hion of the buffer component(s) used and the number n of proton released:
∆Hprotonation = n.∆Hion. The buffer ionization enthalpy can be high for some buffers like amine
buffers (∆Hion[Tris, pH = 8.1] = 47.44 kJ.mol−1) and much lower with others like phosphate
(∆Hion[Phosphoric acid, pH = 7.2] = 3.3 kJ.mol−1) (41).
As a result, the thermal transfers estimated from the ITC signal integration is a priori not
directly linked to the reaction enthalpy of interest ∆Htarget reactions :
Q = ∑
r ∈ reactions
∆Hr −Wmixing (10.4)
with multiple reactions: target reaction(s), buffer reactions, dilution of the analyte, dilution of
the titrant, reactions linked to buffer mismatches and potential other reactions.
Isolation of the enthalpy of reaction Because of the previous relation, the estimation of an
accurate reaction enthalpy require to isolate the reaction enthalpy terms by performing other
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experiments and/or ensuring that they are negligible. Various experiments of result to be sub-
tracted or added to the vector Q of the main experiment are commonly described (41; 87). For
the work term, a blank experiment, adding the titrant into the buffer and buffer into the titrant
can be used to estimate this work W (41) or check that it is negligible compared to the measured
enthalpies. For a study of a two molecules interactions, the following experiments are required
to estimate the enthalpy terms (dil.: dilution ; buf.: buffer) :
- [Syringe: titrant | cell: buffer only]: Qdil. titrant = ∆Hestim. dil. titrant + Wmixing dilution titrant
- [Syringe: buffer only | Cell: analyte]: Qestim dil. analyte = ∆Hestim. dil. analyte + Wmixing dil. analyte
- [Syringe: buffer only | Cell: buffer only]: Qestim buf./buf. = ∆Hestim. buf./buf. + Wbuf./buf.
It has to be underlined that the signal in these complementary experiments do not perfectly
estimate the enthalpy terms, not only because of the presence of the work terms but also be-
cause of the fact the reaction are not exactly happening in the same conditions than in the main
experiment. Indeed the absence of at least one component can change the properties of the
reaction mixture like the viscosity which can have an effect on the dilution experiments for in-
stance. This comment is also valid for the work term. If we neglect these effects, one can use
the following expression to estimate the enthalpy variation of the target reaction or show that
the correcting sum is negligible and would just add noise.
∆Htarget reactions = Qexp + Qdilution titrant + Qdilution analyte − 3∆Hestim. buffer/buffer
10.2.5 ITC macroscopic models to fit MLn complexes
Various models are always possible to fit to a curve or set of curves. In ITC, two kinds of
thermodynamic models can be fitted to the data: the macroscopic models and the microscopic
(i.e. sites specific) models. The first type represents the dissociation constants related to the
sequential binding process whereas the second type of model corresponds to the site specific
dissociation constants directly related to the kinetic constants.
AITC5: I consider here a reaction involving complexes of type MLm, m∈N∗ . Let n be the
stoichiometry associated to the largest complex. I also consider that the reacting species are
only composed of M and L.
Using the precedent equations and the expression of the concentrations, the classical ther-
modynamic calculations leads to the following equations with the notations in tab. 10.1 :
10.2.5.1 Macroscopic modelization of reaction enthalpies for ITC experiments with MLn
complexes
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Table 10.1: Notations used in models of enthalpies of reaction
Notation Definition
n maximum stoichiometry of complexes MLn
E experiment ∈ N∗
IE number of injections in experiment E
NE number of injection points used in experiment E (NE ≤ IE)
iE injection of experiment E, iE ∈ J1, NEK
viE injection volume in the injection iE
NE,i number of moles of injectant in the experiment E injection i
V effective volume of the cell (V = Vcell −Vplunger)
[X]E,i concentration at equilibrium of species X in experiment E at injection i ; X ∈
{L, M, MLm, m∈ J1,nK}
c(X)E,i total concentration of species X in experiment E at injection i
M0 initial concentration of species M
L0 initial concentration of species L
−−−→
∆rHλ vector of reaction enthalpy of binding step
∆rHλ component of
−−−→
∆rHλ for step λ
−→
βE vector of constant baseline correction of length E
The formula required to fit the macroscopic sequential binding model under the assumptions
AITCi, i ∈ J1, 5K, called from now "ITC formula to fit macroscopic models", is :
∀ (k, i, E) in J1, nK× J1, IK× J1, EK, (10.5)
q(i) =
Ve
NE,i
n
∑
j=1
(
j
∑
λ=1
∆rHj
j
∏
λ=1
Kλ
) [(
1 +
vE,i
2V
)
[M]i[L]
j
i −
(
1−
vE,i
2V
)
[M]i[L]
j−1
i
]
(10.6)
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with :
c(L)i =

L0
(
1− e−
vE,i
V
)
, if L is injectant
L0
(
e−
vE,i
V
)
, if L is in cell
(10.7)
c(M)i =

M0
(
1− e−
vE,i
V
)
, if M is injectant
M0
(
e−
vE,i
V
)
, if M is in cell
(10.8)
[M]i =
c(M)i[L]
j
i
1 +
n
∑
k=1
(
k
∏
j=1
Kj
)
[L]ki
(10.9)
[L]i =


x 6 c(M)i =


n
∑
k=1
k
∏
j=1
Kjx
k
1 +
n
∑
k=1
(
k
∏
j=1
Kj
)
xk

 , x∈[0, c(L)i]


(10.10)
The goal in the ITC data fitting with macroscopic models of type MLn can then be summa-
rized like this :
argmin
−→
K ,
−−→
∆r H,
−→
β
[
e
∑
j=1
(
1
Ne
Ie
∑
λ=1
(
qexpe,E,i
NE,i
− qtheo,E,i
)2)]
(10.11)
10.2.5.2 Microscopic modelization of reaction enthalpies for ITC experiments with MLn
complexes
The richest models are the microscopic models since they enable to compare the behavior
of each site of the macromolecule and to deduce easily the macroscopic constants. However,
the possibility of relevant fitting site-wise models is restricted with the monodimensionnal ITC
data, compared to NMR for instance. A molecule with different binding sites has different site-
wise mechanisms, depending on 2 variables: variable A, identicity of the behavior of the sites
(identical or different behavior) and variable B, independency of the sites (independent, posi-
tively cooperative, negatively cooperative). For a molecule with n binding sites, the number
of these mechanisms Nmechanism(n) is not usually reported. For n sites, there are n among n
possibilities of choosing whether the n sites are identical or not (variable B), and for each pos-
sible pair of sites (n2) there are three possibilities of relation between the sites (variable A). The
two variables A and B are independent so the number of possible mechanism Nmechanism is the
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product of these values :
Nmechanism(n) =
(
n
n
)
3
(
n
2
)
=
3
2
n2(n− 1) (10.12)
Thus taking only into account these two variables A and B, for 2 binding sites, there are 6
possible mechanisms and as many as 27 for a 3 sites interaction. ITC can be used to distinguish
between these possibilities only for a small subset of mechanisms, since different mechanisms
can lead to non distinguishable binding curves. As a result fitting of a site-model to the data
does not guaranty the appropriateness of the model and model comparison strategies are re-
quired.
10.2.5.3 Strategy for ITC data analysis
Criteria for model selection Because of the multiple models fittable to ITC data, a reliable
way to compare models is required. The basics and the choice of this comparison method are
explained in this paragraph. Let’s consider the comparison of successive macroscopic models
of stoichiometry 1 and 2. The two candidate models form what is called nested models. The
2:1 model has four thermodynamic parameters: two dissociation constants and two enthalpies
for the two successive binding reactions. The 1:1 model is a particular case of the 2:1 model
where the second binding constant and enthalpy are equal to zero. This is why it is said to be
nested into the more complex model. In the case of nested models, the model with the largest
number of parameter (i.e. 2:1 here, 4 thermodynamic parameters) will always fit at least as well
- and usually much better - than a model with less parameter (1:1 model, 2 thermodynamic
parameters). As a consequence the quality of the fit, estimated for instance by the RMSD value,
will be always better for the model with the highest number of parameters than for the smaller
nested models. However this does not mean the more complex model is the more appropriate.
The challenge in model selection is to take this phenomenon into account to be able to deter-
mine for a dataset and various candidate models, which one is best supported by the data.
To do this, it is necessary to take into account the fit quality and the number of parameter of
each model. Various indicators are commonly used for model selection. They include reduced
Chi-square statistic, Fisher test and various information criteria, in particular the Akaike In-
formation Criterion (AIC). The reduced Chi-square requires the knowledge of the number of
degree of freedom that can be determined only for linear models, not used in ITC. Akaike Infor-
mation Criterion has theoretical advantages over the Fisher test strategy. It is has been shown
in various works (101; 145; 177) in particular using Monte Carlo simulations that the Akaike
criterion is more reliable than the Fisher test method for different type of models and datasets.
Moreover the AIC can be applied to compare both nested and non nested models as the ones
of step 1 and 3 the proposed fitting strategy. Finally, the Akaike criterion enables to compare
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simultaneously multiple models, it is not restrained to binary comparisons. For these reasons
AIC has been used in this work. A comprehensive review of the theoretical and practical aspect
of Akaike Information Criterion can be found elsewhere (24)
The nature of Akaike Information Criterion (AIC), the practical calculation of Akaike weights
and its interpretation are developed in this paragraph. The Akaike Information Criterion has
been proposed by Hirotugu Akaike in 1973 (4). The AIC value is an estimation of the relative
distance between the fitted model and the unknown mechanism that generated the data.
Let’s consider n data points and a set of candidate models i with ki parameters. We consider
here the particular case, used in this work, of model parameters estimated using maximum like-
lihood strategy with normally distributed errors and a constant variance. In this situation, the
residual sum of square (RSS) can be directly used to calculate the Akaike Information Criterion
(AIC) value for each model (24):
AICi = n ln
(
RSS
n
)
+ 2ki (10.13)
The deviance of the model n ∗ log( RSSn ) is penalized by two times the number of parameters
(ki). The demonstration of this result is out the scope of the present explanation and can be
found elsewhere (24). Because the number of points in a traditional ITC experiment is between
about 15 to 40 points (31 and 39 here but actually more due to global fitting of multiple dataset)
and that the number of parameters to fit is a significant proportion of the number of data points,
the AIC value has to be corrected for this "small sample size" effect. The necessity of this
correction has led to the introduction of the reduced AIC value by Hurvich and Tsai (129).
AICci = AICi +
2ki(ki + 1)
n− ki − 1
(10.14)
This formula is widely considered to be the standard way to calculate Akaike value since
the limit of the fraction when n tend to +∞ is 0. Because of AIC definition, the model with the
lowest AICc value (if any) is the preferred one. It is the differences between AICc values that
are of interest to compare the other models to the preferred one.
∆i = AICci − AICcmin (10.15)
It is often difficult to judge from the AICc differences if one model is slightly or really worse
than the preferred one. Although some ranges of AIC differences have been proposed to qualify
the model considered, a unified and clear approach consists in the calculation of the Akaike
weights that correspond to easily interpretable probabilities.
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For each model i among a set of M candidate models, the Akaike weight is the ratio of the
relative likelihood of the model i over the sum of the relative likelihoods over the different
models :
wi =
exp(−
1
2
∆i)
M
∑
j=1
exp(−
1
2
∆j)
(10.16)
The relative likelihood of the model i given the data, wi, can be interpreted as the probabil-
ity that the model i is the preferred one for the data and the considered set of candidate models.
It is important to underline that these weights enable to compare models but do not indicate
that any of them adjust well the data. These probabilities are called weights because when var-
ious models are well supported by the data, the fitting can be performed using these multiples
models weighted by these probabilities.
Proposed general strategy to analyze ITC datasets I propose the following general strategy
to fit the ITC datasets. The importance of fitting first macroscopic models has already been
underlined in (86). A general strategy using global fitting of the ITC datasets followed by
model comparison with Akaike weights is presented here. This procedure is different from a
common one consisting in starting from the simplest models to the more complicated one and
to stop when a good fit is obtained which can lead to an over/mis interpretation of the ITC
data.
(1) Global fitting of the data on different macroscopic models of different stoichiometries.
For a model of molar ratio n, the number of parameters in the macroscopic model is 2n. Akaike
weights are used to select one (or more) models (i.e. the molar ratio) among the ones that can be
fitted. This first step is valid whatever the microscopic mechanisms for MLn models providing
the data enable reliable fitting of the 2n variables.
(2) Depending on the datasets and potential additional information, one can try to fit the
datasets with site-specific models. If this step is to be used to get insight of the microscopic
mechanisms, all possible models should be checked with and without the selected macroscopic
model of the previous step. The comparison of microscopic models might reduce the number
of possible mechanisms. Some of these microscopic models have less variables than the macro-
scopic one (e.g. independent identical sites) and could be the only model fittable to the dataset
but in such case the hypotheses associated to the model has to be explicited and discussed.
10.3 Development of an open source software for the automated analysis of
ITC data
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10.4 R-ITC experimental design and data analysis
Despite some ITC program are free of charge, no open source program able to fully process
the raw ITC data have been released by the time of writing. I consider this to be necessary so
that the users can actually understand in detail what they are doing in each step of the ITC
processing having access to a fully commented code. Also many programs do not facilitate
multiple model comparison and global fitting. Moreover there is a clear tendency to speed
up the ITC measurement, by reducing the sample size and increasing the sensitivity and to
provide high throughput calorimeter. As a consequence, more dataset are generated and the
usual programs have not been conceived to do batch analysis of multiple datasets. Many of the
available programs require user input or adjustments that are not only time consuming but are
also a source of variability and bias in the data analysis. A comparison of the main available
programs is given in the following table.
Table 10.2: Comparison of the main softwares for Isothermal Titration
Calorimetry data analysis. [1] Sedphat (126) ; [2]: suITCcase (web form
(http://alanine.usc.es/suITCase/suITCase.php)
name raw data source extensible automated simulations
Origin + ITC module yes no yes no 1:1
Sedphat[1] no no no no no
suITCcase[2] no no no no 1:n
Also some in house programs have been written, in Pascal, C, Matlab®, Mathematica®,
Scientist®. They have not been made available nor described.
I’ve written a program for ITC data fitting called RITC to be released latter as an R package
(free, open source) . GNU R (228) is a widely used language that has become the gold standard
for many biological data analysis. The latter program implements all the previously defined
objectives and enable to do multiple processing of ITC data.
10.5 Non trivial indiscernible processes in ITC for the study of equilibrium
- {Reaction signal masked by other co-reactions or by the noise}, {reaction conditions (especially
temperature) where the binding enthalpy is almost zero} or {no reaction happening} can all
lead to no significant signal detected during the mixing. No signal detected during the mixing
does not imply that no reaction is happening. Experiment at different temperatures with at
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least 10°C and / or experiments with higher concentrations can help to find the existence of a
reaction.
- For any non null integer n, {if the M and L species exit only in solution and in the M/L com-
plexes as Mm and Lm, leading to complexes of type MmLm.jj∈1:n } or { if the M and L species exit
only in solution as M and L and the complexes between M and L are only of type MmLm.jj∈1:n }
then the molar ratio of these situation is the same than the reaction leading to a MLn complex
by progressive binding of L on M. This ratio is n and is not the stoichiometries of the two com-
plex situation mentioned. This is why the notion of "molar ratio" is systematically used in this
work rather than the stoichiometry, often used in the literature. Other methods or information
are required to resolve the actual stoichiometry.
- In the working conditions, a system with a non empty set of reactions with negligible en-
thalpy change, associated to a non empty set of reactions with significant enthalpy change can
lead to a similar signal model than a system possessing only the set of reactions with significant
enthalpy change. This is why the molar ratio is qualified in this work to be "apparent". The
term apparent stoichiometry is sometimes used in the literature and in UIPAC recommenda-
tions for ITC (244). Care is required in the interpretation of these key parameters that appear as
minimums.
- The potential reactions including the one to be studied, co-reaction buffer protonation, re-
action related to buffer mismatched and oligomers dilution reaction can all lead to a titration
signal. Nothing indicates the contribution of the reaction under study in the ITC signal. In
order to get relevant thermodynamic parameters, the experiment has to be design so that all
the other processes are negligible or can be estimated with multiple control experiments.
- Let’s consider an ITC experiment and the repetition of this experiment performed by varying
one parameter, for instance the addition of one ligand. If {the parameter has an effect on an
undetected reaction} or if {it has no effect at all}, no difference will be seen on the ITC signal.
So it is not always possible to directly interpret one negative ITC experiment performed in one
condition.
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Chapter 11
svAUC: protocol for the study of reversible interactions and implementation
Definition and main biophysical applications of svAUC In Sedimentation Velocity Analyti-
cal Ultra Centrifugation (svAUC) method, some time dependent optic signals profiles in sector
shaped cells are monitored during a centrifugation performed at a high constant acceleration
(usually 100000-300000 ×g) in an analytical ultracentrifuge. Common applications of svAUC
include the purity analysis of a macromolecular sample with almost no restriction of the size
limit, the stoichiometries of complexes, the overall shape of complex and species in solution,
the dissociation constants and the thermodynamic non ideality of the solution.
11.1 Principle and implementation of svAUC
1. Centrifuge, rotor and cells - implementation Sedimentation velocity experiments were
performed with a Beckmann Coulter XLI analytical ultracentrifuge with an An-50Ti rotor. The
rotor is equipped with 8 holes. One of them is filled with a counterbalance. The 7 remaining
holes can contain double cells that can be filled with samples and buffers. The individual cell
are sector shaped (fig. 11.1) to avoid convection. Contrary to a preparative one, an analytical
centrifuge can measure the distribution of some signal in the sample during the spinning. The
cells were sapphire-windowed cells with 12 mm optical paths. Sapphire window enable the
UV light to pass through the cells and are highly resistant to a wide range of physico-chemical
conditions (pH, temperature).
2. Preparation and filling of the centrifuge cells The elements constituting the cells require
an extensive wash before their filling. Then the reference cell is filled with the buffer alone and
the sample cell with the sample solubilized in the same buffer. Some buffer component might
distribute slightly differently during the ultracentrifugation and the reference cell enable to take
into account a resulting potential change in the absorbance profile of the solvent.
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Figure 11.1: Typical configuration of a svAUC cell with two sectors shaped cells, one for the reference
buffer and the other one for the sample to be studied. The cells are not fully filled and the cell with the
reference buffer is slightly more filled than sample cell to detect a well defined sample meniscus in the
scans. The windows, not visible in this top view, are discs placed on each planar side of the cell.
Implementation. The cells elements were washed with detergent then extensively washed with
distilled water and treated 5 min with RNaseZAP (Sigma-Aldrich). An additional long wash
with RNase free water was performed to remove potential traces of RNaseZAP (Sigma-
Aldrich), and the cell were allowed to dry. Assembly of the cells under RNase free conditions
enabled to get RNase free cells. The cells were filled using a Hamilton syringe that received the
same treatment that the cells. The buffer used, as for the other biophysical techniques is: 23.5
mM potassium phosphate, 100 mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol
3. Equilibration of the centrifuge - implementation Before the experiment, the centrifuge
was equilibrated at 25°C during 40 minutes. During this step a slow speed was applied to
check the waterproofing of the cells before starting the experiment at full speed.
4. Centrifugation and cell scanning During the centrifugation in an analytical ultracen-
trifuge, the cells undergo a constant high centrifugation speed usually between 100000- and
300000 ×g. This centrifuge works under approximate vacuum to avoid frictional heating and
turbulence. The concentration distribution of macromolecules across the cell at various times
during the experiment is measured while the sample is spinning, using either absorbance, re-
fractive index or fluorescence detection. During the centrifugation, the typical Beckmann XL
ultracentrifuge detection systems monitor the redistribution of molecules in the cells with two
detection systems: UV absorption optics and Rayleigh interference optics. The former system
performs a scan along the cell axis and is useful for macromolecules absorbing significantly in
UV like protein and nucleic acid. The concentration dependence of the UV signal is the well
known Beer-Lambert law. The Rayleigh interference is based on the split of a monochromatic
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coherent light beam that passes through two slits placed below the two pairs of cells. The beams
are eventually merged causing interference fringes pattern. If the refractive indexes in the sam-
ple cell and in the reference cell are different, the optical pathes have not the same length and
it creates an interference figure. If the refractive index of one the two pairs cells change in one
region on the centrifugal strength axis, because of the presence of a macromolecule for instance,
there will be an orthogonal shift of the interference fringes directly proportional to the change
of concentration so the knowledge of the concentration at one point can enable to determine
the concentration at any other point.
Implementation. The centrifugation was performed at 50,000 rpm (185,000 g) at 25°C during
15 hours. Acquisition was performed for UV absorbance at 260 nm, 280 nm and using interfer-
ence optics with a laser at 655 nm. For the UV signal, the buffer subtraction is performed by the
recording device, the scans of the cells were recorded at ≈ 10 minute intervals with alternating
scans at 280 nm and 260 nm from 5.85 cm to 7.25 cm to the rotor center, each scan being the
average of two replicates. Interference scans were recorded every 20 minutes.
11.2 svAUC data analysis, approximations and related biases
11.2.1 Transport processes in AUC
The svAUC cells are sector shaped with a carefully chosen geometry in order to avoid con-
vection of the particles during the centrifugation. The design of cell to avoid this phenomenon
is one the most important reason of the applicability of svAUC. From here, it is considered that
no convection occur in the svAUC cells (AAUC1). Despite biological macromolecules are usu-
ally charged, the presence of sufficient salts in the environment compensate these charges so it
is reasonable to approximate that the particles transport behaves like uncharged ones. The fol-
lowing development is valid for uncharged particles or particle with a similar behaviorAAUC2.
Under this hypothesis, two transport processes take place during the ultracentrifugation: sedi-
mentation and diffusion
Sedimentation corresponds to the "separation of a dispersed system under the action of a
gravitational or centrifugal field according to the different densities of the components" (134).
Sedimentation depends on the relative density of the particle compared the environment one
and on the friction of the particle in its environment. If the density of the macromolecules is
higher than the one of the solvent, the high centrifugation depletes progressively the macro-
molecules from the meniscus, forming a boundary that moves to the bottom of the cell until
the centrifugation is stopped or until all the macromolecules form a pellet. For entities with
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density lower than the solvent, the sedimentation transport happens in the opposite direction.
The sedimentation of a particle under the acceleration a causing the sedimentation at a speed v
is characterized by its sedimentation coefficient :
s =
v(t)
a
(11.1)
In order to get simple figures for biological macromolecules, the sedimentation coefficient
is usually expressed in Svedbergs, with 1S = 10−13s but values in seconds have to be used in
svAUC equations. The sedimentation value is intensive and depends mainly on the properties
of the particle and on its environment (buffer, temperature, etc). In non ideal mixtures, the
concentration of the particle itself can also increase the friction of the particles compared to an
infinite dilution situation. This causes a decrease of the sedimentation coefficient. Let’s consider
a particle at infinite dilution and let s and f be the sedimentation and frictional coefficient
respectively, sc and fc the sedimentation and frictional coefficient respectively corrected for non
ideality and ks an experimental correction constant in ml.g−1. A first order correction is usually
sufficient to model the effect of the concentration on the sedimentation coefficient (118) :
fc = f (1− ksc) (11.2)
leading to :
sc = s(1− ksc) (11.3)
For solution behaving very closely to ideal ones, we have (1− ksc) ≈ 1 (AAUC3). This hy-
pothesis becomes wrong in the bottom of the cell where the concentration of macromolecule
are increasingly high during the centrifugation. As a result this region is also characterized
by a much larger contribution of diffusion than is the rest of the cell because of the large con-
centration gradient and almost no sedimentation (bottom of the cell). Thus, the data acquired
at the bottom of the cell region are not included in the type of analysis described here. The
use of AAUC3 is common in AUC and appear very useful when considering fitting of svAUC
equations.
Diffusion characterizes the process by which macromolecules are transported as a result of
Brownian motion in the absence of turbulent mixing. The driving process of diffusion is the
gradient of chemical potential (118). During the ultracentrifugation, diffusion in the cells tends
to equilibrate the increasingly different chemical potentials (including differences of concentra-
tions) of macromolecules. The diffusion process in ultracentrifugation is monodimensionnal
and characterized by the translational diffusion coefficient D (in m2.s−1). Like the sedimen-
tation coefficient, the diffusion coefficient depends on the concentration of the particle but in
a slightly more complicated manner than the sedimentation coefficient. A derivation of the
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relation between Dc and c from first principles has been reported (118) and it can be well ap-
proximated by a linear formula, with D the translational diffusion coefficient at infinite dilution
:
Dc = D(1 + kD(s)c) (11.4)
Very often in AUC, the kD(s)c term is considered negligible compared to 1 here (AAUC4),
which require working at very low concentrations.
11.2.2 Relation between the transport processes and the concentration gradient: the Lamm
equation.
For uncharged particles of any shape in solution that undergo only monodimensionnal dif-
fusion and sedimentation transport processes in a sector shaped cell, the concentration law
for each species can be obtained from the Fick law and the continuity equation, leading to the
Lamm equation, with r the distance from the axis of rotation, t the time from the start of the
centrifugation experiment, ω the rotor angular velocity, i one of the n species participating in
the reaction and qi the chemical reaction flux of i (241) :
∀ i ∈ J1, nK,
(
∂c
∂t
)
+
1
r
∂
∂r
[
r
(
siω
2rci − Di
∂ci
∂r
)]
= qi (11.5)
qi equal zero for non interacting species. Once the number of species in solution is known,
this system of equation can be solved numerically, potentially using the different kind of sig-
nals sensitive to the concentration. This is usually performed after a c(s) analysis described
below than can be use to determine whether the system behaves like a non interacting system;
if not knowledge of the reaction parameters (dissociation constants and kinetics constants) is
required to model the qi terms. When the sedimentation and diffusion coefficients depend on
the unknown concentration, the Lamm equation becomes nonlinear and hence more difficult
to solve. This is not the case here because of the previous approximations (AAUC2, 3)
Implementation Lamm equation modeling with multi-wavelength analysis was performed
with the program Sedphat (10).
11.2.3 Svedberg equation
The Svedberg equations are independent to the Lamm equation and give a relation between
the diffusion and sedimentation coefficients. It enables extraction of mass and shape informa-
tion from the knowledge of the ratio of the sedimentation coefficient and the diffusion coeffi-
cient. The historical formula which is still the main one used in svAUC can be derived with the
second law of motion for a 2 component uncharged system, a molecule i in an organic solvent
(171) and assuming D = RTNA. f with R the gas constant, T the temperature, NA the Avogadro
constant, fi the frictional coefficient of i, v the partial specific volume of i (in ml.g−1) and ω the
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rotor angular velocity (in rad.s−1) :
si
Di
=
Mi(1− ρvi − s2i ω
2)
RT
(11.6)
with the term s2i ω
2 being negligible and usually not reported in the equation. Mb =
M(1 − ρv) is called the buoyant mass. However in svAUC of biological polymers, the sys-
tem is usually not just a two component system. This is usually not explained in AUC textbook
or articles, that usually start with the historical Svelberg equation without reminding its con-
ditions of validity. This has been the subject an interesting vigorous article-interposed debate
in Protein Science: "Modern analytical ultracentrifugation in protein science: a tutorial review"
(160) criticized in "Modern analytical ultracentrifugation in protein science: look forward not
back" (67) and answered in "Back to the future: A rebuttal to Henryk Eisenberg" (161). The key
question that underpins these articles is whether it is more useful/rigorous to start from the
approximate historical equation or the more rigorous equation derived from a multicomponent
theory, both requiring very low concentration :
si
Di
=
(
∂ρ
∂ci
)
Mi
RT
(11.7)
A direct use of last formula would require an estimation of dpdc using density estimations.
The main limitation is that the measurement of dpdc with standard densitometer currently avail-
able (e.g. Paar DAM 5000) is the large amount of material required, 1 ml at 3 to 20 mg.ml−1
respectively. Differences between the resulting estimated mass terms have been calculated in
these articles from system that have been studied in depth. For diluted protein solution the
estimation of these parameter on a 1 mg.ml−1 solution without concentrated cosolvents is sus-
ceptible to add an error larger on the molecular mass (≈1.3%) than the effect on the correction
on this parameters (≪ 1%). Anyhow, the choice of the approach might just be constrained by
the available material. Because of the limited material available in this study and of the han-
dling risk to manipulate RNA in potentially RNA contaminated devices, the common approach
using the historical Svelberg equations has been used. The main point of this paragraph is to
underline that because of the resulting approximation and according to the experimental data
provided in the series of article discussing this issue (160; 67; 161), a bias up to 9 % might affect
the estimation of the molecular weight of RNA and protein/RNA complexes.
Practical use of the classical Svedberg equation The classical Svedberg equation is usually
applied by introducing other parameters closer to experimental information. With D = RTNA. f ,
with the Stockes equation for a sphere in a solvent of viscosity η and radius R0 ( f0 = 6πηR0),
with R0 expressed as (160)
(
3Mv
4πNA
) 1
3 and by replacing R0 by the hydrodynamic radius
f
f0
R0 to
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account for the lack of sphericity, the sedimentation coefficient of a species i can be expressed
as :
si =
Mi(1− ρvi)
NA6πη
fi
f0
(
3Miv
4πNA
) 1
3
(11.8)
This equation enables for instance to predict the sedimentation coefficient of a macro-
molecule (often used in this study). The ratio of the frictional coefficient of the macromolecule
and the one of an equivalent sphere in the same solvent, ff0 , is called the frictional ratio. The
larger the frictional ratio, the higher the difference between the sedimentation of the particle
under study and the one of a sphere, which sediments faster. Experiments have shown that
globular proteins have a frictional ratio of about 1.2 whereas elongated particles has higher
frictional ratio, which can be over 2.
11.2.4 c(s) analysis of the svAUC signal
Principles and implementation One of the first common methods to analyze the svAUC
signal is to determine the diffusion deconvoluted sedimentation coefficient distribution c(s),
which is defined by the following integral equation, with d(r, t) the experimental svAUC
data, c(s) the concentration of species with sedimentation coefficient between s and s + ds,
χ(s, D(s), r, t) a (discrete numeric) solution of the Lamm equation and ǫ the noise :
d(r, t) =
∫ smax
smin
c(s)χ(s, D(s), r, t)ds + ǫ (11.9)
The numerical Lamm solution used in this equation correspond to a system of a large num-
ber of discrete non interacting species (46). This approach requires an estimation of the diffu-
sion coefficient of the species involved from their estimated (inputs) partial specific volume and
frictional ratios using the previously described Svedberg equation. c(s) profiles are thus appro-
priate for non reacting mixture but can be also applied with a good approximation to slowly or
rapidly exchanging systems (next paragraph). The result resembles a SEC profile.
Implementation The c(s) analysis was performed with SEDFIT Version 12.52 (241).
Application of the c(s) analysis to protein/RNA complexes Protocols for svAUC analysis of
protein-RNA complexes with the c(s) analysis have been described (282) and svAUC analysis
of associating systems was recently reviewed (39). The application of c(s) analysis to interact-
ing systems is an efficient way to describe the main sedimentation properties of these systems
(46; 243; 242; 303). Three kinds of behavior can be detected in the c(s) analysis of a complex
depending on the kinetics of the experiment. In an experiment with a concentration variation
of one of the two components, the other being in excess, an undisturbed peak is expected for
the compound in excess. Additionally, if there is n possible complexes, up to n peaks can be
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detected. The sedimentation characteristics of these peaks called reaction boundaries depends
on the sedimentation properties and kinetic of the complex and on the free species (303). All
these time scale are very different from the NMR ones and these regimes are all slow for NMR.
- Slow exchange For complexes with half-life over about 104 seconds the interaction is slow on
the time scale of svAUC and the properties of these boundaries corresponds to the one of the
individual complexes. The contribution of the free species is negligible. In this situation, the in-
tegration of the c(s) profile directly gives an estimate of the concentration of the corresponding
species. Binding constant can be determined from a series of such distributions.
- Fast exchange For complexes with half-life less than 103 seconds, the s-values and buoyant
masses of the concentration boundaries are concentration dependent and thus do not give di-
rect information of the complexes formed. For a system with n components, there will be n
boundaries. The integral of this reaction boundary/ies is obviously not related to the amount
of a given complex. The s-value of the reaction boundary will depends on the s-value of all
the other species, their concentration and on the equilibrium existing between them. The in-
terpretation is thus much more complex than the slow exchange case. However this is a very
common case.
- Intermediate exchange Between the fast and intermediate regime, a mixture of the two extreme
cases happen.
11.2.5 Determination of the parameters used in the svAUC analysis
The use of the previous equations and the fit of related models require some knowledge :
- The mass density (1.005 g.ml−1) and viscosity (0.898 cP) of the phosphate buffer used were
calculated using Sednterp (v20120328 beta, http://bitcwiki.sr.unh.edu/index.php, (157)).
- The molar masses for the polymers were calculated from their composition.
- The partial specific volume (v) can be determined from the known composition of the macro-
molecule. It is however dependent on the solvation, which has led to the introduction of the
"partial specific volume of the macromolecule v", a property dependent only on its compo-
sition and the "effective partial specific volume" ve, relevant in solution. The ratio ve/v has
been determined in some studies and it appears to be significant (118). It reaches 5 for human
macroglobulin. A possibility, which has been used in this study, is to use experimental values
determined for a similar system in similar conditions. This was particularly desirable for the
RNA for which few data is available compared to proteins. The partial specific volume used
for pre-miR-155 (0.508 ml.g−1) was taken from a study of a viral RNA in dilute aqueous KCl
solutions (20). A partial specific volume of 0.74 ml.g−1 was estimated for TRBP-D1D2 using the
software Sednterp version 2 (http://bitcwiki.sr.unh.edu/index.php,(157)). The partial specific
volume for possible protein/RNA complexes was estimated by summing the individual values
of each component weighted by their fractional mass in the complex.
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Chapter 12
Introduction to NMR spectroscopy to study secondary structures and some
exchange processes
12.1 Principles of liquid state NMR spectroscopy
Definition and main biophysical applications of NMR Nuclear Magnetic Resonance spec-
troscopy (NMR) is the spectroscopy of the atomic nuclear Zeeman sublevels i.e. the ones within
the nuclear ground state. Compared to other spectroscopic techniques the quantum states
maintain very long coherence and these states are very diversely controllable. The liquid state
version of NMR, referring to the sample state, enable to get structural and dynamic information
on molecules in liquids in their apo form or in complexes with a site specific information at the
atomic nucleus level. It is to date the only technique enabling to study at atomic resolution
molecules in liquid state. NMR data can also be used to study kinetics and thermodynamic pa-
rameters. NMR is the main technique used in this work to get site specific and dynamical infor-
mation on the TRBP/miR-155 system that the other methods couldn’t solve. The method was
mainly applied to get information on the secondary structure and flexibility of macromolecules
and for the study of chemical exchange process (interactions and conformational exchange).
This introduction focuses on these topics.
12.1.1 Liquid state NMR samples
Common easily NMR detectable nuclear isotopes in biological macromolecules Only the
isotopes with non zero nuclear spin can produce NMR signals. For biological molecules, the
main interesting nuclei for NMR and properties of the defavorable abundant 12C and 14N are
given for comparison in tab. 12.1(194)
NMR sample and isotopic enrichment For proteins and nucleic acids, the nucleus H, N and
C are very abundant and widespread within the polymers chain. This makes them attractive
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Table 12.1: Main isotope of interest for NMR spectroscopy of biological macromolecules as well
as abundant 12C and 14N given for comparison (*: unstable isotope)
Isotope Ground state spin Natural abundance (%) Gyromagnetic ratio
(106 rad.s−1T−1)
1H 1/2 ≈ 100 267.522
2H 1 0.015 41.066
3H* 1/2 0 285.349
12C 0 98.9 NA
13C 1/2 1.1 67.283
14N 1 99.6 19.338
15N 1/2 0.37 -27.126
17O 5/2 0.04 -36.281
19F 1/2 ≈ 100 251.815
31P 1/2 ≈ 100 108.394
for NMR especially because of the advantageous spin 12 of the proton and of two rare isotopes
of carbon (13C) and nitrogen (15N). The samples for NMR are often prepared using isotopically
enriched precursors in order to get macromolecules that are fully or site-specific isotopically
enriched with NMR favorable isotopes.
Implementation The production and enrichment protocols used for the preparation of NMR
samples for the work reported here are given in part III. The large majority of the NMR ex-
periments performed in this thesis were done using concentric tubes as represented and com-
mented in fig. 12.1.
Figure 12.1: Representation of the three different configurations of NMR tubes used in the work. Sam-
ples are represented in yellow and heavy water in light blue. Tubes of 4.2 mm inner diameter (Norell®), 5
mm outer diameter) are filled with 300 µl 2H2O and either with a thinner tube of 2.4 mm inner diameter
tube (Norell®), 3 mm outer diameter) containing about 120 µl sample without added 2H2O (A.) either
with a 1.8 mm inner diameter Shigemi tube (Shigemi Inc.) with about 55 µl sample without added 2H2O
(B.). When more material and/or sensitivity were required a larger Shigemi tube of 5 mm outer diameter
(Shigemi Inc.) with 250 µl to 300 µl of sample with 5% 2H2O was used (C.). Shegemi tubes were used
without plungers in the titrations to avoid material loss and biased protein:RNA ratios.
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12.1.2 NMR spectrometer
Three different NMR spectrometers were used in this study, with DirectDrive consoles :
- 800 MHz (18.8 T) with a cryogenic (1H,15N,13C,2H).
- 600 MHz (14.1 T) with a cryogenic (1H,15N,13C,2H).
- 600 MHz (14.1 T) with a room temperature probe (1H,15N,13C,2H,31P).
As all spectrometers based on Fourier transform spectroscopy, they are composed by :
- a temperature controlled zone where the sample is placed, enabling to set the desired temper-
ature for the experiment.
- a superconducting coil generating an intense and highly homogeneous B0 field (T). Because
of the extremely homogeneous field required for NMR, once the sample is in the magnet, the
electric current passing through a set of additional coils (about 40) called shims and positioned
at different places around the sample, is optimized to get a field as homogeneous as possible
(shimming procedure). For NMR performed on earth, the actual magnetic field felt by the
sample is the sum of B0 more the radiofrequency field from the transmitter more the potentially
fluctuating environmental magnetic field, essentially the earth field of about 0.05 mT, which is
completely negligible compared to B0.
- a probe containing a coil called transmitter that both generate the radiofrequency pulses and
record in first the radiofrequency signal. Since most of the NMR noise comes from the thermal
noise in the coil, the sensitivity can be enhanced (up to 4 times) by using probes with coil
temperature of a few Kelvin (cryoprobes). Two capacitor capacitance are adjusted before each
experiment so that the resonance frequency of the electrical circuit including the coil matches
to the one of the frequency of the spectrometer (tuning procedure).
- a pulse generator, composed of a series of a computer controllable frequency synthesizer, a
controlled gate that will defined the incoming radio-frequency pulse, a tunable attenuator, and
a constant amplifier connected to the transmitter.
- two low noise NMR signal amplifier in series.
- an analog to digital converter that digitize the NMR signal for computer storage.
12.1.3 Principles of NMR experiments
One of the goals of NMR experiments is to get spectra with peaks corresponding to the fre-
quency of allowed Zeeman sublevels transitions, of shape as close as possible to absorption
peaks and from which can be extracted structural and dynamic information . This is however
not straightforward. Introductory quantitative quantum mechanical description of the origin
of the NMR signal can be found in many NMR textbook including the ones of M. Levitt (194)
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and J. Keeler (130) for the foundations and J. Cavanagh (29) especially for the description of
many biological NMR experiments.
Principles of NMR experiments NMR experiments manipulate the spin states using the
properties of different Hamiltonians in order to get information on the related interactions.
During Fourier Transformed NMR experiments, the initial magnetization created by the perma-
nent field B0 is altered by applying temporarily short radiofrequency pulses creating a weaker
magnetic field in a plane orthogonal to the B0 direction. This additional magnetization will
determine the nature of the experiment performed and the goals are not detailed here. Exam-
ple of the EXSY experiment is given below. These fields can excite at the same time a wide
range of frequencies. The first pulses rotate the bulk magnetic moment towards the transverse
plane, leading to a non null transverse magnetization and a reduced component along the B0
direction. After the application of these magnetic fields, the exited spins angular momentum
will undergo precession. Application of multiple radiofrequency pulses in series with delays
determines the experiment performed. For a given nuclei type, the frequency of the preces-
sion of each individual atoms will be influenced by the magnetic perturbations caused by the
chemical environment. This environment corresponds to specific electron density and fields
that depends on the nature of the surrounding atoms, their spatial structure, bounding net-
work and dynamics. As a result each spin is characterized by a frequency (Larmor frequency)
that behaves like a probe of the chemical environment. Each spin contribute to build a signal
that is recorded over time by monitoring the resulting electric current that pass through the coil
that was used for the excitation. This time dependent signal is the fundamental observable in
NMR and called the free induction decay (FID). The FID loses exponentially coherence over
time because of the relaxation of the system. It is then converted to a frequency spectrum using
the Fourier transformation giving Lorentzian peaks characterized by their amplitudes, frequen-
cies (given in chemical shift to account for the field dependency) and linewidth. These are the
secondary NMR observables.
Implementation All experiments were run with the VNMRJ (v3) program (Varian).
NMR Signal processing - implementation All the NMR spectra were processed by NMRPipe
(51) with the classical following steps :
- Zero filling of the free induction decay: As the fast Fourier transform used in NMR processing
(usually the common Cooley–Tukey algorithm) is faster for power of two number of points, the
signal matrix can be completed by zeros in order to reach a more appropriate size. Increasing
more the matrix with zeros (usually 2 times in this work) enables to have better defined NMR
peaks (more points) but does not change the resolution.
- Apodization: During the acquisition time, the maximum of the signal decays exponentially, so
the maximum occur at the beginning and then the signal to noise ratio tend to zero. To enhance
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the sensitivity by weighting more the first portion of the signal and to enhance the resolution
by weighting less the end of the signal, a so called apodization function is multiplied to the
signal. In this work, a square sinebell function was used. The resulting NMR peaks are thus no
longer Lorentzian but closer to a more compact Gaussian distribution with a much narrower
base than a Lorentzian distribution.
- Fast Fourier transform: when the sampling of a multidimensional (nD) spectrum is uniform,
the exact transformation to go from the time dimension to a frequency dimension is given by
an nD Fourier transform.
- Phase correction approximation: The phase of the amplitude of the signal components de-
pends of the experiment. For the experiments used in this work, the phase of the peaks depends
approximately linearly on the center of the spectral region. Thus the phase can be approxi-
mately corrected for all the peaks by finding a linear correction of the phase on each dimension
in order to reduce dispersion modes in the spectrum.
12.2 Analysis of the secondary structure by chemical shifts and NOE
TRBP constructs secondary structure analysis Protein backbone chemical shifts and espe-
cially 1Hα, 13Cα and 13Cβ depend on the local backbone conformation (281). Backbone reso-
nances of proteins are commonly assigned to their corresponding atoms in the sequence with
3D HNC correlation experiments. This information enables to identify regions of stable sec-
ondary structures or secondary structures propensities using empirical rules obtained from
proteins of known structures. In this work, secondary structures were predicted using TALOS+
(247), an algorithm based on a database of structure of known high resolution x-ray structure
and NMR chemical shift data. These predictions were complemented with heteronuclear 1H-
15N Nuclear Overhauser Enhancement (NOE) experiments which provide information about
the motions of 1H-15N bond vectors in the (10−8- 10−12 s−1) time-scale and thus enable to con-
firm qualitatively the backbone rigidity and flexibility. A sequence similar to the one described
in (139) was used, enabling to use the ratio of peaks intensities of a proton saturated experiment
over a reference experiment as a measure of the NOE effect. A 5 s recycling delay was used.
miR-155 precursors secondary structure analysis The Laboratory frame Nuclear Overhauser
Enhancement Spectroscopy SpectroscopY (NOESY) is a 2D experiment used to study the NOE
effects. In NOESY experiments, this effect leads to the presence of cross peaks at the intersection
of the frequencies of the spin that interacts by cross relaxation. The NOE effect between two
spins at a distance r is proportional to 1
r6
which usually restrains observable interactions for spin
spaced by less than 6 A. H,H-NOESY is commonly used to assign the imino protons involved
in base paring of nucleic acid, enabling to study the base pairing patterns. H,H-NOESY exper-
iment has been used for the assignment of RNA imino protons, enabling to get information of
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the secondary structure of the miRNA precursors.
12.3 Study of some chemical exchange processes by NMR
12.3.1 Chemical exchange regimes in NMR
Chemical exchange of a set of spins is a process in which the spin undergoes at least two
different chemical environments as a function of time. The different chemical environments
create at least two states for the spin considered. Chemical exchange can be induced by a
transient interaction with exchange of free and bound state (inter or intra molecular) or by
interconversion of the system with exchange between different conformations (intramolecular).
The effects of chemical exchange on NMR spectra depend on the properties of the interactions
and on the NMR acquisition parameters. A short introduction of typical exchange regime in
NMR is given here. The common case of exchange between two states is introduced in this
paragraph. Let’s consider one spin and let A and B the two states in exchange. The two states
are characterized by their chemical shift in rad.s−1 (ωA and ωB) in one dimension and by the
exchange rate constant kex, sum of the average first order rate of exchange from state A to B and
B to A (in s−1).
The effects of the exchange of the NMR spectrum depends mainly on the frequency differ-
ence ∆Ω = |ωA − ωB| which itself depend on the spectrometer field strength B0, the exchange
rate kex, the nature of the nuclei and also the populations of each states. The differences of
magnitude between kex and ∆Ω determines three classes of exchange regime :
- slow exchange. This is a limit situation for kex ≪ ∆Ω. In this situation, there is no signifi-
cant exchange during the time required for NMR signal detection. Thus the signals of the two
states are detected at their respective chemical shifts. Providing the NMR experiment enable
each state to fully relax, linewidth and populations correspond to the one of each state. EXSY
(Exchange SpectroscopY) experiments enable to detect which peaks are in exchange.
- fast exchange. This is a limit situation, for kex ≫ ∆Ω. In this situation, there is rapid A/B
interconversion leading to averaging of the peak parameters during the detection period of the
NMR experiment. The averaged signal is characterized by population-weighted chemical shift
and relaxation rates.
- intermediate exchange corresponds to all the situations between fast and slow exchange limits,
including the situation kex = ∆Ω characterized by coalescence of the two peaks, which set the
limit for the slow and fast intermediate exchange. The closer to coalescence, the broader the
peaks are and this can lead to a complete disappearance of any observable signal.
12.3.2 Chemical shift perturbation for the study of TRBP/miR-155 precursors interactions
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An important use of secondary NMR observables (chemical shift, magnitude and peak
linewidth) in biology is for the study of the interactions between two macromolecules. Let
consider we look at the spectrum of one entity alone and then at the same spectrum with an-
other molecular entity added in the NMR tube. If there is an interaction there will be a change
of the chemical environment of some nuclei, that can lead to a change of one or more of the 3
secondary NMR observables of peaks detected in the first spectrum. A large application of this
strategy has been done in the present work using chemical shifts. The variations of 1H and 15N
chemical shifts in 1H-15N-HSQC like experiments is a common way to quantify the magnitude
of the binding per protein residue, and was used in this work. These chemical shifts consti-
tute two probes per residue backbone but their variances are different. A solution to combine
both variables in a single indicator has been proposed and called the compound chemical shift
(202). The idea is to scale one of the two chemical shifts with the average standard deviation
of the two chemical shifts (σHN and σH) estimated from the experimental Biological Magnetic
Resonance Bank (BMRB) data. Then the formula of the Euclidean distance was used to create a
monodimensionnal shift, giving the following formula :
∆δcomp =
√√√√∆δ2HN + ∆δ2NσHN
σN
with
σHN
σN
= 6.5 (12.1)
12.3.3 NMR Exchange Spectroscopy Experiments (EXSY)
12.3.3.1 Principle of EXSY experiment
NMR is an effective method to monitor the rate of interconversion of systems that are in slow
equilibrium on the NMR time scale. An asymmetric exchange between two states called F and
U will be considered here. The corresponding equilibrium is noted :
F
kFU
⇋
kUF
U
where kFU and kUF are respectively the forward and reverse average first order kinetics con-
stants (in s−1). These constants correspond to the frequency of the transitions and not their
velocity. When two spins in a molecule are in slow exchange on the NMR time scale with kex
in the range 0.2 s−1 to 102 s−1, with each state detectable by NMR, an experiment called Ex-
change Spectroscopy (EXSY) or ZZ-exchange spectroscopy enable to study the exchange rates,
populations and relaxation rates between the exchanging states.
Let’s consider two sites SF and SU corresponding to nucleus of spin 12 with state F and
U with possible polarization states α and β, characterized by their chemical shift in rad.s−1
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ωF and ωU and by their fractional populations PU and PF (PU + PF = 1). As homonuclear
NOESY, EXSY is based on the transfer of polarization between two spins. In the absence of
scalar coupling between the two spins F and U two mechanisms can lead to this transfer of
polarization, chemical exchange and cross relaxation :
- Chemical exchange changes the site of the spins (SF to SU ; SU to SF).
- Cross relaxation corresponds to the result of a process in which the molecular motion of a spin
at one site interacting via dipole-dipole interaction with other spins can induce polarization
transition at other sites. This leads to the experimental NOE effect. In HN-EXSY, the transfer
occur on the nitrogen for which the polarization transfer due to cross relaxation effects are
negligible compared to the transfer associated with the chemical exchange process (AEXSY1)
because of the low gyromagnetic ratio of 15N, 10 times lower than 10H.
Sequence description of the EXSY experiments, with the classical equations used to ana-
lyze EXSY data are given in (184; 75), with a density matrix description in (184) and detailed
examples of application are given in (76) and (146). Two reviews on diverse aspects of EXSY ex-
periments can be found in (185) and (219). The NMR review (144) presents EXSY experiments
among a broader range of NMR methods used to study dynamics by NMR. The main features
of the EXSY sequence are briefly summarized here fig. 12.2. Heteronuclear HN-EXSY is based
on the transfer of nitrogen polarization between states in slow chemical exchange during a mix-
ing time tm. First, the magnetization on the amide proton is transferred to the bound nitrogen
with an INEPT transfer. z is a dimension parallel to B0 and (~x,~y,~z) a direct basis with x the
dimension along which the NMR signal is detected. The first pulse around y (π2 )y creates trans-
verse magnetization. The next delay t1 (incremented, with a 180° pulse of 1H to decouple the
1H-15N scalar interaction) and the second (π2 )y pulse enable to create frequency labeled longi-
tudinal magnetization by the Larmor frequencies of the spins. This creates non equilibrium 15N
magnetization along the z dimension. The mixing time tm allows polarization transfer between
the two states F and U in exchange which evolve z magnetization (so the zz-exchange name).
Then magnetization is transferred by INEPT back to the amide proton for detection. Depend-
ing of the kinetic of the exchange, some undesirable polarization transfer can occur during the
second INEPT transfer. Eventually the magnetization is recorded during the detection time t2.
If a nitrogen is exchanging between states F and U, characterized by ωNF , ω
H
F and ω
N
F ,ω
H
F ,
the heteronuclear EXSY experiment yields a 2D spectrum with up to four signals: 2 diagonal
peaks FF and UU (autocorrelation) and two crosspeaks FU and UF that reflect the exchanges
(F to U and U to F)fig. 12.2 B. and C.. Standard NMR assignment methods can be used to
assign one or the two sets of peaks related to the spins in slow exchange. The EXSY experiment
can be also useful to assign one of the state using assignments of the other one. The analysis
of classical EXSY spectra require the quadruplet of peaks to be resolved which is rarely the
case for all the peaks in a crowded spectrum. Specific labeling and 3D EXSY are attractive
strategies to simplify these spectra. Relaxation dispersion experiments based on the monitoring
125
of transverse relaxation (vs. longitudinal relaxation in EXSY) covers a broader range of dynamic
time scale than EXSY (3.102 µs to 10 ms) (144) and can be used to investigate the possibility of
faster exchange processes, invisible in EXSY experiments.
Figure 12.2: A. Main steps of an EXSY experiment. The sequence is simplified. INEPT transfers are
indicated by gray boxes; water suppression and gradient are not indicated. d1: recycling delay, t1 indirect
sampling, tm mixing time and t2 acquisition time. DEC.: decoupling. B. Typical EXSY spectrum with
two states in exchange F and U, with no mixing time an assuming no significant exchange during the
second INEPT transfer. C. Same system than B. with a non zero mixing time. Cross peaks FU and UF
corresponds to the polarization transfer during the mixing time from F to U and U to F respectively.
12.3.3.2 Exploitation of EXSY experiments
Equations for EXSY data fitting The following notations are used from now (tab. 12.2) :
Table 12.2: Notations used in the phenomenological equations describing EXSY peaks intensi-
ties
Notation Description
t duration of the EXSY mixing time
IXY(t) volume of the peak corresponding to the transfert of polarization from states X to
Y for the mixing time t
X(0) volume of the peak from states X before the start of the mixing period t
RX1 rates of the longitudinal magnetization return to the equilibrium (s
−1)
RX2 rates of the transverse magnetization return to the equilibrium (s
−1)
Equations to fit EXSY datasets can be conveniently derived using phenomenological equa-
tions of nuclear magnetization including chemical exchange, the Bloch-McConnel equations
(190). This strategy requires first that the exchange occur between weakly coupled systems
(117) (AEXSY2). These equations are theoretically directly applicable to the EXSY data but this
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would include the fit of bi-exponentials that can be unreliable with experimental dataset (117).
EXSY data fitting is usually performed with approximate solution for the following slow ex-
change condition (AEXSY3) :
kFU + kUF ≪ |i(ωU −ωF) + (R
U
2 − R
F
2)| (12.2)
Under the approximation of fully relaxed states (AEXSY4) at the end of the experiments and
without significant exchange during the INEPT transfer (AEXSY5), application of AEXSY3 leads
to the following system of equation describing the evolution of the total intensities (volumes)
of each peak (formulas from (75)) :


a11 = kFU + R
F
1
a22 = kUF + R
U
1
a12 = −kUF
a21 = −kFU
∀i ∈ J1, 2K, λi = 12
[
(a11 + a22) + (−1)3−i
[
(a11 − a22)
2) + 4kFUkFU
] 1
2
]
IFF(t) = IF(0) 1λ1−λ2
[
(λ1 − a11)e
−λ2t − (λ2 − a11)e
−λ1t
]
IUU(t) = IU(0) 1λ1−λ2
[
(λ1 − a22)e
−λ2t − (λ2 − a22)e
−λ1t
]
IFU(t) = IF(0) 1λ1−λ2
[
a21e
−λ1t − a21e
−λ2t
]
IUF(t) = IU(0) 1λ1−λ2
[
a12e
−λ1t − a12e
−λ2t
]
(12.3)
EXSY data fitting and implementation EXSY experiments, like NOESY experiments require
high sensitivity. Accurate quantification of the populations in EXSY experiment require to have
both state in exchange fully relaxed, especially when the relaxation properties of the two states
that undergo chemical exchange are different. However if one of the state is weakly populated
and since the cross peaks intensities will be below the level of the ones of the minor state. As
multiple EXSY experiments with various mixing times are required for an estimation of the
kinetics constants a tradeoff has often to be made between the requirements for an accurate
quantification and the possibility to measure something. To be able to record enough signal for
the cross peaks, high sample concentration were used (around 1 mM) with the BEST (Band-
selective Excitation Short-Transient) versions of the EXSY experiment implemented by Bern-
hard Brutscher (unpublished at the time of writing). Both 2D BEST-EXSY and a 3D BEST-EXSY
sensitivity enhanced version were used in this work. Fitting of EXSY data require a series of
EXSY experiments at different mixing times including a 0 s mixing time with all other sequence
parameters identical.
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12.4 Non trivial indiscernible process in chemical exchange study by NMR
Some of the main indiscernible processes in NMR for the study of chemical exchange and
relevant for the present study are commented here :
- Presence of chemical exchange can be analyzed with atomic site resolution by the set of
NMR observables (chemical shift, peak magnitude, peak linewidth and indirect measurements
including relaxation rates, NOE, paramagnetic relaxation enhancement and residual dipolar
coupling). However absence of detectable differences in one observable does not imply there is
not exchange between multiple states in the system conditions used. For instance the chemical
shifts for an observed nucleus undergoing the exchanging state can be equivalent.
- Local conformational exchange and effects of interactions are indistinguishable using chem-
ical shift. A rigid part of a macromolecule can be close to dynamic part which creates a time
dependent chemical shift in the rigid region. This will resemble conformational exchange in
the rigid part. Chemical shift perturbation for the study of interactions will represent both
interacting nuclei and conformational changes associated with the interaction.
- The linewidth of the peaks in NMR are proportional to the size of the macromolecules. So
without special design of the experiment, a mixture of a small stable monomeric macromolecule
with a large macromolecule or a macromolecular complex (> 100 kDa), the large species might
not be detected without adequate/dedicated experiments. The study of large systems (> 60
kDa) by NMR is an active research area using specific experiments and labeling strategies.
- For one spin with more than two states in intermediate or in fast exchange, the fact the peak
parameters depends on the weighted properties of the peaks of that would appear in slow
exchange often makes the determination of the properties of the different states a challenge; the
data can suggest the exchange phenomenon is simpler that what it actually is.
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Part III
Production of TRBP and miR-155 constructs
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Chapter 13
Production of the RNA binding region of TRBP
13.1 Selection of the production strategy: E. coli
Possible ways to produce human proteins include human cells, recombinant strategies in an-
other host (in particular E. coli) or chemical synthesis with cell free systems (in vitro strategy)
using isolated cellular pathways. Various considerations have motivated the use of the produc-
tion strategy :
- Yield. For the biophysical studies aimed to be performed, in particular NMR, large amount of
proteins in the order of milligrams are required. Among the three types of methods mentioned,
the use of human cells is expected to give much lower yield than the other methods for the
same amount of money spent in the protocol. Production in E. coli or using cell free systems
can give comparable yields for the same cost despite the former system often give much higher
yield for human proteins non toxic for E. coli.
- Ease of stable isotope labeling for NMR. NMR requires for many experiments enrichment of the
proteins by stable isotopes (15N, 13C and 2H in this study). The corresponding labeling media
are very costly for human cells or for other eukaryotic systems like insect cells. Production
in E. coli and in vitro enable generally much lower labeling costs than eukaryotic systems for
comparable yields. In E. coli, NH4Cl and glucose can be used as the sole source of nitrogen an
carbon respectively and the cells can grow in 2H2O solvent.
- Post-translational modifications. Many human proteins are systematically modified after their
translational, including phosphorylations and glycosylations. Production in E. coli and stan-
dard in vitro synthesis do not include these modifications. A study performed on the pro-
tein TRBP in HeLa cells (and insect cells) has shown that TRBP exists as a mixture of multiple
phospho-isoforms, the most abundant form being however the non-phosphorylated protein
(215). There are four phosphorylation sites on serines, two by inter dsRBD regions (215). The
results of this study are also in favor of the absence of other large post-translational modifica-
tions. Thus, study of the non-phosphorylated form of TRBP appeared relevant. In this respect,
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the choice of a system that will not produce an ensemble of variably phosphorylated proteins,
that strongly complicate biophysical studies, appeared interesting.
These considerations led to the choice of E. coli for the protein production in this work. The
strain BL21(DE3) was used since it is widely considered to be an appropriate strain for high-
level protein production (104). The choice of E. coli as a production system has determined all
the purification strategy, set up in order to use the advantages of this system and to alleviate
some related problems.
13.2 Expression vectors for the production of TRBP constructs in E. coli
A poly-histidine tag (MAHHHHHHGHHH) has been use for efficient and quick purification by
Immobilized Metal Chelate Chromatography (IMAC, NiNTA here). As already mentioned,
tags were considered undesirable for this study as they can alter the properties of the protein
sequence of interest. They were systematically removed before the protein analysis by in solu-
tion biophysical techniques. A cleavage site (QLENLYFQ|G) for the Tobacco Etch Virus (TEV)
has been placed just after the poly-histidine tag in order to be able to remove this tag to get the
desired TRBP sequence. A glycine residue remains at the N-terminus after cleavage. Another
design was used to produce TRBP1-dsRBD1 with a maltose binding protein (MBP) followed
by a thrombin cleavage site (LVPR|GSH). For this construct only used in a specific part of the
thesis, 3 residues (GSH) remains after the thrombin cleavage. The cleaved construct design to
include TRBP-dsRBD1, TRBP1-dsRBD1 (long isoform), TRBP-dsRBD2 and TRBP-dsRBD1&2
are named respectively TRBP-D1, TRBP1-D1, TRBP-D2 and TRBP-D1D2. The tagged version
names are the same with the prefix "polyH-TEV".
The synthetic nucleic acid sequence of the selected regions of TRBP were optimized for
expression in E.coli taking into account the different codon bias in this species compared to
humans (despite this codon bias may play a role in the kinetic of protein folding of some or-
ganism).
The resulting sequences were synthesized chemically and inserted into a plasmid PLXR06
with kanamycin resistance or a pMAL vector with ampicillin resistance for TRBP1-dsRBD1 by
the RoBioMol platform at the Institute of Structural Biology in Grenoble (IBS).
13.3 Cultures of 1H-15N labeled RNA binding region of TRBP in E. coli
1. Transformation of E.coli cells For the transformation of E. coli and the first preculture,
the common cell culture rich medium Luria Broth (LB) was used. A solution of 20 g.l−1 LB
media and 15 g.l−1 agar was prepared and autoclaved. All the following steps were performed
in sterile conditions using either gas flame or a sterile hood. At a temperature of about 50°C,
used to solubilize the solution, the LB-Agar media was mixed with a concentrated stock of
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antibiotic (kanamycin or ampicillin) in order to reach a 30 µg.ml−1 concentration. The moderate
temperature avoids too much degradation of the antibiotic molecule. The plates were then
stored at room temperature until full solidification of the liquid. In parallel, aliquots of 40 µl of
competent BL21DE3 cells were mixed with 2 µl of plasmid solution and incubated for 30 min
in 1.5 ml sterile closed tubes placed on ice. Then the tubes were heat shocked into a 42°C water
bath for 45 s. The tubes were then stored on ice at 4°C for 15 min. Eventually 360 µl of liquid LB
media was added to each tube and they were incubated at 37°C during 1 hour. 100 µl samples
of the small cell cultures were then dispersed on LB-agar plates, and incubated 16 h at 37°C.
Two controls were systematically performed using the same protocol without adding plasmids
to the cells or without plating the cells. They were systematically negative.
2. Minimal media preparation In order to obtain labeled proteins, the main cultures were
performed in a minimal media where the sources of 15N and 12C or 13C are provided by defined
components. The composition of the common minimal media M9 used is given in tab. 13.1.
The first part of the M9 media was prepared by mixing phosphate salts, sodium chloride and
[U-15]-labeled NH4Cl (Cambridge Isotope Laboratories) in distilled water before an autoclave
step. The resulting sterile solution was supplemented with minerals from sterile stock solutions
whose concentration are reported in tab. 13.2. The latter minerals could not be added before the
autoclave step to avoid their precipitation. The media was supplemented with vitamins from
a sterile stock solution tab. 13.3 with 2 ml per liter of culture. The stock solution of vitamins is
prepared by adjusting the pH to 7 previously to a filtration at 0.22 µm. The pH of the solution is
then reduced to about 5 to get a higher preservability of the solution. The vitamins would have
been degraded by the autoclave step if they would have been added before it. Then 4 g.l−1
of [U-12C] glucose or 3 g.l−1 [U-13C]-labeled glucose (Cambridge Isotope Laboratories) when
required, were dissolved in a fraction of the medium, filtered at 0.22 µm and reinjected in the
medium. 30 µg.ml−1 of antibiotic (kanamycin or ampicillin) was added to the solution before
the inoculation step. The initial pH of the medium is about 7.
Table 13.1: Composition of the autoclavable basis of the M9 media used.
Compound mass concentration (g.l−1)
Na2HPO4, 7H2O 10
KH2PO4 3
NaCl 0.5
15NHCl4 1
3. Precultures Four to eight isolated colonies on LB-agar plates were used to inoculate a first
preculture of LB media of 5 to 20 ml with 30 µg.ml−1 antibiotic (kanamycin or ampicillin). The
latter culture was incubated at 37°C with agitation at 180 rpm for 6 hours. The LB preculture
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Table 13.2: Concentration of the mineral supplemented to the M9 medium.
Sterile solution Concentration (mM) Added volume (ml.l−1culture)
MgSO4 1000 1
CaCl2 100 1
MnCl2 100 1
ZnSO4 50 1
FeCl3 100 0.5
Table 13.3: Composition of the stock solution of vitamins supplemented to the M9 medium.
Compound stock mass concentration (g.l−1)
Pyridoxin 25
Biotin 25
Panthothenate, hemi calcium 25
Folic acid 25
Choline choride 25
Niacineamide 25
Riboflavine 2.5
Thiamine 125
was used to inoculate a volume v of [U-15N]-labeled or [U-15N,U-13C] M9 minimal media to
an initial optical density (OD) at 600 nm, OD600, of 0.05 to 0.1. This second preculture was
incubated overnight at 37°C with agitation at 180 rpm and the volume was chosen in order to
have enough cells to inoculate the main culture, expecting a final optical density of about 2.5
4. Main cultures and cell storage The desired volume of M9 media for the main culture
was inoculated with sufficient M9 pre-culture to give a starting optical density (OD) at 600 nm,
OD600nm of 0.05 to 0.1. The cultures were incubated at 37°C with agitation at 180 rpm. The incu-
bation was performed until OD600nm reached 0.7 to 0.8. The cultures were then stored at 25°C
for 45 minutes. Protein expression was induced with isopropyl β-D-1-thiogalactopyranoside
(IPTG) to a final concentration of 1 mM by adding a sterile stock solution of 1 M IPTG in water.
The induced cultures were incubated at 15°C for 18 hrs. The incubation at low temperature was
used since it is the recommended temperature to favor high yields of soluble proteins accord-
ing to a specific study (273) and a large scale study performed by multiple structural biology
consortium and structural genomic centers (104). This empirically observation is likely to be
related to a slower protein production enabling recombinant proteins to fold more properly.
Moreover, preliminary experiments have suggested that the yields were better after a long in-
duction at 15°C compared to an induction at 37°C. The final OD600nm was in the range 3.5-4.5.
The culture was harvested by centrifugation and the cell pellet stored at -80°C until required.
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13.4 Cultures of U-2H labeled TRBP-D1, TRBP-D2 & TRBP-D1D2
13.4.1 Culture of [U-2H,13C,15N]-labeled TRBP-D1D2
Double colony selection A study reported that the recombinant protein production of iso-
lated E. coli colonies in 2H2O media was heterogeneous (250). A protocol to select the best
colonies regarding protein yield was proposed by performing a double colony selection (250).
This protocol was adapted for the present study, leading to the following steps :
- Transformation of plasmid in BL21DE3 E. coli cells
- Culture in LB-H2O media at 37°C to OD600nm = 0.7
- Spreading on LB-2H2O plates
- Incubation of plates at 37°C during 36h
- Selection of 5 colonies with the largest diameters on the plate and of a smaller one so that the
diameter distribution between selected colonies is heterogeneous, which is important to see a
selection effect.
- Cultures of the selected colonies in LB-2H2O media at 37°C to OD600nm = 0.7. 6 colonies were
used to inoculate two similar series of 6 cultures.
- Induction overnight at 15°C with agitation
- Estimation of OD600nm of the 6 duplicated cultures and protein production on gel for one
series of 6 cultures.
- Spreading on LB-2H2O plates of the 6 remaining cultures
- Incubation of plates at 37°C during 36 h
- Cultures from biggest colonies in LB-2H2O media at 37°C to OD600nm ≈ 0.7
- 20 % glycerol stock stored at -80°C for future use, as recommended in (250) to avoid the long
selection step before each new culture.
The results of the main steps of the double colony selection for TRBP-D1D2 are given in fig.
13.1 with details in the legend. The protocol enabled to significantly increase the yield of the
protein by a factor of about 2 (2.3) compared to a bad colony choice (colony 6). All the cultures
of TRBP-D1D2 in 2H2O were performed from the cell stock in glycerol. The cells were grown in
M9 media prepared with [99.85 %-2H]-labeled water and 3g.l−1 [U-2H,13C] glucose and 1g.l−1
15NH4Cl. Applied on TRBP-D1D2 this protocol enabled to get about 300 µL of purified protein
at 500 µM per liter of culture (3.4 mg.l−1)
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Figure 13.1: First round of colony selection for their growth ability and TRBP-D1D2(19-228) production
in E. coli BL21DE3. A. Comparison of the final OD600nm of the largest colonies selected on LB-D2O plates
and grown in LB-D2O media. Each initial culture was spitted into 2 sub-cultures and 3 measurement of
the final OD were performed for each culture. The error bars represents +/- one standard deviation of
these six measurements. B. 15 % acrylamide SDS-PAGE gel of lysates of cultures 1 to 6 after induction.
Lysis was performed by incubating the cultures in the SDS-PAGE loading buffer and passing them 6
times in a syringe capped with a long narrow needle. The amount of material loaded on the gels was
normalized to take into account the different concentration of cells at the end of each cultures. C. Quan-
tification of the intensity of the TRBP-D1D2 band in each lane obtained by summing pixel intensities in
the boxes of B. for the ones over the background intensity.
13.4.2 Cultures of U-2H-15N labeled TRBP-D1, TRBP-D2 & TRBP-D1D2
Cultures of [U-2H,15N]-labeled TRBP constructs were performed without double colony se-
lection for TRBP-D1 and TRBP-D2. Multiple colonies of TRBP-D1 and TRBP-D2 were used to
inoculate pre-cultures of LB media and then M9 media, both prepared in H2O. The culture were
then used to inoculate a M9 media prepared in [50 %-2H]-labeled water to progressively adapt
the cells to 2H2O. Cells from this culture were then used to inoculate a preculture in M9 media
prepared with [99.85 %-2H]-labeled water, 4 g.l−1 unlabeled glucose and 1 g.l−1 15NH4Cl. The
stock of TRBP-D1D2 prepared after double colony selection was used from this step, just after a
preculture in LB prepared in [99.85 %-2H]-labeled water. For TRBP-D1 and TRBP-D2, the yields
were rather low: for one liter of culture of the single domains of TRBP, about 100 µl at 100 µM
for TRBP-D2 (0.08 mg.l−1) and 200 µL at 100 µM for TRBP-D1 (0.1 mg.L−1) were obtained after
purification. That’s why after the first culture, some deuterated 15N Isogro® has also been used
for the single domains at the induction time with a concentration of 0.5 g per liter, in order to
get a higher yield (increased by at least 4 times).
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Purification comment The deuterated proteins were purified like the non deuterated protein,
at room temperature in protonated solvents to allow exchange of amide deuterons to protons.
The purification protocols are developed in the following paragraphs.
13.5 Development of a cell lysis strategy
Soluble protein purification Human recombinant proteins expressed in E. coli are produced
in the cytoplasm of the bacteria and a fraction of the proteins often form inactive aggregates
called inclusion bodies. The latter phenomenon usually results from the lack of appropriate
folding conditions, folding machinery, processing enzymes, availability of partners and/or
very high protein concentration in the bacterial cell. As a result there are usually at least two
fractions of protein in the bacterial cytoplasm: soluble proteins and protein in inclusion bodies.
The repartition of proteins in the two fractions depends on multiple factors, including the prop-
erties of the protein produced, cell expression conditions, bacterial strain, etc. As the protein in
inclusion bodies are often misfolded and are hard to dissociate without altering their structure,
two general purification strategies are commonly used to purify recombinant proteins in E. coli:
purify the soluble protein in native conditions or use denaturing or mild denaturing conditions
to solubilize the fraction of protein in inclusion bodies. In the latter case, the proteins will be
unfolded and will have to be refolded. Protein refolding is usually a long, inefficient and time
consuming step. Indeed, the resulting protein fold might not be the same on obtained after
the native purification. The protein TRBP is predicted to have flexible regions (section 5.1.1) so
the refolding strategy would complicate the analysis since the experimental evidence of flexible
regions could be a real property of the protein or a mis-refolded region. For these reasons the
protein were purified under native condition. In this case, it is hoped but not guaranteed that
the fold of the protein will be very similar to the one in human cells; functional tests can help
to detect problems.
13.5.1 Criteria for the development of a purification strategy
A protocol had to be set up in order to screen the protein constructs. Various steps are re-
quired to produce a protein recombinantly: culture, cell lysis and protein purification. There
are at least 4 key requirements when some screening is performed :
- no volume constraint: the method should be applicable for any sample volumes.
- volume independent result: the best conditions found for small scale cultures must also work
for large scale ones.
- parallelizability: the method should be easily performed in parallel for multiple cultures or
fast enough to apply in order to minimize any incubation time effects between different sam-
ples.
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- damage free: as for any technique, the method should avoid to alter the fundamental proper-
ties of the proteins under study.
13.5.2 Comparison of cell lysis strategies
Although it is easy to scale the culture and purification columns, it is harder to lyse the cells
with a scale independent strategy. This can be an issue since cell lysis, a key step in the purifi-
cation, aims to extract the protein in the in vivo experiment to an in vitro environment where
the protein should be stable. Various cell lysis methods are commonly used for recombinant
protein expression in E. coli: sonication, high pressure, freezing and thawing cycles, mechan-
ical cell disputers or chemical lysis. The main advantages and limits of the previously cited
methods will be briefly compared here to argument the choice of the selected strategy :
- Sonication. This method is based on ultrasounds to break the bacterial cell wall. The method is
an efficient way to lyse E. coli cells and to break nucleic acids. This is an advantage for proteins
interacting with nucleic acids when it is desired to get the protein alone. However, sonication
has various drawbacks. It is usually difficult to reproduce the same effect with various sonica-
tors. The main drawback is that the proteins can be damaged and form aggregates. A study
of the effects of sonication on various unrelated proteins with different sequences has been
performed (255). The latter work also report many other works leading to similar side effects
consequences of sonication. To avoid such a risk that could impact both the protein properties
and the evaluation of the protein concentrations, sonication was not used in this biophysical
study (condition "damage free" potentially not matched).
- Freezing and thawing cycles. Repeated cycles of freezing and thawing can contribute to cell
lysis. This is not a very efficient cell lysis method (about 50% efficiency with a standard protocol,
(131)) and the repeated formation of crystals during each cycle, responsible for the lysis, can
damage the proteins. For these reasons, this method was not selected here (condition "damage
free" not matched).
- Mechanical, bead-vortexing and pressure-based methods. These methods include the widely used
French press, Eaton presses and Microfluidizers. These methods are efficient but are time con-
suming, not parallelized in the standard design and not applicable for small scale samples like
50 ml cultures (conditions "no volume constraint" and "parallelizable" not matched).
- Chemical lysis. Various components can be added to a cell pellet to trigger lysis:
• Enzymes, like lysozyme can disrupt the cell wall of Gram negative bacteria. The mecha-
nism in vitro mainly involves disruption of some small part of the cell wall that diminish
locally the resistance of the wall to osmotic pressure. The cell will eventually be broken a
release its content into the solution.
• Detergent. They disrupt lipids and protein interactions that are required for the cell stabil-
ity. Some small ionic size detergents like SDS denature proteins and are thus not of interest
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to release the soluble proteins whereas many non ionic detergents have been used to sol-
ubilize proteins and for cell lysis. Non ionic detergents have also often the advantage to
increase the solubilization of proteins but can also solubilize aggregates. A chemical lysis
using enzymes and non denaturing detergents fulfills the 4 conditions mentioned before.
It is easy to adjust the volume of lysis buffer to the amount of cells to be lysed so the
conditions "no volume constraint" and "volume independent result" work. The paralleliz-
ability just requires to mix pairs of solutions. And the damages are limited by the use of
gentle detergents. A key requirement would be to be able to remove the detergents which
might be difficult for proteins with large hydrophobic surfaces. Eventually because of the
mechanism of action of the detergents the chemical lysis method might not be the pre-
ferred one if the goal is to purify complexes formed in the bacteria. As the current project
is not concerned by the last two limits and because of the fulfillment of the 4 conditions,
this method has been preferred.
13.5.3 Setup of a chemical lysis buffer for E. coli BL21 DE3
Setup of the lysis buffer recipe One widely used commercial reference for a detergent-based
E. coli cell lysis is BugBuster®. It is a lysis buffer based on detergents with a patented com-
position using octyl-glucoside detergents. Together with its cost (12.8 €.od−1600nm.l
−1 without
nucleases), these properties motivated me to use a home made lysis buffer. The set up of this
buffer was not performed with a large screening of many compounds but mainly by merging
the knowledge of various compounds and buffers expecting additivity effects. The build up of
the lysis buffer recipe is detailed step by step here :
- buffer basis. Previous experience in yeast proteomics had suggested me that the buffer Hepes
at pH 7.5 with 100 mM KCl and 10 % glycerol worked well to solubilize many proteins. The pH
should be adjusted to match solubility conditions of the recombinant proteins produced, which
was the case here (pI[TRBP-D1D2] = 9.5). Hepes has a low pH temperature dependence which
allows to incubate at different temperatures (4 to 30°C) without significant pH effects. Glycerol
helps to reduce protein/protein interaction and increases protein solubility.
- Lysozyme from chicken egg white was used at 1 mg.ml−1 concentration to contribute to the
lysis. In order to facilitate lysozyme cleavage the lysis was performed at 30°C.
- Triton X-100 is a commonly used non-ionic detergent (0.6 kDa) that was used at 0.1 % (v/v).
It is compatible with the activity of many enzymes including lysozyme and nucleases. It is
often used at low concentration for in vitro synthesis of macromolecules using isolated cellular
machinaries.
- DNAse I and RNase A. The detergent doesn’t cleave the DNA and this can be an important
issue since the DNA makes the lysate solution highly viscous. The viscosity can impede further
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column based purification steps. Thus some DNAse was added to the lysis buffer at 25 µg.ml−1.
Since TRBP is known to bind RNA, to avoid co-purification of protein and RNA some RNase
at 25 µg.ml−1 was used to cleave RNA (single stranded).
- Calcium and magnesium chloride. DNAse I and RNase A require respectively calcium and
magnesium for the reaction they catalyse. Both were used at 10 mM.
- Antiproteases. In order to limit the effects of E. coli proteases on the recombinant proteins,
pepstatin and leupeptin were used at 1 µg.ml−1.
- Imidazole at 10 mM was added to the lysis buffer in order to have a molecule that can compete
with the weakly bound protein on the NiNTA resin. This enables to get higher yield in the first
purification binding step. The addition of imidazole can inhibit some lysozymes (259) but the
presence of this molecule is considered very important for the purification step and was added
in the lysis buffer for convenience.
Protocol for cell lysis nl
(1) Preparation of the lysis buffer. The lysis buffer was made just before use but could also be
stored at -20°C and used after thawing in a room temperature water bath. The latter method
appeared to work well, was very convenient and mainly used for tests.
(2) Cell pellets resuspension in lysis buffer (50 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2,
10 mM CaCl2, 10 mM Imidazole, 10 % (v/v) glycerol, 1 mg/ml lysozyme, 0.5 % triton X-100, 1
µg/ml leupeptin, 1 µg/ml pepstatin, 20 µg/ml DNase and 20 µg/ml RNase).
(3) In order to standardize the amount of lysis buffer to the amount of cells, the volume of lysis
buffer Vlysis buffer used was standardized to the measured optical density at 600 nm at the end
of the culture OD600 final of volume Vculture using the following ratio :
vlysis buffer =
vlysis buffer ∗Vculture
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(13.1)
(4) Cell lysis was performed at 30° C for 40 minutes with agitation (180 rpm) in a closed glass
bottle of volume about 5 times the volume of lysis buffer in order to ensure an efficient agitation.
(5) 5 mM β-mercaptothanol was then added to avoid protein oxidation. This reducing agent
couldn’t be added before because it would have reduced the key disulfites bound that structure
lysozymes.
(6) The lysis reaction was clarified by centrifugation at 30000 ×g, during 30 minutes at 4°C.
Effects of Triton X-100 and glycerol concentration on the lysis In order to understand the
potential effects of glycerol, Triton X-100 and lysozyme on the lysis efficiency, a series of lysis
has been performed on a non-induced protonated E. coli culture with the standard recipe or
without triton or with fraction of the glycerol used fig. 13.2.
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Figure 13.2: Effects of Triton X-100 and glycerol concentration on the lysis of a non induced culture of
E. coli BL21DE3 analyzed by SDS-PAGE. The percentage (v/v) of both Triton X-100 and glycerol were
varied for different lysis.
The results show that the lysozyme has a moderate effect on the lysis, the key component is
Triton X-100. The efficiency of the lysis by Triton X-100 does not depend on the glycerol con-
centration in the range 0% (v/v) to 10% (v/v). Doubling the concentration of Triton-X100 does
not lead to an increase of the lysis efficiency in the range tested. Both glycerol (10% (v/v)) and
lysozyme (0.5 % (v/v)) were kept in the recipe for their expected roles, protein solubilization
and degradation of bacterial cell walls respectively.
Comparison of the lysis recipe with other lysis techniques The commercially available
BugBuster® was a good reference with which a home made lysis buffer could be compared
with. Since sonication is an efficient lysis method compatible with small samples, it was also
used as reference for cell lysis. 20 ml Cultures of protonated TRBP-D1D2 (19-228), TRBP-D1
(19-99) and TRBP-D2 (157-228) were performed as previously described in section 13.3 and
were complemented with 10 g.l−1 unlabeled Isogro® in order to facilitate the observation of the
recombinant proteins in lysates by SDS-PAGE. To have a comparison of broader significance
for dsRBD containing proteins, the results for TRBP are complemented by similar construct of
PACT produced with the same method with a poly-histidine with a TEV site N-terminal fusion
in a PLXR06 plasmid: PACT[32-102], PACT[124-313], PACT[32-196] and PACT [239-313] as well
as TRBP[257-366]. The cell pellets of each culture were separated into 3 equal parts and resus-
pended in 1.5 ml lysis buffer. They were lysed with 3 different methods: BugBuster®, home
made lysis buffer and sonication. To avoid general buffer effects, the basis of the lysis buffer
for each lysis method was the home made lysis buffer including antiprotease inhibitors and
nucleases but without glycerol and Triton X-100. To avoid a differential effect coming from the
presence of lysozyme in the home made buffer, this enzyme was added at the same concentra-
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tion in the three lysis buffers. Method specific protocol features and additional components are
listed for each method (called A, B and C) :
- A: 1× BugBuster® (using a 10× stock), with a one hour incubation at room temperature (≈
25°C) and regular homogeneization by reversing the tubes.
- B: home made lysis buffer with one hour incubation at 30°C with agitation at 180 rpm.
- C: Sonication in home made lysis buffer with lysozyme, nucleases and glycerol but without
Triton-X100. Four times 10 seconds impulsion pulses were alternated with 20 seconds breaks
on ice.
After lysis, the samples were centrifuged during 30 min at 30000 ×g at 4°C. The pellet was
resuspended in water and homogenized with multiple passes through a narrow needle using a
syringe. The supernatant and resuspended pellets were then prepared for SDS-PAGE as previ-
ous described and loaded on gels. The Lysozymes (14.3 kDa) and the acrylamide percentage of
the gel (15 %) do not enable to clearly resolve the single domains constructs in a few cases. The
results are given in fig. 13.3.
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Figure 13.3: Comparison by SDS-PAGE of the efficiency of three lysis methods (A: BugBuster®, B: home
made lysis buffer, C: sonication) on different protein constructs of TRBP and PACT. The methods are
performed as described in the main text. Ladder lanes are described with a "L". The composition of the
other lanes are described by three letter, indicating from top to bottom the protein construct (1 to 9), the
lysis method used (A, B, C) and the fraction loaded (S: Soluble, P: from resuspended pellet). The vertical
positions of the recombinant constructs of TRBP or PACT are indicated on the right axis. [Polyhistidine-
TEV site]-tagged proteins codes: 1: TRBP[257-366], 2: PACT[32-196], 3: TRBP[19-228] (TRBP-D1D2), 4:
TRBP[19-99] (TRBP-D1), 5: TRBP[157-228] (TRBP-D2), 6: PACT[32-102], 7: PACT[124-313], 8: PACT[239-
313])
The gels on fig. 13.3 show that both chemical lysis buffers are more efficient than the soni-
cation conditions used despite a large proportion of the proteins is not solubilized with all the
techniques, probably because of their production in inclusion bodies. The protocol of home
made lysis buffer appears even more efficient than the BugBuster® used in these conditions
and for these proteins. This might not only be linked to the composition differences between
the lysis buffers but also to the shaking (180 rpm) and temperature (30°C) that were used with
the home made lysis buffer and not with BugBuster®. Because of the low cost (cf. infra) of
the home made lysis buffer, its clear and controllable composition and its efficiency for these
proteins, it was used for all the cell lysis in the work reported here.
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Cost comparison with BugBuster® The main costly components in the buffer used are the
nucleases, leading to a cost of 1.5 €.od−1600nm.l
−1 with the previous protocol. Using the recom-
mended volume of 1 × BugBuster® (Novagen), 5 ml for 1 g of wet cell pellets and assuming
that 1 l at OD600 = 1 corresponds to a wet pellet weight of 1.7 g, with 330 euros for 50 ml 10×
product this imply a cost of 12.8 €.od−1600nm.l
−1. With the same amount of nucleases, the Bug-
Buster strategy cost about 10 times (14.2 €) the cost of the home made buffer. And this factor is a
minimum as it seems that more BugBuster is useful to better lyse the cells. In the Novagen pro-
tocol, they mention a BugBuster/Culture ratio for small cultures of 1/20, which corresponds to
a cost of at least 75 €.OD−1600nm.l
−1 assuming a culture OD600nm over 1.
13.6 NiNTA purification
The supernatant were passed over 4 ml of Ni-NTA affinity chromatography resin (QiaGEN)
per culture liter. The column was pre-equilibrated with storage buffer (50 mM HEPES pH
7.5, 100 mM KCl, 10 mM MgCl2, 10 mM CaCl2, 10 mM Imidazole, 10% (v/v) glycerol and 5
mM β-mercaptoethanol). The resin was washed sequentially with 20 column volumes (CV) of
storage buffer with 50 mM Imidazole, 20 CV of storage buffer with 2 M NaCl to remove nucleic
acids and 20 CV of storage buffer alone. Bound proteins were eluted with fractions of storage
buffer with 250 mM Imidazole, starting with a 1 CV fraction followed by pairs of 1 minute
incubation and 14 CV fraction of eluted buffer. A typical SDS-PAGE used to monitor each step
of the purification is given in fig. 13.4 for polyH-TEV-TRBP-D1D2 (19-228).
Figure 13.4: Example of the monitoring of sample purity during a NiNTA purifications, corresponding
to TRBP-D1D2 (19-228). The purification was performed as described in the main text. L: ladder, S: sol-
uble fraction after home made lysis, P: resuspension of the lyaste pellet obtained after centrifugation of
the lysate at 30 000 ×g, FT: column flow through of the lysate, W1: column wash with 50 mM imidazole,
W2: column wash with 2 M NaCl, W3: column wash with storage buffer alone, E1-E8 elutions with 250
mM imidazole of 1 column volume.
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The ultraviolet spectra of each elution fraction were systematically checked to select the more
concentrated fraction and to avoid taking fractions contaminated with nucleic acids. The last
fractions were systematically characterized by a high absorbance at 260 nm and were not pooled
with the other ones.
13.7 Cleavage of the poly histidine tag
Protocol The observation that the proteins had a tendency to precipitate during the dialysis
performed to remove the imidazole after NiNTA and that the cleavage of the histidine tag was
inefficient, motivated to perform both dialysis and TEV cleavage at the same time. The eluted
protein were incubated with 0.1 equivalents of TEV protease (stored in 50 mM Tris-HCl pH 8.0,
25 mM NaCl, 0.5 mM EDTA, 2 mM DDT and 20 % glycerol). The reaction mixture was dialyzed
against 2 × 2 L of storage buffer at 4°C (12 hrs then 4 hrs). The protein solution after cleavage
was centrifuged at 3000 ×g during 5 min at 4°C in order to remove some precipitates formed
during dialysis. In order to remove the TEV protease, the dialysate was passed over Ni-NTA
affinity chromatography resin pre-equilibrated with storage buffer. The same volume of resin
than the one used for the first NiNTA purification step was used. The resin was then washed
with a series of 14 CV fractions of storage buffer added with 1 min interval. The goal of this step
was to bind on the resin the histidine tagged TEV protease, uncleaved proteins and potential
contaminants that could have been co-purified during the first NiNTA step.
Cleaved protein purification monitoring by SDS-PAGE An example of gel used to set up
the purification conditions of the TEV cleavage with a small case test (1 ml NiNTA) is given in
fig. 13.5. Additional salt washes on the column with the storage buffer supplemented by 300
mM NaCl followed by an imidazole elution released TEV protein and show that a significant
fraction of the proteins is uncleaved. Some cleaved proteins are visible in after the imdazole
elution. This might be related with direct or indirect tagged proteins/untagged proteins inter-
actions and/or could be related to protein/column interaction and/or to a cleavage during the
elution where both TEV and uncleaved proteins are eluted. Very low amounts of uncleaved
protein are detected in the first elutions. From these tests, sufficient quantities of NiNTA (equal
to the volume used during the first NiNTA step) and slow loading of the column by the pro-
teins incubated with TEV enable to have only cleaved proteins in the elutions, revealed by the
final purification gels fig. 15.1.
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Figure 13.5: Example of a gel used to monitor TEV cleavage, for TRBP-D2. L: ladder. D2: TRBP-D2
sample after NiNTA. One column volume is used for each elution. TEV: TEV protease. L1 to L5: elutions
with buffer [50 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2, 10 mM CaCl2, 10 mM Imidazole, 10
% (v/v) glycerol and 5 mM β-mercaptoethanol]. S1 to S3: wash with buffer supplemented by 300 mM
NaCl. E1 and E2: elutions with buffer supplemented by 250 mM imidazole. The TEV:TRBP-D2 ratio is
this example is 0.05.
It was observed that without tag cleavage the proteins after the NiNTA step had a tendency to
aggregate and more than 50% of the protein samples were lost when attempting to concentrate
them. This effect was not investigated into detail as the goal was to remove the tag but it
shows that in this case the tag removal step is an important step to get sufficient proteins in the
end. The effect could be linked to a small RNA contamination present after the NiNTA step
that could make the proteins moderately stable at this step of the purification and/or could
be linked to the presence of the affinity tag. A tag effect could be related directly to the TEV
site and/or to indirect interactions between proteins via the tag like the coordination of ions
via poly-histidines. A study on mouse proteins expressed in E. coli (151), reports decreased
solubility related to the introduction of a TEV site after a polyhistidine tag. The results of this
article are more consistent with a causal effect of the TEV site than of the polyhistidines, for
their systems.
13.8 Size exclusion chromatography
In order to improve the NiNTA purification steps and to have a first characterization of the
samples, a Size Exclusion Chromatography (SEC) step as described in chapter 7 was added
at the end of the purification. This step also enabled to change the storage buffer to a more
favorable buffer to study interactions with biophysical techniques. The SEC was performed
with no glycerol, to remove it from the media and in phosphate buffer. Phosphate buffer has
many advantages :
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• invisibity in proton NMR, which is an advantage when the spectrum of small com-
pound is to be measured; it is however highly charged which is a disadvantage for NMR
cryprobes. A balance has to be made between this limitation and the need for salts and
buffer to have a reasonable environment condition for the interactions.
• three pKa values, enabling to buffer the pH in the range 4 to 8
• very low enthalpy of protonation (∆Hion[Phosphoric acid, pH = 7.2] = 3.3 kJ.mol−1) (41))
which is a strong advantage to perform Isothermal Titration Calorimetry
• high buffering capacity
• low dependence of pKa on the temperature: at 100 mM the second pKa (7.2) follows
dpKa
dT = −0028
• no absorption in the ultraviolet range
Size Exclusion Chromatography 23.5 mM of phosphate buffer was used, keeping the 100 mM
KCl concentration and the 10mM amount of MgCl2 since it is known that some RNA, especially
the large ones, require some MgCl2 to their fold. Since it was not reasonable to adjust the ratio
of MgCl2 to the concentration of RNA, the 10 mM concentration was chosen to be 10 time the
highest usable RNA concentration. Fractions containing protein were concentrated and 500 µL
aliquots were passed over an analytical Superdex S75 10/300 GL column (GE Healthcare) pre-
equilibrated with a gel filtration buffer (23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10
mM MgCl2 and 5 mM β-mercaptoethanol). The chromatograms were characterized by a single
well resolved peak. A full analysis of the SEC results is given in section 15.2.1.
Concentration The protein-containing fractions were pooled and concentrated with cen-
trifugal filter units to the desired concentration for biophysical studies. 5 mM tris(2-
carboxyethy)phosphine (TCEP) at pH 6.5 was added to most protein samples as TCEP has
the advantage to be a strong and stable reducing agent.
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Chapter 14
Production of the oncogenic microRNA 155 precursors
miR-155 precursors were produced by in vitro transcription by Lionel Imbert at the IBS cell
free platform. In vitro transcription is one of the most common methods to produce RNA and
was well developed in the host lab. Recombinant production of RNA in cells using fusion with
transfer RNA has also been reported (309). in vitro transcription enabled to produce efficiently
the amounts of unlabeled RNA required for this study.
14.1 Design of miR-155 precursors constructs for in vitro production
As each translated RNA sequence was required to start with a GG dinucleotide it was
necessary to modify the native RNA sequences. Additional sequence changes were re-
quired to preserve the Watson-Crick base pairing. The non-native nucleotides are em-
phasized in the sequences provided in fig. 14.1. The related RNA oligonucleotides
are: Pre-miR-155 (5’-ggaau gcuaa ucgug auagg gguuu uugcc uccaa cugac uccua
cauau uagca uuccc a-3’) or miR-155/miR-155* (miR-155: 5’-ggaau gcuaa ucgug
auagg ccu-3’; miR-155*: 5’-ggccu acaua uuagc auucc ca-3’). These sequences were
used to design fully complementary double-stranded DNA oligonucleotides containing a T7
promoter (Eurogentec). This are referred to as template oligonucleotides
14.2 Large-scale production of pre-miR-155 and miR-155/miR-155*
- Nucleotide preparation. Frozen template oligonucleotides were incubated at about 22°C
during 15 minutes. They were homogenized by pipetting and shortly centrifuged.
- Annealing. Oligonucleotides were then diluted in RNase free water and a 3× concentrated
buffer (120 mM Tris-HCl pH 8.1, 3 mM spermidine, 15 mM dithiothreitol, 0.3% Triton X-100, 240
mg.mL−1 polyethylene 8000) to reach a 100 µl mix composed of 40 mM Tris-HCl pH 8.1, 5 mM
dithiothreitol, 0.1% Triton X-100, 80 mg.ml−1 polyethylene 8000 and a DNA concentration to
reach 35 µg.ml−1 in the final transcription volume of next step. The mix is vortexed to homoge-
nize it and quickly centrifuged. The mix was heated 5 min at 95°C and then incubated 20 min at
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about 22°C in order to anneal (hybridization) the complementary parts of the oligonucleotides.
- Transcription mix preparation During the annealing step, a standard T7 RNA polymerase
buffer of 5 to 20 ml was prepared: 40 mM Tris-HCl pH 8.1, 1 mM spermidine, 5 mM dithio-
threitol, 0.1% Triton X-100, 80 mg.ml−1 polyethylene 8000, 4 mM of each NTP and 15-20 mM
MgCl2. The solution was vortex and quickly centrifuged to homogenize the components. Then
the proteins were added: 40 µg.ml−1 bovine serum albumin, 1 U.ml−1 pyrophosphatase and
extemporaneously 0.1 mg.ml−1 of in-house produced T7 RNA polymerase stored at -20°C.
Figure 14.1: mfold (309) predicted secondary structure of the two engineered microRNA precursors
of miR-155, corresponding to the step before and after Dicer cleavage. G and C in uppercase indicate
a modified base, used for transcription efficiency. The neighboring base, above or below in parenthesis
indicate the native ones. Two symbols representing these RNA constructs are given in the column on
the right.
- Transcription The hybridized DNA oligonucleotides were introduced in the transcription mix
(final concentration: 35 µg.ml−1 DNA matrix) and homogenized by reversing slowly the con-
tainer tube. The mix was split in 1 ml fractions placed in 1.5 ml Eppendorf tubes. The reaction
mixture was incubated at 37°C for 3 hours.
14.3 Purification and folding of RNAs
RNA products were purified by polyacrylamine gel electrophoresis, dialyzed multiple times
against water and lyophilized. The folding of each RNA was achieved by heating each sam-
ple in water at 96°C for 5 minutes followed by rapid cooling by the addition of ice-cold 2 ×
phosphate buffer.
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Part IV
Characterization of the apo RNA binding region of TRBP and pre-miR-155
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The main goal of the thesis reported here is to analyze in vitro the interaction of the RNA
binding region of TRBP and microRNA precursors, to address the role of each dsRBD in this
region, the potential effects of the interdomain region, and whether TRBP can differentiate mi-
croRNA precursors before and after their cleavage by the enzyme Dicer. The aforementioned
goals require a thorough characterization of the isolated partners involved in the interaction via
multiple biophysical techniques. This is the object of this part. The following chapters present
the apo characterization of the RNA binding region of TRBP and of the last two precursors of
the oncogenic human microRNA 155. This includes an assessment of the homogeneity of the
macromolecules involved, some analysis in solution of their potential homo-oligomerization
and studies of their general structure and flexibility.
This part contains the following chapters :
- Chapter 15: Characterization of the apo RNA binding region of TRBP
- Chapter 16: Characterization of apo pre-miR-155 and miR155/miR155*
Structure of the experimental work presentation From here in the chapters devoted to the
experimental analyzes, the following organization is adopted, without always an explicit struc-
ture :
- Motivations, relating the biological question with the selected biophysical techniques.
- Experimental design, indicating the samples and special conditions, with references to the
biophysical part II.
- Results.
- Data analysis, including possible explanations of the results using a search of a set of biases
and situations that can lead to a similar result. Information from the "Non-trivial indiscernible
processes" presented the part II will be used. This part leads to theories that can enhance the
knowledge on the system and that can be tested with other experiments.
- Integration and (partial) conclusions using a restriction of the set of hypothesis using previ-
ously known results and with the remaining potential non checked/non checkable assumption
required to analyze the data.
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Chapter 15
Characterization of the apo RNA binding region of TRBP
15.1 Homogeneity analysis of recombinant TRBP constructs
Motivations For an appropriate interpretation of the results of the biophysical techniques and
thus for the related biological conclusions, an assessment of the purity and homogeneity of the
TRBP constructs is required. In addition absence of large aggregates that could indicate irrel-
evant precipitated form of the protein and absence of nucleic acid contamination are potential
biases to be checked
Experimental design and results The purity of the samples was assessed by the combined
use of SDS PAGE, SEC chromatography fig. 15.1 and svAUC for TRBP-D1D2fig. 15.4. These
methods are complementary: SEC UV signal is easily quantifiable but the resolution is limited
and presence of very large aggregates can be undetected on the column used. SDS-PAGE (15
% acrylamide here) allows a better resolution in a defined range of masses and svAUC has a
lower resolution but enables to study the whole sample without risk of aggregates filtration.
In order to detect potential RNA contamination, an UV spectrophotometer was also used to
estimate the ratio between the absorbances at 260 nm over 280 nm of the samples (TRBP-D1D2:
0.47, TRBP-D1: 0.56, TRBP-D2: 0.70). SDS-PAGE and SEC results are given below while svAUC
of TRBP-D1D2 is given later in section 15.2.3.
Data analysis The SDS-PAGE profiles of TRBP-D1 and TRBP-D2 are compatible with pure
proteins. There is a minor low molecular weight species detected in this gel (not reproducible)
for TRBP-D1D2 which very likely comes from a cleavage of the protein related to the SDS-PAGE
sample preparation as this minor species is not detected in SEC or svAUC. SEC chromatograms
are characterized by single peaks far from the exclusion volume (8 ml) and permeation (> 20
ml) volumes of the column used (Superdex S75 10/300 GL column, GE Healthcare) and without
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other species resolved. Despite similar masses and behavior in SDS-PAGE, TRBP-D1 and TRBP-
D2 have a different elution volume, a property which will be commented later. The A260nmA280nm ratios
of TRBP-D1D2 (0.47), TRBP-D1 (0.56) and TRBP-D2 (0.70) are compatible with no nucleic acid
contamination. A further purification step with a heparin column was used to test whether the
ratio could be altered. This purification step is useful when there is nucleic acid contamination
in a sample. The resulting ratio did not differ from the one of measured before the heparin
step. This is also consistent with no nucleic acid contamination so a heparin step has not been
included in the end of the purification protocol. It can also underlined here that the other
biophysical analyzes performed in this part and in the next one led also to the conclusion of an
absence of nucleic acid contamination for the TRBP constructs.
Figure 15.1: Purity analysis of TRBP constructs by SDS-PAGE and SEC at ≈ 25°C. A. 15% acrylamide
SDS-PAGE gels of purified TRBP-D1D2, TRBP-D2 and TRBP-D1 constructs. B. Integration of the signal
on the width of the bands. C. SEC chromatograms at 280 nm of 500 µl of TRBP-D1D2 (34 µM), TRBP-D1
(140 µM) and TRBP-D2 (43 µM), with normalized intensities.
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Conclusion Thus the purity of TRBP constructs was considered to be sufficiently high to ap-
ply biophysical techniques to characterize the properties of the RNA binding region of TRBP
and its interactions with miRNA 155 precursors.
15.2 Oligomerization analysis of the RNA binding region of TRBP
Motivations The goal of this study is to determine the potential intermolecular interactions
occurring for the three type of TRBP constructs produced. The assessment of the oligomeriza-
tion state of this construct is particularly important for all the subsequent biophysical analysis,
including the study of the interaction between TRBP and miR-155 precursors. Three classes
of experiments have been successively used to characterize the oligomerization properties of
TRBP-D1D2, TRBP-D1 and TRBP-D2 constructs.
15.2.1 Oligomerization analysis with SEC
Serial dilution through SEC experiment Samples of TRBP-D1, TRBP-D2 and TRBP-D1D2
were produced using the standard protocol. A first SEC was performed as described in chap-
ter 7 as a final purification step, with the samples in [50 mM HEPES pH 7.5, 100 mM KCl, 10 mM
MgCl2, 10 mM CaCl2, 10 mM Imidazole, 10 % (v/v) glycerol and 5 mM β-mercaptoethanol]. For
each construct, 500 µl of highest concentrated part of the eluate obtained after the SEC part of
the purification step was reloaded on the column 4 times in the phosphate buffer used for bio-
physical studies at ≈ 25°C. This corresponded to 34 µM of TRBP-D1D2, 140 µM of TRBP-D1
and 43 µM of TRBP-D2. Since the elution volumes are defined with a random noise error, the
four dilutions intend to minimize strongly the risk of graduation of elution volume obtained
by chance. Each time, this protocol led to a dilution factor of the protein loaded on the column
of about 2.
Results The results of the serial dilution through SEC are presented in fig. 15.2.
Data analysis At a 1 ml.min−1 flow rate, five points per seconds were recorded for each chro-
matogram so the elution volume for each peak can be very well estimated by the elution vol-
ume for which we have the maximum absorbance of the peak. This leads to the elution volumes
stored in tab. 15.1.
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Figure 15.2: Effect of the concentration of TRBP constructs on their size exclusion chromatography
elution at ≈ 25°C. A. Symbols of the different protein construct used : dsRBD1 in red and dsRBD2 in
green B. Overlay of the series of 4 size exclusion chromatography profiles at 280 nm. The gray dashed
line indicates the position of the mean elution volume averaged over the four experiments.
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Table 15.1: Measurement of the elution volume of TRBP constructs for a series of four succes-
sive elution-reinjection SEC experiments.
Construction Experiment Elution volume (ml)
TRBP-D1D2 1 11.09
TRBP-D1D2 2 11.11
TRBP-D1D2 3 11.15
TRBP-D1D2 4 11.15
TRBP-D1 1 13.57
TRBP-D1 2 13.56
TRBP-D1 3 13.6
TRBP-D1 4 13.67
TRBP-D2 1 14.26
TRBP-D2 2 14.25
TRBP-D2 3 14.25
TRBP-D2 4 14.25
The elution volumes are far from the exclusion (about 8 ml) and permeation limits (over 20
ml) of the column used (Superdex S75 10/300 GL column, GE Healthcare). So the concentra-
tion series comparison can be interpreted with the SEC separation principles. If there would
be any significant populations of different oligomeric states in equilibrium or more generally
significant attractive interactions, we should see a concentration dependence of the peaks or
multiple peaks. The non trivial indiscernible processes underlined in chapter 7 all apply in this
situation. The table shows that in the sampled concentration range the elution volumes of the
protein constructs are extremely similar. A very slight graduation is observed for the two con-
struct with the first domain of TRBP. However, the variation is extremely small compared to the
large difference of concentration used in the experiment. The elution volume comparison does
not suggest any significant intermolecular interaction between the domains. Thus SDS-PAGE
and SEC strongly suggest that there is essentially one species in these peaks. So providing no
bias linked to the SEC matrix, two hypotheses can explain the result observed for each construct
:
- the construct is monomeric in the range of concentration sampled
- the construct is a stable oligomer in the range of concentration sampled
For each construct, an easy way to distinguish between these two hypotheses is to estimate
the molar mass of the species in solution. This can be achieved with the SEC-MALLS technique.
15.2.2 Oligomerization analysis by SEC-MALLS
SEC-MALLS experiment To estimate the molar mass of the species eluting after the SEC step,
a SEC-MALLS was performed for the three TRBP(-D1,-D2,-D1D2) samples at one concentra-
tion, in the range of what is use for NMR. 55 µl samples of TRBP-D1 (1.8 mg/mL, 420 µM),
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TRBP-D2 (1.7 mg/mL, 380 µM) and TRBP-D1D2 (2 mg/mL, 1.6 mM) were loaded on the SEC
column. The protocol applied here for the SEC coupled to Multiple Angle Light Scattering in
the phosphate buffer at ≈ 25°C is described chapter 8.
SEC-MALLS data analysis Using the classical data analysis protocol used in MALLS and its
multiple assumptions (chapter 8), the proposed estimated masses with their standard deviation
error are given in tab. 15.2.
Table 15.2: Estimation of the mass of the species TRBP-D1D2, TRBP-D1 and TRBP-D2 by SEC-
MALLS
Construct Measured mass
(kDa)
Std. deviation
(kDa)
Theoritical mass
(kDa)
TRBP-D1 8.5 0.5 8.9
TRBP-D2 8.4 0.5 8.2
TRBP-D1D2 23.2 0.9 22.6
To validate this estimation, this result and the previous knowledge on the sample has to be
compared with the assumption used to derive the molar mass values :
• AMALLS1. The estimated masses, very close to the monomeric masses, correspond to
peptidic chains that are well below the laser wavelenght (690 nm) so this assumption is
fulfilled.
• AMALLS2, 3. The assumptions 2 and 3 are hardly testable and their potential effects have
been discussed in the methodological part.
• AMALLS4. The concentration independency profile in SEC is compatible with the absence
of transient interaction in the species responsible for the detected peaks. This is required
for the system to get close to the assumption 4.
So since 2 assumptions might not be perfectly fulfilled, moderate biases are expected. We
see however that the weighted mass is very close to the mass of the monomers and non am-
biguously far from higher oligomerization species. As a result it seems very safe to conclude
that TRBP-D1, TRBP-D2 and TRBP-D1D2 behave as monomers in solution in the concentration
range used for the SEC-MALLS study, which encompass the ones of all the other techniques.
To check this conclusion using completely different theories and assumptions, an independent
study on TRBP-D1D2 by svAUC is presented in the next paragraph.
15.2.3 Oligomerization analysis of the RNA binding region of TRBP by svAUC
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svAUC experiment In order to confirm the previous conclusions, a smaller experiment has
been performed by sedimentation velocity ultracentrifugation (svAUC). Although less precise
than MALLS, svAUC uses a different theories (thermodynamics and hydrodynamics) to esti-
mate the molecular weight of proteins in solution and is thus a good candidate to confirm the
monomeric behavior of the RNA binding region of TRBP. The three dimensional NMR exper-
iments have shown that the samples were stable for longer period than the one required for
this svAUC experiment (about 15 hours, the first 9 hours being useful for data analysis of this
system). The svAUC analysis was performed on two samples of 10 µM and 20 µM using the
protocol presented in the methodological part. As usual, the experiment is performed in the
same phosphate buffer than in the others biophysical studies and at 25°C
svAUC results The concentration profiles recorded during the experiment at 280 nm are given
in fig. 15.3.
Figure 15.3: Superimposition of the 25 first scans recorded at 280nm in the svAUC experiments for
TRBP-D1D2 at 10 µM and 20 µM. The bold dashed lines indicate from left to right the position of the
liquid meniscus and the position of the cell bottom. The two lighter lines in gray indicate the zone used
to fit the data. The right light gray dashed line indicate an approximate position after which the effects
of the cell bottom became obvious in the sedimentation profiles
svAUC data analysis The result of the diffusion deconvoluted c(s) model fitting is given in
fig. 15.4. The c(s) profile indicates that the experimental sedimentation coefficient sexp is con-
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centration independent in the modest low concentration range tested and its value is 2.19 S.
Although only two concentrations are used, this "concentration independency" is perfectly con-
sistent with the one shown more rigorously in a broader range by SEC.
Figure 15.4: Superimposition of the diffusion deconvoluted c(s) profiles of TRBP-D1D2 at 10 µM and 20
µM respectively. The dashed gray line is positioned at the mean of the maximum of both distributions.
As a result of this concentration independency of sexp of TRBP-D1D2 i.e. no intermolecular
interactions, a modeling of the sedimentation with the Lamm equation with a single non inter-
acting sedimenting species can be applied. This model, without assumptions about the shape of
the sedimenting species, leads (via the classical Svedberg equation) to a molar mass estimation
of 22.4 kDa which is close to the real mass of 22.6 kDa. Taking into account the assumptions
used in the derivation of the model used (chapter 11) this estimation is considered very good.
As a result, this svAUC analysis confirms the monomeric behavior of the RNA binding region
of TRBP. Additionally, fixing the mass in the c(s) model to fit the data leads to a frictional ratio
of 1.43. This value is larger than the one expected for a spherical particle (1.25) and means the
protein has an elongated shape in solution. This property will be commented later in the light
of the NMR results. This frictional ratio value is in excellent agreement with one previously
reported in the literature (1.43) for the region of human PKR containing its two dsRBDs linked
by the 23 residue flexible linker (270).
15.2.4 Validation of the relevance of the oligomerization study by 2D-NMR
A previous study in the literature has shown that folded structures of the first and the sec-
ond dsRBD of TRBP could be obtained by X-ray crystallography and NMR respectively (290).
If the proteins used here are fully unfolded, it would suggest an inconsistency between the
protein produced in this study and the results obtained in the literature. Thus the monomeric
property of the protein produced has a general meaning providing their also have folded re-
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gions in solution. The moderate size of the monomeric constructs below 211 residues allows to
study qualitatively their fold using standard BEST-TROSY experiments. A spectrum for each
construct is given in fig. 15.5. The high dispension for most peaks suggest constructs mainly
folded.
Figure 15.5: BEST-TROSY spectra of TRBP constructs recorded at 25°C at 600 MHz. The constructs are
symbolized by cartoons : dsRBD1 in red and dsRBD2 in green.
Conclusion Thus the SEC experiments have shown that the RNA binding region of TRBP
and its two isolated dsRBDs in highly purified samples forms stable single excluded species
in the physico-chemical conditions used. Quantification of the mass of these species with two
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independent methods, MALLS and svAUC (for TRBP-D1D2), show unambiguously that they
are monomeric. Additional NMR experiments show that this property is not linked to an ob-
vious potential bias corresponding to a production of fully unfolded constructs that would be
incompatible with previous data on TRBP.
15.3 NMR study of the secondary structure and dynamics of the RNA bind-
ing region of TRBP
NMR was used to characterize at atomic resolution in solution the backbone of the RNA bind-
ing region of TRBP and to compare it the presence of miR-155 precursors. This should enable to
reveal properties of the TRBP / miR-155 precursors interactions(s). NMR experiments are the
key methods in this study to analyze the behavior of each dsRBD and of the interdomain region
in the apo form and with miR-155 precursors. To reach this goal, a relation between peaks in
NMR spectra and pairs of atoms has to be performed and is called NMR spectrum assignment.
This chapter presents the NMR backbone assignment of the RNA binding region of TRBP re-
quired to analyze interaction by NMR, and the high frequency dynamics of the backbone HN
vectors. The latter information can be used to determine the folded regions of the proteins and
the (CA, CB, CO) chemical shifts complement this information by giving the secondary struc-
ture propensity of the residues. Apart from clearly mentioned cases, the results presented in
this part have been recorded in the phosphate buffer [23.5 mM potassium phosphate pH 6.5,
100 mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol, 5mM TCEP].
15.4 NMR Assignment, secondary structure and dynamics of TRBP2-D2
15.4.1 Assignment of TRBP-D2
Experiments and results A set of BEST experiments has been used to assign the [1H,15N]
TRBP2-D1 resonances: HN(CO)CACB, HNCACB, HNCO and inter-residual HADAMAC ex-
periments. Figures representing spectra used for this assignment as well as an assigned HSQC
spectra is given in fig. 15.6. The number of non side chains peaks in the spectrum of TRBP2-D2
constructs (67) matches well the expected number according to the sequence (73). 91.8% of the
backbone [1H,15N] resonances have been assigned; the missing residues are the three first ones
including the residual glycine. The residues without [1H,15N] resonances assigned are repre-
sented in red in the following sequence of the construct and the prolines with no amino groups
in gray :
GECNPVGALQELVVQKGWRLPEYTVTQESGPAHRKEFTMTCRVERFIEIGSGTSKKLAK
RNAAAKMLLRVHTV
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The fact the very first residues of the constructs were not detected in HSQC spectra is very
common in usual conditions because of the fast exchange with the solvent. All the 13CO, 13Cα
and 13Cβ resonances have been assigned apart for the first 3.
Figure 15.6: (1H,15N) BEST-TROSY spectrum of 15N-labeled TRBP(157-228), recorded at 600 MHz
and 25°C in [23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10 mM MgCl2 and 5 mM β-
mercaptoethanol, 5mM TCEP with 5% 2H2O added]. Backbone 15N-1HextN resonance assignments are
indicated as well as the signal coming from the tryptophan ǫ amino group. The unassigned signal peaks
on the top-right corner labeled with stars (*) of the spectrum are generated by side chains amino groups;
the three peaks of higher intensity in this region (**) have a spectrum width dependent position and are
likely to be aliased arginine side chain amino groups.
15.4.2 Secondary structure and 1H -15N-NOE of TRBP-D2
Secondary structure The secondary structure was estimated using the 13CO, 13Cα and 13Cβ
chemical shifts using TALOS+ (247). The estimated secondary structure obtained with data col-
lected from TRBP-D2 construct containing is in excellent agreement with the secondary struc-
ture found in the previously reported NMR structure (2CPN) of the second domain of TRBP
(fig. 15.7).
1H -15N-NOE In order to characterize the flexibility of TRBP-D2, 1H -15N NOE were mea-
sured. This parameter provides information about the high frequency motions (10−8- 10−12
161
s−1) of 1H -15N bond vectors (fig. 15.7). The NOEs were classically calculated (section 12.2).
To avoid biases caused by chemical shift degeneracies, 2 residues closed to other peaks, S184
and H226, were not included in the analysis. The high 1H -15N NOE values in each dsRBD
secondary structure elements confirmed that the second domain of TRBP alone is folded in the
sampled time scale. One flexible region (resid. 184 to 191) is also detectable in the dsRBDs,
corresponding the common β1-β2 flexible loop that has been observed in other dsRBDs.
Figure 15.7: Secondary structure prediction based on TALOS+ (A.) and HN heteronuclear NOE (B.)
for TRBP-D2 construct. The propensities in favor of mainly helical and sheet secondary fold are colored
in blue and orange respectively. Error bar represents +/- one strandard deviation estimated by simulat-
ing 100 ratios using the spectral noise and assuming a Gaussian distribution. The secondary structure
obtained from the deposited structure of the second domain of TRBP (PDBid: 2CPN) is given for com-
parison with the same color code. For an easier visualization, the proline residues are represented in
red.
15.5 NMR Assignment, secondary structure and dynamics of TRBP2-D1
HSQC spectra of TRBP-D1 The number of backbone amide groups detected in the spectra
of TRBP2-D2 is globally equal to the non proline sequence length, apart from the three first
162
undetected residues. On the contrary, at high signal to noise ratio, the HSQC or TROSY spectra
of TRBP-D1 is reproducibly characterized by a total number of non side chain peaks slightly
exceeding two times the number expected from the sequence. This is a reproducible feature,
observed with different experiments (HSQC, TROSY) on different spectrometers and on every
sample in the phosphate buffer with or without 5% D20 added.
Figure 15.8: BEST-TROSY spectrum of TRBP-D1 (19-99) at 1.4 mM recorded at 600 MHz an 25°C in
[23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol, 5mM
TCEP, with 5% D20 added]. The spectrum is plotted a high contour level (A.) or at a lower contour level
with the superposition of the spectrum at high contour level (B.)
HSQC spectra of TRBP-D1 The dispersion of the peaks enable to distinguish artificially at
least three sets of peaks (fig. 15.8) :
- The major set correspond to a well dispersed set of intense peaks similar to the one obtained
for TRBP-D2. These are the peaks we see at high contour level in fig. 15.8 A.
- The second set of peaks has about 20% the volume of the first one. A striking difference
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between the first two sets of peaks is their chemical shift range. The set with the higher signal is
well dispersed whereas this one is included in a narrow 1H range (8 to 9 ppm) suggesting that
the peaks come from an unfolded protein (fig. 15.8 B).
- Additionally a few peaks are clearly doubled: they have a very similar NH chemical shift
and very close CA, CB and CO chemical shifts fig. 15.8 B. This adds another complexity to the
system.
Deeper investigation of these forms is presented after the establishment of a similar behavior
in TRBP-D1D2.
15.5.1 Assignment strategy of the set of intense peaks in TRBP-D1 spectrum
Experiments and results As for TRBP2-D2, a set of BEST experiments has been used to as-
sign the [1H,15N] TRBP2-D1 resonances: HN(CO)CACB, HNCACB, HNCO and inter-residual
HADAMAC experiments. Correlations between the spins related to the peaks of high intensity
have shown that these peaks belong to TRBP-D1 (fig. 15.9). Thus there is a least two species in
the sample: TRBP-D1 and a probable unfolded species. Because of the abundance of the latter
form, about 1/5 of the main one, and since only one band is seen in SDS-PAGE gel, the second
set of peaks must be another species of TRBP-D1. By now, I will call the main species TRBP-D1F
and the main minor one TRBP-D1U
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Figure 15.9: (1H,15N) BEST-TROSY spectrum of 15N-labeled TRBP-D1 (19-99), recorded at 600 MHz
and 25°C in [23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10 mM MgCl2 and 5 mM β-
mercaptoethanol, 5mM TCEP with 5% D20 added]. Backbone 15N-1HextN resonance assignments are
indicated. The unassigned signal peaks on the top-right corner of the spectrum are generated by side
chains amino groups and are labeled with stars (*). A peak of higher intensity in this region (**) has a
spectrum width dependent position and is likely to be aliased arginine side chain amino groups.
89% of the backbone [1H,15N] resonances have been assigned; the missing residues are the
three first ones including the residual glycine from the purification tag. The residues without
[1H,15N] resonances assigned are represented in red in the following sequence of the construct
and the prolines with no amino groups in grey :
GIEQMLAANPGKTPISLLQEYGTRIGKTPVYDLLKAEGQAHQPNFTFRVTVGDTSCTGQG
PSKKAAKHKAAEVALKHLKGGS
All the 13CO, 13Cα and 13Cβ resonances have been assigned apart for the first 4 residues.
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15.5.2 Secondary structure and 1H -15N-NOE of TRBP-D1F
Secondary structure The secondary structure of TRBP-D1F was estimated with the same
methods as TRBP-D2. It is very similar to the one of TRBP-D2 (fig. 15.10). The estimated
secondary structure is also in excellent agreement with the secondary structure found in the
previously reported crystal structure (PDBid: 3LLH) of the first domain of TRBP.
1H -15N-NOE In order to characterize the flexibility of TRBP-D1F, 1H -15N NOE were mea-
sured (section 12.2), and the results are given in fig. 15.10. The profile is highly similar although
the lower NOE values in the β1-β2 loop suggests more flexibility of this region in this domain,
which could be linked to two more residues in this loop compared to TRBP-D2
Figure 15.10: Secondary structure prediction based on TALOS+ (A.) and HN heteronuclear NOE (B.)
for the intense set of peaks of TRBP-D1 construct. The propensities in favor of mainly helical and sheet
secondary fold are colored in blue and orange respectively. The secondary structure obtained from the
deposited structure of the second domain of TRBP (PDBid: 3LLH) is given for comparison with the same
color code. For an easier visualization, the proline residues are represented in red. Error bar represents
+/- one strandard deviation estimated by simulating 100 ratios using the spectral noise and assuming a
Gaussian distribution.
166
15.6 NMR Assignment, secondary structure and dynamics of TRBP-D1D2
HSQC spectra of TRBP-D1D2 (19-288) As for TRBP-D1, various sets of peaks are repro-
ducibly visible on the spectra of TRBP-D1D2 (19-228). The number of non side chain amino
peaks exceeds 300 and includes about 160 ones in the central region H 7.75 ppm - 8.5 ppm (fig.
15.11). The same naming convention (F/U) is use to refer to the main form (TRBP-D1FD2) and
the form with an unfolded state (TRBP-D1UD2).
Figure 15.11: BEST-TROSY spectrum of TRBP-D1D2 (19-228) at 1.4 mM recorded at 600 MHz and 25°C
in [23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol,
5mM TCEP, with 5% D20 added]. The spectrum is plotted a high contour level (A.) or at a lower contour
level with the superposition of the spectrum at high contour level (B.)
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Table 15.3: Main parameters of the NMR experiments recorded on TRBP(19-228). tmax: maxi-
mum acquisition time
Sample Experiment Recycle
delay(s)
number
of scans
tmax(H)
(ms)
tmax(N)
(ms)
tmax(C)
(ms)
protonated BEST-TROSY-HSQC 0.5 120 70 80 na
deuterated BEST-TROSY-HSQC 1.5 8 70 75 na
deuterated BEST-TROSY-HN(CO)CACB 1.5 8 64 26 8.3 (CACB)
deuterated BEST-TROSY-HNCACB 1.5 8 64 24 8.3 (CACB)
deuterated BEST-TROSY-HNCO 1.5 4 64 26 10 (CO)
protonated 1H -15N-het-NOE 5 24 70 81 na
15.6.1 Backbone assignment of TRBP-D1FD2
Experiments Because of the larger size of TRBP2-D1D2(19-228) (22.6 kDa) compared to the
single domains, the fact the spectrum of the first domain was already crowded and in order
to prepare the analysis of the interaction with RNA, the assignment of TRBP-D1D2 has been
performed on a sample of produced in a U-[2H,13C,15N]-labeled media. The deuterated protein
was obtained using the double colony selection protocol (section 13.4.1) and purified in H2O to
allow exchange of the amide deuterons with protons. Three dimensional NMR experiments for
backbone assignment were recorded using 90 µL of a 600 µM sample of TRBP-D1D2 (19-228) in
a 2.5 mm diameter Shigemi tube (Shigemi Inc.) placed in a 5 mm diameter standard tube filled
with D2O. 3D BEST-TROSY versions of HNCACB, HNCOCACB and HNCO experiments (77)
were performed at 25°C using a Varian (Agilent) DirectDrive 600 MHz spectrometer equipped
with a triple resonance cryogenic probe. As this experiments concerns the whole RNA binding
region of TRBP, acquisition parameters are detailed in tab. 15.3
Results and analysis The assignment was performed without using the assignment of the sin-
gle domains. However, the analysis of the belonging of the peaks to each domain was regularly
checked for consistency with an overlay of the spectra of TRBP-D1, TRBP-D2 and TRBP-D1D2.
The assignment is presented on a protonated sample [1H,15N] to facilitate the comparison with
the assignment of the single domains fig. 15.12. It was possible to obtain at least one backbone
nuclear assignments (H,N,C) for 209 out of 210 residues of TRBP-D1D2 (19-228), including
99.5% of non proline 15N-HN pairs and 13Cα, 13Cβ chemical shifts, 91% of 13C′ chemical shifts
and 98.5 % of backbone amino groups. Unassigned backbone amino groups are represented in
red in the following sequence and the proline in gray :
GIEQMLAANPGKTPISLLQEYGTRIGKTPVYDLLKAEGQAHQPNFTFRVTVGDTSCTGQGPSKKAAKHKAA
EVALKHLKGGSMLEPALEDSSSFSPLDSSLPEDIPVFTAAAAATPVPSVVLTRSPAMELQPPVSPQQSECN
PVGALQELVVQKGWRLPEYTVTQESGPAHRKEFTMTCRVERFIEIGSGTSKKLAKRNAAAKMLLRVHTV
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Resonance assignments of TRBP-D1D2 (19-228) have been deposited in the BioMagResBank
(BMRB; http://www.bmrb.wisc.edu) under the BMRB accession number 18324. This assigne-
ment of TRBP-D1D2 has been the subject of an assignment note (16)
Figure 15.12: (1H,15N) TROSY-HSQC spectrum of 15N-labeled TRBP-D1D2 (19-228) with backbone 15N-
1HN resonance assignments recorded at 800 MHz and 25°C in [23.5 mM potassium phosphate pH 6.5,
100 mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol, 2 mM TCEP]. The panel on the right shows
an expansion of the region of the full spectrum contained in the dashed box.
15.6.2 Secondary structure and 1H -15N-NOE of TRBP-D1FD2
Secondary structure The secondary structure was estimated with the same method than
TRBP-D2, using TALOS+ (247). The secondary structure prediction of TRBP-D1D2 is in ex-
cellent agreement with the previously reported 3D structures of the two individual domains
(290) (PDBid: 2CPN, 3LLH) (fig. 15.13).
1H -15N-NOE In order to characterize the flexibility of TRBP-D1D2, 1H -15N NOE were mea-
sured. Heteronuclear 1H-15N NOE experiments (74) were measured on a Varian (Agilent) Di-
rectDrive 600 MHz at 25 °C with a room temperature probe using 300 µL of a 1.4 mM sample
of [15N]-labeled TRBP(19-228) in a 5 mm Shigemi tube (Shigemi Inc.) with 5% D2O. The main
parameters used for the experiment are given in tab. 15.3. The NOEs were calculated as de-
scribed in section 12.2. To avoid bias caused by chemical shift degeneracies, 29 peaks with close
1H -15N chemical shifts were not included in the analysis (fig. 15.13). The high 1H-15N NOE
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values in the secondary structure elements of both domains confirm that the two dsRBDs are
folded like in the single domain studies. The interdomain region connecting the two dsRBDs
(residues 99 to 159), without significant secondary structure propensities, is characterized by
negative heteronuclear NOE values indicating a high degree of flexibility; it is thus a flexible
linker.
Figure 15.13: Secondary structure prediction based on TALOS+ (A.) and HN heteronuclear NOE (B.)
for TRBP-D1D2 construct. The propensities in favor of mainly helical and sheet secondary fold are
colored in blue and orange respectively. The secondary structure obtained from the deposited structure
of the isolated dsRBDs of TRBP (PDBid: 2CPN, 3LLH) is given for comparison with the same color code.
For an easier visualization, the proline residues are represented in red. Error bar represents +/- one
standard deviation estimated by simulating 100 ratios using the spectral noise and assuming a Gaussian
distribution.
The only positive heteronuclear NOE value in the linker region concerns a residue preceding
two adjacent prolines, a motif that is known to add local order to polypeptide chains. Finally,
each domain contains a short stretch of decreased heteronuclear NOE values that centers on
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the conserved histidine of the loop between β-strands 1 and 2 (residues 53-61, dsRBD-1, and
residues 183-191, dsRBD-2). This loop comprises the second of three regions in dsRBDs that
form direct or water-mediated contacts with dsRNAs (264). The enhanced flexibility of this
loop compared to the rest of the domain may indicate a role in target recognition.
15.7 Comparison between apo TRBP-D1D2 and TRBP-D1 & TRBP-D2
15.7.1 Chemical shifts comparison between TRBP-D1D2 and TRBP-D1 & TRBP-D2
The absence of intermolecular interaction in the samples of TRBP-D1D2, TRBP-D1 and TRBP-
D2 has been established previously by SEC-MALLS, complemented with svAUC for TRBP-
D1D2. In order to investigate potential intramolecular interaction between the first two dsRBDs
of TRBP and/or between the dsRBD and the interdomain region, a comparison of the chemical
shifts of TRBP-D1FD2 with TRBP-D1F & TRBP-D2 was performed in fig. 15.14. It represents
the variation of chemical shift in TRBP-D1 and TRBP-D2 with TRBP-D1D2 as a reference. We
see that all shifts are very small (< 0.05 ppm) apart a few residues located at the C-terminus
of TRBP-D1 and at the N-terminus of TRBP-D2. The latter changes are expected because of
the large change of chemical environment related to the presence of the interdomain region,
including 2 new covalent bounds at each extremity of the linker region. The result shows that
apart from these trivial 3 residues, the chemical environments of the two first domains of TRBP
are the same in the tandem construct or when they are isolated. This imply that there are no
significant intramolecular interaction between the domains influencing chemical shifts, neither
interactions between the linker and the domains, apart from the localized truncation effects
on the linker boundaries. TRBP-D1U has also an extremely similar spectrum in TRBP-D1 and
TRBP-D1D2 samples, which is similar to what is observed for the folded form of D1. (fig.
15.14, C.). Thus the two first domain of TRBP have an independent conformation in their apo
form. An overlay of the spectra of TRBP-D1,TRBP-D2 and TRBP-D1D2 show differently this
independency (fig. 15.14). The assignment of each peak, required for a proper comparison
is not plotted for an easier visualization since the identicity of the closest peak information is
already contained in fig. 15.14.
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Figure 15.14: Comparison of the chemical shifts of TRBP-D1,TRBP-D2 and TRBP-D1D2. A. Estimation
of the deviation of backbone H-N chemical shifts for the residues assigned in both TRBP-D1F, TRBP-D2
and TRBP-D1FD2 in their apo forms. Chemical shifts deviation of 1H and 15N nucleus are composed
in a combined "compound" chemical shift. Unassigned residues and prolines are indicated by a small
negative bar. B., C. Overlay of (1H,15N) BEST-TROSY spectrum of 15N-labeled TRBP-D1(19-99), TRBP-
D2(157-228) and TRBP-D1D2(19-228) at 1.4, 1.4 and 1 mM respectively, recorded at 600 MHz and 25°C
in [23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol,
5mM TCEP with 5% D20 added]. Less coutours are used for the single domain constructs (TRBP-D1 and
TRBP-D2) than for TRBP-D1D2 to be able to see the peaks overlay. The comparison is plotted at high
contour level (A.) or low contour level (B.)
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15.7.2 Comparison of the secondary structure and Het-NOE between TRBP-D1FD2 and
TRBP-D1F & TRBP-D2
Secondary structure and 1H-15N NOE comparison To further get insight on the behavior
of the first two dsRBDs of TRBP within the miRNA binding region, the results of secondary
structure prediction and 1H-15N obtained previously were compared for TRBP-D1FD2 with
TRBP-D1F and TRBP-D2 fig. 15.15. The secondary structure and 1H-15N NOE match very
well in the isolated domain and in the tandem construct. Complementary to the previous 1H-
15N chemical shifts comparison, these observations confirm the independency of the first two
dsRBDs of TRBP in solution. On average, 1H-15N NOE values are slightly lower in the first
dsRBD compared to the second one, either in the tandem construct or in isolated domains.
This could be related to a difference of stability between the fold of the two dsRBDs. The next
paragraphs explore the special behavior of the first dsRBD of TRBP. Additionally, the β1-β2
loop of the first dsRBD has lower 1H-15N NOE values compared to the second dsRBD in the
tandem construct and in isolated domains. This may just relates to the fact the loop is slightly
longer in the first dsRBD (8 residues) than in the second one (6 residues).
15.8 Analysis of TRBP-D1U
Efforts have been directed to characterize TRBP-D1U. Since this minor species has very simi-
lar HN chemical shifts in TRBP-D1 and TRBP-D1D2 spectra and because of the similarity of the
behavior of the main species of the first domain of TRBP in isolated or in the tandem construct
(HN chemical shift, secondary structure and HN-NOE) it is reasonable to consider that the
same phenomenon is responsible for the existence of the minor species in both samples. This
is why the construct TRBP-D1, with less signal crowding than TRBP-D1D2 has been used to
analyze TRBP-D1U. The [1H,15N] chemical shift dispersion of species U is characteristic of un-
folded proteins. Taking into account TRBP-D1 has be shown to be monomeric in the previous
chapter, two hypotheses can be proposed to explain the presence of this species :
- Independent signals. This would mean that there is a folded species and an independent
unfolded species: either part of the folded protein unfolds in the production process, either two
forms, folded and unfolded, are purified from E. coli cells.
- Dependent signals. Both signals come from the same polypeptide, meaning that it under-
goes an exchange between the two detected sets of peaks. This would imply that the protein
alternates between a folded and unfolded conformation.
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Figure 15.15: Comparison of the secondary structures prediction based on TALOS+ and HN heteronu-
clear NOE for TRBP-D1, TRBP-D2 and TRBP-D1D2 construct. The propensities in favor of mainly helical
and sheet secondary fold are colored in blue and orange respectively. The secondary structures obtained
from the deposited structure of the first and second domain of TRBP (3LLH and 2CPN respectively)
are given for comparison with the same color code. Error bar represents +/- one standard deviation
estimated by simulating 100 ratios using the spectral noise and assuming a Gaussian distribution.
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15.8.1 SEC analysis of TRBP-D1
Previous knowledge of TRBP-D1 profile on SEC was first used to clarify the situation. It is
known that folded and unfolded form of one protein have different elution volume in an ap-
propriate size exclusion chromatography for the protein under study. They elute as molecules
of molecular weight 2 to 6 times higher (271; 269) than they folded counterpart. So if the first
hypothesis is true, with two distinct forms of the proteins before the SEC step, then two peaks
are expected in the chromatogram, or at least a peak much broader than the one of TRBP-D2.
However only one was reproducibly detected, with the same shape than the one of TRBP-D2.
It was still possible that partial unfolding of TRBP-D1 occur during the concentration step of-
ten used after the SEC step to prepare the samples for NMR, or more generally between the
SEC step and the NMR analysis. However, the spectra of TRBP-D1 recorded just after the SEC
and without concentration are also characterized by the two sets of peaks. Additionally the
chromatogram of a sample after NMR analysis is also characterized by one peak. So the un-
folded form was not induced by the post-SEC steps. These results were not consistent with the
first hypothesis and led me to the formulation of the second alternative hypothesis: the folded
and unfolded species of TRBP are two forms of the same protein molecule. Since one set of
peaks per species are detected, NMR was an excellent technique to test the latter hypothesis. If
two forms are in exchange in the millisecond to second time scale, the Exchange SpectroscopY
technique (EXSY) can detect the correlation between the peaks of the two forms, as explained
section 12.3.3.1.
15.8.2 BEST-EXSY of TRBP-D1: evidence of exchange
In order to detect potential exchange between TRBP-D1F and TRBP-D1U, some BEST-EXSY
experiments have been performed: one with a mixing time of 0 s and another with a mixing
time of 0.16 s. The results of these experiments are given in fig. 15.16. The spectra show that
each peak of the main species of TRBP-D1 (in red on the figure) is in exchange with a peak
of the species 2. Thus these two species are actually two forms in exchange. No exchange is
observed with the peaks of the third species.
15.8.3 Quantitative NMR analysis of TRBP-D1U
The narrow chemical shift range of the form U already suggested that the form was an un-
folded one. But to get more information on this form including the residues affected by the
exchange, a direct proof of the unfolded state and the potential residual secondary structure,
additional NMR experiments have been used.
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Figure 15.16: BEST-EXSY experiments of TRBP-D1 with a 0 s mixing time and 0.16 s mixing time
recorded at 600 MHz on a sample at 600 µM and 25°C in [23.5 mM potassium phosphate pH 6.5, 100
mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol, 5mM TCEP]. A. Spectra with 0 s mixing time. To
easily see the main species of TRBP-D1 compared to the other species, the spectrum is plotted at high
and low contour level. B. Spectra with 0.16 s mixing time, overlaid with the spectra A. The identified
peaks in exchange are linked by rectangle purple lines.
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15.8.3.1 Assignment of TRBP-D1F
In order to analyze the second form by NMR, the first step was to assign its 1H, 15N, Cα, Cβ
and CO resonances. These experiments were recorded on a 300 µl sample of TRBP-D1 at 1.4
mM in the phosphate buffer with 5% 2H2O added and placed in a 5 mm diameter Shigemi tube.
Three types of experiments were used to achieve this using a 600 MHz spectrometer: the set of
3D HNC experiments used to assign the main form of TRBP, a (2D) EXSY experiment with a
mixing time of 0.16 s to transfer the assignment from the peaks of the main form to the one of
the second form, and a 3D EXSY experiment with a mixing time of 0.16 s that was very useful
to help the assignment in the crowded central region of the spectrum. The assignment result is
given in fig. 15.17 together with the assignment of the main form.
15.8.3.2 Secondary structure and 1H - 15N-NOE of TRBP-D1F
Using the same protocol as for the one used for TRBP-D1F, the secondary structure propen-
sities and 1H - 15N-NOE were estimated (fig. 15.18). The differences between the chemical
shift of the Cβ and Cα chemical shifts is also provided since it is well known to depends on
the secondary structure. No clear secondary structure propensities are detected in this analysis
suggesting that the U form is actually really unstructured. This property seems incompatible
with the definition of a molten globule state. The 1H - 15N-NOE are low, globally positive
apart from the boundaries of the construct, with a mean value of about 0.4. The 1H - 15N-NOE
of TRBP-D1F are given for comparison in fig. 15.18. These results indicate that TRBP-D1U is
clearly less structured and more flexible than TRBP-D1F.
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Figure 15.17: (1H,15N) BEST-TROSY spectrum of 15N-labeled TRBP-D1(19-99), recorded at 600 MHz
and 25°C in [23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10 mM MgCl2 and 5 mM β-
mercaptoethanol, 5mM TCEP with 5% D20 added]. Backbone 15N-1HextN resonance assignments are
indicated for the major of minor form. The unassigned signal peaks on the top-right corner of the spec-
trum are generated by NH side chains.
178
Figure 15.18: Secondary structure prediction based on TALOS+ (A.) and 1H - 15N-NOE (B.) for TRBP-
D1U. A. The secondary structure obtained from the deposited structure of the first domain of TRBP
(PDBid: 3LLH) is given for comparison with the same color code. For an easier visualization, the proline
residues are represented in red in the sequence. B. 1H - 15N-NOE of TRBP-D1U in dark gray, overlaid n
the ones of TRBP-D1F plotted in light gray. Error bar represents +/- one standard deviation estimated
by simulating 100 ratios using the spectral noise and assuming a Gaussian distribution.
15.8.3.3 Relative populations of TRBP-D1F and TRBP-D1U
The assignment of both TRBP-D1F and TRBP-D1U enables to compare the populations of the
two states using relative volumes of the well resolved peaks for both states in fully relaxed NMR
experiment (fig. 15.19). The mean of the volumes of well resolved peaks of the U form over the
F form is about 0.21 with a standard deviation of 0.06, which is rather high and corresponds to
a strong contribution of the noise in the spectrum and some residue related heterogeneity. Ne-
glecting the few peaks found in TRBP-D1 and not in TRBP-D1D2, TRBP-D1F alternates between
a least two states folded (F) and unfolded (U) of average populations 83% and 17% respectively
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with a standard deviation of 4%.
Figure 15.19: Relative volumes of the peaks of TRBP-D1U over TRBP-D1F for the well resolved peaks
in the HN spectrum of both forms. The experiment used is an unsaturated Het-NOE experiment with
no mixing time and a recycling delay of 5 seconds. It was recorded on a 1.4 mM sample of TRBP-D1
at 600 MHz and 25°C. Error bars (small) represent +/- one strandard deviation estimated by simulating
100 ratios using the spectral noise and assuming a Gaussian distribution.
15.8.3.4 Attempt to estimate the folding/unfolding kinetics of TRBP-D1
In order to estimate the values of the exchange constants and the ratio between the two forms,
a series of EXSY experiments was performed by varying the mixing time 0 ms, 20 ms, 40 ms,
60 ms, 80 ms, 100 ms, 120 ms, 140 ms, 160 ms and 180 ms. The analysis of these spectra was
complicated by the peak crowding. No more than 4 peaks had the four peaks fully resolved.
Integration of the volume of the peaks and attempts to fit them with the equations given in
table 12.2 showed that some curves that could be fit for a few residues but the moderate signal
to noise ratio did not enable to get reasonably accurate values. An attempt to globally fitted
the data did not enable to retrieve relevant information because of an important heterogeneity
in the volume evolution of the different residues. This could be related to the moderate signal
to noise ratio and/or a lack of data points for longer mixing times and/or to a process more
complex that a homogeneous two state exchange. The normalized trends of the peak intensities
for a few resolved residues are given as illustration in fig. 15.20. The data suggest an exchange
rate time scale in the range 10-100 ms. Further analysis on this kind on data would be interesting
to get more precise kinetic information.
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Figure 15.20: Evolution of the diagonal and cross peaks intensities recorded in a series a BEST-EXSY
experiments with various mixing times (0 ms, 20 ms, 40 ms, 60 ms, 80 ms, 100 ms, 120 ms, 14 0ms, 160
ms and 180 ms). To show the global trends, the values from different resolved peaks are normalized so
that the highest value is 1.
15.8.4 Factors influencing the folding-unfolding equilibrium in TRBP-D1
The goal of this part is to assess whether the second form or TRBP-D1 can be considered as a
relevant phenomenon in vitro or just a bias linked to the physico-chemical environment used.
15.8.4.1 Effect of environmental conditions
In this part some the potential effects of the physico-chemical environment used in the bio-
physical studies on the formation of the second form is analyzed.
Molecular denaturants The exchange between a folded and an unfolded form can be
obtained experimentally by adding denaturant molecules (urea, guanidine hydrochloride,
sodium dodecyl sulfate ...) to a protein solution or with some special protein in a system with
extremes (too low or too high) salt amounts. The phosphate buffer used through the study has
an ionic strength of 150 mM, which is very close to the mean physiological conditions in hu-
mans so the second possibility seems unlikely. Although not known as a denaturant, the only
molecule that could affect the folding of the protein in the purification is the Triton-X100 de-
tergent used during the cell lysis. Extensive washes, many dialysis and 2 column purification
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are used after the first NiNTA step with Triton-X100 so together with the existence of the full
folding/unfolding equilibrium there should not be any Triton at the end of the purification. So
the folding/unfolding phenomenon detected does not relate to the presence of a denaturing
molecule in solution. Extreme pH and temperature (too high or too low) are also known to
induce the folding and unfolding of proteins.
pH effects The pH of 6.5 used in this study is close but does not exactly match the physio-
logical one of about 7. To analyze the effect of the pH on the folding/unfolding equilibrium, a
protein sample of TRBP2-D1 has been produced with the standard protocol and split into three
subsequently dialyzed in parallel at 4°C during 16h in the NMR buffer at three different pH:
5.5, 6.5 and 7.5. The resulting HSQC spectra recorded at 25°C are plotted in fig. 15.21. Peaks
of the U form are detected in the three pH conditions (6.5 - 7.5). An increase of the volume of
the peaks of the U form is observed as the pH decreases. The same experimental parameters,
including the short recovery delay (0.2 s), has been used for the three BEST-HSQC experiments.
This delay is not optimal for a precise quantification of the population of the two states U and
F. Peak volumes were quantified for a few intense and well resolved glycine peaks with de-
tectable intensities for the U form at the 3 pH. For the last two reasons, the ratios for these
selected peaks are not good estimate of the mean for the whole sets of peaks, but represents the
trend. The present study at pH 6.5 compared to pH around 7 displace the folding-unfolding
equilibrium towards the unfolded enough to allow an easy detection and study by NMR.
The overlay of the HSQC also shows that there is a region of the protein, the β1-β2 / N
terminus of the β2 sheet that undergoes the largest chemical shift changes upon the pH change.
This region is composed of residues 56-QAHQPNF-62. This effect very likely corresponds to the
protonation of the only protonable side chain in this loop, the histidine 58. The imidazole side
chain has a pKa of about 6 which is in the pH region explored here. Being part of a flexible loop
according to the NOE data of TRBP-D1, solvent accessibility of this histidine is thus expected.
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Figure 15.21: Effect of the pH on the folding/unfolding equilibrium in TRBP-D1 at 25°C. A. Overlay
of three BEST-HSQC spectra recorded on TRBP-D1 at pH 5.5, 6.5 and 7.5 with the same acquisition
parameters. Peaks of sequential residues undergoing the larger chemical shift changes present in the
β1-β2 loops are surrounded by rectangles and labeled. B. Comparison of the ratio of peaks intensities
for a few resolved and intense glycine peaks detectable in the U and F state at the three pH. The error
bars indicate +/- one standard deviation.
Temperature effects To analyze the effect of the temperature (25°C in the previous experi-
ments), a series of BEST-HSQC spectra of a sample at pH 6.5 has been recorded at different
temperatures. In order to avoid potential slight inter sample variability, only one sample was
used for the different measurement. Since temperature increase can alter some proteins, the
spectra were recorded by increasing the temperature, from 15°C to 45°C by 5°C increments. An
additional last spectrum was recorded at 25°C to check whether some alteration of the sample
occurred during the heating experiment. Importantly, the experiment is performed in 23.5 mM
phosphate buffer which second pKa (7.2) is only very weakly dependent on the temperature
(dpKa2dT = −0.028 at 100 mM) so the effect of pH is neglegible and the experiment essentially
reports the temperature effects. The results of this experiment are presented in fig. 15.22.
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Figure 15.22: Effets of the temperature on TRBP-D1. A. BEST-HSQC experiments of TRBP-D1 from
15°C to 45°C by 5°C increments. B. Control experiment. A spectra of the protein sample before the
experiment at 25°C is compared to the spectra at 25°C of the sample that underwent the heating experi-
ment.
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Importantly, on fig. 15.22 B., no changes are detected between the spectrum of the in relation
to the heating experiment including no increase of the population of the U state. The peaks vol-
umes of the state TRBP-D1U increases with the temperature whereas TRBP-D1F decreases. This
is likely a change of the population of the two states. The largest chemical shifts changes are ob-
served for the U state which is perfectly consistent with the fact it is an unfolded form so highly
sensitive to the environment. The absence of changes in the control experiment imply that the
folding/unfolding evolution as the temperature change is reversible, which is consistent with
the previous conclusion of the existence of the equilibrium.
Folding-unfolding exchange at physiological pH and temperature conditions Eventually in
order to get closer to physiological conditions, a spectrum has been recorded at pH 7, 37°C
fig. 15.23 from a sample at pH 6.5 dialyzed at pH 7. We see that peaks of the second form are
present. Despite the signal to noise of the spectra recorded is rather low, its shows the presence
of some peaks that by comparison to the spectrum at 25°C and pH 6.5 correspond unambigu-
ously to the U state of the protein. Additional peaks are visible at the center of the spectrum but
are not identifiable by direct spectrum comparison. Identifiable peaks correspond to residues
distributed homogeneously along the sequence. These observations confirm the existence of
the folding/unfolding equilibrium at a temperature and pH closer to the physiological condi-
tions in human cells. These conditions are however defavorable for a structural analysis by
NMR because of a lower protein stability and because of peaks of the main F form present at
much lower intensity that at pH 6.5, probably because of a faster exchange of the amide proton
with the solvents (about 80 times faster at pH 7 compared to 6.5 (29)). The observations made in
this paragraph underline the interest to study the protein samples in the conditions used here
(pH 6.5, 25°C), making both the folded state and folding/unfolding event more detectable by
NMR and not too far from the physiological ones.
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Figure 15.23: BEST-HSQC spectrum of TRBP-D1 in recorded at pH 7.0 and 37°C at 800 MHz in [23.5
mM potassium phosphate, 100 mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol, 5mM TCEP]. The
rectangles indicate a few peaks of the unfolded state (U) of TRBP-D1 identified by comparison with the
assigned spectrum at pH 6.5 and 25°. Unambiguous assignment for a few residues of the U state is also
given.
15.8.4.2 Analysis of the effect of the construct boundaries
The aim of this part is to study whether the folding/unfolding phenomenon of TRBP2-D1
could be the result of the truncation effects. Indeed since TRBP-D1 construct it is only a part of
TRBP, the presence of the rest of the C-terminal polypeptide could stabilize it; for instance if a
secondary structure motif has been cut in the construction design or if C-terminus folds with
the first domain. In this case, the folding-unfolding process would be irrelevant and would be
a truncation artifact.
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Figure 15.24: BEST-EXSY experiments of TRBP-D1D2 at 25°C with mixing times of 0 s and 0.16 s
recorded on a sample of 480 µM at 800 MHz in [23.5 mM potassium phosphate pH 6.5, 100 mM KCl, 10
mM MgCl2 and 5 mM β-mercaptoethanol, 5mM TCEP]. A. Spectra with 0 s mixing time. To easily see the
main species of TRBP-D1 compared to the other species, the spectrum is plotted at high and low contour
level in black and orange respectively. B. Spectra with 0.16 s mixing time, overlaid with the spectra A.
Some well resolved EXSY cross peaks are highlighted with gray circles.
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Folding/unfolding on the first domain in the presence on the linker and second domain of
TRBP The peaks of the second form of TRBP2-D1 are also detected in the TRBP-D1D2 con-
struction and the exchange happen at similar time scale, according to one EXSY experiment
performed with a mixing time of 160 ms on an 800 MHz spectrometer, with a protein concen-
tration of 480 µM (fig. 15.24).
Folding/unfolding on the first domain of TRBP and TRBP isoforms The first isoform of
TRBP (TRBP1) has an extended N-terminal region that could also stabilize the first domain.
TRBP-D1 and TRBP-D1D2 correspond to the second isoform of TRBP (TRBP2) with 21 N ter-
minal residues in the N-terminus than the first isoform of TRBP (TRBP1). In TRBP-D1 and
TRBP-D1D2 3 additional N-terminal residues of the first isoform and a residual glycine from
the TEV cleavage site are present so there is not a truncation at this extremity. However an
effect on the first 20 residues of TRBP1 on the folding/unfolding process could help to under-
stand the biological selection of the two isoforms. The folding/unfolding equilibrium could
also occur in both isoforms.
To clarify this NMR experiments on TRBP1-D1 were performed fig. 15.25 . The HSQC and
EXSY experiment show that the peaks characteristic of the U state are also present in the TRBP1-
D1 construct and with the two forms in exchange ; the relative intensities of the U and F state
in the two form recorded in similar conditions are not distinguishable. Thus, similarly to the
extension of the C-terminus, the presence of the exchanging unfolded form of the first domain
of TRBP is not influenced by the length of the N-terminus. Although a more quantitative study
could have been performed on the TRBP1 isoform, the highly similar HSQC spectra and the
absence of in vivo data suggesting a relevant behavior difference between the two isoforms has
not motivated it.
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Figure 15.25: Evidence of an exchange in TRBP1-D1 (first dsRBD of TRBP with the 22 residue N-
terminal extension) at 250 µM in phosphate buffer at pH 6.5, 25°C. A. N-HSQC and a BEST-EXSY exper-
iment (mixing time 0.16s) recorded at 800 MHz are overlaid.
15.8.4.3 Analysis of the buffer effect on the folding/unfolding equilibrium
Finally, to test a potential effect of the phosphate ions on the observed folding-unfolding
process, some samples were dialyzed in 50 mM PIPES buffer at pH 6.5 with 100 mM KCl and 5
mM TCEP. Both the folded and unfolded form were detected (HSQC and EXSY), with the same
characteristics than in the phospahate buffer used fig. 15.26. So the use of a phosphate buffer is
not responsible to the phenomenon observed.
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Figure 15.26: Evidence of an exchange in TRBP-D1 at 750 µM in PIPES buffer at pH 6.5, 25°C with 100
mM KCl and 5 mM TCEP. An N-HSQC and a BEST-EXSY experiment recorded at 600 MHz are overlaid.
The assignment of TRBP-D1F and TRBP-D1U at 25°C in the phosphate buffer used in this study was
overlaid to show the network of peaks in exchange.
15.8.4.4 Conclusion
As the result of these analysis, the existence of the newly detected folding-unfolding equi-
librium of the first domain of TRBP appears to be an intrinsic property of this protein in vitro,
not caused by obviously adverse physico-chemical conditions in the media, nor by truncation
effects and is not isoform dependent.
15.8.5 Hypotheses to explain the origin of the folding/unfolding equilibrium of the first
domain of TRBP
It is hard to get mechanistic information on the folding/unfolding processes using biophysi-
cal techniques recording properties of an ensemble of molecules, even for site resolved solution
NMR experiments. Fast pulsing techniques and tricks to slow down the folding process have
been applied to favorable systems. Ultra-high time-resolved site specific information would
be necessary. The goal of this paragraph is just to present a few hypotheses that could explain
the special behavior of the first dsRBD of TRBP using the data from this study and the ones
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reported in the literature. Since the folding/unfolding equilibrium was not detected in the sec-
ond dsRBD (but could exists at different time scale and/or with much lower U population), a
comparison of the sequence and structures of these dsRBDs can be interesting. The structures
of the folded form of D1 has been obtained by X-ray diffraction (PDBid: 3LLH) whereas the one
of the second domain was solved by NMR (PDBid: 2CPN).
15.8.5.1 Sequence comparisons
Sequences differences As the first two dsRBDs of TRBP only share 34% identity, the search
of sequence determinants for the different behavior of TRBP-D1 and TRBP-D2 is not straight-
forward (fig. 3.2). On the structural point of view, according to the published structural data,
the main form of the first two TRBP domains have a very similar fold but a fold compari-
son might not be relevant as the structures were solved in different conditions, in solution for
TRBP-dsRBD2 and in a crystal for TRBP-dsRBD1. A few sequence features are discussed here.
- A tryptophan appears inserted at the position 14 of the alignment (152 in TRBP) in the α1-
β1 loop of the second domain of TRBP. This residue is one of main the difference between the
fold of the first two domains of TRBP as underlined by the study that reported both structures
(290). The aromatic ring of the tryptophan interacts with the side chain of lysine 12 (150 in
TRBP) through a cation-π interaction. This study has found using circular dichroism that the
thermal stability of the first domain of TRBP is significantly lower than the one of the second
domain. The authors used a protein construct very similar to the ones reported in this work
but didn’t removed the purification tags in N-terminus. Their result get more sense in light of
the folding/unfolding equilibrium of TRBP-D1 discovered in this thesis and thus both studies
appear consistent. To understand the thermodynamical differences, they suggested that the
cation-π interaction present in the second domain but not in the first one stabilizes the second
domain. They found that the mutation of the tryptophan residue involved in that interaction to
an alanine make the second domain of TRBP unfolded. However this result is not a definitive
proof of a role for the cation-π in the stability of TRBP-dsRBD2. Another mutation at another
place could have led to the same result. Even if the tryptophan is actually an important residue
for the second domain the reason for the destabilization of the construct might not be caused
just by its removal.
- The alignment shows that 3 prolines are present at almost the same position in the each dsRBD,
but the first domain of TRBP has an additional proline at the N terminus of the helix α2, at the
center of a long region that appear rather rigid in the NOE time scale and that seem important
for the dsRBD fold as mentioned in the first part. Proline cis/trans isomerization is a common
source of kinetic step limiting process in the folding of proteins and this reaction in this region
could contribute to the phenomenon observed.
Anyhow, the origin of the folding/unfolding equilibrium in TRBP-D1 is potentially not lo-
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calized to a few residues and could be a global result related to the overal chemical composition
of the dsRBD. The combination of the special features at the C and N terminus of the two helices
(no stabilizing tryptophan, and presence of a proline respectively) with the shorter C terminal
helix could cooperate in the low domain stability.
Figure 15.27: Sequences and secondary structure comparison between TRBP-D1, TRBP-D2. A. Multi-
ple alignments was performed with the MUSCLE program (65). The Shannon’s information theoretic
entropy (246) was used with a 10 letter alphabet to measure the residue diversity ([V,I,L,M], [F,W,Y],
[S,T], [N,Q], [H,K,R], [D,E], [A,G], [P], [C], [-]) and normalized, implemented by the R bio3D package.
The color scheme is the following one: (A, V, M, I, L, F, C and W) are colored in light blue, (S, T, N and
Q) are colored in green, D,E and R,K are colored in purple and red respectively, H and Y in blue-green
and G are colored in orange. Aligned residues with a normalized entropy of conservation value below
0.40 are not colored. The secondary structures of TRBP-D1 and TRBP-D2 are the ones obtained in this
work whereas for PACT-dsRBD1, they are derived from its reported solution structure (PDBid: 2dix)
with Stride algorithm (89).
15.8.5.2 Towards an understanding of the folding/unfolding process of TRBP-D1
I propose here potential research directions that could contribute to understand the determi-
nants of the folding-unfolding event in the first binding domain of TRBP :
- Mutational studies Providing that the phenomenon observed could be a general property of
some dsRBDs, a good method to understand the origin of the folding-unfolding process could
be to generate mutants that destabilize the second domain so that a folding unfolding phe-
nomenon appear and other mutants that stabilize the first domain to diminish the unfolding
propensity. However as the potential observed effects are not obviously related to the changes
we expect to induce, a correct analysis of these multiple mutants would require to analyze the
mutants by NMR and to solve their solution structure, which would have been very time con-
suming especially with part of the signal coming from the unfolded forms that would give a
lot of "contaminating" peaks in the NOESY spectra. Even the assignment of the HN backbone
resonances have been strongly complicated by the presence of the minor form that also gave
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strong 3D signals, often overlaid with peaks of the main form. Mutations to understand fold-
ing processes have often been performed on proline motivated by the idea that the cis/trans
isomerization can impact the folding kinetics. Such a study would require many mutations per
site on various sites to be conclusive as the result cannot just be interpreted as a proline effect:
the effect of the residue used to replace the proline can also have an important effect on what
will be observed. A good example of these ambiguities has been published (26) for the protein
CRABPI, a protein characterized by a slow folding phase. This work shows that mutating pro-
line 85 into an alanine abolish the slow folding phase whereas a mutation to valine does not
change the folding kinetics. Some mutation of the tryptophan 152 of TRBP-dsRBD1, aimed to
get insight into the difference of thermal stability between the first two domains of TRBP have
been published during the course of my PhD (290) as already mentioned but they did not fulfill
all the criteria required to provided a definitive explanation.
- Cis-trans proline isomerization contribution analysis A simpler approach could easily assess
whether the proline isomerization have a contribution to the folding-unfolding exchange de-
tected. Prolyl isomerase could be added to an NMR sample and HSQC and EXSY experiments
could monitor whether or not the equilibrium has shifted towards the folded form. Even if
this isomerization appears to be responsible for the folding-unfolding process, the equilibrium
would still be relevant in vitro since in the absence of the isomerase, the protein should go back
to the folding-unfolding equilibrium.
15.8.6 Perspectives regarding the folding/unfolding of the first domain of TRBP
The first remark that is worth saying, as already underlined, is that the solution structure be-
havior of a protein can be different from the one obtained by the analysis of the x-ray diffraction
pattern of protein crystal. Indeed the "x-ray" structure of TRBP-D1 shows a folded protein and
it is very likely that the crystallization has shifted the folding/unfolding equilibrium toward
the folded form. The possibility to study the solution structural and dynamical behavior of a
macromolecule is a major advantage of NMR spectroscopy over crystallography.
The second remark is more a semantic one. In the last 10 years it has been shown that a large
portion of the human proteome is composed of unfolded protein or contain unfolded region
that are now called intrinsically disordered proteins (IDP). NMR spectroscopy has enabled to
get many insights into these proteins showing, among other things, that these proteins are
often not completely random coils. Using this terminology, the first domain of TRBP-D1 can be
considered as an IDP with a high propensity of structure. To my knowledge the first domain
of TRBP is the first reported evidence of a full folding / unfolding equilibrium in a human
protein domain at pH and temperature around physiological conditions. Thus this example
underlines well that there are not two worlds of proteins, the folded ones and the intrinsically
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disordered ones but a continuum, the two latter cases being extremes situations. The TRBP-
D1 protein appears as a special member of this continuum and it would be in the future to
see whether similar behavior are found in other human proteins and could be related to any
/ many function(s). This requires a careful analysis of the NMR spectra to understand all the
peaks and minor forms present in them.
This original TRBP-D1 behavior among the dsRBDs family appears a unique property apart
from the previous reported behavior of some SH3 protein domains that surprisingly resemble
a lot what has been detected here. SH3 domains are a class of domains found in many proteins
participating to signaling pathways. Like dsRBDs, SH3 domains have also many structural
variations. Despite most SH3 structures have been reported to form stable structures in solu-
tion, a group has shown the existence in Drosophila of an equilibrium between a folded and
an unfolded state in the N terminal SH3 domain at pH 6 of an adaptor proteins composed of
an SH2 domain surrounded by two SH3 domains, called drk (302; 301; 76). Another group
reported the same phenomenon in the mammalian homolog GRB2 but at pH 3.5 (102). The
case of drk has been extensively studied and is characterized by two almost equally populated
states with a mean rate of exchange of 0.9 s (76) with no evidences of an intermediate state in
the folding pathway (200). A mutation study has been performed for the drk N terminal SH3
domain where a conserved glycine was occupied by a threonine (200) the threonine to glycine
mutation stabilized the domains.
15.8.7 Summary of the characterization of the apo-RNA binding region of TRBP
Figure 15.28: Summary of the main properties of apo TRBP-D1D2 found in the present study.
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The main properties found here in TRBP-D1D2 are summarized in fig. 15.28. These prop-
erties will constitute a basis for the study of the interaction between this region of TRBP and
miR-155 precursors.
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Chapter 16
Characterization of apo pre-miR155 and miR155/155* duplex
16.1 Homogeneity analysis of microRNA 155 precursors
As the RNAs were produced in vitro and purified on gel to be sure to get a high purity, the
technique to purify and analyze the purity are similar. An example of a urea-PAGE of pre-miR-
155 and miR-155/miR-155* and a SEC chromatogram of a pre-miR-155 are given in fig. 16.1
and fig. 16.2.
Figure 16.1: Urea-PAGE gel analysis with 15% acrylamide of pre-miR-155 (hairpin) and miR-155/miR-
155* (duplex) constructs after their purification and activation. Methylene blue was used for the staining.
A. Two lanes juxtaposed, extracted from a larger gel. B. Integration of the gel lanes with arbitrary signal
units. The signal saturates around 0.9.
One the gel, fig. 16.1, one band is obtained as expected for the hairpin. Two bands are
resolved in the lane of miR-155/miR-155 which corresponds to the 23 bp miR-155 and 22 bp
miR155*. The purity of the samples was considered sufficient to perform biophysical studies
with them.
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16.2 Oligomerization analysis of pre-miR-155 by SEC-MALLS
SEC-MALLS experiment Because of the low yields of miR-155/miR-155*, most biophysical
analysis were performed with pre-miR-155; the duplex was mainly used in the interaction study
by NMR. A SEC analysis with mass estimation with an on-line MALLS detector was performed
for pre-miR-155. The protocol is described in chapter 8. A sample of 50 µL of pre-miR-155 at
200 µM (4 mg/ml) was loaded on the SEC column. Because of the very large absorption of
the RNA in the UV range, this sample saturated the detector so the resulting chromatogram is
given in fig. 16.2 using the refractive index detector signal.
Figure 16.2: SEC refractive index profile of a sample at 200 µM of pre-miR155 in phosphate buffer
loaded on an analytical Superdex S75 10/300 GL column (GE Healthcare) coupled with an in-line re-
fractive index detector (RI 2000, Spares) used to follow the differential refractive index of the SEC eluate
relative to the solvent (1.34)
SEC-MALLS data analysis Two peaks are present in the chromatogram, despite the SDS-
PAGE gel of pre-miR-155 is characterized by only one band. This indicates the presence of two
species of pre155 in the sample. The MALLS molar mass estimation of the molecule in the
main peak matches very well what is expected for monomeric RNA (19.6 kDa): 19.14 kDa with
standard deviation (sd) of 0.76 kDa. The amount of the species corresponding to second peaks
is too low for an accurate MALLS estimation. Two hypotheses can explain the presence of these
two species of RNA :
- Hairpin interaction. Because of the high density of negative charge in the RNA and providing
the secondary structure prediction is valid, it is hard to conceive the possibility for this RNA
to form dimers of hairpins. Such interactions have already been observed for perfect duplex of
DNA with blunt ends. In such case, staking interactions can lead to the dimerization of part of
the sample. However, no such extremities are present in the RNA construct. This hypothesis
seems very unlikely.
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- Partial duplex formation. The RNA have been folded using a quick cooling of a hot (96°C)
solution of RNA. This should favor the kinetic product of the reaction, which is the intramolec-
ular folding leading to the hairpin. Another fold are also possible (although not predicted by
the mfold algorithm (309)), corresponding for instance to an imperfect two strands duplex that
contains two times more base pairing than the hairpin fold fig. 16.3 Presence of this product
could be favored under thermodynamic control (slow folding, low temperature). Such hairpin
and homo-duplex coexistence has already been observed, for instance for a 79 nucleotide RNA
(258).
Figure 16.3: A. Secondary structure of pre-miR-155 according to mfold prediction. B. Author proposed
secondary structure to account for the detection of a small fraction of dimerized pre-miR-155.
To validate MALLS estimation, this result has to be compared with the assumption used to
derive the molar mass values :
• AMALLS1. The estimated masses very close to the monomeric mass, correspond to RNA
chains that are well below the laser wavelength (690 nm) so this assumption is fulfilled.
• AMALLS2, 3. The assumptions 2 and 3 are hardly testable and their potential effects have
been discussed in the methodological part.
• AMALLS4. Providing a intermolecular base pairing formation is the mechanism that gen-
erates the species with a large molar mass, two stables RNA species are present in solution
without transient interaction. This is required for the system to get close to the assump-
tion 4.
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16.3 Oligomerization analysis of pre155 by svAUC
svAUC experiment In order to analyze the pre-miR-155 sample with a different theoretical
framework to confirm the SEC-MALLS observations, a svAUC analysis has been performed. 1H
1D NMR experiments have shown that the RNA samples were stable for at least 5 months. They
were however used much before this long delay. This stability enables to study the RNA using
a svAUC experiment (about 10 hour). The svAUC analysis was performed on two samples of 1
µM and 2 µM in the using the protocol presented in the methodological part. In particular the
experiment is performed in the same phosphate buffer than in the others biophysical studies.
The low concentrations of RNA enable to avoid saturation of the UV detector and to get closer
the important assumption in svAUC requiring to work at very low concentrations.
svAUC results The concentration profiles recorded during the experiment at 280 nm are given
in fig. 16.4. The data are rather noisy. This could come from impurities on the surface of the
cells windows (e.g. oil) or damaged cells windows.
Figure 16.4: Superimposition of the 10 first scans recorded at 280 nm in the svAUC experiments for
pre-miR155 at 1 µM and 2 µM. The bold dashed lines indicate from left to right the position of the liquid
meniscus and the position of the cell bottom. The two lighter lines in gray indicate the zone used to fit
the data. The right light gray dashed line indicate an approximate position after which the effects of the
concentration of the sample at the cell bottom became obvious in the sedimentation profiles
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svAUC data analysis The result of the diffusion deconvoluted c(s) model fitting is given in
fig. 16.5.
Figure 16.5: Superimposition of the diffusion deconvoluted c(s) profiles of pre-miR155 at 1 µM and 2
µM respectively. The dashed gray line is positioned at the mean of the maximum of both distributions.
The star (*) indicates a minor species, with represents 4% of the main signal species sedimenting faster.
Because of the rather noisy svAUC data for the precursor and the reduced range of concentra-
tion tested, it is not possible to assign an origin to the slight change of sedimentation coefficient
at 1µM and 2 µM around 4.4 S. However, the c(s) profile of the sample at 2 µM shows the pres-
ence of a minor larger species sedimenting at 7.2 S. This signal from this species corresponds
to 4 % of the main one and is consistent with the small fraction of larger RNA species detected
previously in SEC-MALLS experiments. Assuming a concentration independency of sexp for
the RNA, a modeling with a single sedimenting species can be applied. This model, without
assumptions about the shape of the sedimenting species leads to a molar mass estimation of
19.4 kDa which is close to the real mass of 19.6 kDa. Taking into account the assumptions used
in the derivation of the model used, this estimation is considered very good. As a result, this
svAUC analysis confirms the mainly monomeric behavior of pre-miR155, with a minor part of
the population existing as a larger species. Additionally, fixing the mass in the c(s) model to fit
the data leads to a frictional ratio of 1.4. This value is larger than the one expected for a spheri-
cal particle (1.25) and indicates an elongated particle. This is expected for an hairpin structure.
Using this frictional ratio it is possible to predict the sedimentation coefficient of an RNA dimer
with a similar frictional ratio (6.75 S), which can be adjusted to 7.2 with a frictional ratio of 1.31.
Thus the minor peak in svAUC is consistent with the dimerization of a small fraction (≈ 10%)
of pre-miR-155. Because of the moderate yield of pre-miR-155, the low proportion of dimers,
the handling risk associated with additional purification steps to try removing the potential
dimer and the very high probability that the larger RNA species is in slow equilibrium with the
hairpin, it has been decided to keep the RNA sample as it is, without additional purification
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steps.
16.4 Secondary structure of miR 155 precursors - NMR assignment of imino
protons
16.4.1 Secondary structure of pre-miR-155
Imino protons of guanine and uracil bases protected from exchange with the solvent i.e. in-
volved in hydrogen bounding (93) have NMR signal in the 10-15 ppm range (93). The imino
spectra of pre-miR-155 are characterized by about 20 resolved peaks that show existence of base
paring in this RNA fig. 16.6.. All RNA samples samples produced were systematically analyzed
by 1D (1H) NMR spectroscopy to check for a correct in vitro folding and they shown identical
spectrum to the one reported in fig. 16.6. In order to study experimentally the validity of the
secondary structure predicted for the pre-miR-155, assignment of the imino spectra of this RNA
was performed. For unlabeled RNA, imino proton of assignment is commonly performed by
1H-1H-NOESY experiment. Lowering the temperature (e.g. 5°C) increases the stability of the
base pairing so it usually enables to detect the less stable base pairs at 25°C, especially the ones
present at the boundaries of hybridized regions. In order the check the relevancy of the RNA
assignment at 5°C for an inference of its structure at 25°C (the temperature at which all inter-
action studies were performed), the effect of the temperature on the 1D 1H imino spectrum on
pre-miR-155 was analyzed. fig. 16.6.
The temperature titration shows only moderate shifts and intensity changes mainly related
to the separation of two peaks at 14 and 12 ppm. These moderate changes suggest that the base
pairing pattern of the RNA in the range [5°C-25°C] does not change importantly apart from ex-
pected stabilization of weak base pairs. It is thus meaningful to study the secondary structure
at 5°C for an assignment at 25°C. The spectra used for the assignment of pre-miR-155 are given
in fig. 16.7 and assigned imino protons are represented in fig. 16.7. Two independent paths
are detected in the HH-NOESY exactly as predicted by the theoretical secondary structure. Ad-
ditional peaks detected in the 1D imino proton spectrum and in the HH-NOESY indicate than
additional weaker base paring interactions exist which is also consistent with the predicted sec-
ondary structure. In particular a peak at 11.2 very likely correspond to the two G:U in position
24. Dots have been used to represent these weak interactions in the structure of pre-miR-155 in
fig. 16.7.
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Figure 16.6: A. Imino proton spectrum of pre-miR-155 of a 890 µM sample recorded at 25°C at 800MHz.
B. Effect of the temperature in the range [5°C, 25°C] on the imino proton spectrum of pre-miR-155. In
order to facilitate the comparison of the spectra, they were scaled so that the sums of the intensities are
equal.
16.4.2 Secondary structure of miR-155/miR-155*
Direct comparison between the assignment imino proton spectrum of pre-miR-155 with miR-
155/miR-155* suggests that the first base pairing region (nt 1 to 10 and 50 to 60) has a similar
base paring structure in miR-155/miR-155*. It is not possible to make conclusion for the second
segment of base pairs (nt 17 to 22 and 41 to 46) because of important shift of the peaks compared
to pre-miR-155. This is expected as this second region is shorter in the duplex compared to the
hairpin and since its chemical composition is different: G:U and G:C at position 21 and 22
respectively are replaced by two C:G. The absence of the strong signal from the assigned G:U
pair at position 21 in pre-miR-155 is thus consistent with the composition of the duplex. In
addition to the peaks of the first base paring region, four imino peaks are detected and imply
a base pairing in the second region, so the base paring structure proposed in fig. 16.8. There
is an excellent match of the imino protons peaks expected to be found in the longest helix of
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the duplex precursor and an expected less correspondance for the shorter helix due to the two
mutations and the absence of the helix.
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Figure 16.7: Spectra used to assign the imino protons of pre-miR-155 (engineered). A. imino proton
spectrum of pre-miR-155 at 890 µM recorded at 800 MHz and 5°C in the phosphate buffer with 5% 2H20.
B. SOFAST NH-HMQC of pre-miR-155 at 890 µM recorded at 600 MHz and 25°C in the phosphate buffer
with 5% 2H20. C. HH-NOESY of pre-miR-155 at 890 µM recorded at 800 MHz and 5°C in the phosphate
buffer with 5% 2H20
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Figure 16.8: Comparison of the imino proton spectrum of engineered pre-miR-155 and miR-155/miR-
155*. A. Overlay of the imino proton spectrum pre-miR-155 and miR-155/miR-155* recorded at 25°C.
The assigned imino protons of pre-miR-155 are indicated. B. Secondary structure for pre-miR-155 ac-
cording to the HN-HMQC and HH-NOESY study. C. Proposition of secondary structure for miR-
155/miR-155* according a the proton imino spectrum comparison with assigned pre-miR-155 (A.). The
base numbering is the one used for pre-miR-155 to facilitate comparison.
16.5 Summary of pre-miR-155 and miR-155/miR-155*
The different biophysical methods applied to pre-miR-155 have shown that this RNA is
mainly monomeric with a small fraction (< 4%) present probably as a dimer in solution. The
monomer adopts a hairpin structure in solution as expected and has an elongated shape in
solution. Presence of base pairing in the miR-155/miR-155 duplex is also consistent with the
expected structure.
From these informations on miR-155 precursors and on TRBP-D1D2, TRBP-D1 and TRBP-
D2 in their apo form, a biophysical study of the interaction between the two kinds of macro-
molecules could be performed.
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Part V
Characterization TRBP-D1D2 interaction with miR-155 precursors
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Goals In the case of TRBP interaction with microRNA precursor, as underlined in the bibliog-
raphy, the stoichiometry and macroscopic binding parameters have not been studied in depth
in the literature. In particular it was still unclear whether there is one RNA binding to each
dsRBD, one or more protein interacting per RNA or a mixture of these cases. Another key
question was to determine whether the RNA binding region of TRBP interacts differently with
the hairpin or duplex type of microRNA precursors. The latter question is equivalent to know
the potential role of the loop on the binding parameters or to compare the role of the RNA
binding region of TRBP before and after Dicer cleavage for miR-155 precursors system. To ad-
dress the last point, the magnitude of the binding constants of the microRNA binding region
had also to be estimated for both types of precursors. Then deeper study of the interaction at
atomic level, using atomic sites specific information by NMR, will be analyzed.
As previously explained in part II, the combined used of ITC and svAUC can enable to char-
acterize the macroscopic equilibrium between interacting species. Then NMR was used to get
site specific informations :
- Chapter 17: Study of TRBP interaction with miR-155 precursors by ITC
- Chapter 18: Stoichiometry analysis of the RNA binding region of TRBP by svAUC
- Chapter 19: Site specific characterization of the RNA binding region of TRBP with mi-
croRNA precusors : two independent binding domains
- Chapter 20: Conclusion and discussion of the main results
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Chapter 17
Study of TRBP interaction with miR-155 precursors by ITC
17.1 ITC experimental design and implementation
The molecular ratio of TRBP and microRNA in their complex was not known at the time of
the design of these experiments. There is the possibility that this ratio might not be unique:
an excess of protein or an excess of RNA can potentially lead to different complexes. To avoid
missing one of them, ITC experiments were performed in two ways, either by adding more
and more RNA to a low concentrated protein sample, either by doing the opposite. Because
of the methodological consideration on the concentration of the species in the calorimeters,
this resulted in experiments either with the protein in the syringe and the RNA in the cell or
the other way. The concentrations used in these experiments were mainly determined by the
available material and the necessity to perform repetition of the experiments. The different
experiment conditions are summarized in tab. 17.1. ITC experiments were conducted using a
MicroCal ITC-200 at 25°C using the steps detailed in the methodological part II, Chapter 10.
17.2 ITC analysis of TRBP-D1D2 interaction with miR-155 precursors
17.2.1 ITC datasets
Different typical ITC datasets for the interaction between TRBP-D1D2 interaction with pre-
miR-155 and miR-155/miR-155* duplex as well as dilution controls are given in fig. 17.1. In
each case the titrations generated a binding isotherm characterized by a sigmoidal shape. The
control experiments showed only very minor power change during the injection. Instead of es-
timating these constant negligible effects with a risk to add errors to the main experiments, the
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Table 17.1: Concentration of protein and RNA used in the different ITC experiments. The
component with the higher concentration is systematically the one in the syringe. The first line
full of zeros indicate multiple control experiments with buffer in both the syringe and the cell.
TRBP-D1 (µM) TRBP-D2 (µM) TRBP-D1D2
(µM)
pre-miR-155
(µM)
miR-155/miR-
155* (µM)
0 0 0 0 0
0 400 0 0 0
0 0 250 0 0
0 0 0 300 0
0 0 59 300 0
0 0 500 30 0
0 0 42 275 0
0 0 43 275 0
0 0 50 300 0
0 0 54 300 0
0 0 250 40 0
0 0 450 30 0
0 0 500 40 0
0 0 500 30 0
0 0 375 0 33
0 0 400 0 25
45 0 0 300 0
48 0 0 275 0
800 0 0 30 0
800 0 0 30 0
0 20 0 160 0
0 36 0 150 0
0 37 0 300 0
0 1200 0 35 0
0 1200 0 35 0
0 1200 0 50 0
experiment was analyzed without control subtraction but with a constant baseline as described
in section 10.2.1.
17.2.2 Application of the fitting procedure
The fitting procedure applied is the one described in section 10.2.5.3. The relevance of the
different ITC data analysis assumptions 10 will be discussed at the end of the analysis. Two
kinds of experiments were performed with TRBP-D1D2 a miR-155 precursor, either with TRBP-
D1D2 added in an RNA solution either with an RNA solution injected in a TRBP-D1D2 solution.
For convenience, from now the experiments with protein added to the RNA will be called
"forward" experiments and the opposite titration, "reverse" experiments.
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Figure 17.1: Examples of ITC datasets of TRBP-D1D2 injected into miR-155 precursors recorded on ITC-
200 (MicroCal) at 25°C. A. Baseline corrected ITC dataset of 500 µM TRBP-D1D2 injected into a solution
of pre-miR-155 at 30 µM. 39 injections of 1 µl lasting 2 s spaced by 3 minutes interval were performed.
B. Baseline corrected ITC dataset of 400 µM TRBP-D1D2 injected into a solution of miR-155/miR-155*
at 25 µM. 31 injections of 1.25 µl lasting 2.5 s spaced by 3 minutes interval were performed. C. Control
experiment with phosphate buffer injected into the same buffer; 31 injections of 1.25 µl lasting 2.5 sec
with 180 s time interval were used. C. Control experiment with buffer injected into a solution of pre-
miR-155 at 30 µM. 18 injections of 4.3 µl spaced by 3 minutes intervals were performed. E. Control
experiment with TRBP-D1D2 at 250 µM injected into the phosphate buffer. 15 injections of 1 µl lasting 2
s and spaced by 3 minutes.
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17.2.2.1 Application of the fitting procedure to forward experiments
Determination of a set of candidate macroscopic models The first step was to determine a
set of reasonable macroscopic models that can reasonably fit the data. In particular this aimed
to determine whether multiple TRBP-D1D2 can interact with miRNA precursors whether mul-
tiple RNA can bind TRBP-D1D2 or whether only one miR-155 precursor interact with TRBP-
D1D2. Thus, models to test included {1 protein: 1 RNA} ; {2 protein: 1 RNA} ; {2 RNA: 1
protein}. The folding unfolding equilibrium occurring in TRBP-D1 was not taken into account
in the ITC analysis as it would add too many parameters in the models to enable to get mean-
ingful binding and folding parameters. This is further discussed and justified in the light on the
NMR study of the interaction in part V. Both models {2 protein: 1 RNA} and {2 RNA: 1 protein}
could fit all the forward and reverse experiments with TRBP-D12. The {2 RNA: 1 protein} model
could not fit the data at all, meaning that the process could not be explained by this model. This
means either that TRBP-D12 do not interacts with two precursors, either that this happen but
with a zero enthalpy of reaction. Despite the last possibility seems unlikely, the svAUC analy-
sis is necessary to clarify this ambiguity. To distinguish between the {1 protein: 1 RNA} and {2
protein: 1 RNA} models, forward ITC experiments were performed with as many injections as
possible in order to be able to detect potential multiple binding steps. This is illustrated on fig.
17.2 for two experiments with pre-miR-155.
Figure 17.2: Illustration of the fits of the ITC data of the interaction between TRBP-D1D2 and pre-
miR-155. The plot represents the integration of the ITC power signal of a baseline corrected dataset
corresponding to an experiment with 500 µM TRBP-D1D2 injected into a solution of pre-miR-155 at 30
µM. 39 injections of 1 µl lasting 2 s spaced by 3 minutes interval were performed. A. Fit with a 1:1
protein:RNA binding model. B. Fit with a 2:1 protein:RNA binding model.
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Two experiments with 31 or 39 injections of 1.1 or 1 µl were performed in parallel for both
pre-miR-155 and miR-155/miR-155* in order to compare the behavior of these two precursors.
These data were globally fitted with both {1 protein: 1 RNA} and {2 protein: 1 RNA} models.
The quality of the fit is attested by the low root mean square deviations (RMSD) values in tab.
17.2.
Table 17.2: Root mean square deviations and results of the model comparison using Akaike
weights for the successive binding models that could be globally fitted to the data for each
miR-155 precursors. The stoichiometry column indicate the maximal protein over RNA ratio in
the model used
System stoichiometry RMSD (kcal/mol) Akaike weight
TRBP-D1D2 + pre-miR-155 1 0.13 1.10−27
TRBP-D1D2 + pre-miR-155 2 0.053 ≈ 1
TRBP-D1D2 + miR-155/miR-155* 1 0.14 7.10−31
TRBP-D1D2 + miR-155/miR-155* 2 0.044 ≈ 1
Macroscopic models comparison The comparison of the macroscopic models {1 protein: 1
RNA} and {2 protein: 1 RNA} with Akaike weights in tab. 17.2 for the globally fitted data show
non ambiguously that given the data and these 2 models, the model of successive binding of
two proteins on one RNA has a probability of about 1, whereas it is almost 0 for the other model.
This proves that the molar ratio that best explain the data is 2 proteins for 1 RNA. Assuming
this molar ratio is the actual stoichiometry, which is expected from the behavior of the single
partners but require a check with another method (svAUC, Chapter ), this means that for both
miR-155 precursors, two molecules of TRBP-D1D2 can successively interact with them, leading
to 1:1 and then 2:1 protein: RNA complexes. The forward titration appears well suited for the
study of such equilibrium, with the complexes progressively formed during the titration.
Binding parameter estimation The selected macroscopic {2 protein: 1 RNA} model enables to
get estimates of the macroscopic parameters of the interaction between TRBP-D12 and pre-miR-
155 or miR-155/miR-155* (tab. 17.3). As explained in section 6.2.2 the constants estimated are
"concentration" dissociation constants and their confusion as real dissociation constant is under
the hypothesis of activity coefficients very close to 1, that all the reaction were detected and that
the protein:RNA molar ratio correspond to the actual stoichiometry. Anyhow, the estimations
show very similar binding parameters for the two RNA precursors. This implies a very similar
recognition of these precursors by TRBP-D1D2 with no clear selection effects.
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Table 17.3: Result of the estimation of thermodynamic parameters for TRBP-D1D2 with both
pre-155 precursors. The standard deviation for each fitted parameter is indicated in parenthe-
ses and was determined by running 100 Monte Carlo simulations of each pair of ITC curve
followed by a global fitting of each pair of experiments. D1D2: TRBP-D1D2 ; hairpin: pre-miR-
155 ; duplex miR-155/miR-155*.
system Kd1
(10−7)
∆H1
(kcal.mol−1)
∆G1
(kcal.mol−1)
∆S1
(Cal.mol−1K−1)
Kd2
(10−6)
∆H2
(kcal.mol−1)
∆G2
(kcal.mol−1)
∆S2
(Cal.mol−1K−1)
D1D2 +
hairpin
0.49
(0.03)
-17.7
(9.4.10−2)
-8.6
(5.5.10−2)
-30.5
(0.17)
6.2
(0.2)
-8.3
(1.10−1)
-7.1
(2.6.10−2)
-4.2
(0.3)
D1D2 +
duplex
1.0
(0.7)
-20.6
(1.5.10−1)
-8.15
(4.10−2)
-41.9
(4.10−4)
5.7
(0.33)
-2.3
(1.8.10−1)
-7.1
(3.4.10−2)
16.3
(0.6)
17.2.2.2 Comparison between forward and reverse experiment and tentative of global fit-
ting of both datasets
Fits of the experiments with pre-miR-155 injected into TRBP-D1D2 (reverse experiments) lead
to dissociation constants of 0.5 µM and 4 µM for the first two dissociation constants, consistent
with the results of the experiment with TRBP-D1D2 injected on pre-miR-155. However the two
sum of the two successive reaction enthalpies are about -30 kcal.mol−1 (fig. 17.4), different from
the one obtained from the fit of experiments realized with TRBP-D1D2 in the syringe of about
-25 kcal.mol−1. This difference did not enable to have a convergent fit using both forward and
reverse experiments. As both forward and reverse experiments are consistent with 2 protein
binding one RNA, the results of the forward experiments performed with as many injection
as possible in order to progressively form the complexes (adding proteins on the RNA) were
preferred for the estimation of the binding parameters. Additionally, the dilution of a highly
concentrated RNA solution in reverse experiments could explain the difference observed ef-
fect as the RNA has a potential small tendency to self interact. Anyhow, the main goal of the
ITC experiment being the estimation of the dissociation constant and possible molar ratios and
not the enthalpies of reaction, this choice does not lead to significant differences. Since the
larger detected complex formed has a protein/RNA molar ratio of 2, a more complex binding
pathway with possible sides effects linked to the kinetic is possible when the experiment starts
with this complex and goes towards a complex of protein/RNA ratio of 1. Moreover, in the
reverse experiments, pre-miR-155 is used in the syringe at high concentration and the potential
small effect linked to the dimerization of the RNA could lead to an additional dilution reac-
tion contributing to the heat transfer providing the equilibrium is fast, and leading to errors in
the measurement. For this reasons the reverse experiment is considered less relevant than the
forward experiments.
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17.2.2.3 Comments of potential microscopic mechanisms
The macroscopic model parameters suggest a higher affinity for the first equilibrium than for
the second one. Importantly, this does not directly correspond to the affinity of given sites on
the macromolecules. Fitting of a microscopic (i.e. site specific) model was not attempted for
the reasons developed in the methodological part and as it would not enlighten the situation
at this stage of the study. Weak explanations can be proposed to account for the differences of
macroscopic affinities. For two identical independent binding sites on the RNA, two different
macroscopic constants are expected due to the difference of the number of free sites at the two
successive binding steps, following Kd2Kd1 = 4. Here the
Kd2
Kd1
≈ 6 for pre-miR-155/pre-miR-155*
and 12 for pre-miR-155, which is slightly higher than what is expected for the reference model
of independent sites and would compatible with a slight negative cooperativity on the two pro-
teins binding the RNA. However as underlined in the ITC chapter, many other more complex
microscopic mechanism could lead to the same pair of macroscopic dissociation constants, like
an effect on the RNA in the first binding event triggering an RNA structural/dynamical change
enabling another TRBP-D12 to bind to a newly favorable site, that couldn’t binds TRBP-D12
without the first binding event (example of positive cooperativity).
17.3 ITC analysis of TRBP-D1 & -D2 interaction with pre-miR-155
In order to get insight on the behavior of each dsRBDs in TRBP-D1D2 in the 2:1 complex
previously detected, additional ITC experiments were performed with TRBP-D1 and TRBP-D2.
17.3.1 ITC datasets
An example of a typical forward and reverse ITC data obtained with TRBP-D2 without base-
line correction are given in fig. 17.3. The same kind of data was recorded for TRBP-D1. Contrary
to the experiments with TRBP-D1D2 the forward experiments generated signal with a very non
flat baseline, since the power signal never comes back to the baseline during the experiments.
The importance of this process led to the conclusion that no relevant fitting could be extracted
from these experiments. Control with injection of TRBP-D2 in the buffer with the same condi-
tions than in the forward experiment does not show peaks that could indicate homo-interaction
(fig. 17.3). This is consistent with the analysis of the apo constructs of TRBP. The strong de-
crease of the baseline when TRBP-D2 is injected on the RNA could be explained by a very slow
kinetics or more likely by the formation of some aggregates in solution. Multiple experiments
performed with both TRBP-D1 and TRBP-D2 shown that this phenomenon was reproducible
and not dependent on the concentration in the range tested. As a result, only the reverse exper-
iment could and were analyzed. They were reproducibly characterized by a common baseline,
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flat or slightly drifted as in fig. 17.3 A.. A direct consequence of this is that the comparison of
these binding events with the single domains and the double domain construct required to use
the reverse datasets of TRBP-D1D2.
Figure 17.3: Examples of ITC datasets of TRBP-D2 recorded on ITC-200 (MicroCal) at 25°C, without
baseline correction. A. Experiment with a solution of pre-miR-155 at 150 µM injected into a solution of
TRBP-D2 at 36 µM with 26 injections of 1.5 µl lasting 3 seconds and spaced by 3 minutes intervals. B.
Experiment with a solution of TRBP-D2 at 1.2 mM injected into a solution of pre-miR-155 at 35 µM with
26 injections of 1.25 µl lasting 2.5 seconds and spaced by 3 minutes intervals. C. Control experiment with
a solution of TRBP-D2 at 400 µ injected into the phosphate buffer solution of pre-miR-155 at 35 µM with
26 injections of 1.25 µl lasting 2.5 seconds and spaced by 3 minutes intervals.
17.3.2 Application of the fitting procedure on TRBP-D1 and TRBP-D2
Fitting of the ITC data of the isolated first two dsRBD of TRBP The application of macro-
scopic models of the reverse experiments with TRBP-D1 and TRBP-D2 did not lead to good
fits with protein: RNA molar ratio of 1 and 2 and higher models had too much parameters
for the few features of the datasets. Thus an accurate determination of the molar ratio and
binding affinities could not be estimated with macroscopic models. Exceptionally, TRBP-D1D2,
TRBP-D1 and TRBP-D2 ITC data interaction with pre-miR-155 were fitted with a model of sin-
gle independent sites with a floating molar ratio parameter. As already mentioned, the strong
assumptions of this model are absolutely not guaranteed in the present case. The use of this
simplified model enabled however a global comparison of the binding properties of the three
proteins constructs under the same the hypothesis of independent binding domains. The fitting
results are given in fig. 17.4. Application of this model led a molar ratio of 2 for TRBP-D1D2
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as expected, and a molar ration of 4 for TRBP-D1 and TRBP-D2 meaning that 4 dsRBDs are
able to bind to a single molecule of pre-miR-155, a result that seems reliable even with the as-
sumption used. The binding constant however provides information of the global affinity of
the TRBP constructs and suggests a higher affinity for the second dsRBD of TRBP compared
to the first one. The result for TRBP-D1D2 can be compared to the ones obtained without the
site identicity and independency. Under these hypothesis of identical and independent sites,
the microscopic constant Kmicro can be used to express the two related successive macroscopic
constants Kd,1 and Kd,2 with Kd,1 = 0.5Kmicro and Kd,1 = 2Kmicro, leading to Kd,1 = 0.510−6
and Kd,1 = 6.810−6. Despite the absence of guaranties of the aforementioned hypotheses, these
values are very similar to the ones obtained without these strong hypotheses (0.49 10−6 and 6.2
10−6 respectively), suggesting that is approach is not completely unrealistic for the system un-
der study. The results of the fitted parameters are provided in tab. 17.4. Under the hypothesis
of identical independent sites, these microscopic constants correspond to the following succes-
sive macroscopic constants: 3.8 10−6, 10.3 10−6, 23.1 10−6 and 61.6 10−6 for TRBP-D1 and 1.0
10−6, 2.7 10−6, 6.1 10−6 and 16.4 10−6 for TRBP-D2.
Figure 17.4: Comparison of the binding behavior of TRBP-D1D2, TRBP-D1 and TRBP-D2 on pre-miR-
155 using ITC experiments with pre-miR-155 injected into TRBP protein constructs recorded on ITC-200
(MicroCal) at 25°C. Data fitting for this comparison is performed under the hypothesis of a single type
of independent sites on pre-miR-155. From left to right, pre-miR-155 (160 µM, 300 µM, 300 µM) injected
into a solution of TRBP-D1D2 (50 µM), TRBP-D1 (45 µM) and TRBP-D2 (20 µM). Experiments were
performed with 26 injections of 1.5 µl lasting 3 seconds and spaced by 3 minutes intervals.
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Table 17.4: Result of the estimation of thermodynamic parameters for the interaction between
TRBP-D1D2 or TRBP-D1 or TRBP-D2 with pre-miR-155. This estimation is performed only
for comparison purpose under the strong hypothesis of independent identical binding sites on
pre-miR-155. The standard deviations of each parameter are indicated into parenthesis, using
fitting from two experiments per system.
System Kd (10−6) Molar ratio ∆H
(kcal.mol−1)
∆S
(Cal.mol−1K−1)
pre-miR-155 + TRBP-D1 15.4 (0.8) 3.9 (0.2) 6.0 (0.2) 1.9 (0.2)
pre-miR-155 + TRBP-D2 3.7 (0.5) 4.1 (0.1) 9.4 (0.2) 6.8 (0.2)
pre-miR-155 + TRBP-D1D2 3.4 (0.8) 2.0 (0.1) 16.1 (0.3) 28.8 (0.3)
17.4 Conclusion of the ITC analysis
Under the probable hypothesis of identity of the molar ratio with the stoichiometry and on
the absence of undetected interactions, the ITC analysis shown that two RNA binding region
of TRBP are able to bind with a similar affinity with the miR-155 precursor product (pre-miR-
155) and substrate (miR-155/miR-155*) of Dicer. The affinity of the binding events is around
10−6. The aforementioned hypothesis will be test in the next chapter by svAUC. Both isolated
dsRBDs are able to interact with pre-miR-155, with and higher affinity for the second dsRBD
which is close to the affinity of TRBP-D1D2 under the hypothesis of a single type of independent
interacting sites on the RNA. The data do not enable a reliable study of microscopic mechanism
of this interaction (e.g. cooperativity).
Various mechanisms could be compatible with the 2 TRBP-D1D2: 1 RNA molar ratios. For
the simplest case with a stoichiometry of 2, it can be conceived :
- only one of the two TRBP domains binds in the two successive events, either the same of two
different domains, without or without a contribution to the interdomain region. The fact both
isolated dsRBDs are able to bind the pre-155 precursors so this seems unlikely at this stage.
- all the domains binds when each molecule bind, without or without a contribution to the
interdomain region.
- intermediates between the last two situations.
And the possibilities are higher for more complex stoichiometries. The available data on the
complex at this stage of the study does not allow to restrain this set of hypothesis. The steps
performed to get additional insight on the interaction are the following ones :
- use of an additional technique to check if the molar ratio is the actual stoichiometry and
potential undetected interactions: svAUC
- use of NMR to get site specific information of TRBP-D1D2 binding surfaces, on a system with
a protein-RNA ratio well chosen from the stoichiometry and binding constant information.
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Chapter 18
Stoichiometry analysis of the RNA binding region of TRBP by svAUC
Requirement of additional experiments to determine the stoichiometry and validate ITC
dissociation constants The goal of this chapter is to get an independent validation of the
stoichiometry proposed in the ITC study, and as a consequence of the ITC derived binding con-
stants. A molar ratio of 2 TRBP-D1D2 for 1 RNA has been obtained non ambiguously from
ITC data. But as mentioned in the ITC part there are multiple phenomena that can give sim-
ilar results. First there is still the possibility of additional reactions happening without en-
thalpy change. Then, even in the absence of additional undetected reactions, there are many
stoichiometries compatible with protein/RNA molar ratios of value 2 (2 protein / 1 RNA; 4
protein / 2 RNA, etc). The knowledge of the actual stoichiometry is one of the most impor-
tant parameter to define macroscopically an interacting system. Importantly, no information
was reported in the literature about the stoichiometry of TRBP with miRNA precursors. This
analysis is performed with TRBP-D1D2 and pre-miR-155.
18.1 svAUC analysis of TRBP with pre-miR-155
18.1.1 svAUC experimental design
Sedimentation velocity experiments were performed as described in the methodological part.
The initial estimations of the dissociation constants by ITC have driven the choice of the con-
centrations for the svAUC experiment. As in the ITC experiment, the protein had to be in
excess over the RNA concentration in order to have the complexes of high protein/RNA ratios
formed, corresponding to the molar ratio of 2 found in ITC. The svAUC data had also to show
the potential existence of a 1 protein: 1 RNA intermediate complex, formed during the forma-
tion of the 2 protein: 1 RNA complex, as well as potential other complexes not detected in ITC.
These goals have contributed to the experimental design of the svAUC experiment. Additional
constraints include the work at low concentration to avoid UV detector saturation, to get close
the assumptions used to derive svAUC equations and to avoid non ideal hydrodynamic and
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thermodynamic effects. It is an advantage to have the RNA at the lowest concentration since it
is more prone to non ideal effects and because it absorbs strongly in the UV region.
The study of the isolated components was performed at the same time as the study of the
complexes. The results have already been developed in the parts devoted to the apo-TRBP
and apo-miRNA-155. The parallel characterization of the free and bound macromolecule was
important since the sedimentation parameters of the free species were required to study the
complexes. As a result, 3 cells among the 7 ones of the An-50Ti rotor were available for the
complexes. Using the pair of dissociation constants estimated in the ITC part, it is possible
to estimate the abundance of the potential 1:1 and 2:1 complexes for the selected total con-
centration of TRBP-D1D2 (P) and pre155 (R) (tab. 18.1). Results are given for the conditions
selected for the svAUC experiment. These calculations were performed under the hypothesis
that the measured binding constant in ITC is equivalent to the real binding constant and that
the protein/RNA molar ratios of 1 and 2 corresponds to complexes of {1 protein: 1 RNA} and
{2 protein: 1 RNA} respectively. Despite some errors in the ITC measurement have been taken
into account, it is likely that this assumption is not perfectly true as already mentioned in the
thermodynamical part on the binding constants. As a result, the actual ratios [RP2]
[RP1]
might not be
exactly the ones in solution i.e. in the svAUC cells.
Table 18.1: Prediction of the concentration of the species in solution in the svAUC conditions
and assuming a macroscopic equilibrium with two successive addition of TRBP-D1D2 on pre-
miR-155. R: pre-miR-155 ; P: TRBP-D1D2.
C(P) C(R) [P] [R] [RP] [RP2]
[RP2]
[RP1]
sd
(
[RP2]
[RP1]
)
µM µM µM µM µM µM
10 0.5 9.2 10−6 1.1 10−8 2.0 10−7 2.9 10−7 1.50 0.11
10 1 8.4 10−6 2.4 10−8 4.1 10−7 5.6 10−7 1.37 0.10
10 2 7.0 10−6 6.4 10−8 9.0 10−7 1.0 10−6 1.15 0.08
The Monte Carlo simulation done to estimate the parameter errors in the ITC fitting can be
also used to estimate the distribution of [RP2]
[RP1]
. This shows that 95% of the values are within
the mean +/- two standard deviations. The values of the expected [RP2]
[RP1]
ratios are given in
tab. 18.1. As a result, the conditions used appeared to a be a compromise between the different
constraints previously mentioned. Another possible design of this experiment would have been
to add variable amounts of proteins to a constant low RNA concentration. A more targeted
demonstration of the existence of the potential {2 protein:1 RNA} complex would have been
possible using a much higher amount of protein (100:1) in order to have almost no contribution
of a potential 1:1 complex.
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18.1.2 Data analysis with a c(s) model
c(s) fitting As explained in Chapter 11, the partial specific volumes for possible protein/RNA
complexes were estimated by summing the individual values of each component weighted by
their fractional mass in the complex. For {1 TRBP-D1D2: 1 pre-miR-155 }, {2 TRBP-D1D2: 1 pre-
miR-155 } and {1 TRBP-D1D2: 2 pre-miR-155 } complexes this led to partial specific volumes
of about 0.41ml/g, 0.64 ml/g and 0.43 ml/g. c(s) profiles reported here were fitted with a
partial specific volume value of 0.64 ml/g. Importantly, the sedimentation coefficient, s, of each
complex estimated from the distribution of sedimentation coefficients, c(s), was not affected by
the choice of the 3 possible v values. The overlaid c(s) profiles for the different cells are given
in fig. 18.1.
Sedimentation coefficients analysis SvAUC data acquired at three concentrations with an
excess of protein in fig. 18.1 show the disappearance of the RNA contribution at 4.4 S and
the concomitant emergence of a new faster contribution, which sediments at about 5.9 S. An
additional minor contribution (6 % of the main peak) is also detected at 7.5 S only in the sample
with 2 µM RNA, at almost the same position than the probable RNA dimer detected in the
experiment with pre-miR-155 alone at 2 µM. The nature of this peak will be discussed later, in
the buoyant molar mass analysis.
Three concentrations of RNA were used to try to estimate the kinetic regime of the exchange
on the svAUC time scale. The different kinetics regimes were described in eq. (11.9). There is
not a clear tendency in the relative peak position of the main peak as a function of concentra-
tion. However, only three concentrations have been used so it is not possible to discriminate
between positions changes caused by errors in the data or real effects of the concentration. The
lowest concentrated sample with 0.5 µM of RNA is the most likely to have a significant error
contribution in the c(s) analysis. Despite this we see that in the range of concentration sampled,
the s-value for the main peak is almost concentration invariant. Because of the detection of at
least two complex species in ITC, the peak at 5.9 S should corresponds to a reaction boundary
that contains a mixture of oligomeric species (242; 243; 303). This is consistent with the behav-
ior of complex exchange on fast or intermediate svAUC regime. For a reaction boundary, it is
predicted that the sedimentation coefficient and apparent buoyant molar masses determined
from the diffusion broadening of the fast boundary, would be less than the value expected for
the largest possible complex formed (242; 243; 303).
In order to understand the stoichiometries that can lead to the observed sedimentation co-
efficient values, the experimental values resulting from the c(s) analysis were compared to
theoretical ones obtained for different protein/RNA ratios. This calculation requires the prior
knowledge of the unknown frictional ratio of the complexes. Since both the free protein and
the free RNA has a frictional ratio of about 1.4, this value was used in this modeling as well as
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a value of 1.25 corresponding to a spherical complex. Values of frictional ratio higher that 1.4
would imply the formation of a complex more elongated than the individual partners. It is per-
fectly conceivable and will be discussed later. The results of these calculations are summarized
in tab. 18.2 and the corresponding range of sedimentation coefficient is represented in fig. 18.1.
Figure 18.1: Comparison of the diffusion deconvoluted sedimentation coefficient distribution of TRBP-
D1D2 (10 µM), pre-miR-155 (1 µM) and 3 mixtures of these two macromolecules at 25°C. The region R11,
R21 and R12 correspond to the expected position of 1:1, 2:1 and 1:2 TRBP-D1D2:pre-miR-155 complexes
under the hypothesis of slow exchanging complex on the svAUC time scale. The range of sedimenta-
tion coefficient reflects the uncertainty of the frictional ratio of these complexes. The region starts from
a frictional ratio of 1.4 (similar to the asymmetric isolated TRBP-D1D2 and pre-miR-155) to 1.25, corre-
sponding to a spherical complex.
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The s-value determined for the fast boundary in fig. 18.1 is larger than that expected for a
1:1 TRBP-D1D2/pre-miR-155 complex, for the frictional ratio 1.4 and 1.25 and very close to the
one expected for a reaction boundary with a high proportion of 2:1 complex. Considering the
calculated s-values for possible globular protein/RNA complexes with stoichiometries of 1:1,
2:1 and 1:2 in tab. 18.2, only the complex composed of two proteins and a single RNA is close
to the experimentally determined value. The other possible complex compositions differ by
more than 1 S. As a consequence these results are not compatible with the exclusive presence
of protein/RNA complexes whose stoichiometry is a multiple higher than 1 of the protein over
RNA molar ratios of 1 and 2 estimated with ITC. The minor peak at 7.5 S has a sedimentation
coefficient similar to the one of a complex associating two RNA and a protein with a globular
shape.
Table 18.2: Prediction of the concentration of the species in solution in the svAUC conditions
and assuming a macroscopic equilibrium with two successive addition of TRBP-D1D2 on pre-
miR-155. R: pre-miR-155; P: TRBP-D1D2.
Experimental values Calculated values
System sexp
(S)
Mb
(kDa)
A260
A280
∆J
A280
∆J
A260
P:R Mcalc
(kDa)
v
(ml.g−1)
Mcalc
(kDa)
Mb,calc
(kDa)
A260
A280
∆J
A280
∆J
A260
D1D2 2.1(0.1) 5.7 1.73 5.7 9.9 1:0 22.3 0.74 2.1 5.7
pre155 4.4(0.2) 9.1 0.46 0.3 0.14 0:1 19.6 0.508 4.3 9.2
1:1 41.9 0.64 4.9-5.5 14.9 0.47 0.53 0.25
Complex 5.9(0.1) 18.3 0.49 0.8 0.41 2:1 61.5 0.67 5.7-6.4 20.6 0.49 0.75 0.37
1:2 64.2 0.60 7.0-7.8 24.0 0.47 0.42 0.20
18.1.3 Data analysis with Lamm equation modeling of non interacting species
Buoyant mass analysis Information can be obtained on reaction boundaries considering them
as a non interacting species (303). The estimated protein buoyant molar mass is 4.4 ± 0.4 kDa
instead of 5.7 kDa for the monomer. The apparent buoyant mass estimation for the fast bound-
ary is 18.3 ± 1.0 kDa, which is between the values calculated for a 1:1 or 2:1 TRBP-D1D2/pre-
miR-155 complex and close to the 2:1 complex. Thus the non interacting species model yields
under-evaluated buoyant masses. This is what is expected for a system with both 1:1 and a
larger complex in equilibrium. Thus this analysis shows the existence of the 1:1 complex but
does not add key information on the larger one(s). The buoyant molar mass calculated for the
minor species (s = 7.5 S) was similar to that of the main complex, thus irrelevant with the data at
hand. This peak could correspond either to the potential RNA dimer detected on the free RNA,
either to an artifact linked to deconvolution used in the c(s) analysis which requires high qual-
ity. The buoyant mass analysis gives with no surprises less information that the comparison of
the sedimentation coefficients with theoretical ones.
222
Multiple wavelength analysis To further characterize the complexes contributing to the
boundaries, a composition analysis of the complex using the data obtained from the 3 dif-
ferent optics used was performed. This analysis based only on signal intensity and not on the
sedimentation parameters is independent of the sedimentation coefficient and buoyant mass
analysis presented before. The extinction coefficients at 280 nm for TRBP-D1D2 (10,084 cm−1
mol−1) and at 260 nm for pre-miR-155 (490,000 cm−1 mol−1) were fixed in order to derive the
other extinction coefficients (at 280 nm and 260 nm) and increments of refractive index (dndc ). The
sedimentation profiles obtained for the three optics and the c(s) distributions were simultane-
ously analyzed for each of the free compounds using a hybrid model with three non-interacting
species. The resulting ratios of absorbance and interference fringes are given in tab. 18.2. These
ratios were used to calculate values for different protein/RNA stoichiometries. The experimen-
tal ratios measured in the c(s) analysis for the fast boundary reflects an enrichment of protein
in the complex characterized by about 2 times more protein signal than RNA signal. This ratio
is higher than the one expected from the experimental design of the svAUC experiment under
the assumption than the ITC dissociation constants match the true constants and with the sim-
plest stoichiometries compatible with the molar ratio. The observed difference might be linked
to the activity and additional small species contributions to the actual binding constant pre-
sented, caused by ITC biases (co-reactions for instance) or because of the presence in solution
of a species in equilibrium with the other ones characterized by a protein/RNA molar ratio
higher than 2. These hypotheses are all compatible. This situation will be clarified in the next
paragraphs.
Conclusion: svAUC contribution to the stoichiometry information The diffusion decon-
voluted sedimentation coefficient analysis (c(s)) and modeling of the sedimentation data by
Lamm equations assuming the species in solution sediments like non interacting ones (buoy-
ant mass analysis and multiple wavelength analysis) gives sedimentation parameters that are
intermediate between a 1:1 complex and another complex enriched about two times in proteins,
the smaller conceivable one being a {2 protein: 1 RNA complex}. Because of the properties of
the reaction boundaries, this show the (unsurprising) existence in solution of a 1:1 stoichio-
metric protein/RNA complex (intermediate), expected from the first binding event detected in
ITC. The svAUC data analyzed at this step do not enable to go further. Various increasingly
complicated hypotheses are compatible to them regarding the complexes of molar ratio higher
than 1 :
- Among the complexes with TRBP-D1D2/pre-miR-155 molar ratio over 1, only the complex
with 2 molecules of TRBP-D1D2 and one pre-miR-155 exists. This would be compatible with
all the svAUC data and ITC data. This complex is formed by the successive interaction of 2
TRBP-D1D2 on a pre-miR-155.
- Among the complexes with protein/RNA molar ratio over 1, only complexes of molar ratio 2
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exists (2 TRBP-D1D2 with 1 pre-miR-155 or 4 TRBP-D1D2 with 2 pre-miR-155, etc). This would
be compatible with all the svAUC data and ITC data but would require to adapt the estimation
of the ITC dissociation constants.
- Among the complexes with protein/RNA molar ratio over 1, complexes of molar ratio 2 and
more exists. Molar ratios higher than 2 would require reaction enthalpies of almost 0 in the ITC
condition used (i.e. not detected in ITC).
The last two hypothesis seem very unlikely.
18.2 Simulation of svAUC data using the ITC data as knowledge
The experimentally estimated sedimentation coefficient and buoyant masses of the reaction
boundary are larger than the ones expected for the existence of only 1:1 complexes, indicating
the existence of a larger complex. This deduction was obtained from the successive analysis
of the svAUC data. To complete the analysis and prove the overall consistency of the reason-
ing, prediction of the svAUC data can be attempted using the available information. Under
the hypothesis that the ITC dissociation constants are good estimates of the constants of the
equilibrium involved in solution, implying that there is both 1:1 and 2:1 stoichoimetric TRBP-
D1D2:pre-miR-155 complexes, do the information obtained from the svAUC analysis combined
with ITC dissociation constants enable to reproduce the svAUC data ? As svAUC raw sedimen-
tation data are not easily directly exploitable, the diffusion deconvoluted analysis was use to
analyze the simulated datasets. The goal was not to simulate exactly the experimental c(s)
curves since the frictional ratios of the complexes are not known, but to test the compatibility
of the experimental data in reasonable range of the frictional ratios. Without enabling to clearly
select one of the three aforementioned hypotheses, good prediction of the sedimentation data
would give an additional (weak) argument to the existence of these two simple complexes
compared to the more other alternatives. On the other hand these simulations enable to check
whether the dissociation constants reported in ITC are consistent with the svAUC data, espe-
cially regarding the number and shapes of peaks observed in svAUC. Two strategies were used
:
- The sedimentation coefficients and buoyant mass values observed experimentally can be pre-
dicted using numerical simulations of Lamm equations with non null chemical reaction flux
between the species followed by a diffusion deconvoluted c(s) analysis. This required previous
knowledge on dissociation constants and hypothesis on kinetics constants.
- Under the assumption of a fast exchange on the svAUC time scale, Schuck and colleagues
have investigated the analysis of bimodal boundaries (like the one observed here) with Lamm
equation modelization of non-interacting species analysis. They term the fast boundary an
"effective particle" (243; 242; 303). This "effective particle" model proved to be also useful for
other exchange regimes.
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The results of both approaches are reported in the next two sections.
18.2.1 Simulation protocol for Lamm equation modelization of TRBP-D1D2 / pre-miR-155
equilibrium
18.2.1.1 Description of svAUC simulation with numerical Lamm equation
The simulations were performed for a model {R + 2P = RP + P = RP2}, with R being the RNA
pre-miR-155 and P the Protein TRBP-D1D2. The conditions correspond to pure water at 20°C
(s20w; ρ = 0.99828 g.ml−1 and η = 1.002 cp), required by the Sedphat program (10). The program
Sedfit was initially used to generate 60 svAUC profiles for the sedimentation at 50,000 rpm of
a molecule at a concentration c = 1.0 (arbitrary unit), from radial distances of 6.0 to 7.2 cm, in
600 second increments, with an artificially generated Gaussian noise of standard deviation 0.01
arbitrary unit. For these simulations we used s = 4 S and D = 5.10−7 cm2 s−1. The noise, c, s
and D values are arbitrarily defined and did not impact the analysis below. The experimental
conditions defined by the set of profiles generated in this way were then used in the program
Sedphat to generate sedimentation profiles corresponding to the association equilibrium under
study. The s20w profiles were calculated with a frictional ratio of 1.4. The partial specific volume
v for all species was 0.75 ml g−1, so that apparent molar masses used were Mapp =
Mb
1−ρv with Mb
the actual buoyant molar masses. The simulation was performed using extinction coefficients
at 280 nm. A summary of the parameters used in the simulations is given in tab. 18.3.
Table 18.3: Summary of shared parameters used in the simulations to model svAUC profiles
using Sedphat (10)
Molecule s20w Mb (kDa) Mapp (kDa) ǫ280nm (cm−1
M−1)
R (pre-miR-155) 3.84 9.6 38.177 225975
P (TRBP-D1D2) 1.92 5.7 22.745 10084
RP 4.45 15.3
RP2 5.18 21.0
Three kinetic regimes were used for each of the 3 concentration conditions used in the ex-
perimental part. Simulations groups 1-4, 5-8 and 9-12 show the effect of varying the association
kinetics from fast to slow, i.e. from conditions under which a single effective particle would be
seen to conditions where two sedimenting boundaries for species RP and RP2 would be seen.
Exaggeratedly slow off rates have been used in the latter case. In these groups, the dissociation
constants used in the simulation corresponds to the dissociation constants that reflect those de-
termined by ITC apart from the simulations 3, 7 and 11 that were performed to see the effect
of equal macroscopic constants on the svAUC profiles. Kinetics faster than the fastest regime
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and lower than the lowest one are expected to give no distinguishable changes in the svAUC
profiles. In each simulation group 1-4, 5-8 and 9-12, the concentrations of protein and RNA
are varied to match the range used in our experimental study. Finally, simulations 13-15 re-
flect conditions in which the equilibrium is skewed towards the formation of a 1:1 complex, RP
(simulations 13 and 14) or the 2:1 complex, RP2 (simulation 15). These simulations establish the
theoretical s-values of RP and RP2 complexes.
Table 18.4: Concentrations of pre-miR-155 (R) and TRBP-D1D2 (P), equilibrium constants and
kinetic dissociation constants used in the simulations.
Simul.
Name
[R]
(µM)
[P]
(µM)
log(Ka1) log(k−1) log(
Ka2
Ka1
) log( k2−k−1 ) Kd1 Kd2 k−1
(s−1)
k−2
(s−1)
1 0.5 10 6.3 -1 -1 3.01.10−1 0.5 5.0 0.1 0.2
2 1 10 6.3 -1 -1 3.01.10−1 0.5 5.0 0.1 0.2
3 1 10 5.3 -1 0 3.01.10−1 5.0 5.0 0.1 0.2
4 2 10 6.3 -1 -1 3.01.10−1 0.5 5.0 0.1 0.2
5 0.5 10 6.3 -3 -1 3.01.10−1 0.5 5.0 1.10−3 2.10−3
6 1 10 6.3 -3 -1 3.01.10−1 0.5 5.0 1.10−3 2.10−3
7 1 10 5.3 -3 0 3.01.10−1 5.0 5.0 1.10−3 2.10−3
8 2 10 6.3 -3 -1 3.01.10−1 0.5 5.0 1.10−3 2.10−3
9 0.5 10 6.3 -6 -1 3.01.10−1 0.5 5.0 1.10−6 2.10−6
10 1 10 6.3 -6 -1 3.01.10−1 0.5 5.0 1.10−6 2.10−6
11 1 10 5.3 -6 0 3.01.10−1 5.0 5.0 1.10−6 2.10−6
12 2 10 6.3 -6 -1 3.01.10−1 0.5 5.0 1.10−6 2.10−6
13 2 10 6.3 -6 -3 3.01.10−1 0.5 5.102 1.10−6 2.10−6
14 2 10 6.3 -6 -6 3.01.10−1 0.5 5.105 1.10−6 2.10−6
15 2 10 9 -6 -1 3.01.10−1 1.10−3 0.0 1.10−6 2.10−6
The generated sedimentation profiles were saved with a Gaussian distributed noise of stan-
dard deviation 5 10−3 arbitrary unit (c = 1 arbitrary unit). The simulated data were then ana-
lyzed with a diffusion deconvoluted c(s) analysis and fit of numerical Lamm equations of non-
interacting species. In the latter the fast boundary is treated as an effective particle (303; 242),
even if it corresponds to the different interacting species and complexes.
18.2.1.2 Results of the svAUC simulations
The results of the simulations are plotted on the two following figures.
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Figure 18.2: Effect of the association/dissociation kinetics on svAUC profiles generated with the ITC
dissociation constants for different concentrations corresponding to the ones used in the experiments.
The vertical dashed lines indicate the theoretical position of the 1:1 and 2:1 protein RNA complexes if
there would be only one type of complex in solution.
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Figure 18.3: A. Effects of varying the dissociation constants to favor 1:1 or 2:1 protein/RNA complexes.
B. Kinetic effect on the svAUC profile with equal macroscopic dissociation constants. The vertical dashed
lines indicate the theoretical position of the 1:1 and 2:1 protein RNA complexes if there would be only
one type of complex in solution.
Modification of the association kinetics from fast to slow causes an asymmetric enlargement
of the fast peak (at about 4.9 S) in the c(s) distribution fig. 18.2, first row). The shape of the c(s)
distribution is only slightly modified as a function of the RNA concentration. Apart from the
case of a very slow kinetic, the peaks shapes are very similar fig. 18.2. A numerical summary of
the three sets of c(s) distributions and non-interacting species analysis are provided in the two
tables below. s20w values for the two peaks seen in the simulated c(s) distributions are given in
tab. 18.5 and the result of Lamm fitting for a non interacting system is given in tab. 18.5.
For all the simulated data sets, in the c(s) and the non-interacting species analysis, the slow
component has a s-value close to that expected for the pure monomeric protein (s20w value: 1.92
S). The buoyant mass Mb in the model of non-interacting species is also close to the expected Mb
for this species (5.7 kDa). The s-value of the fast peak in simulations which uses equilibrium
constants that reflect those we determined by ITC, is s20w = 4.9S. This value is intermediate
between that of RP (4.45 S) and RP2 (5.18S). The s-value of the fast peak, for simulations 13-
14 and 15 corresponds as expected to the inputs RP and RP2, respectively. For simulations
which corresponded to the equilibrium constants determined for our system by ITC and with
the fastest kinetics rates (simulations 1,2 and 4), the Mb-value of the fast peak, is about 18
kDa which matches the experimental value. This value is intermediate between the inputs
of the pure RP (15 kDa) and RP2 (21 kDa). The calculated Mb is decreased for simulations
corresponding to slower kinetics. In simulations designed to skew the equilibrium towards RP
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Table 18.5: Summary of c(s) analysis performed on the simulated datasets. s20w values are
those expected for a frictional ratio of 1.4. Mb is the buoyant molar masses.
Slow component Fast component
Simulation s20w signal % s20w signal %
1 1.92 0.11 43 4.90 0.14 56
2 1.94 0.10 26 4.88 0.29 73
3 1.94 0.10 27 4.73 0.28 73
4 1.94 0.08 13 4.83 0.57 87
5 1.93 0.11 43 4.90 0.14 56
6 1.94 0.10 26 4.88 0.29 73
7 1.93 0.10 27 4.70 0.28 73
8 1.96 0.08 13 4.83 0.57 87
9 1.93 0.11 44 4.93 0.14 56
10 1.94 0.10 26 4.91 0.29 73
11 1.96 0.11 28 4.78 0.28 72
12 1.97 0.09 13 4.87 0.57 87
13 1.98 0.10 16 4.44 0.56 84
14 1.98 0.10 16 4.43 0.56 84
15 1.94 0.07 11 5.18 0.59 89
or RP2, respectively, the Mb is close but slightly smaller than the input value.
18.2.1.3 Conclusions
The simulations reported here resemble strongly the peak shapes observed in the experimen-
tal svAUC data, especially for fast and intermediate kinetic regimes. Even under conditions of
extremely slow off rates, they is only a small shoulder on the fast reaction boundary in the c(s)
profile, due to the coexistence of 1:1 and 2:1 species under these conditions. In all other cases,
the c(s) profile is characterized by a single peak corresponding to an effective particle that sed-
iments faster than an ideal 1:1 species but slower than a 2:1 species. The exact position of the
fast reaction boundary is, obviously, dependent on the kinetic and thermodynamic parameters
input into the simulation. It is important to underline here that the frictional ratios of the com-
plexes is unknown. The frictional ratio used for the complex in these simulations was the one
determined experimentally for the free interactants (1.4) but they are likely to be between 1.4
and the one expected for a globular complex (1.25). In both cases, the theoretical sedimentation
coefficient difference of the 1:1 and 2:1 complex is 0.8 S and 0.9 S. So the peak shape observa-
tions made from these simulations with a frictional ratio of 1.4 would be the same for the other
extreme case of a spherical complex.
18.2.2 Simulation of the properties of sedimentation profiles using the effective particle
explorer of Sedphat
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Table 18.6: Summary of the fits of the simulated datasets with Lamm equation of non-
interacting species analysis.
Slow component Fast component
Simulation s20w c Mb (kDa) s20w c Mb (kDa)
1 1.92 0.11 5.63 4.89 0.14 18.55
2 1.92 0.10 5.73 4.87 0.29 18.12
3 1.92 0.10 5.53 4.71 0.29 16.23
4 1.90 0.08 5.25 4.83 0.58 17.57
5 1.92 0.11 5.63 4.90 0.14 17.84
6 1.92 0.10 5.73 4.88 0.29 17.87
7 1.93 0.10 5.35 4.72 0.29 15.55
8 1.92 0.08 5.55 4.83 0.58 17.34
9 1.92 0.11 5.79 4.92 0.15 15.10
10 1.95 0.11 5.20 4.92 0.28 15.48
11 1.98 0.12 4.98 4.79 0.27 13.22
12 1.97 0.09 5.89 4.87 0.57 15.06
13 1.96 0.10 4.64 4.44 0.56 14.25
14 1.92 0.10 6.03 4.42 0.56 14.69
15 1.87 0.07 9.18 5.17 0.59 20.02
18.2.2.1 Description of the simulations
This part used a routine described by Schuck and colleagues (303), which is available within
the Sedphat software ((10),v10.40 June 2012). The results are presented in fig. 18.4 in the con-
dition of Simulation 2 above (i.e. a simulation performed under a fast equilibrium with the
equilibrium constants determined from ITC). The phase transition line (blue line) separates the
concentration conditions for which the slow reaction boundary has the sedimentation coeffi-
cient of isolated R or P (upper and lower part of the figures, respectively). The black line repre-
sents the concentration condition we explored in our experimental AUC data. The color scale
of the s-value of the reaction boundary plot in fig. 18.4 A. gives s-values from 1.92 S (white) to
5.18 S (red). The color scale of the composition of the reaction boundary plot in fig. 18.4 gives
the molar ratio of TRBP-D1D2 over pre-miR-155 ([P]/[R]) from 0 (white) to 2 (red).
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Figure 18.4: Prediction of the s-value of the reaction boundary (A.) and composition of the reaction
boundary (B.) using the effective particle theory implemented in Sedphat (10).
18.2.2.2 Results and conclusion
The experimental results are in agreement with this description, with the slow boundary at
the s-value of the protein, the s-value and composition (evaluated experimentally from the ratio
of A280nm, A260nm and interference signals) of the fast boundary are close to the value expected
for the largest complex composed of two protein and one RNA molecule. The three experi-
mental concentration conditions are similar in term of fast boundary s-value and composition.
18.2.3 Conclusion of the crossed svAUC and ITC approach
Thus under the assumption of a fast exchanging complex on the svAUC time scale, the re-
sult of these simulations match very well the experimental ones ; they are also good estimate
of the sedimentation according Shucks and college in condition of intermediate exchange on
sedimentation time scale. Perfect demonstration of the 1:1 and 2:1 complexes with this kind
of simulation would require to repeat them with the other possible larger complexes but this
would require to know their dissociation constants and obviously some conditions are expected
to be also compatible with the experimental results presented here. Thus, the conclusion is that
the high similarity between the data simulated with ITC knowledge and svAUC experimental
data does not invalidate the conclusion that the 1:1 and 2:1 protein/RNA complexes are the es-
sential complexes that can be formed in the solution conditions of this study. This compatibility
validation between ITC and svAUC results was the main goal of these simulations.
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18.3 ITC and svAUC combined conclusion: macroscopic model of TRBP
interaction with microRNA 155 precursor
Although a presence of a small fraction of a complex of protein/RNA molar ratio of 2 and
a stoichiometry higher than 2 protein: 1 RNA might exists, the combination of the ITC and
svAUC data enable to conclude to the existence in solution of the following macroscopic models
fig. 18.5 for TRBP-D1D2.
Figure 18.5: Illustration of TRBP-D1D2 and pre-miR-155 (A.) or miR-155/miR-155* (B.) macroscopic
model from combined ITC and svAUC analysis.
For TRBP-D1D2, we can note that the first binding event has almost the same apparent affin-
ity with the two precursors. The apparent affinity of the second binding event is slightly lower
for the shorter precursor. Before starting the interpretation, I want to remind here that the
shorter precursor engineered here is almost the equivalent of the product Dicer would lead
from the cleavage of the longer one apart from the pair of GC nucleotides required for the in
vitro production of this RNA. As a result the two RNA have a common stem, differs at the top
of the stem by 4 nucleotides and one of them has an additional loop. Strictly, the difference is
not just the presence/absence of a loop. Whatever the potential effect of this small sequence
change, the similarity in the binding constants shows that the apical loop of pre-miR-155 is not
required for the binding of two TRBP-D1D2. This does not mean that TRBP does not interact
with it.
Multiple hypotheses can be proposed to explain the high similarity between the affinity of
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the RNA binding region of TRBP and the two successive microRNA precursors of miR-155 :
- The RNA binding region of TRBP does not interact with the loop, it is restricted to the double
stranded parts of the stem. This loop is undetected by NMR experiments on the imino protons
regions which suggests that it is single stranded.
- The RNA binding region of TRBP interacts with the loop as strongly as it does with the engi-
neered apical extremity (GC) of the shorter precursor. This hypothesis appear much less likely
than the first one but can’t be excluded from the available data.
- Coincidence could also explain the similarity. The measured constants are macroscopic ones
and despite the relation between the first one and the second one are the ones expected in
the case of a small negative cooperativity, much more complicated mechanisms potentially not
identical with both RNA could lead to the same result.
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Chapter 19
Site specific characterization of the RNA binding region of TRBP with
microRNA 155 precursors: two independent binding domains
Combination of ITC and svAUC experiments have enabled to established a macroscopic
model of the interaction between TRBP-D1D2 and pre-miR-155 and miR-155/miR-155*. De-
spite the RNA binding ability of each dsRBDs for pre-miR-155 has been established by ITC,
the exact part of TRBP-D1D2 implicated in the interaction with miRNA precursors was yet to
be established. This included the role of each dsRBDs in the two kind of complexes observed,
the potential interaction between them on the RNA and the behavior of the interdomain region
which was never reported even for siRNAs. Additionally, potential different binding behavior
of TRBP on miRNA precursors before or after their cleavage by the enzyme Dicer (pre-miR-155
cleavage
−−−−→
Dicer
miR-155/miR-155*) was yet to explore. In particular, the effects of the presence of the
loop were not reported in the literature. The macroscopic models suggested very similar affini-
ties of TRBP-D1D2 for both precursors of miR-155. As both differences and similarity of the
recognition of these RNA by TRBP would be an interesting result, a site specific comparison
of the RNA binding region of TRBP to both precursors was performed. Since the macroscopic
model of the interaction enable to choose the condition under which one of the two complexes
is predominant, NMR is particularly well suited to answer the aforementioned objectives. Thus
this chapter aims to determine the RNA binding surface of the miRNA binding region of TRBP
(TRBP-D1D2) on pre-miR-155 and miR-155/miR-155*.
19.1 NMR assignment of the backbone of TRBP-D1D2, TRBP-D1 and
TRBP-D2 on miR-155 precursors
In order to get insight into the behavior of the first two dsRBDs of TRBP in the tandem con-
structs, both TRBP-D1D2 and TRBP-D1 & TRBP-D2 were assigned in complex with pre-miR-
155. miR-155/miR-155*, with lower yields than pre-miR-155 was used only for the interaction
with TRBP-D1D2. As the study of the {TRBP / miRNA precursors} complexes by NMR was
performed by looking at the TRBP signal, saturation of the protein required to add an excess of
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RNA. Additionally, as the molecular weight of the {2 TRBP-D1D2: 1 pre-miR-155} is larger than
the {1TRBP-D1D2: 1 pre-miR-155} complex (64.8 kDa vs. 42.2 kDa respectively) and because
of exchange between free and bound partners in these systems, it was preferable to have only
the 1:1 complex with the standard NMR experiments used (faster rotational correlation time
and thus longer relaxation time for the smaller complex). The estimations of the macroscopic
binding constants were used to design titration experiments by adding miR-155 precursors
on solutions of TRBP constructs. The titrations starts from a state with a large proportion of
large protein-RNA complex to a state were the equilibrium is displaced towards an excess of
1:1 protein:RNA complex fig. 19.1. RNA-bound states of the different TRBP constructs were
analyzed using 2D 1H-15N BEST-TROSY experiments at various protein concentrations and
protein/RNA ratios on [U-2H,U-15N] labeled samples with unlabeled pre-miR-155 and miR-
155/miR-155*. The parameters of the different titration points reported here are given in tab.
19.1 and tab. 19.2. The time required to collect individual titration points depended on the
protein concentration and the signal-to-noise ratio (S/N). The experiments were recorded and
analyzed as explained in Chapter 12. A titration with TRBP-D1D2 was performed with a [U-
2H,U-15N,U-13C] labeled sample up to a 2.3 excess of unlabeled pre-miR-155. At the end of
the titration a sample with an RNA:protein ratio over 2.3 and a TRBP-D1D2 concentration of
230 µM was used to assign some (1H,13C and 15N) backbone resonance assignments with a
combination of 3D BEST HNCO and HNCA triple resonance NMR experiments. Partly be-
cause of the limited protein and RNA yields and because of the intermediate exchange of the
interaction in the backbone NH planes, the TROSY signals of the complexes were weak. As a
consequence, the common assignment strategy using sequential 3D experiments could not be
used. Because of the moderate chemical shift change observed for most of the residues, the
assignment was performed using the assignment of the apo forms as a basis. Using an overlay
of the free and bound state HSQC spectra, from each free peak, the titrations enabled to reduce
the number of possible candidates for the bound peaks. Then the comparison of the CO and
inter/intra-residual CA, when present, enabled to complete the identification. The latter chem-
ical shifts were very similar in the bound and free forms. Titration experiments were used for
the assignment of the backbone amide resonances of TRBP-D1 and TRBP-D2 interacting with
pre-miR-155 and for TRBP-D1D2 interacting with miR-155/miR-155*. Both titrations and the
3D HNCA and HNCO experiments were required for the assignment of the NH backbone of
TRBP-D1D2. For a few residues, the titrations performed with the single domains were used
to resolve the ambiguity on crowded titration signal in TRBP-D1D2 TROSYs. An additional
small titration was performed by monitoring the imino proton spectrum of pre-miR-155 with
injections of TRBP-D1D2 (tab. 19.2).
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Table 19.1: RNA:protein ratios and expected total concentrations of the different titration points
of TRBP-D1D2 by either pre-miR-155 or miR-155/miR-155*. The initial concentration of TRBP-
D1D2 for both titration 500 µM in 70 µl, titrated by a solution of 2 mM pre-miR-155 or 970 µM
of miR-155/miR-155*. C(X) indicate the loaded concentration of the species X.
TRBP-D1D2 titration by pre-miR-155 TRBP-D1D2 titration by miR-155/miR-155*
C(RNA)
C(D1D2) C(D1D2) (µM) C(RNA) (µM) C(D1D2) (µM) C(RNA) (µM)
0 500 0 500 0
0.1 486 56 474 51
0.2 473 108 452 94
0.3 461 158 432 132
0.5 443 228 398 198
0.75 422 313 361 270
1.0 402 391 333 323
1.25 381 477 304 380
1.5 364 543 280 427
1.75 348 608 262 461
2.0 333 667 246 492
2.3 318 727 233 517
Table 19.2: RNA:protein ratios and expected loaded concentrations of different titration points
of TRBP-D1 and TRBP-D2 by pre-miR-155. The initial concentration of TRBP-D1 and TRBP-D2
are 400 µM and 575 µM respectively with an initial volume of 55 µM in placed in 1.8 inner
diameter Shigemi tubes. Additional points were recorded for TRBP-D1 at protein:RNA ratio of
0.2, 0.22, 0.29, 0.33 and 0.4. C(X) indicate the loaded concentration of the species X.
TRBP-D1 titration by pre-miR-155 TRBP-D2 titration by miR-155/miR-155*
RNA: protein ratio C(TRBP-D1) (µM) C(RNA) (µM) C(TRBP-D2) (µM) C(RNA) (µM)
0 400 0 575 0
0.1 382 38 549 53
0.5 324 162 524 103
0.75 296 222 465 224
1.0 272 273 425 305
1.5 237 347 390 376
Table 19.3: TRBP-D1D2:pre-miR-155 ratios and expected loaded concentrations of different
titration points of TRBP-D1 and TRBP-D2 by pre-miR-155. C(X) indicate the loaded concen-
tration of the species X.
TRBP-D1D2: RNA ratio C(RNA) (µM) C(TRBP-D2) (µM)
0 200 0
0.1 191 21
0.5 165 86
1 140 146
2.0 108 222
236
19.2 Results
Spectra corresponding to the interaction between TRBP constructs and miR-155 precursors
are given in fig. 19.2. Quantification of the combined proton and nitrogen backbone chemical
shift are given in fig. 19.3.
Figure 19.1: Prediction of the evolution of the concentration of the different protein/RNA complexes
and single species during the NMR titrations. The calculation used the macroscopic models for TRBP-
D1D2 with pre-miR-155 and miR-155/miR-155* derived without microscopic assumptions, and the
rough constants estimates for TRBP-D1 and TRBP-D2 with pre-miR-155 derived under the hypothesis of
identical and independent binding sites of pre-miR-155
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Figure 19.2: (1H,15N) TROSY-HSQC spectrum of (U-2H2O-15N)-labeled TRBP-D1 (A.), TRBP-D2 (B.)
and TRBP-D1D2 (C.) in the free state or interacting with pre-miR-155 with 1.5, 1.5 and 2.3 RNA equiva-
lent respectively. The spectra were recorded at 800 MHz at 25°C in [23.5 mM potassium phosphate pH
6.5, 100 mM KCl, 10 mM MgCl2 and 5 mM β-mercaptoethanol, 2 mM TCEP]. The panels of the second
row show an expansion of the region of the full spectra of the first row contained in the dashed box ;
assignments of a few peaks are given as example. Panel D. is an overlay of the TROSY spectra of the
bound state of TRBP-D1 (A.), TRBP-D2 (B.) and TRBP-D1D2 (C.) interacting with pre-miR-155 with 1.5,
1.5 and 2.3 RNA equivalent.
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Figure 19.3: Comparison of backbone amide chemical shift (c.s.) perturbation of TRBP-D1D2, TRBP-
D1 and TRBP-D2 upon interaction with pre-miR-155 or miR-155/miR-155*. The hydrogen and nitrogen
chemical shift are calculated with the compound chemical shift formula given in Chapter 12. Secondary
elements are taken from the secondary structure prediction of free TRBP-D1D2 performed in this work
from NMR chemical shift in solution. The vertical scale for the chemical shift perturbation and differ-
ences of chemical shifts perturbations is the same for all plots.
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Figure 19.4: Typical examples of peak behavior in titrations of TRBP-D1 and TRBP-D2 with pre-miR-
155.
Figure 19.5: Titration of pre-miR-155 by TRBP-D1D2 monitored by recording 1D imino protein spectra
(SOFAST-HMQC) at 25°C. A. Prediction of the evolution of the concentrations during the titration using
the macroscopic model established in this study. B. Evolution of the imino proton spectrum of pre-miR-
155 during the titration. All the experiments were recorded with the same parameters and total time of
acquisition.
Information on {TRBP-D1D2/miR-155 precursors} complexes For TRBP-D1FD2, TRBP-D1F
and TRBP-D2 interacting with pre-miR-155, 93.2%, 84% and 97% respectively of non proline
backbone amide resonances were assigned. 62% of non proline CO and 66% of non proline Cα
were assigned for TRBP-D1FD2 interacting with pre-miR-155 and 93.2% of non proline back-
bone amide resonances for TRBP-D1FD2 with miR-155/miR-155*. Most of the peaks of the
proteins constructs have different position and diminished intensities upon the mixture of the
RNA solution and the protein solution. This implies a change of the chemical environment of
the amide protons. As both macromolecules are in the same buffer, these changes correspond
to the interaction between the TRBP constructs and miR-155 precursors. Titrations were char-
acterized by a strong diminution of the signal intensities characteristic of NMR intermediate
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exchange between free and bounds species. Two different regimes for TRBP-D1 and TRBP-D2
were observed and are illustrated in fig. 19.4. The exchange for TRBP-D2 is globally closer to
slow exchange than the one of TRBP-D1, closer to fast exchange. These differences reflect ki-
netic differences that are consistent with the higher affinity of TRBP-D2 compared to TRBP-D1.
When detected, the peaks displacements were almost linear. No significant chemical shifts are
observed for the unfolded form of the first dsRBD of TRBP in either TRBP-D1 or TRBP-D1D2 ;
however the relative intensity of this form over the folded one diminish as RNA is added to the
protein solution, which may corresponds to an expected displacement of the F = U equilibrium
towards the RNA interacting form. The chemical shift perturbations are given for the end of the
titrations. Observation of the imino protons signals of pre-miR-155 with TRBP-D1D2 fig. 19.5
mainly show the spectrum of the free RNA in solution according to the prediction of complexes
concentration. Providing the free RNA is not in NMR slow exchange with the bound form the
lack of peak shift suggests no major structural change on the RNA in the complex. TROSY
experiments are more informative ; according to the predictions of the complex abundance in
fig. 19.1 the system for which chemical perturbation are given correspond to complexes with
1 TRBP-D1D2 on pre-miR-155 or on miR-155/miR-155* and one or two TRBP-D1 or TRBP-D2
on pre-miR-155. Using this information, the backbone chemical shift comparisons and assum-
ing the backbone amide chemical shifts reflects the behavior of the protein/RNA interaction
surface, the following conclusion can be driven :
- Both dsRBDs of TRBP-D1D2 are involved in the interaction with one molecule of pre-miR155
or miR-155/miR-155*. The interdomain region is not directly involved in RNA recognition.
Absence of significant shifts and high intensities of interdomain region peaks suggests by com-
parison to free TRBP-D1D2 that this region remains flexible in the TRBP-D1D2/RNA complex.
Thus this region can be qualified as a tether.
- Amplitudes of chemical shifts perturbation in TRBP-D1D2, TRBP-D1 and TRBP-D2 interacting
with pre-miR-155 are almost the same. This implies that the chemical environment of the two
dsRBDs in the tandem construct TRBP-D1D2 is almost the same than when they are allowed to
interact freely with pre-miR-155. Thus, both dsRBDs of TRBP-D1D2 interact independently on
the RNA in a system where the {1 TRBP-D1D2: 1 pre-miR-155} is predominant. Three regions
of the dsRBDs have large chemical shift perturbation. These regions correspond to the three
canonical RNA binding regions of dsRBDs presented in part I. So in addition to the independent
binding, the first two dsRBDs of TRBP interact with the canonical dsRBD RNA binding surface.
Similar secondary structure chemical shifts are compatible with no large structural changes
during the binding and in particular not change of secondary structure. A similar conclusion
was deduced from the study of the crystallized form of a complex between the second domain
of TRBP and a small RNA duplex (290). So it is possible and useful to plot the chemical shift
perturbation on the available free structures of the first two dsRBDs of TRBP (fig. 19.6).
- Amplitudes of chemical shifts perturbation in TRBP-D1D2 interacting with pre-miR-155 or
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with miR-155/miR-155* are almost the same. This imply that the RNA binding surface of TRBP-
D1D2 with either pre-miR-155 or miR-155/miR-155* in a system where the {1 TRBP-D1D2: 1
RNA} is essentially the same. This observation is consistent with the similar affinities for these
complexes derived from ITC experiments.
Importantly, despite the NMR results give the evidence that 2 dsRBDs of TRBP can bind
the same precursor molecule, the present results corresponds to an average information on
an ensemble of molecules and cannot exclude the possibility that the dsRBDs are not exactly
bound at the same time.
Figure 19.6: Representation of chemical shift pertubation on the structures in the apo state of the first
two dsRBDs of TRBP (PDBid: 3LLH, 2CPN).
Figure 19.7: Typical examples of peak behavior in titrations of TRBP-D1D2 with pre-miR-155.
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NMR derived information on {(TRBP-D1D2)2 / miR-155 precursors} complexes Previous
conclusions were derived from experiments based on the observation of TRBP-D1D2 signal
with an excess of RNA, shifting the equilibrium towards a 1:1 protein:RNA complex. With the
available experiments, structural information of the complex with two TRBP-D1D2 on miRNA
precursors can only be obtained from the beginning of the titrations where this complex is pre-
dominant. However, there is also an excess of free protein at the beginning of these titration so
the signal reflect largely this species before an RNA:protein ratio of 0.4. Titration example of
typical behavior of peaks from dsRBD1 and dsRBD2 in TRBP-D1D2 are given in fig. 19.7. The
signal to noise of the spectra in the first points of the titration and the intermediate exchange
did not allowed to perform a systematic study for all peaks and especially for the ones with
the largest chemical shift changes. If significant non linearity in the peak displacement would
be detected, including peaks at a stage were the 2:1 protein:RNA complex is highly predom-
inant ( C(RNA)
C(TRBP-D1D2) = 0.5), this would indicate a different structure of the complex with two
TRBP-D1D2 on one miR-155 precursor. The rather linear displacement does not enable to make
conclusion on the properties of this complex from the detectable peaks in these experiments.
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Chapter 20
Conclusion and discussion of the main results
Much of the information concerning the roles of TRBP in small silencing RNA synthesis (miR-
NAs and siRNAs) has been obtained from studies with siRNAs whereas miRNAs are a more
important small RNA class in humans. The 3D structures of the first two dsRBDs of TRBP
have been published (290) as well as the structure of TRBP-dsRBD2 in complex with a short
10 bp dsRNA (294) but without information on the actual binding sites, binding behavior, sto-
ichiometry with microRNA precursors, behavior of the free partners, etc Little biophysical or
structural analysis of how multiple domain constructs of TRBP interact with miRNA precursors
have been previously reported. The data presented here represent the first, in depth biophysical
analysis of the interaction between TRBP and human miRNA precursors which have an imper-
fect dsRNA stem. The main conclusion of the TRBP/miR-155 precursors interaction found is
this thesis are summarized in the following paragraphs and compared with other similar sys-
tems reported in the literature, in the light of the first part of the thesis.
Importantly, it has to be underlined here that the conclusions proposed from this study are
valid under the in vitro conditions used. The in vivo behavior in the crowded in cell environment
might be different. It is however expected that this study on isolated macromolecules reveals
some of their fundamental properties that should contribute to what happen actually in vivo.
RNA binding sites are restricted to the dsRBDs The RNA binding sites in the RNA binding
region of TRBP are restricted to the two dsRBDs and do not involve the interdomain region.
This region is flexible in the free and bound form of the protein. The existence of such a flexible
linker has been previously demonstrated in PKR, ADAR2 and HYL1 where a long unstructured
linker connects the two dsRBDs.
The two first domains of TRBP behave independently in the free and bound form on the
protein As presented in part I, dsRBDs are part of modular RNA-binding proteins, either in
multiple copies (mainly tandems) or in combination with other functional domains such as
RNase III, RNA Helicases, PAZ domains, etc. All solution studies in dsRBD tandems, using
liquid state NMR spectroscopy, have shown that the dsRBDs were independently folded, with
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no intramolecular interaction between these domains in the apo form: first two dsRBDs of
HYL1 (231), the two dsRBDs of human PKR (203) and human ADAR2 (256). The two dsRBDs
of human ADAR2 bind to distinct regions of the dsRNA stem without inter-domain contact or
contribution from the inter-domain linker (257; 256).
The work performed is this thesis has shown that the first two dsRBDs of the RNA binding
region of TRBP (TRBP-D1D2) are also independent in the apo form and in the RNA holo form
to either one pre-miR-155 or one miR-155/miR-155*. SEC-MALLS and svAUC demonstrated
the absence of detectable intermolecular interaction between the dsRBDs in the apo form and
NMR chemical shift perturbation studies on TRBP-D1D2, TRBP-D1 and TRBP-D2 enabled to
show the independency of the dsRBDs in the apo form and the independency of their RNA
binding surface in the 1:1 protein:RNA complex.
The two first domains of TRBP binds to the same RNA and up to two copies can bind on
miR-155 precursors A second important feature of the interaction between the RNA binding
region of TRBP and cytoplasmic miR-155 precursors is the stoichiometry. ITC combined with
svAUC experiments has enabled to propose macroscopic models for the interaction between
TRBP-D1D2 and pre-miR-155 or miR-155/miR-155*. For both precursors, the models showed
the presence of 1:1 and 2:1 TRBP-D1D2:RNA complexes. Pre-miR-155 was shown to be mainly
monomeric using both SEC-MALLS and svAUC and its secondary structure is compatible with
the predicted miRNA precursor hairpin. Knowledge of the state of the precursor is of high
importance to have an accurate understanding of the stoichiometry in complexes involving
dsRBDs since the longer the dsRNA, the more dsRBDs are expected to bind. The stoichiom-
etry of 2 is the first reported for TRBP with miRNA precursors. A study of the interaction
between TRBP and a siRNA, performed during the course of the present study, has reported
by ITC that two TRBP-D1D2 (similar construct) and that full length TRBP could bind to a 19
base pairs siRNA duplex with perfect base pairing but without structural information on the
complexes. This result is consistent with the observation made here with miR-155 precursors.
HYL1, a dsRBD containing cofactor of Arabidopsis thaliana DCL1 has been shown to form 2:1
protein:RNA complexes with dsRNA sequences of suitable length (294).
In contrast to the 1:1 protein:RNA complex, no structural information was obtained here for
the complex with 2 TRBP-D1D2 and one miRNA precursor by NMR. The macroscopic model
could not exclude preferential binding of only one of the two dsRBDs of TRBP-D1D2 in this
complex. ITC experiments with the isolated dsRBDs (TRBP-D1 and TRBP-D2) of TRBP also
indicate their ability for form a complex containing 4 dsRBDs on one pre-miR-155. This obser-
vation (4 independent dsRBDs interacting with one precursor) suggest that each dsRBD in the
[2 TRBP-D1D2]/pre-miR-155 complex could bind the miRNA precursor.
The functional stoichiometry of the Dicer/TRBP complex has not yet been determined (156).
A study reports that a tertiary complex containing Dicer, TRBP and PACT can be formed which
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implies that two TRBP-like proteins can interact simultaneously with Dicer in the presence of
pre-miRNAs (148). This corresponds to 8 dsRBDs in a complex, some of them being potentially
not able to bind dsRNA. Thus, the high occupancy of dsRBDs on a relatively short sequence
of dsRNA, as seen here with TRBP and two miRNAs precursor, is potentially functionally rel-
evant. Whether the 2:1 ratio observed here is a standard feature of the complexes formed be-
tween TRBP and miRNA precursors or whether the stoichiometry is determined by features
in the target miRNA precursor, such as the length or percentage of canonical dsRNA, remains
to be determined. Additionally, the possibility of a preferential position of the dsRBDs on the
precursors in the 1:1 and 2:1 protein:RNA complexes could be worth to investigate.
The behavior of TRBP-D1D2 is similar with both hairpin and duplex miR-155 precursors
RNA experiments have shown that in the 1:1 TRBP-D1D2:RNA complex, the protein interac-
tion surface was identical with pre-miR-155 and miR-155/miR-155*, which are the cytoplasmic
precursors of miR-155 before and after Dicer cleavage respectively. The proposed macroscopic
models also provided information on the affinity of the different binding events of TRBP-
D1D2 for these two precursors. Analysis of ITC data yielded dissociation constants for the
TRBP/pre-miR-155 complex in the low µM range, which is consistent with other investigations
of dsRBD/dsRNA interactions (231; 294; 252; 57; 284). Importantly the dissociation constants
are very similar for the two precursors, a comparison that was not studied before. A recent
study on TRBP with similar construct and an additional 6 histidine tag (290) reported by ITC
a much tighter binding in the sub nanomolar range with a 19 base pair perfect siRNA duplex.
The affinity difference with the one estimated in the present study could come from the RNA
used (imperfect base paired miRNA precursors here vs. siRNA perfect duplex, sequence ef-
fects) and/or an effect of the protein purification tag and/or an influence of the different buffer
used (20 mM Hepes-NaOH buffer (pH 7.5) with 150 mM NaCl in their study). However, the
moderate affinity of the RNA binding region on TRBP with miR-155 is compatible with the dis-
placement of the domains by the enzyme Dicer or other proteins of the RISC loading complex
that process the RNA.
Despite the independency of the RNA binding surfaces of each dsRBD in TRBP-D1D2, a
complex network of cooperativity interaction with the miRNA precursors, especially in the 2
protein:1RNA complex cannot be excluded. It can however be noted that the relation between
the first and second macroscopic binding constants corresponding to the successive binding of
two TRBP-D1D2 on the precursors are compatible with a quasi independent/slight negative
cooperativity interaction of these two proteins. The potential absence of positive cooperativity
result would be consistent with earlier studies, which compared the RNA-binding properties
of TRBP with C. elegans RDE-4 (214).
The very similar affinities of TRBP for pre-miR-155 and miR-155/miR-155* duplex is of in-
terest. Whether the protein binding sites on the RNA and whether the loop is involved cannot
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be rigorously obtained from this information. However with the identical RNA binding surface
for TRBP-D1D2 with pre-miR-155 and miR-155/miR-155* in the 1:1 complexes strongly suggest
that TRBP-D1D2 interacts on the substrate and product of Dicer via the same RNA sites. In ad-
dition to its role in the Dicer complex, TRBP is a component of the RLC (35; 106; 182). The
similar affinities of TRBP-D1D2 and protein binding surfaces suggest that TRBP may have in
vivo an RNA binding activity upstream and downstream of the cleavage of miRNA precursors
by Dicer, an ability that was not yet clear. Therefore TRBP may participate in the recognition
of Dicer substrates as well as the transfer of the cleavage product to RISC via the RISC loading
complex. To illustrate the main interaction results and to investigate the steric possibility of
2 TRBP-D1D2 (4 dsRBDs) on each miR-155 precursors with no interdomain contacts, a struc-
tural model of the complexes has been generated using Rosetta (49). It is combined with the
macroscopic model in fig. 20.1 The description of the generation of this model is given in the
second publication made during this thesis (15). The model uses the TRBP-dsRBD2 construct
bound to an RNA duplex (PDBid: 3ADL). Although no information are available on the rela-
tive position of each dsRBD in these complexes, the double stranded RNA surface might allow
a 2 protein:1RNA complex without significant dsRBD contact. Experiments with deuterated
and 15N labeled RNA could advantageously enable to work in conditions with saturated 2:1
protein:RNA complex and try to further characterize the largest complex.
Figure 20.1: Possible model of the interaction between the RNA binding region of TRBP and miR-155
precursors using the macroscopic model established from SEC-MALLS, ITC and svAUC combined with
the site specific interaction of the 1:1 complex performed by NMR and showing an independent behavior
of the dsRBDs on the precursors.
The binding affinity and dynamics of the two first dsRBDs of TRBP are different Differ-
ences between the behavior of each dsRBD in TRBP-D1D2 were also detected in the present
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study. First, the affinities measured for the isolated dsRBDs indicate that TRBP-D2 interacts
with pre-miR-155 about 4 times more strongly than TRBP-D1. The relative affinity is consistent
with a study performed with similar isolated dsRBDs of TRBP, interacting with a 19 base pair
siRNA duplex (290) in which the affinity of the second dsRBD is twice the one of the first one.
As developed in part I, differences of affinity in dsRBDs in tandems are very common but the
potential roles are unclear.
Another striking difference discovered in this thesis is the high dynamic difference be-
tween the two first dsRBDs of TRBP: the second domain appears to be stable on the sampled
time scales whereas the first domain undergoes a full folding/unfolding equilibrium slightly
shiftable towards the folded form in the presence of RNA. According to the author knowledge,
this full folding/unfolding process is the first one reported for a human protein in conditions
close to physiological ones in pH and temperature. The in vivo relevance of this interesting
mechanism remains to be determined as well as the potential links with the affinity. The dif-
ference in dynamics between two dsRBDs domains has already been reported for the pair of
dsRBDs in PKR (204), but evidences of folding-unfolding equilibrium. These two domains were
also reported to have also different RNA binding affinities. The study proposes "a direct cor-
relation between the conformational flexibility at a millisecond timescale and dsRNA binding
activity". The proposed interpretation is that there is a concerted motion at the milliseconds-
microseconds timescale in the first dsRBD with the higher RNA binding affinity generate multi-
ple conformations required for the binding of different RNAs. The argument is however weak
as the "correlation" observed for 2 individuals and 2 variables might just be coincidence. As
they report, the binding sites of these two domains is known and the residues involved are
different in the two domains. This chemical difference could also explain/contribute to the dif-
ference. Additionally, the authors have shown that the second domain, more rigid can interact
with the third one, a property that could be suffice to explain the natural selection of a more sta-
ble second dsRBD, independently to the RNA affinity variable. Both the protein and the RNA
structures & dynamic have an effect in this type of interaction so the deconvolution of the differ-
ent processes is challenging. The dynamic range on the isolated protein side does not indicate
the type of interaction mechanism that will happen with the RNA, which can range from con-
formation selection to induced fit types of recognition. A conclusion that can be made from the
present study and the one on PKR dsRBDs is that in addition to the common affinity differences
in dsRBDs tandems, significant dynamical behavior exists in two studies. The consequences of
these differences on the RNA interaction are still very elusive. Only hypotheses can be formu-
lated. It is possible that the higher number of conformations adopted by one domain allow it to
recognize a large variety of substrates. Because these pairs of dsRBDs are usually involved in
multiproteins complexes, it is also possible that the weaker affinity of one domain enables it to
be displaced more easily than the other one by another RNA binding protein. A more detailed
study of the dynamics of dsRBDs on their RNA target in a multiple systems in a competitive
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multi-protein environment seems required to further investigate in this direction.
Proposition of future research directions In the future, it would be interesting to test whether
the properties found here for TRBP-D1D2 are influenced by the presence of the third domain
of TRBP which may shift the equilibrium towards the 2:1 protein:RNA complex because of its
homodimerization capability. Additionnaly the effects of the phosphorylation state of the pro-
tein and of the binding of the anticancer drug Enoxacin are interesting. Preliminary studies
performed during this thesis have suggested that it was respectively not the case with phos-
phomutants and slightly the case with enoxacin.
The original behavior of the first domain of TRBP, undergoing a folding-unfolding exchange
in a wide range of in vitro conditions merits further investigations, in particular the existence
of a similar phenomenon in other dsRBDs and assessment of the its potential functional rele-
vancy. In parallel to the work reported here, a collaborator of the host lab, found that a plant
dsRBD in a dsRBD tandem was fully unfolded in the free state and able to fold upon addition
of the miRNA precursor. The 1:1 protein:RNA complex obtained in this case is a mixture of a
folded form bound to the RNA and of the apo unfolded form. I performed EXSY experiments
on this complex which help the team to assign the RNA bound state and demonstrated the
exchange (to be published). This dsRBD appears to be another interesting case in the dsRBDs
family. Together with the behavior reported here for TRBP-D1, it might indicate a much larger
heterogeneity in dsRBD conformations that what is suggested by the available structures.
It would be interesting to relate the properties found for TRBP-D1D2 with the recent report
of a movement of TRBP on dsRNA (147) for which the first two dsRBDs are indispensable.
This property of TRBP, also found in PACT, enable the Dicer-TRBP complex to diffuse on the
dsRNA, which was not detected for Dicer alone with dsRNA. The authors propose a role for
this process in the correct positioning of Dicer and on its cleavage rate. This process might be
important for the processing of siRNA which originate from long dsRNA precursors. It would
be interesting to study the influence of the linker on this process and the influence of the differ-
ent properties of the two dsRBDs including the affinity difference and the folding/unfolding
equilibrium in TRBP-D1. The use of chimeras with tandems of dsRBD2 or dsRBD1 could help
in these investigations. Finally, the influence and potential conservation of TRBP-D1D2 prop-
erties in the context of larger complexes with the enzyme Dicer and within the RISC loading
complex are obvious future research directions.
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20.1 Résumés en francais
20.1.1 Résumé général
Les microARNs (miARNs) sont une classe de petits ARNs non codants qui régulent
l’expression des gènes via un mécanisme d’interférence par ARN. Les microARNs humains
sont produits par une série de réactions enzymatiques. En particulier, dans le cytoplasme le
précurseur de miRNA (pre-miRNA) est reconnu et clivé par un complexe contenant l’enzyme
RNase III Dicer et plusieurs cofacteurs protéiques. La protéine TRBP (HIV TAR RNA binding
protein) est l’un de ces cofacteurs ; il augmente la stabilité du complexe, influe sur la cinétique,
la position du clivage et a rôle potentiel dans la reconnaissance du substrat et dans le transfert
du produit vers le complexe RISC (RNA-induced silencing complex) effecteur de l’interférence
par ARN. TRBP est composé de 3 domaines de liaison aux ARN doubles brin (dsRBDs). La ré-
gion d’interaction de TRBP avec les ARNs est composée des deux premiers dsRBDs liés par une
région interdomaine non caractérisée. La présente étude est une caractérisation biophysique
in vitro de la région d’interaction avec les ARNs de TRBP dans l’état apo de TRBP ou dans
l’état lié avec chacun des deux précurseurs cytoplasmiques successifs du microARN oncogène
miR-155 comprenant la tige boucle pre-miR-155 et le duplex miR-155/miR-155* résultat du
clivage de pre-miR-155 par Dicer. L’étude montre que la région d’interaction de TRBP avec
les ARNs est monomérique, est composée de deux dsRBDs de conformations indépendantes
en solution et que la région interdomaine de 60 résidus est flexible. Le premier dsRBD, non
caractérisé précédemment en solution est le siège d’un équilibre plié/déplié intégral dans une
grande gamme de conditions physico-chimiques. Les deux premiers dsRBDs de TRBP peuvent
interagir avec un même précurseur de microARN et deux régions d’interaction de TRBP avec
les ARNs peuvent interagir avec un même precurseur. La région d’interaction de TRBP avec
les ARNs interagit avec pre-miR-155 et le duplexe miR-155/miR-155* avec des affinités très
similaires. Dans le complexe avec une région d’interaction de TRBP avec les ARNs liée à pre-
miR-155 ou au duplex miR-155/miR-155*, aucun indice de contact entre les deux dsRBDs n’a
été detécté et la protéine interagit avec les deux précurseurs par la même surface d’interaction.
Les informations récoltées suggèrent notamment que TRBP peut jouer un rôle avant et après le
clivage des pre-miARNs par Dicer, en particulier dans le complexe de chargement de RISC.
20.1.2 Résumé de la partie I
La partie I présente le contexte biologique dans lequel le travail de thèse a été effectué. Elle
est constituée d’une revue critique de la littérature accompagnée d’analyses structurales. A
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partir de l’an 2000, l’identification progressive de petits ARNs régulateurs présents chez les
plantes et les animaux a prouvé l’existence d’un nouveau mode général de régulation génique.
Les petits ARNs impliqués, d’environ 20 à 30 nucléotides, sont responsables d’un mécanisme
d’interférence par ARN dans lequel leur interaction avec un ARN messager engendre la dégra-
dation ou le stockage de ce dernier. Six principales classes de petit ARNs régulateurs sont
généralement reconnues. Les microARNs canoniques, les microARN mirtrons, les microARNs
dérivés d’ARNs fonctionnels, les siARNs (si : short interfering) endogéniques et exogéniques
et les piwiARNs. Le travail de thèse s’est focalisé sur la biogenèse des microARNs (miARNs)
et siARNs dont la machinerie de production est similaire. La biogénèse des miARNs et siARN
chez divers organismes modèles pluricellulaires, le vertebré Homo sapiens, le vers Caenorhabditis
elegans, l’insecte Drosophila melanogaster et la plante Arabidopsis thaliana montre de nombreuses
similarités impliquant notamment une ou plusieurs endoribonuclease III de type Dicer associée
à des cofacteurs protéiques. Quasiment toutes les protéines en jeu dans ces voies de biogenèses
contiennent des domaines de liaison aux ARNs double brin (dsRBD). TRBP est l’un des co-
facteurs de l’unique Dicer humaine et est composé de 3 dsRBDs. Bien que les dsRBDs soient
composés de 3 feuillets β encadré de 2 hélices α il existe une variabilité dans leur structure
et leurs fonctions cellulaires. Une comparaison des séquences et des structures des dsRBDs,
à l’état libre, impliqué dans la biogenèse des miARNs and siARNs est réalisée. Les dsRBDs
peuvent conférer de multiples fonctionnalités aux protéines qui les contiennent. Ils peuvent
moduler l’activité des enzymes auxquels ils sont associés, peuvent avoir un effet sur la pré-
cision du clivage chez les plantes, influencent la production d’isoformes et leur distribution
chez les metazoaires, peuvent avoir des rôles dans la sélection des substrats par les enzyme
RNase III, semblent contribuer au moins faiblement à la sélection du brin chargé sur les ARNs
messagers et certains dsRBD associés aux enzymes ADAR interagissent spécifiquement avec
des séquences d’ARN double brin, contrairement à la majorité des dsRBDs. Les dsRBDs sont
souvent présents en multiple copie, très souvent en tandems. Il y a souvent dans ce cas des
différences d’affinité entre les dsRBDs dont l’origine est souvent obscure (zone d’interactions,
dynamique). Le travail de thèse est focalisé sur le cofacteur TRBP.
20.1.3 Résumé de la partie II
La partie II explicite la stratégie et les principes et limites des méthodes biophysiques utilisés
dans l’étude expérimentale. La construction de TRBP utilisée est celle correspondant à la ré-
gion d’interaction avec les ARNs. Cette région correspond aux 228 premiers résidus de TRBP et
comprends deux domaines de liaisons aux ARN doubles brins (dsRBD) séparée par une région
interdomaine d’environ 60 résidus. Elle est notée TRBP-D1D2. Afin de pouvoir étudier le com-
portement des deux dsRBD dans la région de TRBP intéragissant avec les ARNs doubles brins,
deux constructions réduites aux deux dsRBDs ont été produites (notées TRBP-D1 et TRBP-D2).
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La comparaison du comportement de TRBP-D1D2 avec TRBP-D1 et TRBP-D2 permet d’obtenir
des informations sur le comportement des dsRBDs dans TRBP-D1D2. Les précurseurs de
microARN utilisés dans cette étude sont les deux précurseurs cytoplasmiques du microARN
oncogène humain pre-miR-155 correspondant aux états avant et après clivage par l’enzyme
Dicer. Afin que des conclusions fiables puissent être générées, le système a été analysé par
plusieurs techniques biophysiques sélectionnées pour répondre aux questions posées tout en
étant compatibles c’est à dire applicable sur le même système en solution et dans les mêmes
conditions physico-chimiques. Pour chaque technique biophysique, les propriétés importantes
pour comprendre l’origine du signal, les approximations principales utilisées pour démontrer
les équations appliquées, ainsi que les protocoles utilisés dans cette thèse sont présentées. De
plus, le développement s’attache à présenter différents phénomènes pouvant générer de façon
non triviale des résultats indistinguables. La connaissance de ces processus est particulière-
ment utilisée lors de l’analyse des résultats expérimentaux. Les méthodes présentées inclu-
ent la chromatographie d’exclusion stérique, la diffusion de lumière, la calorimetrie isotherme,
l’ultra-centrigugation analytique et plusieurs expériences de résonance magnétique nucléaire.
20.1.4 Résumé de la partie III
La partie III présente les méthodes de production des macromolecules biologiques utilisées
dans le travail de thèse : les constructions de TRBP et des précurseurs de miR-155. La pro-
duction des constructions de TRBP a été faite dans E. coli en milieu mimimum afin de faciliter
les marquages pour la RMN. Pour augmenter les rendements de protéine en milieu deutéré,
une sélection de colonie a été réalisée comme préalablement décrit (250). Une recette de lyse
chimique des cellules a été mise au point pour augmenter la quantité de protéine récupérée à
partir des cellules d’E. coli. Les protéines ont été purifiées par purification d’affinité sur colonne
de Nickel avec des versions étiquetées des protéines comprenant une répétition d’histidines.
Les étiquettes utilisées pour la purification d’affinité ont été systématiquement retirées pour
éviter un possible biais. La dernière étape de purification est une chromatographie d’exclusion
stérique. Les précurseurs de microARN 155 ont été synthetisés in vitro avec l’ARN polymérase
du phage T7 avec par la plateforme cell-free de l’Institut de Biologie Structurale.
20.1.5 Résumé de la partie IV
La partie IV présente l’étude des constructions de TRBP et des précurseurs cytoplasmique de
miR-155 à l’état isolé, ce qui est un préalable à leur étude en mélange (cf partie IV, complexe pro-
téine/ARN). La combinaison de l’analyse des constructions protéiques par SDS-PAGE et par
chromatographie d’exclusion stérique (SEC) a permis de valider leur homogéneité. Des expéri-
ences de SEC à plusieurs concentrations ont montré qu’il n’y a qu’un seul type d’assemblage en
solution et leur analyse par diffusion de lumière à angles multiples (MALLS) a montré que ces
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constructions sont monomériques. La même conclusion est obtenue avec TRBP-D1D2 par ultra-
centrifugation analytique (svAUC), une méthode avec des approximations très différentes de
celles du MALLS. L’analyse par svAUC montre aussi que TRBP-D1D2 a une forme allongée en
solution. La structure secondaire des différentes constructions a ensuite été analysée par RMN.
La structure secondaire et la flexibilité des dsRBDs isolés (TRBP-D1 et TRBP-D2) ou dans la con-
struction double sont identiques. La région interdomaine de 60 résidus est entièrement flexible.
Les deux dsRBDs 1 et 2 ont une structure majoritaire typique des dsRBDs et compatible avec
les deux structures rapportées dans la littérature dans un cristal et en solution respectivement
(290). Cependant le premier dsRBD subit un échange intégral plié-déplié (80%-20%) dans les
constructions TRBP-D1 et TRBP-D1D2. Cet échange existe dans une large gamme de pH et de
températures. L’analyse comparée des déplacements chimiques des dsRBDs isolés montre que
les deux domaines n’intéragissent pas dans la construction TRBP-D1D2 : les deux domaines ont
des conformations independantes. Une étude similaire réalisée sur le précurseur pre-miR-155 a
montré que l’ARN produit est homogène et essentiellement monomérique bien qu’environ 4%
des molécules soient présentes dans un état d’association plus gros, probablement un dimer.
L’analyse par svAUC revèle que l’ARN a une forme allongée en solution. L’attribution des pro-
tons iminos par RMN a permis de confirmer que la conformation de l’ARN en solution est une
tige-boucle typique des précurseurs de microARN. Ces informations sur les conformations en
solution des constructions de TRBP et de pre-miR-155 ont servi de base pour l’étude de leurs
intéractions.
20.1.6 Résumé de la partie IV
La partie IV présente l’étude de l’interaction entre la région de TRBP interagissant avec les
ARNs (TRBP-D1D2) et les deux précurseurs cytoplasmiques du microARN miR-155. En pre-
mier lieu, l’utilisation combinée de la calorimetrie isotherme et de l’ultracentrifugation analy-
tique a permis de construire un modèle macroscopique de cette interaction. Ce modèle indique
que pour les deux précurseurs cytoplasmiques de miR-155, deux TRBP-D1D2 peuvent intera-
gir successivement avec l’ARN avec des affinités similaires. La calorimetrie isotherme permet
de mettre en évidence les deux associations successives, ce qui est confirmé par ultracentrifu-
gation. Des modélisations du signal d’ultracentrifugation montrent qu’il est compatible avec
les constantes de dissociation estimées par ITC. L’analyse de l’interaction par RMN montre que
dans le complexe avec 1 TRBP-D1D2 interagissant avec l’un ou l’autre des précurseurs cytoplas-
miques du microARN 155, les deux dsRBDs sont impliqués dans l’interaction et que la région
interdomaine reste flexible et n’est pas impliquée dans l’interaction tout comme l’état déplié
du premier dsRBD. Cette étude est la première analyse en détail de l’intéraction entre TRBP et
des précurseurs de microARN. Les principales découvertes sont que la zone d’interaction avec
les ARNs est restreinte aux dsRBDs, les deux dsRBDs sont impliqués dans la liaison avec une
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surface d’interaction canonique mais des dynamiques différentes, les deux premiers domaines
de TRBP ont des conformations indépandentes dans les formes libres et liées avec les ARNs et
deux TRBP-D1D2 peuvent lier une même molécule d’ARN. Les données suggèrent notamment
que le rôle de TRBP peut être similaire avant et après le clivage du premier précurseur cyto-
plasmique par Dicer. Ces propriétés ouvrent la voie à une meilleure compréhension du rôle du
cofacteur TRBP dans la biogenèse des microARN humains.
20.2 Assignement Note
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Abstract TAR-RNA binding protein (TRBP) is a multi-
domain human protein involved in micro-RNA (miRNA)
biogenesis. TRBP is a component of both the Dicer com-
plex, which processes precursor miRNAs, and the RNA-
induced silencing complex-loading complex. In addition,
TRBP is implicated in the human immunodeficiency virus
replication cycle and interferon-protein kinase R activity.
TRBP contains 3 double-stranded RNA binding domains
the first two of which have been shown to interact with
miRNA precursors. Here we present the backbone reso-
nance assignments and secondary structure of residues
19–228 of human TRBP2.
Keywords TRBP  Triple resonance NMR experiments 
Micro-RNA  Double-stranded RNA binding domain
Biological context
The majority of human micro-RNAs (miRNAs) are syn-
thesized via a common two-step maturation pathway (Kim
et al. 2009). Human miRNAs are transcribed as 1–2 kilo-
base (kb) primary transcripts. The 20–25 nucleotide (nt)
miRNA sequence is located in a 60–70 base-pair (bp) stem-
loop structure which is recognized and excised by the
nuclear microprocessor complex. The resulting hairpin
precursor miRNA (pre-miRNA) is exported to the cyto-
plasm where is it further processed by the Dicer complex.
Cleavage of the pre-miRNA produces an imperfect double-
stranded (ds) RNA duplex which is transferred from Dicer
to Ago2 to form RISC, the protein complex responsible for
miRNA-directed RNA interference.
Each miRNA maturation step is performed by a multi-
protein complex that contains an RNase III enzyme and
one or more accessory proteins. In humans the enzymatic
component of the microprocessor, Drosha, interacts with a
dsRNA binding domains (dsRBD)-containing protein,
DGCR8, while Dicer has been shown to interact with two
homologous proteins, HIV-1 transactivation response
(TAR) element binding protein (TRBP) and/or PACT (Kim
et al. 2009). In other organisms, the maturation of miRNAs
or short interferring RNAs (siRNAs) is performed by
protein complexes with similar compositions of homolo-
gous proteins.
TRBP was originally discovered via an interaction with
HIV-1 TAR RNA and has subsequently shown to be
implicated in the regulation of protein kinase R (PKR)
activity. Two isoforms of TRBP exist, TRBP1 and TRBP2.
The only difference between these isoforms is that TRBP2
has an additional N-terminal 21 residues. TRBP contains 3
dsRBDs and exhibits high sequence homology with PACT,
which also regulates PKR. Both TRBP and PACT have
been shown to associate with PKR via interactions medi-
ated by dsRBDs, but the two proteins have opposite
functional roles: TRBP inhibits PKR activity while PACT
stimulates it.
Despite a clear involvement, the precise role of TRBP in
miRNA biogenesis remains to be determined. TRBP has
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been shown to interact with Dicer and components of the
RISC complex. The first two dsRBDs of TRBP interact
with miRNAs (Chakravarthy et al. 2010) and siRNAs
(Yamashita et al. 2011). Four serine phosphorylation sites
exist in TRBP all of which are located in the inter-domain
linker regions (Chakravarthy et al. 2010). Phosphorylation
of TRBP by the mitogen-activated protein kinase (MAPK)
Erk has been shown to stabilise the interaction between
TRBP and Dicer but not significantly affect the dicing
activity of the complex.
Three dimensional (3D) structures of the first two dsRBDs
of TRBP have been reported (PDB code: 2CPN, 3LLH). The
3D structure of dsRBD-2 in complex with a 10 bp siRNA
duplex has also been elucidated (PDB code: 3ADL). These
3D structures reveal canonical dsRBD structures. Compari-
son of the 3D structure of dsRBD-2 alone and in complex
with dsRNA reveals only minor RNA-induced conforma-
tional changes. To date only low resolution structural studies
of larger constructs of TRBP have been reported and, despite
several NMR studies of TRBP, no resonance assignments
have been published. Here we report backbone 1H, 13C and
15N chemical shifts and heteronuclear 1H–15N NOE values
for a 210 residue fragments of human TRBP2 containing the
two dsRBDs that interact with miRNA precursors, and 2
serine phosphorylation sites.
Methods and experiments
Expression and purification of [U-2H, 13C, 15N]-labeled
TRBP(19–228)
A codon-optimised cDNA encoding residues 19–228
of TRBP was cloned in to pLX06 plasmid (Pro-
tein’eXpert) to generate a construct with an N-terminal
6-histidine purification tag and a TEV cleavage site.
The plasmid was transformed into Escherichia coli
BL21(DE3) cells.
The production of deuterated TRBP was optimised using
a double colony selection protocol in D2O-based media as
previously described (Sivashanmugam et al. 2009). The
selected colony was used to inoculate pre-cultures of Luria
Broth media (LB) prepared in D2O and incubated at 37 °C
with agitation (180 rpm) for 6 h. The LB pre-culture was
used to inoculate 200 mL of [U-2H, 13C, 15N]-labeled M9
minimal media to an initial optical density (OD) at 600 nm,
OD600, of 0.1. This second preculture was incubated over-
night at 37 °C with agitation (180 rpm). M9 media was
prepared with 1 g/L of [U-15]-labeled NH4Cl (Cambridge
Isotope Laboratories) and 3 g/L of [U-2H,13C]-labeled glu-
cose (Cambridge Isotope Laboratories) using [99.85 %-2H]-
labeled H2O (Euriso-top). 2 L [
13C,15N]-labeled M9 media
prepared inD2Owas inoculatedwith sufficient pre-culture to
give a starting OD600 = 0.1. The cultures were incubated at
37 °C with agitation (180 rpm) until OD600 reached 0.7 and
then stored at 25 °C for 45 min. Protein expression was
induced with IPTG to a final concentration of 1 mM. The
induced cultures were incubated at 15 °C for 18 h. The final
culture was harvested by centrifugation and the cell pellet
stored at -80 °C until required.
TRBP(19–228) was purified at room temperature in pro-
tonated solvents to allow exchange of amide protons. Cell
pellets were resuspended in lysis buffer (50 mM HEPES
pH 7.5, 100 mM KCl, 10 mM MgCl2, 10 mM CaCl2,
10 mM imidazole, 10 % (v/v) glycerol, 1 mg/mL lysozyme,
0.5 % triton X-100, 1 lg/mL leupeptin, 1 lg/mL pepstatin,
20 lg/mL DNase and 20 lg/mL RNase). The volume, V, of
lysis buffer requiredwas determined by the finalOD600 of the
expression culture such that, V(buffer) = OD600(tmax) 9
V(culture)/40. Cell lysis was performed at 30 °C for 40 min
with agitation (180 rpm). 5 mM b-mercaptoethanol was
then added and the lysis reaction clarified by centrifugation
(30,000g, 30 min, 4 °C). The supernatant was passed over
Ni-NTA affinity chromatography resin (2 mL of resin per L
of bacterial culture; QiaGEN) pre-equilibrated with storage
buffer (50 mM HEPES pH 7.5, 100 mM KCl, 10 mM
MgCl2, 10 mM CaCl2, 10 mM imidazole, 10 % (v/v) glyc-
erol and 5 mM b-mercaptoethanol). The resin was washed
sequentially with 20 column volumes (CV) of storage buffer
with 5 mM imidazole, 20 CV of storage buffer with 2 M
NaCl and 20 CV of storage buffer alone. Bound protein was
eluted with 2.5 CV of storage buffer with 250 mM imidaz-
ole. The eluted protein was incubated with 0.1 equivalents of
TEV protease (stored in 50 mM Tris–HCl pH 8.0, 25 mM
NaCl, 0.5 mM EDTA, 2 mMDDT and 20 % glycerol). The
reaction mixture was dialysed against 2 9 2 L of storage
buffer at 4 °C (12 h then 4 h). The dialysate was passed over
1 CV of pre-equilibrated (storage buffer) Ni-NTA affinity
chromatography resin and then washed with storage buffer.
Fractions containing protein were concentrated and 500 lL
aliquotswere passed over an analytical Superdex S75 10/300
GL column (GE Healthcare) pre-equilibrated with gel fil-
tration buffer (23.5 mM potassium phosphate, pH 6.5,
100 mM KCl, 10 mM MgCl2 and 5 mM b-mercap-
toethanol). The chromatograms were characterized by a
single well resolved peak (data not shown). The protein-
containing fractions were pooled and concentrated. [15N]-
labeled samples were produced with the same protocol using
H2O and unlabeled glucose. NMR data of TRBP(19–228)
were collected in the presence of 5 mM b-mercaptoethanol
or 2–5 mM tris(2-carboxyethyl)phosphine (TCEP)
NMR spectroscopy
Three dimensional (3D) NMR experiments for backbone
assignment were recorded using 90 lL of a 600 lM
M. P. M. H. Benoit, M. J. Plevin
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sample of TRBP(19–228) in a 2.5 mm diameter Shegemi
tube (Shigemi Inc.) placed in a 5 mm diameter standard
tube filled with D2O. 3D BEST TROSY versions of
HNCACB, HNCOCACB and HNCO experiments (Favier
and Brutscher 2011) were performed at 25 °C using a
Varian (Agilent) DirectDrive 600 MHz spectrometer
equipped with a triple resonance cryogenic probe. Het-
eronuclear 1H–15N NOE experiments (Farrow et al. 1994)
were measured on a Varian (Agilent) DirectDrive
600 MHz at 25 °C with a room temperature probe using
300 lL of a 1.4 mM sample of [15N]-labeled
TRBP(19–228) in a 5 mm Shegemi tube (Shigemi Inc.)
with 5 % D2O. All NMR data were processed with
NMRPipe (Delaglio et al. 1995) and analysed using
CCPNMR v 2.1.5 (Vranken et al. 2005). Heteronuclear
NOE values of well-resolved crosspeaks were calculated
as previously described (Farrow et al. 1994).
Resonance assignment and data deposition
It was possible to obtain assignments for 209 out of 210
residues of TRBP(19–228), including 99.5 % of non pro-
line 15N–HN pairs and 13Ca, 13Cb chemical shifts and 91 %
of 13C0 chemical shifts. An example of a (1H,15N) TROSY-
HSQC spectrum of [13C,15N]-labeled TRBP(19–228) with
sequence-specific assignments is given in Fig. 1.
Resonance assignments of TRBP(19–228) have been
deposited in the BioMagResBank (BMRB; http://www.
bmrb.wisc.edu) under the BMRB accession number 18324.
Secondary structure and backbone flexibility
Secondary structure predictions of TRBP(19–228) were
calculated using TALOS? (Shen et al. 2009) and the
results compared with the 3D structures of dsRBD-1 (PDB
Fig. 1 (1H,15N) TROSY-HSQC spectrum of [15N]-labeled TRBP
(19–228). 15N–1HN resonance assignments are indicated. The panel
on the right shows an expansion of the region of the full spectrum
contained in the dashed box. The spectrum was acquired on a Varian
(Agilent) DirectDrive 800 MHz spectrometer at 25 °C in 23.5 mM
phosphate buffer at pH 6.5 with 2 mM TCEP
Table 1 NMR experiments recorded of TRBP(19–228)
Sample Experiment Recycle delay [s] Number of scans tmax(H) [ms] tmax(N) [ms] tmax(carbon)
Protonated BEST-TROSY-HSQC 0.5 120 70 80 na
Deuterated BEST-TROSY-HSQC 1.5 8 70 75 na
Deuterated BEST-TROSY-HN(CO)CACB 1.5 8 64 26 8.3 (CACB)
Deuterated BEST-TROSY-HNCACB 1.5 8 64 24 8.3 (CACB)
Deuterated BEST-TROSY-HNCO 1.5 4 64 26 10 (CO)
Protonated 1H–15N-het-NOE 5 24 70 81 na
tmax maximum acquisition time
Backbone resonance assignments
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code: 3LLH) or dsRBD-2 (2CPN) in Fig. 2. The secondary
structure prediction obtained with data collected from a
construct containing both dsRBDs is in excellent agree-
ment with the previously reported 3D structures of the two
individual domains (Yamashita et al. 2011).
In order to characterize the flexibility of TRBP(19–228),
we measured heteronuclear 1H–15N NOE values, which
provide information about the motions of 1H–15N bond
vectors on the ns-ps time-scale. The high 1H–15N NOE
values in the secondary structure elements of both domains
confirm that the two dsRBDs are folded. The linker con-
necting the two dsRBDs is characterized by negative het-
eronuclear NOE values indicating a high degree of
flexibility. The only positive heteronuclear NOE value in
the linker region concerns a residue preceding two adjacent
prolines, a motif that is known to add local order to
polypeptide chains.
Finally, each domain contains a short stretch of
decreased heteronuclear NOE values that centers on the
conserved histidine of the loop between b-strands 1 and 2
(residues 53–61, dsRBD-1, and residues 183–191, dsRBD-
2). This loop comprises the second of three regions in
dsRBDs that form direct or water-mediated contacts with
dsRNAs (Tian et al. 2004). The enhanced flexibility of this
loop compared to the rest of the domain may indicate a role
in target recognition.
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ABSTRACT
MicroRNAs (miRNAs) are small non-coding RNAs
that regulate gene expression through RNA interfer-
ence. Human miRNAs are generated through a
series of enzymatic processing steps. The precursor
miRNA (pre-miRNA) is recognized and cleaved by a
complex containing Dicer and several non-catalytic
accessory proteins. HIV TAR element binding
protein (TRBP) is a constituent of the Dicer
complex, which augments complex stability and po-
tentially functions in substrate recognition and
product transfer to the RNA-induced silencing
complex. Here we have analysed the interaction
between the RNA-binding region of TRBP and an
oncogenic human miRNA, miR-155, at different
stages in the biogenesis pathway. We show that
the region of TRBP that binds immature miRNAs
comprises two independent double-stranded RNA-
binding domains connected by a 60-residue flexible
linker. No evidence of contact between the two
double-stranded RNA-binding domains was
observed either in the apo- or RNA-bound state.
We establish that the RNA-binding region of TRBP
interacts with both pre-miR-155 and the miR-155/
miR-155* duplex through the same binding
surfaces and with similar affinities, and that two
protein molecules can simultaneously interact with
each immature miRNA. These data suggest that
TRBP could play a role before and after processing
of pre-miRNAs by Dicer.
INTRODUCTION
The majority of human micro-RNAs (miRNAs) are
produced from long RNA transcripts in a two-step
process (1,2). The initial primary miRNA (pri-miRNA)
transcript can be 1-2 kilobases (kb) in length. Within the
pri-miRNA, a short, imperfect stem-loop structure is
recognized and excised by the nuclear ‘Microprocessor’
complex. The product is a 60–70-nucleotide (nt) precursor
miRNA (pre-miRNA), which is exported from the nucleus
by an Exportin-5/Ran-GTP complex. In the cytoplasm,
the pre-miRNA is further processed by the Dicer
complex into a 20–25-base-pair (bp) duplex, which
contains the final miRNA and its reverse complement,
termed miRNA*. The imperfect miRNA/miRNA*
duplex is then transferred to the RNA-induced silencing
complex (RISC), which is the mediator of miRNA-
directed RNA interference in humans.
The multidomain human TAR element binding protein
(TRBP) is a component of the Dicer complex and has
been implicated in the processing of pre-miRNAs (3,4).
TRBP was initially discovered as a protein that associates
with the HIV TAR RNA (5) and was later demonstrated
to interact with and regulate interferon-induced protein
kinase R (PKR), a kinase involved in the cellular
response to viral infection (6,7). In the context of
miRNA biogenesis, TRBP associates with Dicer, the
RNase III enzyme that catalyses the removal of the
apical loop of pre-miRNAs (8) and processes small
interfering RNAs [siRNAs; (9)]. TRBP has been shown
to enhance dicing and augment Dicer stability (3,4,10),
although the molecular mechanisms for these activities
have not been elucidated. Downstream of Dicer, TRBP
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is also a component of the RISC-loading complex (RLC),
the protein assembly responsible for transferring the
miRNA/miRNA* duplex from Dicer to RISC (11,12).
TRBP contains three double-stranded (ds) RNA-binding
domains (dsRBDs), but only the first two dsRBDs interact
with dsRNA. The third dsRBD is believed to mediate
protein/protein interactions and bind to other proteins in
the Dicer complex. The contribution of TBRP to the
function of either the Dicer complex or RLC is not well-
understood. The presence of two types of dsRBD supports
the hypothesis that TRBPmediates both protein/RNA and
protein/protein contacts, although the targets, location
and consequences of these interactions in the context of
the Dicer complex or RLC remain to be elucidated.
Dicer homologues are found in Drosophila melanogaster
and Caenorhabditis elegans, and they associate with
proteins with a similar domain composition to TRBP.
Proteins such as R2D2 (13) and Loquacious (14,15) in D.
melanogaster and RDE-4 (16) in C. elegans all contain two
N-terminal canonical RNA-binding dsRBDs as well as a
non-canonical C-terminal dsRBD, which is implicated in
protein–protein interactions with the respective Dicer
homologue. In plants, Dicer-like 1 (DCL1) is found in
complex with HYPONASTIC LEAVES 1 (HYL1), an ac-
cessory protein, which contains only two dsRBDs (17).
HYL1 interacts with pre-miRNA and miRNA/miRNA*
duplexes primarily through its first dsRBD (18,19).
Human Dicer has also been shown to associate with a
TRBP homologue, Protein Activator of PKR [PACT;
(20,21)]. A complex containing Dicer, TRBP and PACT
can be purified from human cells (21). PACT also contains
three dsRBDs and, like TRBP, is implicated in the regu-
lation of PKR. However, unlike TRBP, PACT activates
PKR (22).
miRNAs regulate gene expression at the post-
transcriptional level (1,2). To date, 1500 human
miRNAs have been documented in the database of
miRNAs, miRbase (23). miRNAs are believed to
regulate the expression of upwards of 30% of human
genes by enabling RISC to recognize complementary se-
quences in target messenger RNAs. Many miRNAs have
oncogene- or tumor-suppressor-like behaviour (24).
Mis-expression or mutation of miRNAs can have consid-
erable cellular consequences (25). For example, miR-155
has been implicated in lung and breast cancer as well as
different leukaemias and lymphomas (24). Mutations in
the proteins involved in the processing or regulation of
miRNA biogenesis have also been linked to different
cancers. For example, certain frame-shift mutations
implicated in colorectal or endometrial cancers result in
truncated forms of TRBP that lack dsRBDs 2 and 3 (26).
Furthermore, TRBP is phosphorylated by the mito-
gen-activated protein kinase Erk (27), and it has been sug-
gested to interact with the anti-cancer drug enoxacin (28).
These recent studies have provided further evidence of the
importance of TBRP in miRNA biogenesis.
Over the past decade, there has been a drive to under-
stand the structural biology of miRNA biogenesis (29,30).
Nuclear magnetic resonance (NMR) spectroscopic and
X-ray crystallographic studies of TRBP have elucidated
the isolated 3D structures of the first two dsRBDs (31)
as well as the second dsRBD in complex with a short
siRNA duplex (18). Negative-stain electron microscopy
studies of miRNA biosynthesis complexes containing
TRBP have also been reported; however, the level of reso-
lution is not yet sufficient to accurately describe the
location of TRBP in these complexes or determine how
it interacts with other components (32,33). Many bio-
chemical studies have sought to explore the mechanism
for RNA recognition by TRBP or examine how TRBP
associates with Dicer (3,4,10–12,34,21). However, despite
these efforts, the exact role of TRBP in immature miRNA
recognition and processing remains unclear.
Here we present an in-depth biophysical analysis of the
complex formed between the RNA-binding region of
TRBP and biosynthetic precursors of the oncogenic
human miRNA miR-155. We establish that the two
dsRBDs that form the RNA-binding region function in-
dependently in apo- and RNA-bound forms. We show
that this region of TRBP interacts with both pre-miR-
155 and miR-155/miR-155* with affinities in the low
micromolar range and that it can form a large complex
in which four dsRBDs interact with a single immature
miRNA molecule. These data, which concern functional
regions of the protein and their interactions with relevant
biological targets, further enhance our understanding of
the role of TRBP in miRNA biogenesis.
MATERIALS AND METHODS
Protein expression and purification
Residues 19–99 (TRBP-D1; monomeric molecular weight:
8.7 kDa), 157–228 (TRBP-D2; 8.2 kDa) or 19–228
(TRBP-D12; 22.6 kDa) of TRBP were sub-cloned into
pLX06 (Protein’eXpert, France) using a codon-optimized
TRBP2 (AAA36765) cDNA template (GeneArt). Each
construct was expressed with an N-terminal 6-histidine
purification tag and a tobacco etch virus cleavage site.
Protein constructs were expressed and purified as previ-
ously described (35).
Large-scale production of pre-miR-155 and
miR-155/miR-155*
Pre-miR-155 (5’-GGAAU GCUAA UCGUG AUAGG
GGUUU UUGCC UCCAA CUGAC UCCUA CA
UAU UAGCA UUCCC A-3’) or miR-155/miR-155*
(miR-155: 5’-GGAAU GCUAA UCGUG AUAGG
CCU-3’; miR-155*: 5’-GGCCU ACAUA UUAGC
AUUCC CA-3’) were produced by in vitro transcription
using in-house produced T7 RNA polymerase and fully
complementary ds DNA oligonucleotides containing a T7
promoter. As each translated RNA sequence was required
to start with a GG dinucleotide, it was necessary to
modify the native RNA sequences. Additional sequence
changes were required to preserve the Watson–Crick
base-pairing. Non-native sequence nucleotides are
underlined in the sequences provided previously.
Template oligonucleotides (Eurogentec) were annealed
by incubation at 95C for 5 minutes. The transcription
reaction was performed in a standard T7 RNA polymer-
ase buffer (40mM Tris-HCl pH 8.1, 1mM spermidine,
2 Nucleic Acids Research, 2013
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5mM dithiothreitol, 0.1 % Triton X-100, 40 mg/ml bovine
serum albumin, 80mg/ml polyethylene 8000, 4mM of
each nucleotide triphosphate, 15-20mM MgCl2, 35 mg/ml
DNA matrix, 0.1mg/ml T7 RNA polymerase and 1U/ml
pyrophosphatase). The reaction mixture was incubated at
37C for 3 hours. RNA products were purified by poly-
acrylamide gel electrophoresis, dialyzed multiple times
against water and lyophilized. The folding of each RNA
was achieved by heating each sample in water at 96C for
5 minutes, followed by rapid cooling induced by the
addition of ice-cold 2 NMR buffer. All RNA samples
were analysed by 1D (1H) NMR spectroscopy.
NMR spectroscopy
(1H,13C,15N) backbone resonance assignments of TRBP
constructs in complex with either pre-miR-155 or
miR-155/miR-155* were obtained using a combination of
3D BEST triple resonance NMR experiments (36) and ti-
tration experiments. (1H,13C,15N) backbone resonance as-
signments of apo-TRBP-D12 were taken from our previous
work [BioMagResBank code: 18324; (35)]. Assignments of
TRBP-D12 in complex with pre-miR-155 were obtained by
analysing 3D (1H,13C,15N) HNCA and HNCO
experiments, which were acquired using a 230mM
[U-2H,13C,15N]-labelled sample of TRBP-D12 and a
3.5-fold excess of unlabelled pre-miR-155. The results of
titration experiments (see later in the text) were also used
to aid assignment of TRBP-D12 in complex with pre-miR-
155 or in complex with miR-155/miR-155*.
Apo- and RNA-bound states of the different TRBP
constructs were analysed using 2D BEST (1H,15N)
TROSY experiments at various protein concentrations
(0.4 to 0.8mM) and RNA/protein ratios. Titration experi-
ments were performed with the following RNA/protein
ratios: (i) TRBP-D12 with 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.75,
1.0, 1.25, 1.5, 1.75, 2.0 and 2.3 molar equivalents of
pre-miR-155 or miR-155/miR-155*; (ii) TRBP-D1 with
0, 0.1, 0.22, 0.29, 0.33, 0.4, 0.5, 0.75, 1.0 and 1.5 molar
equivalents of pre-miR-155; or (iii) TRBP-D2 with 0, 0.1,
0.5, 0.75, 1.0 and 1.5 molar equivalents of pre-miR-155.
The time required to collect individual titration points
depended on the protein concentration and the
signal-to-noise ratio.
All NMR experiments were performed at 25C using a
Varian (Agilent) DirectDrive 800MHz spectrometer
equipped with a triple resonance cryogenic probe. NMR
spectra were processed using NMRpipe (37) and analysed
using CCPNMR Analysis, version 2.1.5 (38). Compound
chemical shift differences, d, between free protein and
RNA-bound protein were calculated using the following
equation: d=[2H+(dN/6.5)
2]½, where dX is the
different in chemical shift between comparable resonances
in different 2D spectra (39).
Multi-angle laser light scattering
Fifty-microlitre samples of TRBP-D1 (1.8mg/ml),
TRBP-D2 (1.7mg/ml), TRBP-D12 (2mg/ml) and
pre-miR-155 (4mg/ml) were loaded onto an analytical
Superdex S200 size exclusion chromatography (SEC)
column (GE Healthcare) pre-equilibrated with NMR
buffer. SEC was performed at 0.5 ml/min with an in-line
multi-angle laser light scattering (MALLS) spectrometer
(DAWN EOS, Wyatt Instruments) with 18 angles
measuring at 690 nm. An in-line refractive index detector
(RI 2000, Spares) was used to follow the differential re-
fractive index relative to the solvent (1.34). Masses were
estimated with the Debye model using ASTRA software
version 5.3.4.20 (Wyatt Instruments) using a theoretical
dn/dc value of 0.185ml/g.
Sedimentation velocity analytical ultracentrifugation
Sedimentation velocity experiments were performed with a
Beckmann Coulter XLI analytical ultracentrifuge at
50 000 rpm (185 000g), 25C with an An-50Ti rotor.
Samples or reference (NMR buffer) were loaded into
sapphire-windowed cells with 12-mm optical paths,
which had previously been treated with RNase ZAP
(Sigma-Aldrich). Acquisition was performed at 260 nm
and 280 nm, and using interference optics. The molar
masses for the polymers were calculated from their com-
position. A partial specific volume ( v) of 0.74 ml/g was
estimated for TRBP-D12 using the software
SEDNTERP version 2 (40). The v used for pre-miR-155
(0.508 ml/g) was taken from a study of a viral RNA in
dilute aqueous KCl solutions (41). The data were analysed
in SEDFIT [Version 12.52; (42)] using the c(s) analysis and
non-interacting species models. The latter was used to
estimate buoyant molar masses, Mb, using the equation,
Mb=M [1ÿ (r v)], where M is the molar mass and
r the solvent density. Hybrid models and multi-
wavelength analysis were performed in the program
SEDPHAT (43). Results in terms of buoyant mass and
multi-wavelength analysis are given for the more
concentrated sample, which yielded higher signal-to-noise
ratios. The mass density (1.005 g/ml) and viscosity (0.898
cP) of the buffer were calculated using SEDNTERP
(v20120328 beta, www.jphilo.mailway.com).
The v for possible protein/RNA complexes was
estimated by summing the individual v values of each com-
ponent weighted by their fractional mass in the complex
(Supplementary Table S1). The sedimentation coefficient,
s, of each complex estimated from the distribution of sedi-
mentation coefficients, c(s), was not affected by the choice
of the three possible values. c(s) profiles reported here
were fitted with a value of 0.64 ml/g. The Svedberg and
Stokes equations were used to analyse the value of the
experimental sedimentation coefficients.
Isothermal titration calorimetry
All isothermal titration calorimetry (ITC) experiments
were conducted using a MicroCal ITC-200 at 25C. ITC
experiments were performed in two ways: either with the
‘ligand’, in this case the protein, in the cell, or with ‘ligand’
in the syringe. Protein concentrations varied between 30
and 60 mM in the sample cell and 250 and 500 mM in the
syringe. RNA concentrations varied between 25 and
40 mM in the sample cell and 150 and 300 mM in the
syringe. The heat evolved after each injection of protein
or RNA was obtained from the integral of the
baseline-corrected calorimetric signal. The equations
Nucleic Acids Research, 2013 3
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used to analyse ITC data of TRBP-D12 were derived from
the classical sequential binding equation using activity
coefficients of 1. Previous assumptions of independency
or co-operativity were not made. The resulting binding
isotherms were fitted to maximize the likelihood of the
data assuming a Gaussian noise distribution. The titration
data were globally fitted for each pair of experiments using
previously described protocols (44). The standard devi-
ation of the estimation of each binding parameter was
determined by computing 100 Monte Carlo simulations
of each experiment performed assuming a Gaussian
noise of 70 nanocals (estimated from our data) followed
by a global fitting of the data. The stoichiometry for each
protein/RNA pair was estimated by comparing the fits of
sequential models for 1:1 and 1:2 protein/RNA complexes
(see Supplementary Material).
RESULTS
Two independent dsRBDs comprise the RNA-binding
region of TRBP
Three constructs derived from the RNA-binding region
of TRBP were produced (Figure 1a) and characterized
by SEC. Analysis of the eluted protein by SEC-MALLS
reported values of 8.5±0.5 kDa, 8.4±0.5 kDa and
23.2±0.9 kDa for TRBP-D1, TRBP-D2 and TRBP-
D12, respectively (Figure 1b). These values correspond
well with the respective monomeric masses of each
protein construct.
Two dimensional (1H,15N) HSQC spectra of each of the
three constructs displayed good 1H resonance dispersion,
which indicated that the dsRBDs adopt folded 3D struc-
tures. The spectrum of the double-domain construct,
TRBP-D12, can be reconstituted by overlaying the
spectra of TRBP-D1 and TRBP-D2 (Supplementary
Figure S1a–d). The additional peaks visible in the
spectrum of TRBP-D12 correspond to residues 96–151,
which are located in the linker region. The (1H,15N) res-
onance frequencies of a given residue in a single-domain
construct compare well with their counterparts in the
double-domain construct, with root mean squared
deviation (RMSD) values of 0.02 and 0.09 ppm for 1H
and 15N frequencies, respectively (Figure 1c). The largest
deviations in compound chemical shift differences between
comparable sites are predictably found at the C-terminus
of TRBP-D1 (Supplementary Figure S1e). These differ-
ences can be easily attributed to the presence of the
inter-domain linker in the double-domain construct. The
similarity in corresponding NMR signals strongly suggests
that the two domains do not interact in the tandem
dsRBD construct. This observation is consistent with pre-
viously reported (1H,15N) heteronuclear NOE data, which
demonstrated the flexibility of the inter-domain linker
(35). Taken together, these data suggest that the
RNA-binding region of TRBP is composed of two inde-
pendent dsRBDs connected by a flexible linker and, there-
fore, that it is similar to the tandem dsRBDs that form the
dsRNA-interacting region of PKR (45).
Both dsRBDs of the RNA-binding region of TRBP
interact with pre-miR-155
Large, site-specific changes in (1H,15N) chemical shifts are
observed when unlabelled pre-miR-155 is added to con-
structs of TRBP (Figure 2a). Backbone resonance assign-
ments were obtained of TRBP-D12 in the presence of an
excess of pre-miR-155. Using these sequence-specific as-
signments, it was possible to evaluate which regions of
each dsRBD were involved in the formation of protein/
RNA complexes. A comparison of the amide chemical
shifts of apo- and RNA-bound TRBP-D12 revealed
large RMSD values between the two data sets (0.11 ppm
for 1H and 0.54 ppm for 15N frequencies; Supplementary
Figure S2). The largest chemical shift changes observed on
complex formation are restricted to amino acids located in
the two dsRBDs. Only negligible chemical shift changes
occur in the linker region (Figure 2a–c). The profiles of
residue-by-residue chemical shift changes of the two
dsRBDs in TRBP-D12 are highly comparable
(Figure 2a–c).
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Figure 1. Analysis of the solution behaviour of dsRBDs from TRBP. (a) Diagram of the three constructs of TRBP used in this study. The same
colour scheme for TRBP-D1 (red) and TRBP-D2 (green) is used throughout; (b) analytical SEC profiles showing elution volume vs. absorbance at
280 nm, A280, for TRBP-D1 (red), TRBP-D2 (green) and TRBP-D12 (black). The molecular weight of each species determined by MALLS is given;
(c) site-by-site comparison of the (1H,15N) chemical shift of a residue in the single domain and the corresponding residue in TRBP-D12. Circles
denote (15N) chemical shifts and squares (1H) chemical shifts. Amide groups from TRBP-D1 are coloured in red and those from TRBP-D2 in green.
The points corresponding to the large outliers are annotated in grey. RMSD values for 1H and 15N chemical shifts are provided.
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Three critical regions in canonical dsRBDs mediate the
interaction with dsRNA (47): region 1, a-helix 1 (a1);
region 2, the loop between strands b2 and b3 (b2/3); and
region 3, the N-terminus of a2 (Figure 2b and c). The
NMR chemical shift perturbation profiles showed that
both TRBP-D1 and TRBP-D2 interact with pre-miR-
155 through the classical dsRBD interaction site.
Residues located in regions 1, 2 and 3 exhibit the largest
changes in chemical shift or disappear entirely from the
spectrum, even after the addition of 2.3-fold excess of
pre-miR-155 (Figure 2). These chemical shift changes are
consistent with previously published structural and bio-
chemical analyses of other dsRBD/dsRNA complexes
(31, 47–50). The 3D structure of TRBP-D2 in complex
with a short siRNA was reported in 2010 (18). The
residue-by-residue changes in solvent accessible surface
area, ASA, that occur on the formation of this
complex highlight the location of the three critical RNA
interaction regions in TRBP-D2 (Figure 2a). The profile
of ASA for the TRBP-D2/siRNA complex and d
observed for dsRBD-2 in the TRBP-D12/pre-miR-155
complex correspond well. These observations suggest
that the interaction between TRBP-D2 and the imperfect
stem-loop of pre-miR-155 in solution is similar to that
reported for a perfect A-form dsRNA duplex and, further-
more, that highly similar protein/RNA contacts are
formed in the context of the tandem dsRBD construct.
Titration of [15N]-labelled TRBP-D1 or TRBP-D2 with
unlabelled pre-miR-155 revealed that both of the isolated
dsRBDs of TRBP can interact with pre-miR-155.
Two-dimensional (1H,15N) HSQC spectra of either
TRBP-D1 or TRBP-D2 showed clear and significant
chemical shift perturbations after the addition of RNA.
NMR data from sub-equimolar titration points were
characterized by severe line-broadening. Many cross-
peaks broaden beyond detection after the addition of 0.1
equivalents of RNA and reappear when the RNA/protein
ratio exceeds 0.3–0.5 (Supplementary Figure S3).
Two-dimensional (1H,15N) HSQC spectra of TRBP-D12
in complex with pre-miR-155 superpose nicely with
spectra of either of the single dsRBDs in complex with
the same RNA (Figure 3a–d). As was the case for the
apo-protein (Supplementary Figure S1), the spectrum of
the double-domain construct in complex with pre-miR-
155 is essentially a superposition of the spectra of the in-
dividual dsRBDs in complex with the same RNA
(Figure 3a–d). Site-by-site differences in (1H,15N) reson-
ance frequencies between single-domain and double-
domain data sets are very small, with RMSD values of
0.02 and 0.11 ppm for 1H and 15N frequencies, respectively
(Figure 3e). That is, a cross-peak for an amide group in
the TRBP-D1/pre-miR-155 complex, for example, has
almost exactly the same (1H,15N) resonance frequencies,
and therefore experiences a near-identical local chemical
environment, as the comparable amide group in the
tandem domain/pre-miR-155 complex. This similarity of
resonance frequencies between single- and double-domain
constructs suggests that each dsRBD forms essentially the
same interaction regardless of whether it is a component
of the tandem domain construct. If the interaction with
pre-miR-155 led to (or resulted from) the formation of
contacts between the two dsRBDs, this would result in
chemical shift differences between NMR spectra of the
single- and double-domain constructs. However, the
small RMSD between these data sets suggests that each
dsRBD in TRBP-D12 interacts independently with
pre-miR-155.
The RNA-binding region of TRBP can form a 2:1
complex with pre-miR-155
ITC experiments were conducted to further characterize
the complex formed between the dsRBDs of the RNA-
binding region of TRBP and pre-miR-155. The resulting
binding isotherms were globally fitted and best described
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Figure 2. NMR analysis of the interaction between TRBP-D12 and pre-miR-155. (a) Compound chemical shift values (d) measured when
TRBP-D12 interacts with pre-miR-155 plotted as a function of residue number (black). d=[2H+(dN/6.5)
2]½, where dX is the difference in
chemical shift between apo- and RNA-bound spectra (39). Prolines and unassigned residues have been given values of ÿ0.05 and ÿ0.1 ppm,
respectively. For comparison, the change in accessible surface area (ASA) when TRBP-D2 forms a complex with dsRNA is shown (green).
ASA were calculated using the POPS* server (46) from 3ADL (18). The boundaries of secondary structure elements were taken from the 3D
structures of TRBP-D1 [3LLH; (31)] and TRBP-D2 [3ADL; (18)]; (b,c) TOP: cartoon representation of the 3D structures of TRBP-D1 and
TRBP-D2 showing the three regions in canonical dsRBDs that are implicated in dsRNA binding; (b,c) BOTTOM: d values plotted on the
respective 3D structures. Each amide nitrogen is represented by a sphere and coloured according to the d scale provided. The b2/3 loop was
not resolved in the 3D structure of TRBP-D1 and is shown by a broken line.
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by a two-site sequential binding model in which the first
molecule of TRBP-D12 binds pre-miR-155 approximately
10 times more strongly than the second molecule
(Kd,1=0.5±0.03 mM; Kd,2=6.2±0.2mM; Figure 4a
and Supplementary Table S2). The difference in affinity
measured for the two molecules of TRBP-D12 is most
likely due to a decrease in the number of sites available
for the second binding event with respect to the first. The
interaction between TRBP-D12 and pre-miR-155 exhibits
an exothermic character, which suggests that polar inter-
actions are the primary driving force of the binding event
and which is consistent with the electrostatic nature of
interactions between dsRNAs and dsRBDs (47).
A comparison between the binding modes of single- and
double-domain constructs was also performed. ITC data
obtained from the titration of TRBP-D1, TRBP-D2 or
TRBP-D12 with pre-miR-155 were analysed using the
standard single-site model. The resulting macroscopic dis-
sociation constant, within the context of a identical
independent sites model for the complex formed between
TRBP-D12 and pre-miR-155, is 3.4±0.8 mM
(Supplementary Figure S4b and c and Supplementary
Table S2). ITC analyses of the interactions between
single-domain constructs and pre-miR-155 revealed that
both single-domain constructs, TRBP-D1 and TRBP-D2,
interact with pre-miR-155 to form 4:1 complexes
(Supplementary Figure S4b and c and Supplementary
Table S2). All macroscopic binding constants measured
were in the mid-to-low micromolar range, consistent with
results of TRBP-D12. TRBP-D2 (Kd=3.7±0.5mM)
interacts 4 times more strongly than TRBP-D1 (15.4±
0.8mM). Like TRBP-D12, both TRBP-D1 and TRBP-D2
exhibit an exothermic binding enthalpy, again suggesting
that polar interactions mediate binding. Furthermore, the
macroscopic binding enthalpy obtained for TRBP-D12 is
approximately equal to the sum of that of TRBP-D1 and
TRBP-D2, which indicates that the polar interactions
formed by each single domain and pre-miR-155 are
unaffected in the context of the full-length protein. Thus,
these ITC data support the conclusions derived fromNMR
analysis that each dsRBD interacts independently with
pre-miR-155.
The formation of a complex between TRBP-D12 and
pre-miR-155 in solution was evaluated by sedimentation
velocity analytical ultracentrifugation (svAUC). A series
of samples were prepared to characterize the behaviour of
the free protein, free RNA and the protein/RNA complex
under different conditions. SEC-MALLS (Figure 1b)
strongly suggests that TRBP-D12 is monomeric in
solution. This observation was supported by svAUC data
at 10 and 20 mM, which revealed an experimental sedimen-
tation coefficient, sexp, of 2.19 S andwhich was independent
of the protein concentration used (Figure 4b). A frictional
ratio of 1.43 for TRBP-D12 was calculated by combining
sexp and the molecular mass (22.3 kDa) of the monomeric
protein. This value is in excellent agreement with one pre-
viously reported for a protein composed of two dsRBDs
connected by a flexible linker (51). When a single sediment-
ing species is considered, a molar mass of 22.4 kDa is
calculated from the sedimentation profile of TRBP-D12,
without assumptions about the shape of the sedimenting
species, which is in excellent agreement with the expected
molecular mass. Similar svAUC experiments indicated that
pre-miR-155 is largely monomeric in solution at sample
concentrations of 1 and 2 mM. A sexp of 4.4 S is obtained
for pre-miR-155 at both 1 mM and 2 mM, which corres-
ponds to a frictional ratio of 1.35. Non-interacting
species analysis gives a molecular mass of 18.5 kDa,
which is again close to the theoretical value of 19.4 kDa.
An additional minor contribution at 7.2 S (6% of the main
peak) was also detected. This peak is likely to result from a
small fraction of dimerized pre-miR-155. This species was
also observed by SEC-MALLS (data not shown).
SvAUC analysis of the TRBP-D12/pre-miR-155
complex was performed using three samples, each with a
different excess of protein. In the resulting sedimentation
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Figure 3. Comparison of NMR data collected of single- and double-domain constructs in complex with pre-miR-155. Two dimensional (1H,15N)
spectra of (a) TRBP-D1/pre-miR-155 in red, (b) TRBP-D2/pre-miR-155 in green, and (c) TRBP-D12/pre-miR-155 in black. A coloured graphical
representation of each construct is provided above the spectrum. (d) Superposition of the spectra shown in (a-c) retaining the same colour scheme
and construct graphics. (e) Comparison of the (1H,15N) resonance frequencies of a residue in the single domain and the corresponding residue in
TRBP-D12. Circles denote (15N) chemical shifts and squares (1H) chemical shifts. Amide groups from TRBP-D1 are coloured in red and those from
TRBP-D2 in green. The points corresponding to the large outliers are annotated. RMSD values for 1H and 15N chemical shifts are provided.
6 Nucleic Acids Research, 2013
 b
y
 g
u
est o
n
 M
ay
 1
5
, 2
0
1
3
h
ttp
://n
ar.o
x
fo
rd
jo
u
rn
als.o
rg
/
D
o
w
n
lo
ad
ed
 fro
m
 
profiles, the RNA contribution at 4.4 S has disappeared
and a new faster contribution is visible, which sediments at
5.9 S (Figure 4c). The composition of the 5.9 S peak was
estimated using the data obtained from the three different
optical signals. The ratios of these signals as well as
theoretical values calculated for TRBP-D12/pre-miR-155
complexes with different stoichiometries are given in
Supplementary Table S1. The experimental ratios
measured in the c(s) analysis for the fast boundary
(Supplementary Table S1) reflect an enrichment of
protein in the complex and strongly suggest that a
protein/RNA complex with a stoichiometry of 2:1 can
be formed in solution.
The combination of ITC and AUC analyses demon-
strates that two molecules of TRBP-D12 can interact
with a single molecule of pre-miR-155. These data are
consistent with ITC analysis of the two single-domain
constructs, which demonstrated that four molecules of
either TRBP-D1 or TRBP-D2 can interact with a single
pre-miR-155. It is therefore likely that pre-miR-155 has a
minimum of four dsRBD-binding sites.
The RNA-binding region of TRBP interacts with the
substrates and products of Dicer
Dicer excises the apical loop of pre-miR-155 (nucleotides
24–39) to generate a largely double-stranded molecule
containing the 23-nucleotide miR-155 and its complement,
miR-155* (Supplementary Figure S3a). ITC experiments
were conducted to characterize the interaction between
miR-155/miR-155* and the RNA-binding region of
TRBP (Figure 5a). These data revealed many similarities
to those measured for the interaction between TRBP-D12
and pre-miR-155. The interaction between TRBP-D12
and miR-155/miR-155* was also exothermic in character
(Figure 4a). In addition, the binding isotherms were also
optimally described by a two-step sequential binding
model (Kd,1=1.0±0.7 mM; Kd,2=5.7±0.3 mM;
Supplementary Table S2). Finally, as was seen for the
TRBP-D12/pre-miR-155 complex, the first molecule of
TRBP-D12 binds miR-155/miR-155* more strongly than
the second molecule. The difference in dissociation con-
stants is again likely due to the reduced probability of the
second molecule of TBRP-D12 binding.
NMR spectroscopy was used to assess which regions of
TRBP-D12 interact with the miR-155/miR-155* duplex.
Large chemical shift changes are observed in 2D (1H,15N)
HSQC spectra of [15N]-labelled TRBP-D12 on the
addition of unlabelled miR-155/miR-155* (Figure 5b
and Supplementary Figure S5b and c). Comparison of
the spectra of the two TRBP-D12/RNA complexes
shows little difference between the magnitude or
sequence location of chemical shift perturbations. The
changes in chemical shift for TRBP-D12 on binding
miR-155/miR-155* are largest in the three RNA inter-
action regions of each dsRBD (Supplementary Figure
S3b). Again, residues in the linker are barely perturbed.
NMR spectra of TRBP-D12 in complex with either
pre-miR-155 or miR-155/miR-155* are nearly identical
(Figure 5b and Supplementary Figure S5b and c).
Site-by-site differences in (1H,15N) resonance frequencies
between single-domain and double-domain data sets are
very small, with RMSD values of 0.02 and 0.11 ppm for
1H and 15N frequencies, respectively (Supplementary
Figure S5c). These data suggest that the complexes
pre-miR-155
(µM)
0
2
pre-miR-155
(µM)
0.5
1.0
2.0
TRBP-D12
(µM)
10
0
TRBP-D12
(µM)
10
10
10
(a)
0 40 80
0.0
-0.5
-1.0
-10
0
-20
0.0 2.0 4.0
Molar Ratio ([protein]/[RNA])
Time (minutes)
µc
al
/s
1 2
kc
al
/m
ol
 in
jec
tan
t
Kd,1: 0.5 ± 0.3 µM
Kd,2: 6.2 ± 0.2 µM
(b)
(c)
0.0
1.0
0.5
A 2
80
(s)
0.0
1.0
0.5
A 2
80
(s)
sexp
0.0 2.0 4.0 8.0 10.06.0
Figure 4. Characterization of the interaction between TRBP-D12 and pre-miR-155. (a) An example of ITC data recorded of the titration of
pre-miR-155 with TRBP-D12. The top panel shows power vs. time together with a schematic of the components of the sample. The bottom
panel shows the integrated injection enthalpy per mole of injectant plotted as a function of the ratio of protein and RNA concentrations. The
data were fitted to a two-site sequential binding model shown by a solid black line. The two dissociation constants are given. The thermodynamic
parameters calculated are provided in Supplementary Table S2. (b) Comparison of c(s) distributions of TRBP-D12 (grey) and pre-miR-155 (purple);
(c) c(s) distributions of a sample prepared with 10 mM TRBP-D12 and different concentrations of pre-miR-155. The protein and/or RNA concen-
tration corresponding to each curve is provided.
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formed between TRBP-D12 and either pre-miR-155 or
miR-155/miR-155* are highly similar.
ITC and NMR data demonstrate that TRBP-D12 inter-
acts with two different precursors of miR-155. These data
support the formation of two highly similar complexes,
which are dependent on the same protein/RNA inter-
action surfaces. These data also suggest that the apical
loop of pre-miR-155 is neither directly recognized by
TRBP nor is it required for the interaction. The similarity
in the measured affinities also suggests that the RNA-
binding region of TRBP alone cannot differentiate
between the two precursor molecules.
DISCUSSION
dsRBDs often appear in modular RNA-binding proteins,
either in multiple copies or in combination with other
functional domains such as RNase III, RNA helicases
and PAZ domains (47). Structural studies of modular
proteins containing single or multiple copies of dsRBDs
have frequently revealed that these domains do not
interact with other structured regions in the same
protein. An NMR spectroscopic study of the dsRNA-
binding region of PKR revealed no interaction between
the two dsRBDs (52). Likewise, the two dsRBDs of
ADAR2 (50) and HYL1 (19) were also shown to behave
independently. In PKR, ADAR2 and HYL1, a long, un-
structured linker connects the two dsRBDs. We have
shown here that the first two dsRBDs of TRBP are also
independent. Solution NMR analysis of different con-
structs of the RNA-binding region of TRBP revealed no
contact between the two dsRBDs (Figure 1c and
Supplementary Figure S1), while SEC-MALLS indicated
that each isolated dsRBD is monomeric in solution.
NMR (Figure 3) and ITC analysis (Supplementary
Figure S4) of TRBP-D1 and TRBP-D2 revealed that
each isolated domain interacts with pre-miR-155, which
is consistent with previous conclusions that these
two dsRBDs constitute the main interaction site for
immature miRNAs in TRBP (18,31). However, little bio-
physical or structural analysis of how multiple-domain
constructs of TRBP interact with immature miRNAs
has been previously reported. The NMR analysis of the
interaction between TRBP-D12 and pre-miR-155 pre-
sented here reveals several interesting features: first, com-
parison of NMR spectra of single- and double-domain
constructs in complex with pre-miR-155 shows no
evidence of an interaction between the two dsRBDs
(Figure 3). NMR spectra of each complex studied
revealed no examples of peak doubling that would typic-
ally indicate the formation of multiple different protein/
RNA or protein/protein interfaces. Furthermore, the very
small perturbations of the (1H,15N) chemical shifts of the
inter-domain linker indicate that this region does not
interact with pre-miR-155 nor does RNA binding induce
contacts with either dsRBD. The elevated signal intensity
of residues in the linker with respect to the two dsRBDs is
consistent with this region remaining flexible in the
TRBP-D12/pre-miR-155 complex. Taken together, these
data strongly suggest that each dsRBD interacts with
pre-miR-155 independently. This mode of interaction is
similar to that used by ADAR2. A recently elucidated
3D structure of the complex formed by ADAR2 and a
71-nt stem-loop RNA revealed that the two dsRBDs
(a) (b)
Figure 5. Interaction of the RNA-binding region of TRBP with the substrate and product of Dicer. (a) An example of an ITC analysis of the
titration of miR-155/miR-155* with TRBP-D12 showing power vs. time data (top, with a schematic of the components of the sample) and the
integrated injection enthalpy per mole of injectant plotted as a function of the protein/RNA ratio (bottom). The data were fitted to a two-step
sequential binding model shown by a solid black line. The two dissociation constants and their standard deviations are given. The complete
thermodynamic parameters derived are provided in Supplementary Table S2. (b) Comparison of the changes in (1H,15N) NMR spectra of
TRBP-D12 resulting from the addition of either pre-miR-155 (left) or miR-155/miR-155* (right). The nucleotide sequence and predicted secondary
structure of each RNA are provided. (1H,15N) assignments of cross-peaks in each spectrum are annotated and coloured according to the dsRBD in
which they reside (red, dsRBD-1; green, dsRBD-2).
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bind to distinct regions of the ds stem without any
inter-domain contact or contribution from the
inter-domain linker (50,53).
dsRBDs in multiple arrays do not always interact with
dsRNA independently. An interesting example that
contrasts TRBP is DGCR8, a component of the
Microprocessor complex, which performs the first process-
ing step in miRNA biogenesis. The two dsRBDs of
DGCR8 interact with each other through a large interface,
which fixes their relative orientation and has important
implications for pri-miRNA recognition. DGCR8 inter-
acts with pri-miRNAs in preference to pre-miRNAs
(54,55), whereas our data show that TRBP can interact
with both pre-miRNAs and miRNA/miRNA* duplexes
with similar affinities. These different patterns of RNA
selectivity displayed by DGCR8 and TRBP could result
from the contrasting ways in which the tandem dsRBDs
interact with immature miRNAs. The compact structure
formed by the DGCR8 core means that the two dsRBDs
are not independent and that a pri-miRNA must bend to
interact with both RNA-binding surfaces (56). A sufficient
conformational change may not be feasible for the shorter
pre-miRNA, leading to the preference for pri-miRNAs.
Conversely, given that TRBP has been implicated in
both the Dicer cleavage reaction and the transfer of the
miRNA/miRNA* duplex to RISC, the independence of
its two dsRBDs demonstrated here may reflect a broader
range of binding targets. Taken together, these results
suggest that there are considerable differences in how
RNA is recognized by the different accessory proteins
involved in the two miRNA biogenesis steps.
A second important feature of the TRBP-D12/pre-miR-
155 complex is the stoichiometry. Both ITC (Figure 4a
and Supplementary Figure S4) and svAUC (Figure 4b)
experiments indicate that a complex containing four
dsRBDs can be formed; that is, a single pre-miR-155 inter-
acts with four single dsRBD constructs or two double-
domain constructs. ITC data of the interactions between
TRBP-D12 and pre-miR-155, and between TRBP-D12
and miR155/miR155*, revealed no evidence of positive
co-operativity. This result is consistent with earlier
studies (34).
The data presented here indicate that one pre-miR-155
can associate with four dsRBDs to form a complex in
which the dsRBDs interact with similar sites on the
RNA but do not form inter-domain contacts. Is there suf-
ficient space on pre-miR-155 to permit this? The theoret-
ical secondary structure of pre-miR-155 is typical of
pre-miRNAs and comprises an imperfect ds stem contain-
ing two GU base-pairs, two unpaired nucleotides and a
four-base apical loop (Figure 5b). The majority of
pre-miRNAs in the miRbase (23) are predicted to adopt
3D structures similar to A-form dsRNA (57). Three-
dimensional structures of large stem-loop RNAs have
revealed that features such as non-Watson–Crick base-
pairs or nucleotide bulges often cause minimal perturb-
ation to the overall ds character (53,58). Canonical
dsRBDs typically interact with a 12–16-bp region of
dsRNA (47). However, the RNA-binding region of
PKR, which also contains two dsRBDs, can interact
with 20–40-bp RNA duplexes with stoichiometries that
are incompatible with a simple 1D lattice model and
which would require binding to multiple surfaces of the
dsRNA with a binding site overlap of 4 bp (51). Several
3D structures of protein/dsRNA complexes have also
demonstrated that multiple dsRBDs can bind in proximity
without forming inter-dsRBD interactions (53,59).
A structural model of the interaction between pre-miR-
155 and dsRBDs was generated to evaluate the feasibility
of a protein/RNA complex containing the four dsRBDs
per pre-miR-155 suggested by ITC and AUC analysis
(Supplementary Figure S6). The model demonstrates
that it is theoretically possible to arrange four non-
contacting dsRBDs on a single molecule of pre-miR-155.
The dsRBDs tessellate optimally when they interact with
the RNA in alternating directions. The inter-dsRBD
linker in TRBP is more than 60 residues and therefore
places little limitation on the respective orientation of
the two dsRBDs in the TRBP-D12 construct. In
addition, NMR data suggest that the linker remains
flexible in both of the TRBP-D12/RNA complexes
analysed here. The arrangement shown in Supplementary
Figure S6 is also compatible with NMR and ITC data of
the interaction between TRBP-D12 and the Dicer product
miR-155/miR-155*, as none of the four proposed dsRBD-
binding sites in the model involve nucleotides from the
excised apical loop.
The functional stoichiometry of the Dicer/TRBP
complex has not been determined (32). However, the
report that a tertiary complex containing Dicer, TRBP
and PACT can be formed implies that two TRBP-like
proteins can interact simultaneously with Dicer in the
presence of pre-miRNAs (21). In addition, the plant
DCL1 accessory protein HYL1 has been shown to form
2:1 protein/RNA complexes with dsRNA sequences of
suitable length (18). Thus, high occupancy of dsRBDs on
a relatively short sequence of dsRNA, as seen here with
TRBP and two different precursors of miR-155, is poten-
tially functionally relevant. Whether the 2:1 ratio observed
here is a standard feature of the complexes formed between
TRBP and immature miRNAs or whether the stoichiom-
etry is determined by features in the target immature
miRNA, such as the length or percentage of canonical
dsRNA, remains to be determined.
Much of the information concerning the role of TRBP
in small regulatory RNA synthesis has been obtained from
studies into siRNAs. The data presented here represent
the first in-depth biophysical analysis of the interaction
between TRBP and immature miRNAs that have an im-
perfect dsRNA stem. Analysis of ITC data yielded macro-
scopic dissociation constants for the TRBP/pre-miR-155
complex in the low mM range, which is also consistent with
other investigations of dsRBD/dsRNA interactions
(18,19,56,60,61). The affinities measured for the isolated
dsRBDs of TRBP indicate that TRBP-D2 interacts with
pre-miR-155 approximately 4 times more strongly than
TRBP-D1. This observation is consistent with earlier
interaction studies of TRBP and siRNAs (31).
Differences between the binding affinities of dsRBDs in
tandem or multi-dsRBD proteins are relatively common—
e.g. HYL1 (18,19) or PKR (45)—and may play a role in
target selection by fine-tuning the overall affinity of a
Nucleic Acids Research, 2013 9
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protein for dsRNA molecules that possess many potential
dsRBD-binding sites.
In addition to its function in the Dicer complex, TRBP
is a component of the RLC (4,11,12). The precise role of
TRBP in the formation and/or activity of RISC is less
clear. We have shown here that the RNA-binding region
of TRBP interacts with both pre-miR-155 and miR-155/
miR-155*—i.e. both the substrate and product of Dicer—
with a comparable affinity (Figure 5a). Furthermore,
NMR spectra of TRBP-D12 in complex with either
pre-miR-155 or miR-155/miR-155* are highly similar
(Figure 5b), which indicates that TRBP interacts with
pre-miR-155 and miR-155/miR-155* through essentially
identical sites. These results suggest that TRBP could par-
ticipate in the recognition of Dicer substrates as well as the
transfer of the cleavage product to RISC through the
RLC.
CONCLUSIONS
Despite several structural studies, many of the mechanistic
details that underpin human miRNA biogenesis remain
unclear. One area in which the link between 3D structure
and function remains particularly obscure concerns the
role of the non-catalytic proteins of that associate with
Drosha or Dicer. We have demonstrated here that the
region of TRBP responsible for interacting with
immature miRNAs is composed of two dsRBDs that rec-
ognize RNA independently. The linker connecting the two
dsRBDs in the RNA-binding region of TRBP remains
flexible and does not interact with the bound RNA.
Therefore, the formation of a complex between TRBP
and immature miRNAs is unlikely to require bending of
the ds stem of the RNA, as has been reported for DGCR8.
Finally, the observation that RNA-binding region of
TRBP can interact with both the substrates and
products of Dicer suggests that TRBP may function at
several stages in the miRNA biogenesis pathway.
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20.4 Expressions of total concentration in ITC titrations
This part explicit the calculation of the total concentration in the cell during an ITC experi-
ment. The following notation are used here for the demonstration of the different concentration
expressions found in the literature
Total concentration of macromolecules under the continuous mixing hypothesis By conser-
vation of the mass during the injection i in the control volume we have :
∆ntitrant = ntitrant coming − ntitrant leaving (20.1)
so, using the concentrations :
(c + dc)V − cV = c0dv− cd (20.2)
which leads to a linear differential equation of the first degree :
dc
dv
+
1
V
c−
1
V
c0 = 0 (20.3)
So, for any injection i :
Ctitrant(i) = Ctitrant in syringe
(
1− exp
(
−
v(i)
V
))
(20.4)
Similarly, the related expression for the analyte is :
Canalyte(i) = Canalyte in cell
(
exp
(
−
v(i)
V
))
(20.5)
Total concentration of macromolecules under the no mixing hypothesis It is considered here
that at injection i the expelled volume is only composed by the solution present in the cell before
this injection. For an injected volume vi during the titration i satisfying vi ≪ V, using the same
notation as the previous paragraph, we have
∆ntitrant = ntitrant coming − ntitrant leaving (20.6)
so, using the concentrations :
ci+1V − ciV = c0V − civi (20.7)
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Table 20.1: Notations
Notation Definition
I number of injections
i injection number in J1, IK
v(i) the injection volume of the injection i
dv an elementary injection volume of titrant
c the concentration of titrant in the cell before injection
ntitrant the molar amount of titrant in the control volume
V volume of the control volume V = Vcell −Vpaddle
which can be written as a recurrent relation :
ci+1
ci
=
(
1−
vi
V
)
(20.8)
and by recurrence :
Ctitrant(i) = Ctitrant in syringe
(
1−
(
1−
v(i)
V
)i)
(20.9)
Similarly, the related expression for the analyte is :
Canalyte(i) = Canalyte in cell
(
1−
v(i)
V
)i
(20.10)
Another approach MicroCal uses another approach, based on an estimation on the concentra-
tion of the expelled volume as the mean of the concentration of the cell before the first injection
and after the injection :
ci = c0V +
1
2
(ci + c0)vi (20.11)
so :
Canalyte(i) = C0
(
1− v(i)2V
1 + v(i)2V
)
(20.12)
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Re´sume´ en franc¸ais Les microARNs (miARNs) sont une classe de petits ARNs
qui re´gulent l’expression des ge`nes. Lors de la biogene`se des miARNs humains, le
pre´curseur de miARN est reconnu et clive´ par le complexe Dicer/TRBP. La the`se
caracte´rise en solution la re´gion d’interaction de TRBP avec les ARNs a` l’e´tat libre
et a` l’e´tat lie´ par le pre´curseur du miARN oncoge`ne miR-155 et par son produit
apre`s clivage par Dicer/TRBP. Une combinaison de me´thodes biophysiques (RMN,
ITC, AUC, SEC, MALLS) a e´te´ utilise´e pour e´tablir les proprie´te´s des interactions.
Les analyses montrent notamment que la re´gion d’interaction de TRBP avec les
ARNs est compose´e, a` l’e´tat libre ou a` l’e´tat lie´, de deux domaines de liaison aux
ARN doubles brins de conformations inde´pendantes en solution et dont l’un est le
sie`ge d’un e´change plie´/de´plie´ inte´gral. La similarite´ des stœchiome´tries, affinite´s
et surfaces d’interactions entre TRBP et les miARNs immatures avant et apre`s leur
clivage par Dicer sugge`re de nouveaux roˆles pour TRBP
Re´sume´ en anglais MicroRNA (miRNAs) are a class of small RNAs that regulate
gene expression. During the biogenesis of human miRNAs, a precursor of miRNA
is recognized and cleaved by the complex Dicer/TRBP. The thesis characterizes in
solution the interaction region of TRBP with ARNs in the free and bound state
by the precursor of the oncogenic microRNA 155 and by its product after cleav-
age by Dicer/TRBP. A combination of biophysical methods (NMR, ITC, AUC, SEC,
MALLS) were used to establish the interaction properties. The analyses show that
the RNA binding region of TRBP is composed, in the free and bound state, of two
double stranded RNA binding domains of independent conformations in solution,
one of them undergoing a full folded/unfolded exchange. The similarity of the
stoichiometries, affinities and interaction surfaces between TRBP and miRNA pre-
cursors before and after their clivage by Dicer suggests new roles for TRBP.
